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la psychiatric illnesses, particularly in the affective
disorders, and to a lesser extent in the schizophrenias,
there are marked deviations from normal behaviour which
have components which may be described, in psychological
terms as aberrant, stereotyped, activity and as abnormalities
in locomotor and exploratory drives.
A hypothesis that a disturbance in one or more of the
dopaminergic, noradrenergic or serotonergic neuronal systems
in the brain may play a role in psychiatric illness has
engendered much research into the functional roles of these
systems in animals and man. The published work has been
reviewed particularly that in relation to the behavioural
abnormalities which may be induced in lower animals such
as the rat and which appear to mimic to some degree the
abnormalities in behaviours seen in psychiatric illness
in man.
The experimental work presented in this thesis is a
further contribution to this investigation using an animal
model. Previous reports in the literature had, when
considered together, indicated that in animals dopaminergic
systems played a major role in the mediation of all three
types of behaviour monitored - exploratory, locomotor and
stereotyped behaviour, with lesser roles being assigned to
noradrenergic and serotonergic systems. Individually, the
previous studies tended to depend on visual observation of
one, or at most two, of these aspects of behaviour, with
exploratory behaviour receiving much less attention than
stereotyped or locomotor behaviour.
11.
This thesis reports the use of a specially designed
automated "hole-board" apparatus for the automated recording
of exploratory, locomotor and stereotyped behaviour in
rata. The automated recordings were backed up by visual
observation of behaviour through closed-circuit television
monitoring.
The behavioural responses to a variety of drugs with
varying degrees of selectivity on individual monoamine
systems were studied. Amphetamine, which releases all
three monoamines from neuronal terminals, at low doses
(2 and 4 mg/kg of the DL-aulphate i.p.) led to a stimulation
of exploratory and locomotor behaviour as well as sniffing
and rearing while a larger dose (8 mg/kg) induced intense
stereotyped activity. Haloperidol, a selective dopamine
receptor antagonist, virtually abolished both spontaneous
and amphetamine-stimulated exploratory, locomotor and
stereotyped behaviour in a dose-related manner. Repeated
weekly administration of amphetamine led to a potentiation
of the response to the drug* Paradoxically, chronic fcalo-
peridol pretreatment also led to a potentiation of the
response to amphetamine. Phenoxybonzamine (20 mg/kg of
the hydrochloride i.p.),an Ji adrenoceptor bloeker reduced
amphetamine-induced exploratory and locomotor behaviour
but not stereotypy. Methysergide, a 5-IIT receptor blocker,
led to a moderate potentiation of the stimulation of all




The "tricyclic" antidepressant drugs desmethylimipramine
and ohlorimipramine caused a reduction in spontaneous
activity which was more marked with the former drug. G3A. 654»
a selective inhibitor of neuronal 5-HT uptake, induced a
moderate stimulation of locomotor and hole-dipping behaviour
not statistically significant.
These three drugs, as well as SKF-525A, an inhibitor
of the hepatic microsomal enzyme systems, all potentiated
the behavioural response to amphetamine; this potentiation
was in the same rank order as their ability to elevate
plasma and brain amphetamine levels.
LRCL 5182, a selective inhibitor of neuronal dopamine
uptake, and benztropine, an inhibitor of neuronal dopamine
uptake which also has potent anticholinergic activity, both
induced a marked stimulation of exploratory* locomotor and
stereotyped behaviour.
Selective bilateral destruction of dopaminergic neuronal
terminals in the accumbens nuclei with 6-hydroxydopamine
reduced spontaneous and amphetamine-induced locomotor and
exploratory behaviour and sniffing activity; amphetamine-
induced stereotyped behaviour appeared to be potentiated.
Similarly induced bilateral destruction of dopaminergic
nerve endings in the caudate-putamen reduced spontaneous
activity; amphetamine-induced stereotyped behaviour was
abolished. Some animals with severe degrees of neostriatal
dopamine depletion were completely unresponsive to amphetamine,
apart from intense sniffing activity. Bilateral electrolytic
lesions of the accumbens nuclei did not lead to any change
in spontaneous or amphetamine-induced activity.
iv.
Bilateral stereotactically-controlled injections of
dopamine (5-50 jig of the hydrochloride salt) into the
nucleus accumbens of nialamide-pretreated rats induced a
marked stimulation of exploratory and locomotor activity,
accompanied by intense sniffing and rearing# Conversely,
bilateral injection of dopamine (12.5 - 50 Jig of the hydro¬
chloride salt) into the caudate-putamen induced intense
stereotyped activity which was dose-related. Both
responses were blocked by i.p. haloperidol.
Bilateral injection of noradrenaline (50 jig of the
hydrochloride salt) into the accumbens nuclei did not produce
any significant behavioural change. The same injection
intothe caudate-putamen led to a moderate stimulation of
stereotyped activity.
Bilateral injection of 5-HT (50 ug of the bimaleinat©
salt) into the accumbens nuclei induced a moderate loco¬
motor activity with some hole-dipping activity and sniffing;
these behaviours were incoordinated and indecisive. The
same injection into the caudate-putamen led to a stimulation
of locomotor activity and hole-dipping which was pre¬
dominantly "stereotyped" in character; on visual observation
no other striking abnormalities were noted.
The experimental results have been critically discussed.
It was concluded that dopaminergic inputs into the accumbens
nuclei exerted a major mediatory influence on exploratory
and locomotor behaviours while dopaminergic inputs into
the caudate-putamen were responsible for the mediation of
stereotyped activities.
The implications of these findings with respect to
the behavioural changes in psychotic illness were discussed.
On the basis of comparisons between the changes in psychotio
illness and the changes in behaviour induced by stereotactic
manipulations of the accumbens nuclei and caudate-putamen»
it was proposed that dopaminergic influences in the accumbens
nuclei probably play a major role in the affective dis¬
orders, with probable additional involvement of the caudate-
putamen in severe illness. Two animal models of mania
were proposed based on the stimulation of exploratory,
locomotor and stereotyped behaviour in animals by amphetamine
and the stimulation of locomotor and exploratory activity
by application of dopamine into the accumbens nuclei.
There were less clear-cut resemblances between the
effects of manipulation of the three monoamine systems on
behaviour in animals and the behavioural changes seen in
the schizophrenias. It was suggested that serotonergic
influences may be involved in the behavioural changes seen
in schizophrenia.
vi.
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Behavioural results are represented by two different
types of graph. The first consists of graphs of activity
(ordinate) versus time (abscissa). In these graphs each
point represents mean activity (" exploratory" dips,
"stereotyped" dips or locomotor counts - see page 61) of
a number of rats - Standard Error of the Mean during
successive intervals of 10 or 30 min.
The second type of graph is in histogram form. In
these figures, each column represents mean activity during
the entire observation period of a number of rats and the
bar above or below it the standard error of the mean. The
column for "stereotyped" dipping is situated directly below
that for "exploratory4' dipping and is plotted in the
opposite direction i.e. downwards. The total dipping
activity is thus seen as an addition of the two columns
and an idea of the S/T ratio (page 61) can also be easily
deduced.
NOTES ON TABLES
The tables in the main text, which represent activity
of animals during successive time intervals during
behavioural recording are given as mean activity - S.E.M.
only. Details of the responses of individual animals are
given in tables in the Appendix. These Appendix tables
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1. The experimental work reported in this thesis
represents a contribution to the continuing study,
using animal models, of the possible roles of
dopaminergic, noradrenergic and serotonergic neuronal
systems of the central nervous system in the mediation
of exploratory, locomotor and stereotyped behaviours.
The rat was the species used in the study.
2. A review of the previous work in this field is
presented together with a discussion of the relevance
of such investigation of behavioural changes induced in
animal models to the elucidation of the cause of
deviations from normal behaviour in psychotic illness
in which components of aberrant, stereotyped activity
and abnormal exploratory and locomotor drives can be
discerned.
3. The use of a specially designed "hole-board" apparatus
located in a constant environment allowed simultaneous
and continuous measurement of all three types of
behaviours, thus improving to some extent on the subjective
visual assessment employed in most previous work of
only one, or at the most two, of the aspects of the
behavioural response. The exploratory and stereotyped
activity monitored in the 'hole-board* apparatus was
characterised by head dipping into the holes in the floor
of the enclosure, the frequency and pattern of movement
in relation to the various holes serving to assess the
intensity of the two types of activity. A closed circuit
S2.
television circuit permitted observation without distur¬
bance to the animal} by this means features of the
behavioural pattern which were not monitored automatically
could be noted.
4. The attempt to assess the roles of the monoamine
neuronal systems was made by analysing the incidence and
variation of the behavioural responses after pharmacological
or physical manipulation of the systems by methods of
varying degrees of selectivity for each system. Such
manipulation included systemic (i.p.) administration of
selected drugs and chemical and electrolytic lesioning
of, and the application under stereotactic control of
each of the monoamines to,the caudate-putamen nuclei
and to the accumbens nuclei, areas which earlier work had
indicated to be of major importance to the behavioural
responses.
5. The behavioural responses to various drugs which
cause, with varying degrees of selectivity, activation
of central monoamine receptors, were studied after i.p.
administration.
Amphetamine, a releaser of monoamine neurotransmitters^
induced in low doses (2 and 4 mg DL-sulphate/kg) a
stimulation of exploratory and locomotor activities which
included sniffing and rearing as well as the measured
hole-dipping and horizontal locomotor movements. With
a higher dose marked stereotyped hole-dipping activity
eventually appeared with reciprocal depression of the
initially stimulated exploratory and locomotor behaviour.
S3.
Haloperidol, a selective dopamine receptor
antagonist^reduced both spontaneous and all eiiphetamine-
induced behaviours in a dose-related manner.
Repeated weekly administration of amphetamine resulted
in potentiation of the responses to this drug. Paradoxi¬
cally, chronic haloperidol treatment also produced an
increase in the sensitivity to amphetamine.
Phenoxybenzamine (20 mg hydrochloride/kg), a mono¬
amine receptor antagonist showing selectivity towards
adrenoceptors, markedly reduced the exploratory and
locomotor response to amphetamine (4 mg DL-sulphate/kg)
given subsequently.
The behavioural responses to this dose of amphetamine
appeared somewhat potentiated by pretreatment with
methysergide (2 mg hydrogen maleinate/kg), a serotonin
(5-hydroxytryptamine, 5-HT) receptor antagonist; the
potentiations were not statistically significant.
Apomorphine, reputedly a selective dopamine (DA)
(on visual observation)
receptor agonist, stimulated/exploratory (0.75 mg hydro¬
chloride/kg) and stereotyped (higher doses) behaviours
both of which had a large component seemingly directed
towards olfactory ('sniffing') and gustatory ('gnawing and
biting') stimulation. Consequently the intensities of
the exploratory and stereotyped responses to this drug
were not adequately quantified by the hole-board technique.
5-Methoxy,-R,N,-dimethyltryptamine, a putative 5-hydroxy¬
tryptamine receptor agonist, induced with all doses in the
tested range (2.5 - 10 mg/kg) a bizarre behavioural
syndrome of incoordinated hyperactivity, tremor, sniffing,
S4.
head-nodding, hyperextension of the body^and abduction
and rigidity of the tail.
The two •tricyclic* antidepressant drugs desmethy¬
limipramine and chlorimipramine, inhibitors of neuronal
NA and 5-HT reuptake, caused behavioural sedation? this
was more marked with desmethylimipramine.
A , selective inhibitor of neuronal 5-HT uptake
GSA 654; caused a moderate stimulation of locomotion and
hole-dipping activity; these changes were not statisti¬
cally significant.
LRCL 5182, a selective inhibitor of neuronal DA
uptake, at the lower dose employed (10 mg/kg) led to a
stimulation of exploratory and locomotor activity; a
dose of 20 mg/kg led to a further increase in locomotor
activity as well as intense stereotyped behaviour.
Benztropine, a drug which combines anticholinergic
properties with potent actions in inhibiting neuronal DA
uptake, led to a stimulation of exploratory and stereotyped
behaviour and, particularly at the lower dose (2.5 mg/kg
of the mesylate salt),, of locomotor activity.
The tricyclic antidepressants, desmethylimipramine
and chlorimipramine and the selective 5-HT uptake
inhibitor GSA 654 markedly potentiated the behavioural
response to amphetamine (4 mg DL-sulphate/kg) as did the
inhibitor of 'liver microsomal enzyme' activity, SKF-525A.
The degree of potentiation was quantitatively associated
with higher concentrations of amphetamine in brain making
it improbable that actions on neuronal uptake mechanisms
played a prominent role in this potentiation.
7. The effects on "behaviour, of localised manipulations
of the monoaminergic systems in selected brain areas were
studied.
a) Selective destruction of dopaminergic nerve terminals
in the accumbens nuclei by bilateral stereotactically
controlled intracerebral administration of 6-hydroxydopamint
reduced spontaneous and amphetamine-induced locomotor and
exploratory behaviour including' sniffing; stereotyped
behaviour appeared to be potentiated.
Similarly induced bilateral destruction of dopaminergic
nerve terminals in the caudate-putamen nuclei reduced
spontaneous activity. The production of stereotyped
behaviour by amphetamine was prevented but the stimulatory
actions of this drug on locomotor and exploratory behaviour
were reduced to a lesser degree. Some animals with severe
neostriatal dopamine depletion were completely unresponsive
to amphetamine, apart from intense sniffing activity.
Bilateral electrolytic lesions of the accumbens
nuclei had no effect on spontaneous or amphetamine-induced
activity.
b) The behavioural responses following stereotactically
controlled intracerebral injections of dopamine» 5-hydroxy-
tryptamine and noradrenaline in nialamide-pretreated rats
were studied.
Bilateral injections of dopamine (5-50 jig of the
hydrochloride salt) into the nucleus accumbens of nialamide—
pretreated rats induced a marked stimulation of exploratory
and locomotor activity, accompanied by intense sniffing
and rearing; stereotyped activity was much less affected.
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In contrast, bilateral injection of dopamine (12.5 - 50 jig
of the hydrochloride salt) into the caudate-putamen
induced intense stereotyped activity which was dose-
related; exploratory and locomotor activity /ere much
less affected. Haloperidol (i*p*) blocked both responses*
Bilateral injection of noradrenaline (50 jig of the
hydrochloride salt) into the accumbens nuclei did not
produce any significant behavioural change. The same
injection into the caudate-putamen led to a moderate
stimulation of stereotyped activity.
Bilateral injection of 5**HT (50 jig of the bimaleinate
salt) into the accumbens nuclei induced a moderate loco¬
motor activity with some hole-dipping activity and sniffing;
these behaviours were uncoordinated and indecisive. The
same injection into the caudate-putamen led xo a slight
stimulation of locomotor activity and hole-dipping which
was predominantly "stereotyped" in character; on visual
observation no other striking abnormalities were noted.
8. The experimental results have been critically
discussed and the following conclusions have been drawn:
Dopaminergic systems play a major role in the
regulation of all three forms of behaviour studied -
exploratory, locomotor and stereotyped. The noradrenergic
and serotonergic systems may also play a minor,
complementary role. Furthermore, the different behaviours
appear to be regulated from different dopaminergically-
innervated areas. The behavioural components of
exploration (as evidenced by "exploratory" hole-dipping,
locomotion, sniffing and rearing) are mediated through
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the accumbens nuclei and possibly also the olfactory
tubercles. Stereotyped behaviour (as evidenced by
"stereotyped" hole-dipping and "non-dipping stereotyped
behaviour" consisting of other types of repetitive head
movements as well as intense gnawing and biting) is
mediated through the caudate-putamen. It also seems likely
that some degree of dopaminergic activity in the caudate-
putamen is necessary for all forms of behaviour to be able
to occur, including those mediated primarily from other areas.
In spite of the fact that the two groups of activities
(exploratory and locomotor activities on the one hand and
stereotyped activities on the other) appear to be mediated
from different anatomical loci, there still appears to be a
close relationship between them in intact animals, as
evidenced in the selective effects of different doses of
dopamine agonist drugs on them. (Observation of these
relationships was facilitated by the hole-board techniq.ua
employed, which allows simultaneous quantitative evaluation
of all these behaviours). The nature of this relationship
has been discussed.
Since many of the behavioural changes observed in the
affective disorders in man appear to be mediated through
dopaminergic systems in the rat, it seems likely that
disturbances of dopaminergic systems play a major role in
the manifestation of these disorders. furthermore, it is
proposed that disturbances in the accumbens nuclei may play
a prominent role, with involvement of the nigro-striatal
system probably also featuring in the more severe forms of
the illness.
Two animal models of mania are proposed (a) the
behavioural effects of increasing dosage with amphetamine
and (b) the response to dopamine injection into the
accumbens nuclei.
less evidence could be found from these animal
studies of a role for dopaminergic systems in schizophrenia.
It was specul ted that 5-hyd roxytryp tamine rgic systems
might be involved in the behavioural changes observed and
the similarities between the behavioural effects of a
systemically administered serotonergic agonist and of
5-hydroxytryptamine injected into the accumbens nuclei and
some of the symptomatology of schizophrenia were discussed.
I. INTRODUCTION
The aim of this study was to examine the roles of
different monoamine transmitter systems in the mediation
of exploratory, stereotyped and locomotor behaviours.
The three monoamine systems concerned are those in which
transmitter function is subserved by dopamine (DA)t
noradrenaline (NA) and 5-hydroxytryptamine (5-HT).
The work represents an extension of a part-time project
reported in an M.Phil. Thesis (Makanjuola, 1976).
Two main lines of reasoning provide the rationale
for this study. Firstly, since there is a large body
of evidence linking functional psychotic illness with
disturbances of monoamine systems, it should assist our
understanding of these illnesses to study the functions,
particularly the behaviours, which are influenced by
these systems, and the specific roles that these mono¬
amine systems play in mediating the behaviours.
Exploratory, locomotor and stereotyped behaviours are
some of the activities known to be influenced by mono¬
amine pathways. Secondly, changes in all three behaviours
have been observed in functional psychotic illness.
Parallel studies of the behaviours in man (both in health
and psychosis) and animals should therefore assist our
understanding of the roles of monoamine systems in the
behavioural changes of psychotic illness and possibly
the aetiology of the illness itself. These points are
discussed in greater detail below.
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1. DEFINITIONS
Exploratory Behaviour. The concept of exploratory
behaviour is open to some variability in definition
particularly when applied to man, where thinking is
taken into consideration in addition to overt activity.
Walker's (1962) definition, which is taken as the
operational definition in this study, states that
exploratory behaviour consists of behaviour motivated
towards sensory stimulation, with the emphasis being on
novel sources of stimulation. I believe this definition
to be valid in relation to behaviour in small animals, in
which it is assumed that the majority of behaviour would
be manifested externally, which makes internalized thought
processes less important.
Stereotyped Behaviour. There is little disagreement
about definition here. Stereotypy is defined as
repetitive, apparently purposeless patterns of behaviour
(Randrup and Munkvad, 1974} 'Wallach, 1974)•
Locomotor Behaviour. This type of behaviour is often
confused with exploratory behaviour. It refers to the
process by which the animal moves from place to place,
and may be motivated by considerations other than
exploration.
General Activity. Locomotion has to be further differ¬
entiated from general activity. This term refers merely
to body movements which may not necessarily be locomotor
in nature. Measurements obtained from 'activity* boxes
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quantify general activity and do not necessarily accurately
measure movement from place to place, yet some authors
use results from such apparatus as indicators of the
intensity of locomotor or even exploratory activity.
2. CLINICAL iidL:dVANQ3 OF 3XPLQAAT0RY. STNBNO'IYPDD AND
LOCOMOTOR BEHAVIOURS
a. MONOAMINE Til SON.IAS OF FUNCTIONAL PSYCHO 3 AS
Disturbances of monoamine systems have long been
implicated in psychiatric illness, in particular the two
major forms of functional psychosis, the affective
disorders and schizophrenia.
The main body of evidence for the assumption that
disturbances of monoamine systems are involved in the
affective disorders lies in the fact that many of the
drugs useful in the treatment of these disorders appear
to alter preferentially activity in these systems.
Antidepressant drugs increase the amounts of monoamine
transmitters available to stimulate post-synaptic receptors,
either by monoamine oxidase inhibition (Zeller et al.1962;
Spencer, 1977) or by the inhibition of the neuronal
re-uptake of released monoamines (Clowinski and'Axelrod,
196,6; Iversen, 1975; Schacht et al. 1977) or by both
mechanisms (Iversen, 1975, Both, 1978). Certain mono¬
amine oxidase inhibitors e.g. tranylcypromine, may also
release monoamines (Marley and Stephenson, 1972).
Depressive illness may also be alleviated by treatment
with L-tryptophan, the amino-acid precursor of 5-HT,
particularly when combined with monoamine oxidase inhib¬
ition (Coppen, 1967; Prange et al. 1974).
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Treatment with L-dihydroxyphenylalanine (Ir-GOPA) the
immediate precursor of DA has been less successful (Goodwin
and Sack, 1974). lithium salts have also been used
successfully in the treatment and prophylaxis of affective
disorders. The mode of action of the lithium ion is
still unclear; it has been suggested that it may produce
effects on monoamine systems by alterations in cellular
ion transport dependent on adenosyl triphosphatase activity
(Glen and Heading, 1974). Electroconvulsive therapy may
produce improvement in depressive illness by increasing
neuronal receptor sensitivity (Evans, et al, 1974).
A variety of drugs which decrease activity in mono¬
amine systems are capable of inducing depressive symptoms.
The best known example is reserpine (Achor et al, 1955;
Muller et al. 1955). This drug causes a depletion of all
three monoamines from their neurones (Holzbauer and Vogt,
1956; Pletscher et al. 1956; Haggendal and iindqvist,
1964). The psychological impact of chronic illness may
make a substantial contribution to depressive symptomatology
associated with antihypertensive mediation, including
reserpine (Bant, 1978). Tetrabenazine, which has similar
actions to reserpine (lingjaerde, 1963) also causes
depressive symptoms (Lingjaerde, 1963). Parachloro-
phenylalanine, which depletes 5-HT neurones of their
transmitter by tryptophan hydroxylase inhibition (Koe
and W'eissman, 1966) also causes depressive symptoms
(Bngelman et al. 1967). Neuroleptic drugs used in the
treatment of mania block monoamine, especially dopaminergic,
receptors (Anden et al. 1970a; Carlsson, 1974, 1978;
Seeman et al. 1976). Neuroleptic drugs do not however
consistently cause depression, possibly because of their
specific action on dopaminergic neuronal systems. Both
triyclic antidepressant drugs and monoamine oxidase
inhibitor's may occasionally precipitate manic episodes
(Davis and Janowsky, 1974).
This evidence regarding drug effects in the therapy
and in the induction of affective disorders would at first
appear overwhelming. However, it must be stressed that
the fact that manipulation of monoamine systems by drugs
leads to amelioration of symptoms in the disorder or to
the induction of symptoms associated with the disorder
does not necessarily imply that the primary disorder lies
within those systems. Whatever area or areas of the
brain is primarily responsible for the affective disorder,
it may be subject to a variety of modifying inputs,
including monoaminergic inputs. Alternatively, changes
in monoamine systems may be the result of inputs into them
from another system or brain area more fundamentally
involved in the affective disorder.
Unfortunately attempts to demonstrate changes in
monoamine systems in patients with affective disorder have
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produced inconsistent results which require increasingly
complicated formulations to explain. Most such studies
have involved biochemical examination of cerebrospinal
fluid (CSF) obtained, in most studies, from the lumbar
region. Decreases in all three major metabolites of the
amines have been reported in depressive illness. This
applies most consistently to the 5-HT metabolite, 5-hydroxy-
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indole acetic acid (5-HIAA) (van Praag et al. 1972;
Goppen et al. 1972; MAG Brain Metabolism Unit, 1972) but
decreases in the DA metabolite, homovanillic acid (HVA)
(Roos et al. 1969; Papeschi and McGlure, 1971; MHC
Brain Metabolism Unit, 1972) and the NA metabolite 4-hydroxy-
3-methoxy, phenethylene glycol (HMPG) (Post et al. 1973)
have also been reported. Changes in mania are less
striking, although rises in HMPG have been described
(Wilk et al. 1972; Pullar, 1973).
The interpretation of these observations is made
difficult by the fact that metabolite levels may not return
to normal on recovery (Goppen et al. 1972; MRC Brain
Metabolism Unit, 1972). Furthermore, the changes in
metabolite concentration were not universally observed.
It was to accommodate these disparate findings that the
concept of changes in post-synaptic receptor sensitivity
was introduced (MAC Brain Metabolism Unit, 1972).
There are major basic problems in interpreting results
from CSF studies. First, changes in monoamine turnover
in specific areas may be masked by changes elsewhere.
Changes in the concentrations of CSF metabolites cannot
even be guaranteed to reflect changes in brain monoamine
activity. While in lumbar CSF the HVA probably derives
from brain BA metabolism, there is considerable doubt as
to what proportion of lumbar CSF 5-HIAA comes from spinal
cord or brain and most of the HMPG appears to come from the
spinal cord (Garelis et al. 1974).
An alternative approach is the study of monoamine and
metabolite content of human brain. Brain biopsy may not
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"be practicable for ethical reasons. Post-mortem studies
are bedevilled by the problems of variable time between
death and delivery of the post-mortem sample and sometimes
of specimen storage. Furthermore the mode of death may
itself have a profound effect on such estimations.
Reduced 5-HT and 5-HIAA levels in brains of depressed
people who committed suicide have been found (Shaw et al.
1967; Bourne et al. 1968). In another study of depressed
persons who committed suicide (Pare et al. 19o9) BA, NA
and 5-HIAA levels were unchanged although there was a
slight reduction in 5-KT levels.
On the basis of the above evidence, and in spite of
the deficiencies, disturbances of monoamine systems have
been embodied in various theories of affective disorder.
These theories imply that in depressive illness there is
a reduction in effective activity of catecholamine systems
(Schildlcraut, 1965) or 5-HT systems (Coppen, 19b7) as a
result either of a decrease in monoamine neuronal activity
itself or a decrease in post-synaptic monoamine receptor
sensitivity (MRC Brain Metabolism Unit, 1972). Mania is
considered to be associated with overactivity of the systems
arising in a manner converse to those operating in
depression. Prange et al. (1974) implicated all three
monoamine systems in affective disorder. According to
their theory central 5-HT underactivity predisposes to
affective disorder whereas episodes of illness manifest
with additional changes in catecholamine systems. The
changes in 5-HT metabolism may represent the constitutional
predisposition to the illness (Schildkraut, 1973).
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Similar problems apply to examination of the hypo¬
theses relating schizophrenia to abnormal function in
monoamine systems. Currently, the most plausible
contender is the "dopaminergic theory" of schizophrenia
(Snyder et al. 1974; Carlsson, 1978) which states that
schizophrenia involves overactivity of dopaminergic systems
resulting either from increased neuronal activity or from
increased DA receptor sensitivity. The main body of
evidence for this theory lies in the fact that drugs
effective in alleviating the symptoms of schizophrenia
are potent DA receptor blockers, and it is this property
that is essential for their clinical effectiveness (Anden
et al. 1970a;Carlsson, 1974, 1978; Seeman et al. 1978).
Amphetamine and related sympathomimetic substances
induce in man an illness very similar to paranoid
schizophrenia (Connell, 1958; Angrist et al. 1974).
Furthermore these drugs are capable of exacerbating the
symptoms of schizophrenia (Davis and Janowsky, 1973).
These drugs increase activity in monoamine systems, mainly
by inducing transmitter release from neurone terminals
(see page 24). Other drugs which stimulate dopaminergic
and other monoamine systems such as cocaine and i-DQPA
can also induce or exacerbate schizophrenia-like illnesses
in man (see Snyder et al. 1974). Psychoses and schizo¬
phrenic exacerbations induced by amphetamine and its
derivatives are alleviated by haloperidol (Angrist et al.
1974) which is a potent antagonist at DA receptors (Anden
et al. 1970a;Seeman et al. 1978).
.Recently, evidence has bean accruing that neuroleptic
drugs alleviate the symptoms of schizophrenia through
their actions on mesolimbic DA systems whereas their
ability to induce "extrapyramidal" symptoms is related
to their actions on the nigro-striatal DA system (Andgn
and Stock, 1974; Grow & Gillbe,1975). Furthermore, the
differential action of some neuroleptic drugs on mesolimbic
or nigro-striatal DA turnover is related to the relative
amount of antimuscarinic activity possessed by the drugs
(Miller and Hiley, 1974). For example, clozapine and
thioridazine which in contrast to haloperidol and chlor-
promazine have relatively high antimuscarinic activity and
tend to be associated with a relatively low incidence of
extrapyramidal side effects, tend to be much more potent
in their effects on DA turnover in the mesolimbic DA
system. It has been demonstrated that whereas drug-
induced alterations in dopaminergic activity leads to
changes in cholinergic function in the nigro-striatal
system, no such changes occur in the mesolimbic DA system
(Ladinsky et al. 1978). It may be that the differential
effects of neuroleptic drugs on mesolimbic as opposed to
nigro-striatal DA turnover is related to this apparent
resistance in the mesolimbic system towards dopaminergically
induced changes in cholinergic function.
More direct attempts to demonstrate changes in
dopaminergic systems in the brains of schizophrenic
patients have not yielded much evidence in support of the
dopamine hypothesis of schizophrenia. There is some
speculation that disorders in the limbic system, most
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areas of which have a very high level of dopaminergic
innervation (Ungerstedt, 1971a; Lindvall and Bjorklund,
1974; Jacobowitz and Palkovits, 1974) are involved in
schizophrenia (Torrey and Peterson, 1974)* liecently it
was demonstrated that in brains of schizophrenics obtained
at post-morteia there was a relatively selective increase
in OA content and decreases in glutamic acid decarboxylase
and choline acetyltransferase activity in the nucleus
accumbens (Bird et al. 1977)• However, these changes
could have been the result of long-term neuroleptic
medication.
While the theories relating monoamine function to
psychotic illness are open to much criticism, no other
satisfactory alternative has been put forward, and the
evidence in favour cannot be ignored. It should still be
a useful approach to -work under the assumption that central
monoamine function is important. If we accept that
monoamine function may be important in these illnesses,
then one way in which our understanding of these illnesses
may be improved is to study the functions, in particular
the behaviours, that these systems are concerned with.
This concept has stimulated an enormous amount of research,
and we now know of a whole host of behaviours influenced
by these systems in animals. It follows from here that
we should then look for changes in these behaviours in
sick people. Once we have an idea as to which of the
behaviours is altered in illness, we can go back to our
ani...al models and ask such specific questions as; which
subdivisions of these systems are responsible for those
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particular behaviours?; how can we modify these behaviours?;
can we apply this knowledge to diagnosis and treatment of
the human animal?
One example of the way in which this dual approach
has been of immense value concerns the treatment of
schizophrenia with neuroleptic drugs. For a long time
drug-induced stereotyped behaviour was regarded as an
animal model for acute psychosis (Angrist and Gershon,
1974; Wallach, 1974). There was also speculation that
the use of anticholinergic drugs to treat neuroleptic-
induced extrapyramidal symptoms might reduce the effect¬
iveness of neuroleptic medication in alleviating schizo¬
phrenic symptoms (Singh and Kay, 1975). We now know
both these ideas to be fallacious since the nigro-striatal
system is now known to play the major role in mediation of
drug-induced stereotyped behaviour (this will be discussed
in detail in subsequent pages), and Parkinson's disease
(Iiornykiewicz, 1972). Neuroleptic-induced Parkinsonism
appears to be a function of drug effects on the nigro-
striatal system whereas these drugs seem to depend for
their therapeutic efficacy on their effects in the
mesolimbic dopaminergic system (see page 8). Anti¬
cholinergic drugs may of course also antagonise neuroleptic
drug effects even in the mesolimbic system through their
ability to inhibit DA uptake (Goyle and Snyder, 1969).
b. IKPLCktATGAY, STmil&IYPdD ANA hOODilOTOA B3HAVIQUA
IN PSYCHOTIC 1LLN3SS
As will be discussed in detail later, there is
substantial evidence that in animals monoamine systems,
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particularly the dopaminergic systems, are involved in
the mediation of all three behaviours under consideration.
It follows from the comments in the previous section that
if changes can be found in these behaviours in patients
with psychotic illness5this might provide further evidence
in support of the monoamine theories of psychotic illness.
A fuller understanding of the mediation of these
behaviours by monoamine systems in animals and of how the
behaviours can be modified should help our understanding
of the disease process as well as assisting in the develop¬
ment of effective therapy. For example, if it were found
that behavioural changes in one form of psychosis were
all mediated by one particular system or subsystem this
then would be an indication that that particular subsystem
wa3 involved in behavioural changes accompanying the
disease. Attention could then be directed towards
finding ways of manipulating that particular subsystem
appropriately and specifically. This m^y now be the case
in schizophrenia, where efforts might now be directed
towards finding drugs with specific effects on mesolimbic
DA function.
In fact quite obvious and often gross changes in
exploratory and locomotor activity occur in functional
psychosis and stereotyped behaviours can also be seen.
These behavioural changes are well documented in the
classical psychiatric literature (e.g. Kraepelin, 1911;
Bleuler, 1950) as well as more recently (MRC Brain
Metabolism Unit, 1971). The changes are most obvious in
the affective disorders. In retarded depression, the
13.
patient becomes increasingly immobile both in thought and
action, and his capacity and motivation for exploratory
activity and thought appear greatly decreased. V/hen
questioned it is clear that the patient's thoughts revolve
slowly round a limited number of topics. However, in
some patients, although they appear retarded in activity,
their thoughts are reported as going faster than normal,
but again these thoughts revolve around a limited number
of topics and it is difficult to initiate or sustain ether
areas of thought. Such thinking can be regarded as
stereotyped. In agitated depression exploration is again
at a minimum but the patient is hyperactive and one
observes intense stereotypy in activity and thought.
In the less severe forms of mania patients are hyper¬
active and appear to indulge in a high level of exploratory
activity which manifests as a restless passage from room
to room, object to object, venture to venture and topic
to topic. The classical 'flight of ideas' of mania
refers to the passage of the subject's thoughts from one
idea to the next in rapid succession - a high level of
exploratory thinking. In more severe cases exploratory
behaviour may be replaced by intense repetitive activity
and thought which appears increasingly aimless i.e.
stereotypy. In some cases these repetitive actions and
thoughts become 30 intense that it is difficult to dis¬
tract the patient from them except momentarily. There
is an analogy here between this situation and that of a
rodent stimulated by drugs into intense stereotyped
behaviour - the animal can only be momentarily distracted
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from stereotyped behaviour by a relatively intense external
stimulation e.g. a loud noise.
A variety of stereotyped behaviours can be observed
in schizophrenia, involving both speech and action. Most
obvious are the actions and posturings of catatonic
schizophrenia. In excited schizophrenic patients much
behaviour is repetitive and apparently purposeless.
It is difficult to interpret schizophrenic symptoms
in terms of changes in exploratory activity and thought.
It could be that the alterations in behaviour do not result
simply from quantitative changes in the thought process
but rather from a qualitative disorganisation of the
thought process. Paranoid ideation in schizophrenia
involves an inability of the patient to consider other
interpretations of incoming stimuli as alternatives to
the delusional interpretation. Changes in motor activity
are evident at the two extremes of catatonic schizophrenia
- stupor and excitement.
It is well-known that in amphetamine addicts and
particularly in amphetamine psychosis stereotyped facio-
buccal and upper limb movements are commonly seen, as well
as more complex stereotyped activities (Ashcroft et al.
1965; Elltttiwood, 1967).
The above clinical observations of changes in these
behaviours in psychotic illness are based on subjective,
often anecdotal, observations. It would be helpful if
they could be examined quantitatively and in a more
objective way. Unfortunately there are great difficulties
here. In animals and children it is relatively easy to
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devise measures of these behaviours, but in adults there
are major problems. First, adult humans internalize
much of their behaviour i.e. much of it involves thought,
which is not readily accessible to external assessment.
Secondly even their overt behaviour is under a variable,
often quite major, degree of constraint from cultural and
social influences. Recently a collection of tests has
been devised to study these behaviours and applied to
the study of changes in these behaviours in affective
disorder (Makanjuola and Blackburn, in preparation).
In general the findings fitted with the descriptions of
changes in these behaviours described above, although
certain deficiencies were apparent in the procedure.
3. 1IQNQAI.1IHS FAIRWAYS IN IH3 RAT BRAIN
Most of the work to demonstrate the diffuse inner¬
vation of different brain areas by monoamine systems has
been carried out in the rat. The work of mapping out the
pathways began following the introduction of the Falck-
Hillarp formaldehyde fluorescence technique (Garlsson et
al. 1962). Progress was facilitated by the introduction
of the neurotoxic dihydroxytryptamines 5» 6- and 5t 7-
diliydroxytryptaaine for the study of 5-HT pathways (luxe
and Jonsson, 1974) and the glyoxylic acid technique for
the demonstration of DA and NA neurons (Lindvall and
Bjorklund, 1974). Biochemical, autoradiographic and
other neuronal labelling techniques have also assisted
in the tracing of these pathways.
Knowledge of the distribution of the monoamine
pathways is now extensive and has been thoroughly
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reviewed (Ungerstedt, 1971a; Fuxe and Jonsson, 1974.;
lindvall and Bjorklund, 1974). The following brief
description cannot do justice to the ,aany observations
that have been documented. Emphasis is laid on those
pathways that are particularly relevant to the present
study. The cell group nomenclature used is that of
Dahlstrom and Fuxe (1965).
a. DQrAMIfljtfiGIC PATHWAYS* There are three main dopamin¬
ergic pathways in the brain: (Fig. 1)
(i) The nigro-striatal pathway arises mainly from
cell bodies in the zona compacta of the substantia
nigra (cell group A9), its rostromedial extension
into the ventral tegmentum and the more caudal A8
group* The fibres pass rostro-medially to form a
distinct nerve bundle ,the nigro-striatal bundle,
which ascends in the postero lateral aspect of the
medial forebrain bundle and passes rostrally to
supply mainly the caudate-putamen. Some fibres
also innervate the nucleus interstitalis stria
terminalis and anterior limbic cortex.
(ii) The riesolimbic DA system. Fibres of this
system arise mainly from cell bodies of the A10 cell
group situated dorsal to the interpeduncular nucleus.
The fibres ascend in a large bundle along the medial
forebrain bundle, where they lie in a ventro-medial
position to the nigro-striatal bundle from which
there is no real demarcation in this position. The
pathway as it ascends divides into various branches
which supply mainly areas of the so-called limbic
i
n.a
FIG-. 1: Dopamine pathways in the rat brain. The
nigro-striatals mesolimbic and tubero-
infundibular pathways are depicted. It
should be noted that the nigro-striatal
and mesolimbic systems cannot easily be
distinguished anatomically during most of
their course.
n.acc - nucleus accumbens
olf.tub. - olfactory tubercles
caud-put. - caudate-putamen
n.amyg.cent.- central nucleus of the amygdala
med.em. - median eminence.
(After Ungerstedt, 1971a).
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system, including the amygdala, piriform, frontal
and anterior limbic cortex, septum, olfactory tubercl
olfactory nuclei and accumbens nuclei. The neo¬
striatum also receives some innervation from this
system.
(iii) The tubero-infundibular system consists of a
system of short dopaminergic neurons within the
hypothalamus which are assumed to be concerned mainly
with endocrine function.
b. NORADhEraQIC PATHWAYS (Fig. 2)
A dorsal NA pathway arises mainly from cell bodies
in the lccus coeruleus (A6). It forms a distinct bundle
as it ascends rostrally in the medial forebrain bundle.
The system supplies mainly dorsal diencephalic and
telencephalic areas, including the thalamus, hippocampus
and neocortex.
A ventral NA pathway arising from cell bodies in
pons and medulla (A1-A6) ascends rostrally and supplies
mainly ventral forebrain areas, including the hypothalamus
thalamus, various mesolimbic areas and the neostriatum.
The dorsal and ventral periventricular systems are
distributed diffusely along the periventricular and
periaqueductal grey matter from the medulla as far as the
rostral diencephalon. The two systems receive fibres
from medullary and pontine NA cell groups as well as cell
bodies distributed along the pathways themselves. The




FIG. 2: Ascending noradrenergic pathways in the rat
brain. The dorsal and ventral periventricular
systems are not shown.
olf.bulb - olfactory bulb
hipp. - hypocampus
hypoth. - hypothalamus
st.term. - stria terminals
(After Ungerstedt, 1971a).
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c. SGRGTOIMIGIC (5-IIT) PATHY/AYS (Fig. 3)
Three major ascending pathways have been identified
(Fuxe and Jonsson, 1974).
(i) A medial ascending subcortical pathway arises
from cell bodies in the pontine raphe (B5 and B6)
and from the dorsal and median mesencephalic raphe
(B7, B8) and supplies mainly the hypothalamus and
pre-optic area.
(ii) A lateral ascending cortical pathway arises
from the mesencephalic B7» B8 and B9 cell groups. It
ascends in the medial forebrain bundle into tlie
cingulum, thence supplying mainly the cortex, and
hippocampus,
(iii) A more lateral pathway arising from 37-B9 cell
groups ascends on the inner surface of the crus
cerebri to innervate extrapyramidal structures,
including the neostriatum and globus pallidus.
On the basis of biochemical and histofluorescence
changes following lesions of the midbrain raphe nuclei, it
appears that these nuclei project to different brain areas.
In particular, the dorsal raphe nuclei (B7) appear to
innervate the striatum, thalamus, hypothalamus and cerebral
cortex whereas the median nuclei (B8) project mainly to
the hippocampus, septum, cerebral cortex and hypothalamus
(Lorens and Guldberg, 1974; Geyer et al. 1976a; Geyer et
al. 1976b; samanin et al. 1978).
cortex hipp.
FIG. 3* Ascending 5-hydroxytryptamine pathways in the rat
brain. The 3 major pathways (page 18) are best
seen in the bottom figure.
1 - medial subcortical pathway supplying mainly hypothalamus
and pre-optic area.
2 - lateral ascending cortical pathway, supplying mainly the
cortex and hippocampus.
3 - a more lateral pathway supplying mainly extrapyramidal
structures.
hipp - hippocampus; caud-put. - caudate-putamen;
st.term - stria terminalis; mes.raphe - mesencephalic raphe.
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d . I.TONOAHim ITURONAL INJECTIONS
From the above it is evident that many brain areas
receive innervation from two or more different monoamine
systems. For example, the neostriatum receives major
innervation from the nigrostriatal (and to a less extent
the mesolimbic) DA pathway, the ventral NA pathway and the
more lateral 5-HT pathway. Evidence has been accumulating
that this anatomical overlapping reflects functional
interactions between all three transmitter systems.
This will be discussed in more detail in the next section.
4. TH3 liOhl OF MQIIOAMIIO SYST1M3 III THE iiTGULATION OF
3XPL0AAT0flY. ST3RH)TYP5D AND LP001,10TQll BgHAVIOUA
A variety of methods have been used to attempt to
study the .roles of monoamine systems in regulating the
r'f " °i
three behaviours under consideration. Assessment of the
results of such experiments is made difficult by the
different techniques used in observing the behaviours.
Km
in addition a variety of animal species have been used.
Uven when these factors are taken into consideration it
is still often difficult to account for the frequent
differences between the observations of different workers.
The studies reviewed in this section can be broadly
grouped into two types:
(i) observations of the effects of systemically
administered drugs on normal animals, and
(ii) observations of the effects of stereotactic
manipulations of discrete neuronal pathways and their
terminal areas in the brain by lesioning and by
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direct application of transmitters and of psycho¬
active drugs.
Except where otherwise stated the studies reviewed
involve observations on rats and mice.
A. U0N0AMIH3 NEURONAL INTERACTIONS
The effects of drugs in intact animals on monoamine
systems can never be regarded as specific even if
evidence is obtained that the drug has direct effects on
only one system. This probably applies equally to the
effects of "specific" lesions. It was mentioned at the
end of the preceding section that the three monoamine
systems are closely related anatomically, particularly in
their projections. With the help of the newer techniques
such as autoradiography and horseradish peroxidase
injection more direct anatomical relationships have also
been demonstrated. Serotonergic input into the locus
coeruleus from raphe nuclei has been convincingly
demonstrated (Bobillier et al. 1978; Descarries and leger,
1978; Pickel et al. 1978; Sakai et al. 1978). Serotonergic
projections to the substantia nigra and certain other DA
cell body groups and to terminal areas for DA and HA
projections (Bobillier et al. 1978) have also been observed.
Close relationships also exist between monoamine and
other systems, especially cholinergic pathways (Jacobowitz
and Palkovits, 1978) and pathways containing the neuro¬
transmitter ^ -aminobutyric acid (GAB/) (Roberts, 1978).
There is an increasing body of evidence that these
anatomical relationships represent functional interactions.
The best known example of this is the inter-action between
cholinergic and dopaminergic systems which appear to act
in antagonistic fashion in the neostriatum (Bartholini et
al. 1973)» and this forms a rationale for the use of anti¬
cholinergic drugs in the treatment of Parkinsonism (Barbeau,
1962; Calne, 1970),although it is now known that these
drugs also inhibit neuronal uptake of DA (Coyle and
Snyder, 1969) which may contribute to their beneficial
action. Biochemical studies have shown that activation
and inhibition of DA systems will produce opposite effects
on striatal cholinergic function (Ladinsky et al. 1978).
Interestingly, cholinergic function in the mesolimbic DA
system is not altex*ed in this way (ladinsky et al. 1978)
and this may explain the preferential effects on mesoliabic
DA turnover by neuroleptic drugs with high antimuscarinic
activity (see page 8).
Biochemical as well as behavioural evidence for a
functional interaction between DA and 5-HT inputs into the
striatum is well-documented. lesions of the mesencephalic
raphe nuclei which contain the cell bodies of serotonergic
(5-HT) neurones reduce the stereotyped behaviour induced
by dopamine agonists (Costall et al. 1975a). Dorsal but
not median raphe nuclei lesions leads to a reduction in
striatal homovanillic acid (HVA) levels, indicating a
decreased turnover of DA (Samanin et al. 1978). 1-tryptophan
administration causes a rise in HVA levels while
P-chlorophenylalanine, an inhibitor of tryptophan
hydroxylase causes a reduction (Samanin et al. 1978).
These latter findings have been interpreted as indicating
that 5-HT inputs facilitate DA inputs into the striatum.
However, if the two systems were mutually antagonistic,
reduction in activity in 5-HT systems might lead to a
reduction in DA activity by inhibitory feedback control,
as a compensatory mechanism. Direct antagonistic
effects of 5-HT on the behavioural response to DA have
been demonstrated following direct application of these
drugs into the nucleus accumbens (Costall et al. 1976).
Serotonergic inputs from raphe nuclei appear to
inhibit activity of noradrenergic cell bodies in the locus
coeruleu3 (Pujol et al. 197S).
Antagonists of the,JL-adrenoceptor type inhibit
activity of raphe 5-HT neurons, this effect being an
indirect one, presumably by alterations in NA system
activity (Gallager and Aghajanian, 1976).
There is also some evidence that NA neurons may
influence activity in DA systems. Pharmacological
manipulation of NA systems withcC-noradrenergic adreno¬
ceptor agcnists and antagonists leads to changes in DA
turnover (Anden and Grabowska, 1976). Unilateral lesions
in the locus coeruleus lead to amphetamine and apomorphine-
induced circling behaviour which is inhibited by DA, but
not NA receptor blockade and appears to be mediated
through the nigro-striatal system (Pycock et al.1976).
Connections between GABA aad DA systems are well-
documented. The output pathways from the neostriatum
to the globus pallidus and substantia nigra, are GABAergic.
(Hattori et al. 1973; Garcia-hunoz et al. 1977). There
is still argument as to whether the striato-nigral pathway
21,
plays a role in the feedback control of nigro-3triatal .
dopaminergic activity (Garcia-Munoz et al. 1977)•
A few biochemical and behavioural studies have been
quoted above to illustrate interactions between different
systems. The important fact to bear in mind is that no
matter how specific the direct effects of a drug (or a
lesion),these effects may lead to secondary changes in
other systems because of these interactions. It may
therefore be difficult to draw conclusions regarding any
specific monoamine system from the observed effects.
For instance, apomorphine, an alleged specific I)A agonist
(Crnst, 1967; Anden et al. 1967a), causes changes in 5-KI
systems which appear to arise from the interaction between
DA and 5—HT systems (Grabowska et al. 1979, 1976). While
it is generally believed that the DA receptor activation
is of primary importance, we cannot ignore the possibility
that secondary effects on the serotonergic systems may
contribute to, or even primarily mediate, the final
response to the drug.
B. STUDI5S OF THIS IFFDC13 OF SY31H.ilGAILY A3MINI3I5R3D
DFXJG3 IH NOhLIAL AHIhALS
There are now available many drugs which are known to
have marked actions on monoamine systems. The investi¬
gations of the effects of these drugs on the behavioural
patterns monitored in the present study are extensive. It
is therefore necessary to be somewhat selective in reviewing
the large body of information available, emphasis being
laid on those studies more directly related to the present
one.
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Amphetamines and Related Sympathomimetic Amines
Of these drugs amphetamine is most probably the one
most widely studied. This drug has a number of actions
on all three types of monoaminergic neurons. It releases
DA (Besson et al. 19&9» Voisgtlander and Moore, 1973; Moore,
1977) NA (Garr and Moore, 1969; Carlsson, 1970; Moore, 1977)
and to a less extent 5-HT (Azzarro and Butledge, 1973;
Moore, 1977) from neurones. Particularly at higher doses,
amphetamine also inhibits neuronal monoamine uptake
(Glowinski, 1970; Horn et al. 1974) and may also inhibit
monoamine oxidase (Glowinski, 1970) although there is some
doubt about the latter effect (Rutledge, 1970). A
direct agonist action on monoamine receptors has also been
claimed (Feltz and de Champlain, 1973)*
In view of its lack of selective action on any type
of monoamine neurone it is at first surprising that the
drug is still so widely used experimentally. This is
probably because its extremely potent effects on behaviour
are very reproducible. evidence regarding the roles of
specific monoamine systems can be obtained by modifying
the amphetamine actions with other, more specific drugs.
Amphetamine is of added interest because of its psycho-
togenic effects (see page 8).
On its own, amphetamine at low doses stimulates
locomotor behaviour in rats, mice and a variety of other
animals (e.g. Del Rio and Puentes, 1969; luxe and
Unjerstedt, 1970; Kelly et al. 1979; Ljungberg and
Ungerstedt, 1976). It also increases exploratory behaviour
(Boissier and Gimon, 1964; Bradley et al. 1968; Fuxe and
Ungerstedt, 1970; ijungberg and Ungerstedt, 1976;
Makanjuola et al. 1977b). As the dose is increased this
locomotor and exploratory stimulation is replaced by-
stereotyped behaviour (Randrup et al. 1963; Del Rio and
Fuentes, 1969; Fog, 1969; Fuxe and Ungerstedt, 1970;
Randrup and Munkvad, 1974; Idakanjuola et al. 1977b). In
rats this stereotypy consists of sniffing and repetitive
head and upper limb movements. As the stereotypy becomes
more intense persistent biting, gnawing and licking also
take place.
Some studies however, have indicated only a reduction
in exploratory behaviour even with the lower doses of
amphetamine (File, 1977) and there is some evidence that
if the form of exploratory behaviour monitored is independent
of locomotor behaviour then exploratory behaviour is
actually reduced by amphetamine (Kumar, 1969; Robbins and
Iversen, 1973).
Amphetamine derivatives, and related sympathomimetic
dru^s v/hich have broadly similar actions on monoamine
systems, produce similar behavioural effects. Certain
derivatives.? however, exercise differential effects on
different monoamine systems and produce different behavioural
responses. For example fenfluramine, (Fig. 4) is said to
preferentially affect 5-HT systems, with less potent actions
on catecholamine systems (Costa et al. 1971; Garrattini
et al. 1975; Reuter, 1975; Kannengeisser et al. 1976).
The drug may even block DA receptors ^Garrattini et al.
1975). Most studies have failed to demonstrate locomotor
stimulant effects or st reotypy with fenfluramine (le
Douarec and Neveu, 1970; Ziance et al. 1970; Coslaet al.1971;
26.
lindquist and Gotestam, 1977) although there are reports
of locomotor stimulation (Dverritt and Hacket, 1972) and
stereotypy (Taylor et al. 1973) at high dosage. Such
observations demonstrate that examination of the behavioural
effects of drugs with more specific effects on one system
might indeed be rewarding. In this respect, it has been
demonstrated that the different potencies of D- and L-
amphetamine on locomotor stimulation and induction of
stereotyped behaviour correlate with the relative potencies
of these isomers to stimulate DA and NA systems, the D-
isomer being more potent in effects on NA systems and in
inducing locomotor stimulation (Taylor and Snyder, 1971;
Scheel-Kruger, 1971). It was concluded by these workers
that stimulation of DA systems was the important element
in the production of stereotyped behaviour whereas NA
systems were concerned with the effects on locomotor behaviour.
Dru;^s with agonist actions on monoamine receptors
Studies with drugs that have more selective effects
in stimulating individual monoamine systems all yield
evidence strongly implicating dopaminergic systems in the
mediation of all three behaviours. Apomorphine and its
derivatives (Fig. 4), and other DA receptor agonist drugs
such as bromocryptine, stimulate both locomotor behaviour
(usually at lower doses) and stereotypy (3rnst, 1967;
Fog, 1969; Ungerstedt, 1974; ljungberg and Ungerstedt,
1976; Johnson et al. 1976; Dolphin et al. 1977). In our
previous study (I/Iakanjuola, 1976; Hakanjuola et al. 1977b)
it was found that at low doses apomorphine induced a form












sensation whereas larger doses converted this behaviour
into a stereotyped form. There is considerable evidence
that apomorphine and bromocryptine interact with post¬
synaptic DA receptors (Ernst, 1967; And£n et al. 1967a;
Johnson et al. 1976; Seeman et al. 1978). Changes in
5-HT and NA systems are probably induced indirectly through
interactions between DA systems and NA and 5-HT systems
(Grabowska et al. 1979» 1976; Snider et al. 1975; Maj, 1977)•
There are no entirely satisfactory specific 5-HT
receptor stimulants. lysergic acid diethylamide (LSD)
is claimed to act centrally as a 5-HT receptor agonist,
its predominant action being a direct inhibition of 5-HT
neurones (Aghajanian&Hajgler,1974 ; Aghajanian et al. 1975).
There is evidence that LSD can also activate DA receptors
(Kelly and Iversen, 1975)* Contradictory findings on
exploratory and locomotor behaviour are reported for LSD
(Davis and Hedfem, 1973; Hughes, 1973; Kelly and Iversen
1975) and behavioural effects similar to those of 5-methoxy-
NjNj-dimethyltryptamine have also been claimed (Fog, 1969;
Jacobs, 1976). 5-Methoxy,-N>N?-dimethyltryptamine
(5-MNODMT), which appears to act as an agonist on 5-HT
receptors (Green and Grahame-Smith 1976) produces a bizarre
hyperactivity syndrome identical to that seen after
administration of amino acid precursors of 5-HT in the
presence of monoamine oxidase inhibition (see page 30).
^uipazine, another 5-HT receptor agonist, produces in
rats an atypical form of stereotypy, similar to the
behavioural response to 5-MEODMT, which is reduced or
abolished by 5-HT receptor antagonists but not DA receptor
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antagonists and is abolished by lesions of the mesencephalic
raphe nuclei (Gostall and Naylor 1975b). Pre-synaptic
actions may therefore contribute to its effects.
Stimulation of central noradrenergic receptors leads
to less clear-cut results. Clonidine is an<?(. -adrenoceptor
agonist (Anden et al. 1970b), and it also diminishes
neuronal NA release, probably by activation of-X -adreno¬
ceptors on the noradrenergic neuronal membranes (Starke and
Matel, 1973; Anden et al. 1976). Clonidine also stimulates
5-HT systems (Maj et al, 1975)* Given systemically the
drug causes motor sedation (Pycock et al. 1977; Zebrowska-
Lupina et al. 1977) although locomotor stimulation has also
been observed in satiated rats (Bednarczyk and Vetulani,
1977). Following destruction of central catecholamine
neurones by intraventricular 6-hydroxydopamine, Zebrowska-
Lupina et al. (1977) found that clonidine induced loco¬
motor stimulation in reserpine-pretreated rats. This
locomotor stimulation was inhibited by central o( -adreno¬
ceptor blockade but not by neuroleptic drugs. These
authors claimed that the locomotor stimulation was induced
because the inhibitory effect on NA release as a result
of its activation of pre-synaptic adrenoceptors was no
longer possible and thus the locomotor stimulant actions
resulting from interaction with postsynaptic^ -adreno¬
ceptors was unmasked. This suggestion would assume that
there is a relatively high basal level of noradrenergic
activity. Further evidence ih support of this hypothesis
might be provided by examination of the effects of selective
pre- and post-synaptic .^-adrenoceptor antagonists on the
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behavioural actions of clonidine.
In nialamide-pretreated rat3 given 1-DOPA into the
lateral cerebral ventricles clonidine inhibited the phase
of locomotor stimulation associated predominantly with
biochemical effects on NA systems (Bednarczyk and
Vetulani, 1977) presumably because of its pre-synaptic
actions. Glonidine induced exploratory behaviour in
reserpinized rats that were also given apomorphine (Fuxe
and Unger3tedt, 1970), and enhanced apomorphine-induced
locomotor activity in reserpinized mice (Anden and
Strombom, 1974; Pycock et al. 1977).
Monoamine Precursor Administration
Increased activity in individual monoamine systems
can be achieved by treatment with appropriate amino-acid
precursors which are converted intraneuronally into the
monoamine transmitters. This increase in transmitter
concentrations is greatly enhanced by pretreatment with a
monoamine oxidase inhibitor. This has been demonstrated
for L-tryptoplian and L-5-hydroxytryptophan (5-OHTP)
which lead to increased 5-HT formation (Moir and Eccleston
19b8; Grahame-Gmith, 1971a,b), as well as L-DOPA (i-dihydroxy-
phenylalanine ) which increases formation of DA and, to a
lesser extent, NA (Butcher and Bngel, 1969; Stromberg
and 3vensson;1970; Dolphin et al. 1975; Green and Kelly
1976).
L-Tryptophan administration produces selective
increases in 5-HT synthesis in 5-HT neurones leaving the
synthesis of catecholamines unaffected (Moir and Eccleston,
1968; Grahame-Smith 1971a) because of the restricted
30.
localization of tryptophan hydroxylase to serotonergic
neurones. In contrast, the decarboxylase enzyme
catalysing the conversion of L-DOPA and 5-OHTP to the
corresponding amine i3 present in both serotonergic and
catecholaminergic neurones and shows no selectivity
between the precursor amino-acids (Garrattini and Valzelli,
196f; Musacchio, 1975). Amine formation from these
precursor amino-acids can therefore take place in both
types of neurone. Administration of Ir-DOPA thus leads
to the appearance of dopamine in serotonergic neurones
with an accompanying fall in the concentration of the
normal transmitter, 5-HT. The contrary situation occurs
after administration of 5-OHTP (Butcher et al. 1972). As
Moir and Sccleston (1968) have shown for dog's brain, the
administration of 5-OHTP and of 1-tryptophan lead to
elevated 5-HT concentrations, but the pattern conformed to
the normal distribution of 5-HT only with the latter.
Given without monoamine oxidase inhibition, L-
tryptophan or 1-5-hydroxytryptophan cause only motor
sedation in mice and rats (Brown, I960; Modigh, 1972,
1973; Jacobs et al. 1974). After pretreatment with a
monoamine oxidase inhibitor, administration of L-tryptophan
or L-5-hydroxytryptophan leads to a characteristically
exceedingly bizarre behavioural syndrome consisting of
hyperactivity, abnormal limb movements, tremor, rigidity,
hyperactivity, stereotyped head movements including lateral
movements as well as nodding, and tail rigidity and
abduction (Grahame-Smith, 1971a,b; Jacobs et al. 1974;
Jacobs, 1976; Green and Grahame-Smith, 1976). It must
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be stressed that this behavioural syndrome cannot be
related to quantitative changes in locomotion or explor¬
ation and any stereotypy is quite different in character
from that seen with drugs such as amphetamine. Indeed,
behaviour seems to be essentially disorganized. The
syndrome is also elicited by the serotonergic receptor
agonist 5-methoxy-N,N-dimethyltryptamine (Grahame-Smith.,
1971b).
The syndrome produced by 5-HT agonists or by the
combination of monoamine oxidase inhibition and amino-
acid precursors of 5-HT is inhibited by neuroleptic drugs
(but not by pimozide) (Grahame-Smith, 1971b; Jacobs*
1974a)and by serotonergic receptor blockade (Jacobs, 1974"t )
but not noradrenergic receptor blockade (Jacobs et al.
1974). The syndrome produced with 5-hydroxytryptophan
or 5-methoxy-N,N-dimethyltryptamine is not blocked by
pretreatment with p-chlorophenylalanine whereas that
produced with L-tryptophan is (Jacobs, 1974; Grahame-
Smith 1971b).
L-DOPA (1-dihydroxyphenylalanine) usually induces
locomotor stimulation (Smith, 1963; Bartholini et al. 1969;
Stromberg and Svensson, 1970; Kulkarni and Dandiya, 1974;
Dolphin et al. 1976; Johnson et al. 1976; Ljungberg and
Unger3tedt, 1976). Most studies using L-DOPA also employ
peripheral decarboxylase inhibitors which potentiate the
increase in central catecholamine synthesis as well as the
motor effects (Bartholini et al. 1969; Bartholini and
Pletscher, 1969; Butcher and Dngel, 1969; Johnson et al.
1976; Molander and Randrup, 1974). The behavioural and
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biochemical responses to 1-POPA are also potentiated by
pretreatment with a monoamine oxidase inhibitor (Svensson
and Waldeck, 1970). A mild form of stereotyped behaviour
has been reported after L-POPA administration at high
dosage (Scheel-Kruger and Randrupj 1967; Rrnst, 1972;
Molander and Randrup, 1974; Johnson et al. 1976; ljungberg
and Ungerstedt, 1976).
Antagonists at monoaminergic receptors
Agents which block monoamine receptors also produce
quite marked effects on behaviour. The neuroleptic drugs
all have potent antagonistic activity on PA receptors
which is now thought to be responsible for the induced
responses (Anden et al. 1970a; Carlsson, 1974, 1978;
Seeman et al. 1976). They also have varying^usually
minor, degrees of blocking action on NA receptors (Anden
et al. 1970a) and possibly on 5-KT receptors (Leysen et al.
1976). Neuroleptic drugs inhibit locomotion and
exploration (Ryall, 1958; Jonasin et al. I960;
Boissier and Simon, 1964; Kumar, 1971b; Nakarna et al. 1972;
File, 1973). Reserpine, which depletes all three types
of monoamine neurones of their transmitter (see page 4)j
also inhibits locomotor behaviour and exploration (Ryall
1958; Boissier and Simon, 1964; Puxe and Ungerstedt,
1970). The inhibition of exploration by these drugs may
be secondary to the locomotor impairment (Battig, 1969;
Shillito, 1970).
Neuroleptic drugs also block the effects of amphetamine
and related sympathomimetic agents and of L-POPA and PA
receptor agonists 3uch as apomorphine and bromocryptine
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in stimulating exploration, locomotor behaviour and
stereotypy (liandrup et al. 1963, Del Rio and Fuentes,
1969; Costall and Naylor, 1974b,c; Ijungberg and Ungerstedt,
1976). In a previous study (Makan|rtl**tl976; Makanjuola
et al. 1977b) it was found that high doses of haloperidol
prevented both amphetamine-induced exploratory and
stereotyped behaviour, while a very small dose blocked
only the stereotypy, leaving some exploratory behaviour to
continue.
It has been demonstrated that drugs such as clozapine
and thioridazine, which show differential effects by
blocking activity in the mesolimbic DA system more than
of the nigrostriatal system (see page 8) are more effective
in inhibiting drug-induced locomotor activity than
stereotyped behaviour whereas on the other hand other DA
antagonists such as haloperidol, pimozide and chlorprom-
azine which show no such differential actions are equally
effective on both forms of behaviour (Costall and Naylor,
1975d; Delini-Stula, 1976; Ungerstedt et al. 1977). Such
differences between the neuroleptic drugs are further
exemplified by the responses following cessation of chronic
treatment. After withdrawal of thioridazine and clozapine
but not of haloperidol there is an increase in spontaneous
and apomorphine-induced locomotor activity; stereotyped
behaviour induced by apomorphine is potentiated after
withdrawal from all three drugs (Smith and Davis, 1976).
The effects of reserpine on drug-induced behavioural
changes are rather complex. This drug has been widely
observed to have no effect on amphetamine-induced
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stereotyped behaviour (Randrup et al. 1963; Fuxe and
Ungerstedt, 1970; Scheel-Kruger, 1971), although in one
study a reduction in amphetamine-induced stereotypy by
reserpine was observed (Herman, 1967)• It was claimed
that this is because amphetamine exerts its transmitter-
releasing effects on a pool of newly-synthesized dopamine
(Scheel-Kruger, 1971; Moore, 1977)• Tyrosine hydroxylase
inhibition by.A-methyl-p-tyrosine which should profoundly
affect such a pool, does inhibit amphetamine-induced
stereotyped behaviour (Scheel-Kruger, 1971). Certain
other sympathomimetic drugs e.g. methylphenidate, were
thought to exert their actions through a more long-term
catecholamine pool since their stereotypy-inducing actions
were blocked by reserpine but no t.7^-me thy1-p-tyrosine
(Scheel-Kruger, 1971). The stimulant actions of
amphetamine administration on locomotion and exploration
are inhibited by reserpine pretreatment in rats (Fuxe and
Ungerstedt, 1970; Scheel-Kruger, 1971) but not in mice
(Thoraburg and Moore, 1973). The former finding was
explained on the basis that noradrenergic systems played
a major role in regulating these two behaviours and that
the NA pool on which amphetamine acted was sensitive to
the depleting effects of reserpine (Fuxe and Ungerstedt,
1970; Scheel-Kruger, 1971). Acute reserpine pretreatment
may potentiate apomorphine-induced stereotypy in rats
(Rotrosen et al. 1972; Costall and Naylor, 1973; Walla ch,
1974; Ilogilnicka and Braestrup, 1976) possibly because of
the development of DA receptor supersensitivity or
alternatively because of the removal of opposing influences
from other monoamine systems.
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-Adrenoceptor blocking agents may cause a decrease
in spontaneous locomotor activity (ljungberg and Ungerstedt,
1976) and also a reduction in the exploratory and loco¬
motor stimulation induced by amphetamine (luxe and
Ungerstedt, 1370; Rolinski and Scheel-Kruger, 1373;
Ljungberg and Un^erstedt, 1976) and by L-BOPA (And en et al.
197 7). -Adrenoceptor blockade either does not affect
drug-induced stereotyped behaviour (Randrup et al. 1963;
Herman, 1967; Del Rio and Fuentes, 1969) or may even
potentiate it (ljungberg and Ungerstedt, 1976; Mogilnicka
and Braestrup, 1976), This potentiation may be caused
by the reduction of the locomotor stimulant effects of tho
drugs. It must be em; .sized that <a-adrenoceptor block¬
ade produces marked peripheral changes including circulatory
collapse which are bound to affect behaviour. In addition
their effects may be relatively non-specific. Phenoxy-
benzamine and other haloalkylamines for example, in
addition to blocking ^-adrenoceptors (Anden et al. 1967b;
Doxey et al. 1972) also block 5-HT, histamine and
acetylcholine receptors (Nickerson and Collier, 1975).
JL -Adrenoceptor antagonists also differ in the relative
selectivity of their actions on pre- and post-synaptic
receptors (Uoxey et al. 1972; Starke et al. 1975). Agents
which block /> -adrenoceptors have no effect on stereotyped
behaviour (Randrup et al. 1963) or reduce it (Herman,1967).
Little information is available regarding the effects
of 5-HT receptor blockade, e.g. with methysergide or
cyproheptadine, on spontaneous or drug-induced locomotor
and exploratory behaviour. Inhibition of spontaneous but
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not amphetamine-induced locomotor "behaviour in mice has
been observed (Van Hiezen, 1972). Most studies have
failed to d'imonstrate an effect on apomorphine-induced
or amphetamine-induced stereotyped behaviour (Handrup
et al. 1963; Bandrup and Munkvad, 1964; Hotrosen et al.
1972; Baldesarini et al. 1979; Bolinski, 1977)» although
potentiation has been reported (V/einer et al. 1973).
Monoamine transmitter synthesis inhibition
Drugs which inhibit monoamine transmitter synthesis
may have marked behavioural effects. -Methy1-p-tyrosine»
a tyrosine hydroxylase inhibitor, causes marked behavioural
sedation and prevents the stimulation of all three behaviours
by amphetamine (Drnst, 1967; Arnfred and Randrup, 1969;
Scheel-Kruger, 1971; iiandrup and Scheel-Kruger, 1973;
Thornburg and Moore, 1973), while there is no effect on
apomorphine-induced stereotypy (Hotrosen et al. 1972)', this is
evidence for the indirect nature of the actions of
amphetamine in contrast to the direct receptor activating
effects of apomorphine.
Dopamine- p -hydroxylase inhibitors, which prefer¬
entially inhibit NA synthesis, have been found to reduce
spontaneous locomotor and exploratory activity (Mayer and
3ybl, 1973; Vetulani et al. 1973) or to have no effect
(ljungberg and Ungerstedt, 1976). They reduce but do
not abolish locomotor and exploratory behaviour induced
by amphetamine (Mayer and 3ybl, 1973; Khalsa and Davis,
1975; Djungberg and Ungerstedt, 1976) although one study
could not demonstrate any effect (Thomburg and Moore,1973).
Jj-DOxJA-induced locomotor* stimulation is also decreased but
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not abolished (Svensson and Waldeck, 1970; Stromberg and
Svensson, 1971; Molander and Bandrup, 1974; Dolphin et al.
1976; Anden et al. 1977)» but again some workers have
failed to observe any effect (Scheel-Kruger and Bandrup,1967).
As with <£, -adrenoceptor blockade, dopamine - f} -
hydroxylase inhibition has been reported to have no action
on drug-induced stereotyped behaviour or to potentiate
it (Bandrup and Scheel-Kruger, 1966; Mayer and ISybl, 1973;
Ljungberg and Ungerstedt, 1976; Mogilnicka and Braestrup,1976).
Depletion of 5-HT neurones of their transmitter by
parachlorophenylalanine or p-chloroamphetamine usually
leads to increases in spontaneous essploratory and loco¬
motor activity (Chrusciel and Herman, 1969; Fibiger and
Campbell, 1971; Jacobs et al. 1975a; Segal, 1976; Marsden
and Curzon, 1977) although in a few studies no effect
(Breese et al. 1974) or an inhibition has been observed
(Vorhees et al. 1975). These drugs also potentiate the
locomotor stimulant actions of amphetamine (Mabry and
Campbell, 1973? Breese et al. 1974; Segal, 1976) but
usually have little effect on amphetamine - or apomorphine-
induced stereotypy (Botrosen et al. 1972; Breese et al.
1974; Baldesarini et al. 1975; Segal, 1976). In one
study a potentiation of amphetamine-induced stereotypy by
p-chlorophenylalanine was obtained but this wa3 not
modified by 5-hydroxytryptophan administration (Baldesarini
and Griffith, 1976).
Antidepressant drugs
Antidepressant drugs are known to exert profound
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effects on monoamine systems. Monoamine oxidase inhibitors
are extensively used as pharmacological tools in the study
of behaviour and in biochemical pharmacology. Certain
problems limit their use in examining the roles of specific
monoamine systems. They have significant effects on the
rate of metabolism of psychoactive drugs and other sub¬
stances (Boakes, 1974; Ho, 1972). We are also a long way
from finding a usable drug with effects on only one system.
Although this seemed a possibility with the alleged demon¬
stration of multiple forms of monoamine oxidase with some
selectivity for different substrates (Neff and Tang 1974;
Youdim, 1974); it has been suggested that the results may
be artefactual (Jain, 1977).
On first consideration monoamine neuronal uptake
inhibitors would appear to provide useful tools in the
study of monoamine systems. The antidepressant drugs of
this group known collectively as the tricyclics exert
effects on both NA and 5-HT uptake mechanisms in their
respective neurones, although some are slightly more
effective on the one than the other. For example,
desmethylimipramine and nortriptyline (Fig. 5) are more
effective inhibitors of NA uptake while imipramine and
amitriptyline are more effective on 5-HT uptake (Iversen,
1975; Schacht et al. 1977)* These drugs are relatively
ineffective in inhibiting DA uptake (Horn et al. 1971;
Iversen, 1975)* Recently compounds with much more
selective actions have been introduced. Chlorimipramine
and zimelidine (Fig. 5) are much more potent inhibitors
of 5-HT uptake than of NA uptake (Ross and Renyi, 1977;
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7/aldmeier et al. 1976). The recently introduced drug
nomifensine is a potent inhibitor of DA as well as NA
uptake and has minimal effects on 5**KT uptake (Hunt et al.
1974; Schacht et al. 1977).
In general, monoamine uptake inhibitors with actions
on NA and 5-HT systems have little effect on behaviour.
Most cause sedation and varying, usually slight, reduction
of motor activity (Sulser et al. 1962; Klerman and Cole,
19o5; Kulkarni and Dandiya, 1974; Spencer, 1977).
Nomifensine, which inhibits DA as well as NA uptake ha3
very potent locomotor stimulant properties, and at high
dosage will induce stereotyped behaviour (Braestrup and
Scheel-Kruger, 1976; Costall and Naylor, 1977; Hoffman,
1977). It would appear that it is the effects on DA
systems that are important for these actions since they
do not occur with compounds which inhibit NA or 5-HT
uptake only.
Uptake inhibitors might also provide specific tools
for modifying the effects of other drugs. The interaction
of amphetamine with tricyclic drugs has been much studied
in this respect and the ability of uptake inhibitors to
potentiate the locomotor stimulant and stereotypy-inducing
effects of amphetamine now appears to be part of the
general test battery employed during pharmacological
evaluation of uptake inhibitors. These drugs potentiate
a variety of behavioural effects of amphetamine (Carlton,
1961; Sulser et al. 1966; Stein and Sifter,1961;Spencer,1977).
The monoamine uptake inhibitors do not appear to have been
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FIG* 5? Some neuronal monoamine uptake inhibitors.
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changes in terms of activity on uptake of specific mono¬
amines. It was originally believed that this potentiation
of amphetamine effects was caused by prevention of the
reuptake of monoamines released by amphetamine, in which
case the effects miJit indeed provide a useful method of
studying specific monoamine systems. However, it has
been shown that tricyclic uptake inhibitors also prevent
metabolism and inactivation of amphetamine in the liver,
mainly by preventing p -hydroxylation for which process
the tricyclic drugs compete (Sulser et el. 1366; Lawander,.
1968; Valzelli et al. 1968; Garrattini et al, 1976).
The marked potentiation of amphetamine effects seems to
be a property common to all neuronal uptake inhibitors,
including several that are structurally unrelated to
tricyclic compounds and which could not be in competition
for the P-hydroxylation process. Moreover, the behavioural
effects of amphetamine are mediated predominantly by
dopamine systems and most of the uptake inhibitors are
relatively ineffective on DA uptake.
Much more information might be gained by testing the
effects of the newer drugs as well as the conventional
" tricyclic" drugs on amphetamine metabolism, to see
whether the potencies of a variety of these drugs on
amphetamine metabolism correlate with their potencies in
potentiating the behavioural effects of amphetamine.
c. ST-miDOIACf 1C MANI1ULATIQN 01 MOHQAMIh 1 lATh.vAYS
Much attention lias focussed recently on the relative
importance of the nigrostriatal and mesolimbic DA systems
in the mediation of locomotor and stereotyped behaviour.
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less attention has been paid to the roles of NA and 5-HT
systems* In the context of manipulation of individual
pathways, exploratory behaviour has been largely ignored.
The individual pathways can be manipulated either by
lesioning them at different points between origin and
termination or by injecting transmitters or psychoactive
drugs into terminal areas. In general, lesioning of
cell body groups or terminal areas providesmore specific
information than lesions in the intermediate pathways
because of the close interrelationships of different
systems and of individual subsystems as they ascend, for
example, in the medial forebrain bundle. In this respect
the use of specific neurotoxins such as 6-hydroxydopamine
or the toxic dihydroxytryptamines allows selective lesioning
of one particular type of monoamine neurone, but even then
no distinction will be possible between individual sub¬
systems subserved by the same transmitter. It is however
possible in some cases to lesion selectively individual
pathways near their origins or termination.
Dopaminergic Systems
During the last decade, two bodies of opinion have
emerged as to the behavioural roles of the nigro-striatal
and the mesolimbic DA systems. Many workers believed
that the mesolimbic system was involved in the mediation
of drug-induced locomotor stimulation whereas the nigro-
striatal system was involved in stereotypy (e.g. Melly et
al. 1975)• Costall and his colleagues (e.g. Gostall and
Naylor, 1974a) held the opposite view. Gradually the two
schools of thought have converged, mainly as a result of
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some accommodation on the part of Naylor and his colleagues.
When reviewing the effects of DA pathway lesions on
behaviour it is necessary to make a distinction between
lesions induced with 6-hydroxydopamine (6-OHDA) and those
by electrolytic or other physical means. 6-Hydroxy-
dopamine is a specific toxin to catecholamine neurones
(Ungerstedt, 1971e; Javoy et al. 1975) and its injection
will produce degeneration in DA and NA neurones only.
Destruction of noradrenergic fibres by 6-OHDA can be
prevented by blocking its uptake into noradrenergic
neurones with desmethylimipramine or protriptyline
(Iversen and Kelly, 1975; Roberts et al. 1975)• Destruction
of the dopaminergic neurones is followed by the development
of supersensitivity of post-synaptic DA receptors.
(Ungerstedt, 1971°; Ungerstedt and Marshall, 1975).
Following a 6-OHDA lesion, therefore, there should be a
potentiation of the effects of drugs such as apomorphine
which act post-synaptically on DA receptors and an
inhibition of the effects of drugs such as amphetamine
which act presynaptically. This has been conclusively
demonstrated (e.g. Ungerstedt, 1971c;,d; Kelly et al.l975)»
Any 6-OHDA lesion which does not induce these opposite
effects with apomorphine and amphetamine must be suspect.
Electrolytic lesions will destroy all fibres and
cell bodies in the area, including afferent and efferent
fibres and fibres of passage. Very different effects
might therefore follow from those seen with 6-OHDA, and
Pa
apomorphine and amphetamine should produce the same
behavioural responses following electrolytic lesions.
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While it is now generally believed that drug-
induced stereotyped behaviour is mediated by the nigro-
striatal pathway, most studies have failed to demonstrate
any effect on apomorphine - or amphetamine-induced stere¬
otypy following electrolytic lesions of the substantia nigra
(Iversen, 1971; Simpson and Iversen, 1971) or of the
caudate-putamen (McKenzie, 1972; Divac, 1972; Gostall and
Naylory 1973a, 1974a). One study demonstrated abolition
of apomorphine-induced but not amphetamine-induced
stereotyped behaviour following lesions in the substantia
nigra (Costall et al. 1972), Apomorphine- and amphetamine-
induced stereotypy is drastically reduced or abolished
following electrolytic lesions of the globus pallidus
(Naylor and Olley, 1972; Costall and Naylor, 1973a,1974a;
Costall et al. 1975a). It should be remembered that the
globus pallidus receives projections from the nucleus
accumbens (Conrad and Pfaff, 1976) a3 well as from the
neostriatum (Szabo, 1970; Garcia-Munoz et al. 1977). A
few studies have demonstrated a reduction in amphetamine-
induced stereotyped behaviour following electrolytic
lesions of the oaudate-putamen (Naylor and Olley, 1972;
Neill et al. 1974).
A 6-hydroxydopamine lesion of the substantia nigra
usually blocks amphetamine-induced stereotypy and enhances
apomorphine-induced stereotypy (Ungerstedt, 1971d; Creese
and Iversen, 1972, 1975; Pibiger et al. 1973; Price and
Pibiger, 1974; Brook and Iversen, 1975). It should be
remembered that b-OHDA lesions of the substantia nigra
may also affect dopaminergic fibres of the ascending
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mesolimbic system which pass nearby. Electrolytic
lesions may, additionally, damage the striato-nigral
pathway (see Garcia-Munoz et al. 1977). b-Hydroxy-
dopamine lesioning of the caudate-putamen enhances apomor-
phine-induced stereotypy while preventing amphetamine-
induced stereotypy (Asher and Aghajanian, 1974; Creese
and Iversen, 1974; Kelly et al. 1975)*
Most studies have shown that 6-OHDA or electrolytic
lesions of the caudate-putamen and substantia nigra do not
affect apomorphine-induced or amphetamine-induced locomotor
stimulation, (Naylor and Olley, 1972; Creese and Iversen,
1972; Costall and Naylor, 1973e; Neill et al. 1974; Brook
and Iversen, 1975; Kel3.y et al. 1975), although a reduction
in amphetamine-induced locomotor stimulation following
o-OHDA or electrolytic lesions of the substantia nigra has
been observed (Iversen, 1971; Simpson and Iversen, 1971;
Creese and Iversen, 1975; lioberts et al. 1975)* The
problems of lack of selectivity with substantia nigra
lesions have already been pointed out.
There are also differing claims regarding the effects
of lesions of uiesolimbic pathways. Iversen ana her
colleagues (Creese and Iversen, 1974; Kelly et al. 1975;
Kelly and Iversen, 1976) found that 6-hydroxydopamine
lesions of the accumbens nuclei, which also affected the
olfactory tubercles, prevented the locomotor stimulant
actions of amphetamine while potentiating the locomotor
stimulant effects of apomorphine. However Naylor and
his colleagues using electrolytic lesions of various
terminal areas of the mesolimbic DA system obtained quite
different results (Gostall and Naylor, 1973a,1974a,1974b;
Gostall et al. 1975a). These workers found that lesions
in these areas produced effects predominantly on stereo¬
typed behaviour induced by amphetamine and apcmorphlne.
Lesions of the accumbens nuclei and olfactory tubercles
abolished the 'low intensity' components of sniffing and
head movements. Lesions of the central nucleus of the
amygdala abolished the 'high intensity' components of
gnawing, biting and licking. One independent study
confirmed that apomorphine-induced stereotypy was
abolished by olfactory tubercle lesions (SlcKenzie, 1972),
Clearly, further experiments are needed to resolve
these conflicting findings, In particular it may be
rewarding to examine more carefully the effects of
discrete lesions of different LA terminal areas in the
mesolimbic system and of different parts of the caudate-
putamen. It would be interesting to see the results of
6-OHDA and electrolytic lesions from the same laboratory
and also to take further the contention of Naylor and his
colleagues that different forms of stereotypy may be
subserved from different anatomical loci.
Lesioning of the *A10' LA nucleus has been found to
cause sustained hyperactivity with diminished attention
to the environment (Galey et al. 1977; Stinus et al. 1977).
It is difficult to fit this in with the above findings
regarding the destruction of terminal areas. The syndrome
appears to be related to LA neuronal depletion in the
frontal cortex (Tassin et al. 1973).
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In summary, observations following 6-OHDA lesions
indicate that amphetamine- and apomorphine-induced loco¬
motor stimulation are mediated through the accuabens nuclei
whereas stereotypy is mediated through the caudate-putamen.
Observations following electrolytic lesions do not provide
such clear-cut results but seem to suggest amphetamine-
and apomorphine-inducsd stereotypy to be mediated through
terminal areas in the mesolimbic dopaminergic system.
Further important evidence regarding the functional
roles of the mesolimbic and nigrostriatal pathways has
come from studies of the effects of application of mono¬
amine transmitters and drugs to DA terminal areas in rats.
Pijnariburg and van Possum (1973) were the first to demon¬
strate that injection of dopamine into the nucleus
accumbens causes locomotor hyperactivity in rats pre-
treated with a monoamine oxidase inhibitor; this was
subsequently confirmed (Costall and Naylor, 1975c;
Gostall et al. 1975b; Jackson et al. 1975). The loco¬
motor stimulation was noticed to be accompanied by
continuous sniffing. Dven without monoamine oxidase
inhibition the locomotor response still occurred although
it was less intense (Jackson et al. 1975; Pijnenburg et
al. 1976). The response was blocked by neuroleptic
drugs but not by NA receptor blocking agents (Jackson
et al. 1975; Gostall and Naylor, 1976; Pijnenburg et al.
1976). Injection of NA into the nucleus accumbens
induced a slight locomotor stimulation only in nialamide-
pretreated rats which was blocked by systemically admin¬
istered haloperidol; ^-noradrenergic blockade had
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inconsistent effects (Pijnenburg and van Bossum, 1973;
Jackson et al. 1975? Pijnenburg et al. 1976). 5-HT
injection has been reported to produce either no behavioural
change (Jackson et al. 1975) or a reduction in locomotor
activity (Gostall et al. 1976; Pijnenburg et al. 1976).
Bilateral application of an inhibitor of gamma-
amino-butyric acid transaminase, ethanolamine-O-sulphate,
to the globus pallidus or electrolytic lesions of the
globus pallidus blocked the effect of DA applied to the
nucleus accumbens (Pycock and Horton, 1976).
DA injection into the caudate-putamen has been shown
to induce stereotyped behaviour, especially the high-
intensity components of licking, biting and gnawing (Fog
and Pakkenburg, 1971; Pijnenburg and Van Bossum, 1973?
Costall et al. 1974a; Costall and Naylor, 1975a? Jackson
et al. 1975 )• NA and 5-HT injection into the striatum
did not result in behavioural changes (Costall et al. 1974;
Jackson et al. 1975).
Application of apomorphine and its derivatives, or
of amphetamine or L-DOPA into the neostriatum or nucleus
accumbens has been reported to produce effects very similar
to those of DA (Ernst and Smelik, 1966; Costall et al.1974?
Costall et al. 1975a, 1975b; Jackson et al. 1975), although
Pijnenburg et al. (1976) have found apomorphine injected
into the nucleus accumbens to produce both stimulation
and depression of locomotor activity; these different
responses which occurred even in the same animals and
were not dose related were inexplicable.
Injections of DA into the olfactory tubercles
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produces similar effects to those of injections into the
accumbens nuclei (Pijnenburg et al. 1975a). DA and
aponiorphine application to the central nucleus of the
amygdala did not affect behaviour (Gostall and Naylor,
1975a; Costall et al. 1975a, 1975k).
Neuroleptic agents injected directly into the nucleus
accumbens has been reported to block the locomotor stimulant
but not the stereotypy-inducing effects of amphetamine
(Jackson et al. 1975; Pijnenburg et al. 1975b) while
haloperidol injection into the neostriatum was found to
block the stereotyped response to amphetamine (Fog & Pakkenburg,
1971; Gostall et al. 197&a).
These observations regarding the effects of direct
drug application to PA-rich areas lend further support to
the idea that the nucleus accumbens and olfactory tubercle
are concerned with the mediation of locomotor activity
and "stereotyped sniffing" while the neostriatum is
involved in the •high intensity* components of stereotyped
behaviour!gnawing, biting and licking. The consistent
failure of Naylor and his colleagues to detect any behavioural
changes following PA or apomorphine application to the
central nucleus of the amygdala casts doubt on the relev¬
ance of their findings regarding the effects of lesions of
that nucleus (page 45)• The behavioural changes following
lesions of this nucleus could be the indirect consequence




Manipulations of NA systems have much less dramatic
effects onbehaviour than do manipulation of dopaminergic
systems. Bilateral lesions of the locus coeruleus produced
no effect on spontaneous activity or on the looomotor response
to apomorphine or amphetamine (Pycock, 1977; Anlezark et al.
1973) and the same applies to the effects of selective
lesioning of the ascending NA pathways (Roberts et al.1975;
Creese and Iversen, 1975; Pycock, 1977). One study, how¬
ever, did indicate a potentiation of amphetamine- but not
apomorphine-induced stereotyped behaviour following lesions
of ascending NA pathways (Braestrup, 1977) while another
indicated a potentiation of apomorphine and amphetamine-
induced stereotypy following locus coeruleus lesions
(Kostowski et al. 1977).
The effects of NA injection into the nucleus accumbens
and caudate-putamen have already been described (pages 4-6,47).
These effects of manipulations of monoamine systems may be
mediated through DA systems. Such an interaction has been
amply demonstrated by the effects of unilateral locus
coeruleus lesions. Such unilateral lesions of the loous
coeruleus lead to contraversive circ?.ing behaviour under the
influence of apomorphine or amphetamine; this turning
appears to be related to indirect effects on the nigro-
striatal DA system since it was unaffected by systemically
administered <^or adrenoceptor blocking agents but abolished
by DA receptor antagonists and reversed by ipsilateral sub¬
stantia nigra lesions or injection of phenoxybenzamine into
the ipsilateral substantia nigra (Pycock et al. 1975}
Donaldson et al. 1976).
Serotonergic (5-HT) Systems
Manipulations of certain 5-HT pathways have been
reported to produce clear-cut behavioural effects. Most
early work involved examination of the effects of
combined lesions of the dorsal and median raphe nuclei
(B7 and B8 cell groups). These lesions led to an
increase in spontaneous locomotor and exploratory activity
(Kostowski et al. 1968; lorens et al. 1971, 1976; Srebro
and Lorens, 1975) and an increase in the locomotor response
to apomorphine and amphetamine (Neill et al. 1972;
Grabowska, 1974; Geyer et al. 1976). More selective
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lesioning experiments showed that it was the median and
not the dorsal nucleus lesion that was responsible for the
increase in spontaneous activity (Jacobs et al. 1974,
1975a,b; Srebro and Lorens, 1975; Geyer et al. 1976;
Costall et al. 1976), although in one study it was reported
that the dorsal raphe lesion was more effective than the
medial lesion in producing such actions (Prsewlocka et
al. 1977).
Lesions of the lateral mesencephalic raphe nuclei
(B9) did not lead to any behavioural changes (Geyer et
al. 1976). As has already been discussed, biochemical
and other evidence indicates that the median nucleus
projects to the hippocampus and other mesolimbic areas
whereas the dorsal nucleus projects to the striatum and
other forebrain areas (page 18). It has therefore been
proposed that the locomotor effects of mesencephalic
raphe lesions are mediated through the hippocampus.
Median or dorsal raphe lesions decrease the stereo¬
typic effects of apomorphine and nomifensine (Costall et
al 1975a; Costall and Naylor, 1977).
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Intracerebroventricular injection or infusion of
5-HT has bean found to cause a reduction in the spontaneous
locomotor activity of rats (Green et al. 1976; Warbritton
et al. 1978) and a reduction in the locomotor effects of
amphetamine (V/arbritton et al. 1978). Injection of 5-HT
into the nucleus accumbens in rats has been reported
either to have no behavioural effects (Jackson et al. 1975)
or to cause a decrease in spontaneous locomotor and explor¬
atory activity (Gostall et al. 1976; Pijnenburg et al. 1976).
The injection of 5-HT into the nucleus reversed in a dose-
related manner the hyperactivity response to DA previously-
applied to the nucleus (Gostall et al. 1976; Costall and
Naylor, 1978). 5-HT receptor blockade by cyproheptadine
reversed both this 5-HT inhibition as well as the inhibitory
effects of neuroleptics on the DA response (Costall and
Naylor, 1978). Pinally, lesions of the median raphe
nuclei potentiated the hyperactivity response to DA applied
to the nucleus accumbens (Gostall et al. 1976). In
contrast to the findings of other workers (page 18) Gostall
et al. have reported their median raphe lesions to produce
large reductions in the 5-HT content of cortex, striatum
and "limbic forebrain". The last includes the accumbens
nucleus and olfactory tubercle.
The behavioural syndrome (page 30) following treat¬
ment with 5-KT precursors in the presence of monoamine
oxidase inhibitors or following 5-HT receptor stimulation
is potentiated by selective degeneration of 5-HT neurones
following intraventricular 5, 7-dihydroxytryptamine
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administration (Trulson et al, 1971). It is not clear
why 5-HT precursors should be effective in situations
where the serotonergic neurones have been destroyed,
lesions of the striatum and serial transections as far
as the posterior midbrain have no effect on the syndrome
(Jacobs, 1976).
CONGLU 3 ION
The drug studies point overwhelmingly to a powerful
influence of dopaminergic systems in the regulation of
exploratory, stereotyped and locomotor behaviours. Nora¬
drenergic influences may also play a less important role
in the mediation of locomotor and possibly exploratory
behaviour. Serotonergic influences 3eem to exert
antagonistic effects on locomotor behaviour but there is
less evidence concerning such influences in the mediation
of stereotyped behaviour.
Studies employing stereotactic lesions of monoamine
pathways or stereotactic application of neurotransmitters
and psychoactive drugs to specific brain areas further
indicate that mesolimbic and nigrostriatal pathways
exert differential effects on locomotor and stereotyped
behaviours and that different systems are concerned with
different forms of stereotypy. These studies have failed
to show any important role of noradrenergic systems, but
the studies of NA pathway manipulations are limited.
Again there is some evidence of antagonistic influences
of 5-HT systems on locomotor and exploratory behaviours.
When examining the roles of individual monoamine
systems on behaviour, the functional interactions of the
three systems must always be remembered.
It is evident that much contradiction exists in the
findings regarding the effects of manipulation of central
monoamine systems on exploratory, stereotyped and locomotor
behaviour, whether the manipulation be with systemioally
or locally applied drugs or with discrete lesioning.
The majority of studies have involved examination of only
one of the three behaviours, or at best,two. The studies
presented in this thesis involve simultaneous quantitative
.
examination of all three behaviours in an attempt to
examine the relationships between these behaviours a3
well as the roles of monoamine systems in their regulation.
54.
II. METHODS AND MATERIAL!.
Experiments reported in this thesis involved a study
of rat behaviour under a variety of circumstances.
Exploratory, stereotyped and locomotor behaviours
were monitored by a "hole-board" method. The effects of
certain drugs administered systemically or intracerebrally
on such behaviour have been studied. In some experiments
rats with electrolytic or chemical lesions in selected
brain areas were employed. Accuracy of location of intra¬
cerebral injections and of electrolytic lesions was
determined histologically post mortem. Estimation of
dopamine and noradrenaline in brain tissue was used to
assess the degree of chemical lesioning and estimation of
amphetamine in plasma and brain tissue were carried out
on occasion.
The various methods are described in detail below.
1. AN ILIALb RNE ThElR MA INT ENANOE
Male Wistar rats were used in all experiments. For
14-21 days before behavioural study, the animals were kept
four to a cage in a room in which the light-darkness cycle
had been artificially altered, the lights being switched
on between 2000 hours and OQOO hours and darkness maintained
between 0800 and 2COO hours. Food and water was supplied
ad libitum. Just before behavioural study each animal
was transferred singly in a small cage to the experimental
room. For the acute drug studies and the studies of the
effect of stereotactic intracerebral injection of monoamines
each animal was used once only. Animals with stereotactic
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lesions were studied on three occasions at intervals of
one week, the first being 10-14 days after lesioning.
Animals weighed 250 - 20 g at time of experiments, except
in certain experiments with stereotactically lesioned
rats, where the weight at time of experiment was difficult
to control.
2. PaOC5UUi.l3 FOE MOITIlOItlHQ BSHAVIOUii FOLLOWING
3P3SIPI1D PATTA1ATL1CNTS
The animal was placed in the middle of the floor of
the hole-board apparatus described below. The door of
the air-conditioned thermostatically-controlled compartment
housing the hole-board apparatus was closed and automated
quantitation of certain aspects of the animal's behaviour
started immediately. Closed-circuit television allowed
observation of the behavioural pattern without disturbance
of the animal. during such observation behaviours such
as head dipping into the holes of the hole-board, locomotor
activity, grooming, rearing, immobility, sniffing and
stereotyped behaviours were noted.
The Hole-Board Apparatus
The hole-board apparatus (Pig. 6) consisted of a
square open field 35x35 cm with an aluminium floor.
■Cvenly spaced on the floor were lb holes 3»5 cm diameter
arranged in four parallel rows of four holes each. The
floor was supported 8 cm above a sturdy table surface.
The field was surrounded by vertical perspex walls 22 cm
high. A detachable perspex roof completed the box.
Ventilation was provided by 21 air holes 0.5 cm diameter
FIG. 6t The hole-board apparatus. A rat is seen
dipping its head into a hole.
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drilled in the roof and completed through the holes in the
floor. A tissue-covered board was positioned under the
floor during each experiment to collect faeces and urine
for easy disposal. The apparatus was kept in an air-
condition ?d compartment 3 m high, 1.7 m long and 1.5 i
wide on a sturdy table-top 1 m above the floor. The
compartment was sound-proof and maintained at a temperature
of 22 - 1°C. Subdued lighting was provided by a 15 watt
red light bulb. After each experiment the apparatus was
cleaned with warm water.
A detection system was installed on the hole-board
so that a record could be obtained of (a) the sequence
of hole-dips performed by an animal on the board and (b)
its locomotor activity, i.e. an estimate of how much the
animal moved around on the hole-board. These behaviours
were monitored using infra-red detectors and recorded on
a teletype machine.
In order to monitor hole-dipping, eight infra-red
transmitters were arranged beneath the sides of the hole-
board so that two sets of four parallel beams each passed
at right-angles to each other at a depth of 1.5 cm beneath
the floor. The depth of the infra-red beams beneath the
floor -was such that they were interrupted when both eyes
of the animal reached the level of the hole. Each beam
passed beneath a row of four holes so that each hole had
two beams passing through its centre at right-angles,
dach hole was thus labelled according to which two beams
passed beneath it (Fig. 7). Each beam was focussed onto
an infra-red receiver on the other side of the hole-board.
FIG. 7: The arrangement of the infra-red transmitters
and receivers beneath the floor of the hole-board.
Discontinuous lines represent the infra-red beams.
Each combination of two intersecting beams is
unique to one individual hole and thus effectively
"labels" that hole.
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When a rat dipped its head into a hole, the two beams that
intersected that particular hole were interrupted, and
this was detected by the two infra-red receivers onto whiph
the beams were focussed. The infra-red transmitters
and receivers were mounted on a sturdy base-plate of 4"
thick mild steel, accurately machined so that each device
could be held rigidly in focus. The two axes on which the
two sets of infra-red beams were arranged were designated
the "X" and "Y" axes (Tig. 7)»
Locomotor behaviour was monitored by four further
sets of infra-red transmitters and receivers arranged on
adjacent sides of the hole-board so that two pairs of
parallel beams passed at right angles to each other 3*5 cm
above the floor. The arrangement of these devices is
depicted in Fig. 8, These overhead infra-red beams were
broken as the animal moved around on the hole-board.
The output from each infra-red receiver was available
as an electrical level which changed when the infra-red
beam which was focussed onto it was broken.
The recording system for the holes is depicted in
Fig. 9, The outputs from the four receivers on each
axis passed onto a 4-input NANG gate used in OR function.
The gate output fed into a bistable.
The eight detector outputs were also fed into a shift
register so that they were available for transmission.
When a gate output changed, the bistable was latched.
When both bistables were latched the outputs were detected
at a 2-Input AND Gate, which triggered a monostable. The







FIG. 8: The arrangement of the four infra-red receivers
and transmitters above the hole-board floor for
monitoring of locomotor activity. The infra-red
beams (discontinuous lines) are interrupted as the
animal moves around.
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ation at X and Y axes, plus a pre-coded (ASCII ) carriage
return and line-feed signal and triggered the teletype
clock generator. This generator clocked the shift
register for the output device and provided pulses to the
counter, which counted up to the required number of pulses
for the total number of output characters. When the
counter reached it3 maximum, a pulse was generated via a
monostable. This reset both input bistables and the
clock generator.
The outputs from the four infra-red receivers sub¬
serving the locomotor recording fed through a 4-input OR
gate into a monostable and thence into a counter (Fig.10).
A timer was set to output every 10 minutes and load a
shift register with the activity count and the time marker
character "X". A character shifting circuit similar to
the one described for the hole-dips was used to output
this information to the teletype and afterwards reset the
activity counter and timer. The hole-dip circuit was
inhibited when the time marker output was operative.
The teletype produced a printed plus a punched paper-
tape output. The printed output consisted of a column
of pairs of numerals representing hole-dips, one
for each hole-board axis. dvery ten minutes a time-marker
character "XM was printed, followed by a five digit number
representing the number of recorded interruptions of
overhead beams during the preceding ten minutes i.e. the
"locomotor activity count". The punched paper-tape output
was employed in computer analysis of the records.
It would have been preferable to record each
f rom
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FIG. 9: Flow diagram of the circuit employed for
monitoring hole-dipping detected in the
hole-board apparatus.
MONO - Monostable
REG - Shift register
COUN - Counter
GEN - Clock generator
& - Gate
1 - OR Gate
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interruption of a locomotor beam as it occurred. This
would have allowed differentiation of repetitive interrup¬
tions of the same infra-red beam from successive
interruptions of different beams which would represent true
locomotor activity. Unfortunately the teletype employed
for the recording could handle only one event every 4C0
milliseconds. If it had been attempted to record both
hole-dips and locomotor beam interruptions as they occurredf
many of these events would have occurx-ed during the 400 m.
sec. period that another event was being recorded by the
teletype, particularly if an animal was indulging in a
high level of both hole-dipping and locomotion. An alter¬
native solution would have been to employ a separate
teletype for the recording of locomotor activity.
Because the infra-red receivers subserving the over¬
head beams fed into an OB gate, there was the situation
that any beam interruption could be recorded only when
every other locomotor beam was intact. This being so
there would be a tendency for a reduction in the counts of
repetitive beam interruptions under the influence of up
and down or to and fro movements of some part of the animal's
body since when this occurred some other stationary part
of the body was usually interrupting another beam. However
when the animal moved about different overhead beams were
continually being successively interrupted and disinterrupted,
so that a continuing registering of locomotor activity was
obtained.
A major problem with the apparatus was caused by the























IG. 10; FloW diagram of the circuit employed for
monitoring locomotor counts from the hole-hoard
apparatus as well as the time—marker facility#
MONO - Monostable
R3G - Shift Register
COUN - Counter
G3N - Clock Generator
ACTIV - Activity Counter
1 - OR Gate
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the electrical supply in the building. There was there¬
for a possibility of a high degree of intermittent
electrical interference which sometimes confounded the
recordings. Such interference would cause an immediate
record of "? ?" on the teletype in the sequence of
numerical characters representing the hole-dip3. That in
itself was no problem, since such an obviously spurious
entry could be excluded from the analysis of the results,
more importantly, the electrical interference sometimes
affected the locomotor activity counter, leading to a
spuriously high measure of activity during that 10 minute
interval. Such items on the record were again easily
recognisable since they invariably appeared as counts of
several thousand or more. Such entries were rejected
from the analysis, the criterion.!or rejection being that
of a locomotor activity count of 1000 or more which was
also over ten times that of the preceding and succeeding
counts. The occasional incomplete locomotor activity
record because of this was unavoidable. The problem was
greatly minimised after the apparatus was connected to a
different phase of the electrical supply and all other
electrical equipment disconnected from that phase.
Another source of spurious counts for hole-dipping was
tue in trusion of the feet and occasionally the tail of
the animal into holes. Such a protrusion was normally
recorded as a hole dip. At other times a limb or tail
intrusion coincided with a head dip into another hole in
which case the numerical characters recorded aid not
correspond to any of the numbers by which individual holes
were identified, the numerals recorded being a summation
of the codes on each axis for the two sets of beams
interrupted. During analysis of the records, spurious
entries were noted as errors and rejected. It follows that
these errors would tend to occur more frequently when the
animal was moving around. In general such "errors"
amounted to less than 3# of the total number of recorded
hole-dips.
Analysis of the Hecords for Hole-Dipping and Locomotor Activity
The rationale for the method of differentiating
exploratory from stereotyped behavioural patterns has been
previously described (Makanjuola, 197b: I.lakanjuola et al.
1977a). The following operational definitions were used.
An "exploratory dip" was defined as any head-dip into a
hole different from the previous one. A "stereotyped dip",
on the other hand, was a dip which occurred into the same
hole as the previous dip. In other words, if a rat dipped
in the following hole sequence (each two-digit number
coding for a particular hole) - 11, 18, 42, 42, 11, 44,
14, 14, 14, 28, a total of seven "exploratory dips" and
three "stereotyped" dips had occurred. The contribution
of "stereotyped" dipping to the dipping activity is given
by the ratio of "stereotyped" dips to the total number of
exploratory plus stereotyped dips during any period of
time (The "S/T ratio").
The punched tape record from the teletype for each
experiment was analysed by a GDC 905 computer. The
numbersof " stereotyped" dips, "exploratory" dips?
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total dips, the S/T ratio and locomotor activity counts were
computed for each 10 minute and 30 minute interval as
well as for the entire period of each experiment.
Statistical Treatment of Results
Non-parametric statistical methods were used through¬
out. When groups of three or more results were evaluated,
a Kruskal-W6.llis one-way analysis of variance was used
(Siegel, 1956). With two groups of results a Mann-Whitney
U test was used, significance levels being those for a 2-
tailed "t" test (Siegel, 1956). Results were regarded as
being statistically significant if the probability of the
differences occurring by chance was less than 0.05^.
3. DRUG TifSATLlKNTS
Systemic administration. All systemically administered
drugs were injected intraperitoneally (i.p.) in a volume
not more than 2 ml/kg body weight. Drug doses are given
in terms of the appropriate salt. With three exceptions,
drugs were prepared for injection by dissolution in
physiological saline. Phenoxybenzamine hydrochloride was
dissolved in a minimal quantity of glacial acetic acid and
made up to the required volume with saline. Haloperidol
was prepared for injection by dilution of the commercial
preparation for injection with saline. Apomorphine
hydrochloride solution (Rvans Medical) was administered
undiluted.
Intracerebral injections* NA and DA (as the hydrochlorides)
and 5-HT (as the bimaleinate) were injected intracerebrally
into conscious animals. 6-Hydroxydopamine was injected
intracerebrally to achieve chemical lesioning of DA
terminals. The procedures are dealt with in detail in
the appropriate section.
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These procedures were carried out under stereotactic
control.
otereotactic procedures
The initial stages of all stereotactic operations
were identical in all three procedures. Male uistar rats
weighing 135 - 5 g at tae time of operation were used.
The animal was anaestnetized with a halothane/medical air
mixture using a "Mini-Boyle" anaesthetic apparatus (B.O.C.).
Gas flow rate was 2.0 litres/minute. Induction was
achieved using a halothane concentration of 5^ and
anaesthesia maintained with a 2-3'/. concentration. The
animal was then secured in a Kopf stereotactic frame on which
the jaw bar was set at -2.5 tun. The ear bars used were
those designed for use in guinea-pigs, which had blunter
ends than those designed for rats and were therefore less
traumatic. The scalp was shaved with electric clippers
and the skin cleaned with tincture of iodine followed by
absolute alcohol. A mid-line incision was made starting
about 1 cm anterior to the bregma and ending a short
distance behind the lambua (fig.11). The two scalp
fiapo were then separated and the periosteum rubbed off
with gauze. Where necessary a retractor was used to
improve exposure of the operation field.
All coordinates used were with reference to the
bregma (antero-posterior (A-M) and lateral coordinates)
and uhe dorsal cortical surface (vertical coordinates).
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The coordinates used originally were derived from the
stereotactic atlas of Konig and Klippel (1963)*
Preliminary experiments showed that these coordinates
did not relate accurately to the brain areas aimed at and
they had to be modified. The final coordinates arrived
at(in mm.) were as follows: The nucleus accumbens; A-P +
1.6, lateral - 1. 5» Vertical - 7*0. The caudate-putamen;
A-P + 0.5* lateral £ 2.7, Vertical - 4«5*
"31ectrolytic lesions of the nucleus accumbens
A variable current DC power supply was constructed
for inducing the electrolytic lesions. The current was
applied through an entomoligical pin, 0.35 mm diameter,
insulated ercept at its terminal t mm. with "INSL-X"
insulating compound. The electrode was secured on the
electrode carrier in a vertical position and carefully
adjusted so that it was exactly vertical. The electrode
tip was lined up on the bregma and the required antero¬
posterior and lateral coordinates determined from the
readings on the frame. Two holes 1.7 mm diameter were
made in the skull on either side of the sagittal suture
over the proposed lesion sites using a "Renda" dental
drill with a No. 6 round burr (ASH). The electrode, which
had been positioned at the antero-posterior and lateral
coordinates for the target area was then lowered the
required depth from the cortical surface. The neutral
alectrode, a crocodile clip, was connected to the skin
flap. A current of 2 mA was passed for 15-30 seconds
on each side to induce the lesion, and the electrodes
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removed. For " sham11 lesions the electrode was lowered
to a vertical coordinate just above the target organ, and
no current was passed. The wound was cleaned, sprayed
with "Folybactrin" antibiotic spray and the scalp incision
sutured.
Chemical lesioning of the dopaminergic terminals of the
caudate-putamen and nucleus accumbens by intracerebral
injection of u-h.ydroxydopamine (6-QHDA). (Fig. 12)
Thirty minutes before the b-hydroxydopamine injection
each animal was pretreated with deamethylimpramine
hydrochloride 25 mg/kg to minimise destruction of NA
terminals (see pa^e 42) and pargyline hydrochloride
50 mg/kg to potentiate the effects of the 6-0hJA (Iversen
and Kelly, 1975).
An "Agla" micrometer syringe mounted on an Agla micro¬
meter injection unit (tVellcome Reagents) was used to
administer measured amounts of 6-OHDA through a "Fortex"
polythene 1 intravenous'cannula which terminated on a 0.3 mm
diameter dental needle. The needle was mounted on the
electrode carrier in a vertical position so that the bevel
faced causally for nucleus accumbens injections and
rostrally for caudate-putamen injections. The needle was
aligned at the cesired coordinates by the same procedure
as used in the induction of electrolytic lesions of the
accumbens nuclei.
b-hydroxydopamine hydrobromide was prepared for intra¬
cerebral injection by dissolving 4 mg (as the base) in
1.0 ml chilled physiologicalValine. L-ascorbic acid
2 mg/ml was added as antoxidant. During preliminary
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experiments, the dosages of 6-OHDA required to produce
effective DA depletion in the two nuclei were determined.
For nucleus accumbens lesions, 20 jig 6-OHDA in 5 Jil saline
were injected on each side. Neostriatal lesions were
achieved with 24 )xg 6-OHDA in 6 jil saline on each side.
The 6-OHDA was infused at the rate of 1 jil per 30 seconds.
"Sham" lesions were made by injection of 2 pi physiological
3aline in each side. The scalp wound was cleaned where
necessary, sprayed with "Polybactrin" and then sutured.
Experiments on operated animals
Animals operated on for the production of lesions or
insertion of guide cannulae were used for further experi¬
mentation after a lapse of l<c-14 days.
Intracerebral Injections of Monoamine Transmitters into
Conscious Animals
These injections were made through permanent guide
cannulae implanted at a previous operation under
stereotactic control.
(a) Implantation of guide cannulae for injection of
monoamine transmitters into the nucleus accumbens
and caudate-putamen (Fig. 13).
The guide-cannulae were made from stainless steel
screws 6.0 mm long, 3*0 mm diameter designed for chronic
recording of electrocorticograms in rats (Fig.14). These
screws were already patent through the upper half. That
channel was made completely patent by drilling a hole
through to the bottom exactly 0.51 mm diameter into which
the injection needle would fit snugly.
FIG, lit Early stages of a stereotactic operation.
The skull has been exposed and holes drilled
bilaterally over the proposed lesion sites or
in the positions for insertion of guide cannulae.
FIG. 12i Stereotactically-controlled injection of
6-hydroxydopamine into the caudate-putamen.
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A 75 gauge drill (0.51 sua diameter) was mounted
vertically on the electrode carrier to 3erve as a guide
for exact placement of the guide-cannulae. U-inj a No. 6
burr, two holes 1.65 mm diameter were drilled in the skull
with their centres at the exact desired antero-posterior
and lateral coordin tes with reference to the bregma.(page 64)
The guide cannulas were screwed in with the aid of specially
modified straight artery forceps. On each side in turn,
the guide drill mounted on the electrode carrier, set at
the exact antero-posterior and lateral coordinates for the
target organ, was lowered into the cannula to hold it in
exact position while it was permanently secured with
acrylic dental cement. The exposed skull wound was
clesihed and sprayed with "Polybaetrin" . With cannulae
inserted for n. accumbens injections, which were close
together on either side of the mid-line, a triangular
piece was cut from each side of the incised skin so that
the edges of the scalp wound could be brought together
around the two cannulae and sutured. With cannulae aimed
at the oaudate-putamen areas, which were further apart, a
hole was made in the skin on each side over the positions
of the cannulae. The edges of the scalp incision could
tuen be repaired with the oannulae protruding through the
two holes.
(b) Intracerebral injection of monoamine transmitters
into conscious animals.
Animals were pretreated with nialamide ("Niamid")
100 mg/kg i.p. k hours before intracerebral injection.
a
FIG* 13I Insertion of guide cannulae for later
injection of monoamines into the caudate-putamen
nuclei in conscious animals; (a) the cannulas
have been inserted into the skull, (b) the
cannulae have been fixed with acrylic dental
cement.
68.
Intracerebral injections were performed using an
"Agla" micrometer syringe and injection unit attached to
a 25 G. "Yale- microlance" disposable needle which had
been shortened to protrude exactly the desired depth from
the bottom of the guide cannulae situated at the cortical
surface. With reference to the mid-point of the bevel
of the needle thi3 distance was 6.5 mm for nucleus accumbens
injections and 4.5 mm for caudate-putamen injections.
The animal was restrained and the injection needle
inserted into the guide cannula, which had previously been
cleared, if necessary, of dried clotted protein and blood
with a specially shortened 25& Yalle needle or with a. No.75
drill bit. The required dose of monoamine (as the
respective salt) was then injected into each side in 1 /il
saline over a 10 second period, followed by a 10 second
pause before removal of the needle. The animal was then




histological examination of injection tracks and
$
electrolytic lesions of rat brain were performed using the
Luxol Fast Blue/Cresyl Echt violet staining method (KliF er
and Barrera, 1953). Animals were deeply anaesthetized
with 0.5 ml of 20^ (w/v) solution of chloral hydrate i.p.f
decapitated and the brain removed. The brain was transected
vertically at the aid-hypothalamic position and the anterior
portion frozen with a Jet of carbon dioxide gas. lections
FIG. 14: Diagram of the guide-cannulas implanted into
the skull for later stereotactically-
controlled injection of monoamines or saline
into discrete brain areas. The guide-
cannulae are made of stainless steel and
measure 6.0 mm long and 3«0 mm diameter.
They are held firmly in position in the
skull with acrylic dental cement.
69
of £0-40 jam thickness starting anterior to the target area
wore cut in^a linde Kryostat a;fc —25°G and collectod onto
microscope slides and stored in 70/ (v/v) alcohol
before staining.
The following materials were employed: 0.1, luxoi
fast Blue (British Drug Houses) in 952 alcohol to each
litre of which was added 5 ml 10% (v/v) acetic acid;
0.IP Cr^syl echt violet (Fluka AG) in distilled water to
which was added 2 ail 10/ (v/v) acetic acid par 350 alj
0.05/ lithium c rbon te in distilled water; 100/ alcohol
(James Borrough)* 95'/- (v/v) and "P > (v/v) alcohol; Xylene
(British drug Houses}| aspex mounting medium (Gurr).
Luxol Past Blue could be made in quantity and stored.
The Cresyl echt violet solution was made up fresh and
filtered before use.
The sections were transferred from, storage in 7Q>
alcohol into 95/ alcohol for 1 ain. ana then stained for
15 min. in Luxol Fast Blue 30lution. Excess stain was
removed by repeated immersion in 95/- alcohol and then the
sections washed by immersion in distilled water, differ¬
entiation was carried out by a quick immersion in 0.05/
lithium carbonate followed by repeated immersion in 70L
alcohol anc then in distilled water. This lithium
carbonata-alcohol-water -equonca was repeated 2-3 times
until satisfactory differentiation of white matter from
grey matter was obtained, the white matter being stained
greenish blue. The sections were oounterstained for
S min. in cresyl echt violet solution at 40 - 5°0.
differentiation of the cresyl violet stain was achieved
70.
by subsequent repeated immersion in 95% alcohol. The
tissue sections ware dehydrated by immersion in absolute
alcohol for 1 min, cleared in .xylene and mounted with
Depex mounting medium. The luxol Fast Blue stained the
white matter greenish blue while the cresyl echt violet
stained cell bodies violet.
Assessment of Electrolytic Lesions and ln.iection Tracks
A standard sheet (Fig.50) of scale drawings of serial
transverse sections of the rat brain was prepared. 3ach
drawin& obtained was an appropriately reduced photograph
of outlines traced from drawings of sections of the rat
brain in a stereotactic atlas (Konig and Klippel, 19b3).
The drawings represent serial sections from antero¬
posterior coordinates of 7.470 mm to 11.050 mm inclusive
i.e. from the position of the bregma to a point 1.5 mm
anteriorly.
When serial sections from the brains of each rat
ware examined the histological changes observed were
represented on the drawing of the corresponding section
on the standard sheet. In this way the position and
extent of electrolytic lesions could be assessed, as well
as the position of needle tracks and any other accompanying
histological changes. The extent of electrolytic lesions
was expressed as a percentage of the entire target organ,




Estimation of .Dopamine end Noradrenaline in Brain Tissue
The method was that of Coyle and Kenry (1973). The
catecholamines are converted to their 3-0-£3H] methylated
derivatives by reaction with [^H-methylj S-adenosylmethionine
(SAM) in the presence of catecho1-O-aethy1 transferase.
The [3h] methyl derivatives are then separated by solvent
partitioning following oxidative cleavage of the side chain
of the noradrenaline derivative at the-hydroxy1 group
with sodium aetaperiodate to give £3H-methyll vanillin,
4-hydroxy, 3- methoxybenzaldehyde.
(a) .Dissection of Tissues
The rats were Killed by a blow on the back of the
thorax and decapitated. The brain was quickly removed
and dissected on a glass plate resting on crushed ice.
Samples were immediately transferred into liquid nitrogen
and stored therein until homogenisation. The dissection
followed the guidelines given by Horn et al. (1374). With
the brain lying ventral surface up, the two olfactory
tubercles were first removed with the aid of curved watch¬
makers' forceps. Then, with the aid of two razor blades
a coronal cut was made 2% mm anterior to the anterior
border of the optic chiasma(F'ig. 13-b) • A second cut was
then made at the anterior border of the optic chiasma, to
produce a slice of tissue 2j> mm thick (Fig. 13b). This
brain slice was then laid flat caudal surface upwards and
a cut made passing through the ventral tips of the lateral
ventricles. A rectangular block containing the two
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aocumbens nuclei was then separated from the ventral part
of the tissue hy makin& vertical cuts passing just lateral
/
to the anterior commisures (Fig. 15b). The caudate-
putamen areas were separated from the rest of the dorsal
piece of tissue by blunt dissection using a microspatula.
A sample of cortical grey matter was also obtained from
the lateral and dorsal surfaces of the remaining tissue by
careful cutting with a ra zorb lade. To allow rapid dissection
and reproducibility, no attempt was made to obtain the
posterior portion of the caudate-putamen.
The pieces of tissue obtained were weighed frozen
just before the start of the assay. Mean weights (j^) +
Standard deviation from samples obtained from all the rat3
were as follows:
Olfactory Tubercles : 11.5 - 2.0
Nucleus Assumbens samples : 24.1-5*0
Caudate-putamen samples : 27.0 - 5.3
Cortical grey matter samples: 70.0 - 13.2
(b) estimation of the catecholamines
Tissues were homogenized with ice-cold Q.1M perchloric
acid (PCA) in a 2 ml glass homogenisation tube using a
Teflon homogeniser (Camlab). 300 jxl 0.1M PCA was used
for each 12.5 mg of samples of olfactory tubercles,
accumbens nuclei and caudate-putamen areas and 300jil for
each 50 rag of cortex. Tissue extracts for making up
standards and blanks were prspared from whole brain using
300 jolI 0. lid PCA for each 12.5 or 50 nig of tissue. To
remove precipitated protein and cell debris, homogenates
4 4 B
FIG.15: Method for dissection of different brain areas (p.71).
A - ventral surface of rat brain showing location of the first
two cuts (1 and 2); B - caudal surface of the slice of brain
tissue thus obtained, showing the position of the cuts required
for separation of the accumbens nucleus sample (3 and 4).
Dotted lines indicate position of accumbens nucleus.
OTr - lateral olfactory tracks; Tub - olfactory tubercle;
OC - optic chiasma; Hyp - hypothalamus; CG - corpus callosum;
Gaud - caudate-putamen; IV - lateral ventricle; Acc - accumbens
nucleus; AC - Anterior commissure.
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of small volumo were centrifuged in an "Gppendorf 3200
centrifuge at 15,000 g for 5 min., while tissue extracts
prepared from whole brain with a volume too large to be
accommodated in this centrifuge were centrifuged in an
MSE Mistral 22 at 10,000 g for 15 min.
300 ^il of supernatant from each sample was placed in
a 15 ml glass conical test tube. Where possible assays
were performed on each sample in duplicate. Routinely,
in addition to the tissues to be assayed, OA and NA
standards were also assayed in duplicate using 300 jil
whole brain homogenate to which was added 25 nig OA or
25 n'g NA (as the base). These were assayed in parallel •
with duplicate portions of the same homogenate with no
added amines. "Tissue blanks" were obtained by processing
two further 300 J*1 portions of whole brain supernatant
through the assay procedure but with the O-methylation
step inhibited (see below). Two 300 jil portions of 0.1M
PGA were used for duplicate reagent blank estimations.
To each tube was added 100 pi of a mixture containing:
500 jfig dithiothreitol
0.5 )imol MgClg (10 jil of a 10.165 mg
MgCl^oK^O/ml solution)
140 m.mol." IRIS" buffer at pH 9.6 (40 of a
424 mg "TRIS"/ml solution
25 jil Catechol-O-methyl transferase preparation
25 yl S-Adenosyl-L- L^H—methyl*] methionine
(lOx dilution of a stocx preparation
containing 9.2 - 12. o Ci/mmol.)
The samples were then incubated at 37°G for oO min.
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before the reaction was ended by addition of 500 jil 0.5M
borate buffer pll 10.0 and transfer to an ice-bath. The
"tissue blank" tubes hod 0.5 ml of the borate buffer
added prior to the incubation mixture and remained in an
ice-bath instead of being incubated.
(c) Attraction of methylated .dopamine and Noradrenaline
Carrier amounts of non-radioactive 3-methoxytyramine
(7 >ig)» metanephrine (3 /tg) and normetanephrine (3 >ig)
were added as a mixture of the hydrochlorides in 50 31I
aqueous solution which also contained 1 mg ethylene diamine
tetracetic acid as the sodium salt. Q-metkylated amines
were extracted into 9*5 ml water-saturated ethyl acetate/
methanol mixture (10/1 by volume) which was added to the
contents of each tube, following which the tubes were
stoppered and shaken manually vigorously for 2 minutes.
The tubes were then centrifug.od at 2000 g for 5 minutes in
an MSB Mistral II centrifuge and 8.5 ml of the upper
organic phase transferred to a fresh tube containing 500 jxlL
0.5M borate buffer pK 10.0. These tubes were then
stoppered and shaken for 2 min. and centrifuge! at 20C0g
for 5 min. A 7.5 ml portion of the buffer-washed organic
phase was transferred to a fresh test tube containing
500 jil of 0.114 hydrochloric acid and shaken for 2 min. in
order to back extract the O-methylated catecholamines into
an aqueous phase. The tubes were then
centrifuged for 5 min. at 2000g before the upper
organic layer was aspirated off. The aqueous phase was
washed by shaking with S ml water-saturated ethyl acetate
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for 2 min.; the phase was separated by centrifuging at
2,000 g and the ethyl acetate layer aspirated off.
(d) Oxidation of the matanephrines to vanillin
^odium phosphate buffer, 500 0.5M ph 7.5» was
added to the washed aqueous exti-act am the tubes transferred
to an ice-bath. To each tube was added 50 y.'L 3/ (w/v)
sodium metaperiodate, the solution mixed and the reaction
allowed to continue in the ice-bath before being terminated
after exactly 3 min. by the addition, with mixing, of
50 jxl 10^ (v/v) glycerol.
(e) reparation of tue vanillin derived from the metaneohrines
from the 3-methox.ytyramine
The vanillin derived from the periodate oxidation of
the metanephrines was extracted by shaking of the solution
with 9-5 ml toluene for 2 ain. followed by centrifugation
for 5 min. at 2000 g. The vanillin was now in the toluene
phase while the 3-methoxytyramine was retained in the
aqueous phase. The two phases were separately treated as
follows:
(i) measurement of C^il-methyl] vanillin. The vanillin
in a 9*0 ml portion of the toluene extract was back extracted
into 1000 ju.1 1H sodium hydroxide by shaking for 2 min. and
centrifuging. The organic phase separated by centrifuga¬
tion was aspirated and discarded. The aqueous phase was
acidified by addition of 100 j*l glacial acetic acid and
the vanillin re-extracted into 9»5 ml toluene by shaking
and centrifuging. A 9.0 ml portion of the toluene extract
containing the £^H-methylJ vanillin derived from the
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3-0-Ph] -metanephrines was added to a 20 ml scintillation
vial containing 400 )il " Liqgiifluor" scintillant. Each
vial was counted for 1 rain, in a Nuclear Chicago Mark II
scintillation counter. Duplicate mixtures of 400 ^1
Liquifluor and 9*0 ml toluene were also counted to provide
background counts.
Cii) Measurement of ll-meth 3-me thox;/1./ ramine.
Following the removal of the toluene phase after the aeta-
periodate reaction and toluene extraction of the vanillin,%
the aqueous phase containing the £%-*methyi3 -3-methoxy-
tyramine was washed with 5*0 ml toluene by shaking and
centrifuging. After removal of the toluene by aspiration,
500 jil 1M borate buffer pH 11 was added to the aqueous
phase and the O-methylated dopamine extracted into 5*5 jml
of a toluene/isoamyl alcohol mixture (3/2 by vol.) by
shaking and centrifugation. A 5.0 ml portion of the
toluene/isoamyl alcohol extract was added to a 20 ml
scintillation vial and mixed with 10 ml "NE 260" 3cintillant
Each vial was counted for 1 min. Background counts were
obtained in duplicate from measurements of a mixture of
10 ml scintiilant and 5.0 ml toluene/isoamyl alcohol mixture
A external standard was employed during
scintillation counting. Disintegrations per minute (d.p.m.
could then be computed from the counts per minute (c.p.m.)
using the samples channel ratio method with the aid of an
Olivetti P602 Programmer with IN 20 teletype tape reader.
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Estimation of Amphetamine in Plasma and Brain Tissue
o
She rnetaod of Anggard et al. (1970) was employed.
The amphetamine after suitable extraction is estimated by-
gas chromatography» using an electron capture detector, of
its trichloroacetyl derivative l-phenyl-2-(trichloroacetamido)
propane.
Animals were killed by a sharp blow on the head
followed by decapitation. Freely flowing blood from the
trunk was collected in a 5 ml capacity perspex tube
containing pre-added potassium EDTA (" Greyward" ) to which
a drop of physiological saline had been added 10 min. before
to facilitate dissolution of the EJTA. The brains were
tnen quickly removed and placed in liquid nitrogen, in
which they were stored until analysed. A portion of each
blood sample in a 1.5 ml "Eppendorf" plastic centrifuge
tube was centrifuge! in an Eppendorf 3200 centrifuge at
15000g for 3 min. to obtain the plasma, which was trans¬
ferred to a fresh tube and stored overnight in a deep
freeze at - 28°C prior to analysis.
Throughout the assay method all test-tubes used had
been siliconised using "Eigmacote" siliconizing fluid. (Sigma).
This was in order to prevent the adsorption of the assay
products onto the glass. The .toluene used was of the
"special for chromatography" grade (B.B.H.).
(a) Estimation of Amphetamine in Plasma
To 500 jal plasma in a siliconized glass 15 ml conical
test tube was added 1000 fxl distilled deionized water and
50 jil 5K sodium hydroxide. The amphetamine was extracted
by shaking the alkaline diluted plasma with 2.5 ml toluene
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in the test tubes, which were tightly stoppered with glass
stoppers,for 30 min. in a "Luckham" rotary mixer at
approximately 150 cycles per minute. After centrifugation
at 2000 g for 5 min. 2.0 ml of the toluene extract was
transferred to a fresh test tube. A 10 ^il portion of a
freshly prepared 1$ (v/v) solution of trichloroacetyl
chloride in toluene was added and the tube tightly
stoppered. The amphetamine in the extract was allowed
to react with the trichloroacetyl chloride in a water bath
at 40°C for 60 min. to form l-phenyl-2-(trichloroacetamido)
propane. It was found that the incubation time of 30 min.
recommended by Anggard et al. (1970) was inadequate for
completion of the reaction since increasing the interval
before the chromatography of the reacted sample led to an
increase in the chromatography reading. This did not
occur when the reaction was allowed to proceed for 60 min.
Incubated samples were allowed to cool to room temp¬
erature before being injected into the gas chromatograph.
A Hewlett-Packard gas liquid chromatoraph model S710A with
(l5mCi)electron capture detector was used. A 2 metre long
4 mm internal diameter glass column was used, packed with
5ca OY 17 on 100/120 mesh diatomite W AW JJMCS. The
operating conditions for the chromatography were as follows
Injection port temperature 200°G, oven temperature 200°G,
detector temperature 200°G. The carrier gas used was
argon/methane (90/10 v/v) at a flow rate of 40 ml/min. An
internal standardization technique was not used. (Anggard
et al. found that technique to have the disadvantage of
variation of detector response factors to standard and to
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amphetamine at different levels of sensitivity). There¬
fore a great degree of care was taken to ensure accurate
injection into the column. The "solvent flush technique"
was used (Anggard et al. 1970). This involved taking up
1.0 ,11 toluene, 0.5 air, 4 jil of the sample and finally
I >il of air into a 10 Hamilton syringe. The entire
contents of the syringe were then injected into the column,
the sample being flushed in by air and solvent.
A calibration curve was obtained from measurements of
known amounts of amphetamine sulphate added to plasma from
untreated animals. A separate calibration curve was also
produced on one occasion using amphetamine standards made
up in water instead of plasma. Amphetamine concentrations
in the samples were read off directly from the calibration
curve produced on the occasion of the assay of each batch
of samples. In determining the gas chromatographic
response the peak height was measured in mm. This
occurred at lit ain. following injection into the column.
(b) Estimation of Amphetamine in Brain
Whole brain was homogenized in 0.4M perchloric acid
(3 ml/gram tissue) and proteins and cell debris removed by
centrifugation for 15 min. at 10,000 g in an MSB Mistral
II centrifuge. A 2.0 ml portion of the extract was
transferred to a siliconized test tube, mixed with 200
5M NaOH and 2.5 ml toluene added. Thereafter the procedure
followed that for plasma. Calibration curves were obtained
from analysis of brain tissue extracts from untreated
animals to which known amounts of amphetamine had been added.
Amphetamine concentrations in the camples were read off
directly from such a calibration curve.
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7. SOURCES Of DItUGO ANG Chl&ICALS
The drugs administered to animals in this study are
listed below, with sources and certain trade names in
brackets:
Apomorphine hydrochloride ampoules containing 3 mg/ml
in 3terile water'for injaction'containing 0.1/ sodium
metabisulphite(Evans Radical); Dlr»amphetamine sulphate
(X. Light and Go.: Smith, Kline and French); benztropine
mesylate (Merck, Sharp and Bohme); chlorimipramine
hydro.chloride (Geigy Pharmaceuticals); desmethylimipramine
hydrochloride (Geigy Pharmaceuticals); dopamine
hydrochloride (Sigma); GEA 654 ("Alaprocate" , Astra
Pharmaceuticals); naloperidol ampoules containing 5 mg/ml
in water'for injection'containing lactic acid 5*83 mg/ml and
8 mg/ml sodium chloride (" Serenace", Searle); b-hydroxy-
dopamine hydrobromide (Goteborg); 5-hydroxytryptamine
bimaleinate (British Drug Houses); LiiCL 5182 (Eli Lilly
and Co.); 5-methoxy-NjNj-dimethyltryptamine (SigmaN;
methysergide hydrogen maleinate (Sandoz); nialamide
('Niamid*, Pfizer); L-noradrenaline hydrochloride (Sigma);
phenoxybenzamine hydrochloride (Smith, Kline and French);
•3KF -525A* (Smith, Kline and French).
S-adenosyl-L- ("*H-methyl) methionine 9.2- 12.6 Cl/m.mol
was obtained from The Radiochemical Centre, Amer3ham.
" Liquifluor" scintillant was obtained from New England
Nuclear Ltd. and "NE 260" scintillant from Nuclear
Enterprises Ltd. A catechol - 0 -methyl transferase
preparation prepared in the department according to the
method of Axelrod and Tomehick (1958) was kindly supplied
31.
by Mrs. A. K. Wright. Toluene "special for chromatography"
was obtained from British Drug Houses. All other reagents




1. Dose-response curve to dL-Amohetamine Sulphate
Animals were studied on the hole-board for two hours
immediately following injection of 2,4 or 8 aig/kg of DL-
amphetamine sulphate or of 1 ml/kg saline i.p.
The results are presented in Figs. 16 and 17, Tables
1 & 2. Behaviour following an injection of saline 1 ml/kg
vs-s similar to that observed previously. An initial burst
of " exploratory" dipping and locomotion was observed during
the first 10 minutes. Thereafter there was a low,
fluctuating level of both types of dipping and of loco¬
motion (Fig.16a). DI/-amphe famine 2 mg/kg produced a
small stimulation of dipping, predominantly of the
"exploratory" type as well as a slight increase in
locomotion (Fig.16b, Table 1). BL-amphetamine at a dose
of 4 mg/kg produced a much greater stimulation of
"exploratory" dipping and locomotion (Fig.16c).
"Stereotyped" dipping was less markedly stimulated and
the S/T ratio was correspondingly low. At a dose of
8 mg/kg, an initial stimulation of "exploratory" dipping
and locomotion was followed by a progressive and marked
stimulation of "stereotyped" dipping with inhibition of
"exploratory" dipping and locomotion (Fig.16d). With
increasing dosage of DL-amphetamine the initial burst of
"exploratory" dipping was enhanced. With increasing
dosage of amphetamine the overall level of dipping
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FIG-. 16: Behaviour in the hole-hoard apparatus following i.p.
administration of 1 ml/kg saline or 2, 4 or 8 mg/kg
DL-amphetamine sulphate. Each point represents mean
activity (no. of hole dips) of six rats - standard
error of the mean (S.E.M.) during successive 10 min.
intervals following the injection.
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TABLE 1: Behaviour of rats in the hole-hoard apparatus following
administration of 1 ml/kg saline or 2t 4 or 8 mg/kg
DL-amphatamine sulphate i.p. Figures denote mean
activity - standard error of the mean (S.E.M.) during
successive 10 min. intervals after injection. Six
animals were studied at each dose level.
S - number of "stereotyped" dips; E - number of
"exploratory" dips; LOC - number of locomotor counts,




0 - 10 10 - 20
DOSE
(mg/kg) s E LOC S
7? LOC
0 18 +MB 2 64 1 5 48 i 5 16 + 4 28 i 6 31 1 6
2 13
+
2 72 i 7 59-3 15
+
4 38 - 7 37-9
4 lo
+












20 - 30 30 - 40
DOSE
(mg/kg) S E LOC S E LOC
0 14
+
4 21 * 4 30-6 10
+
3 15 i 4 18-6
2 14
+
3 37 - 9 50 - 17 19 5 27 - 5 37 - 15
4 17
+
4 57 - 10 62-9 37 16 84 - 14 52-8
8 158
+











40 - 50 50 - 60
i _
DOSE
(mg/kg) s E LOC s E LOC
0 6
+
3 10 ± 4 9-4 12
+
4 13 ± 4 14 - 5
2 13
+
5 31 - 9 23-3 27
+
12 lo ± 4 24 - b
4 39
+
15 81 ± 16 44 - 11 43
+

























(Kruskal -Wallis one-way analysis of variance)
(Details of the responses of individual rats can be found in







60 - 70 70 - 80
DOSE
(Wte) S E LOG S E LOC
C 19 1 5 21 1 7 19 1 5 17 - 9 17 - 5 12-4
2 24 - 8 29 - 8 19 i 6 22 - 5 34 ± 5 18-4
















80 - 90 90 - 100
LOSE
(nig/kg) S E LOC S E LOC
0 22 - 7 20 ± 6 16-4 20 - 5 18 1 5 17-4
2 35 - 9 19 i 5 19-4 ItJ.5 - 7 12 - 6 12-7
















100 - 110 110 - 120
LOSE
(zWks) s E LOG s B LOC
0 14 - 4 21 - 5 18-5 10 ' 4 12 - 4 17 i 6
2 19 - 4 28 - 8 19 - 6 22 ± 6 26 - 8 17-7
4 39 1 15 47 - 10 43 - 16 36 ± 10 44 - 9 51 - 20
8 278 -
***
55 21 - 7 10-4 249 1
***
48 30 1 9 22 t 14
*** p< 0.01
**** p < 0.001
(Kruskal-Wallia one-way analysis of variance)









FIG. 17: Overall behaviour in the hole-board apparatus
during a two—hour period following i.p.
administration of 1 ml/kg saline or 2, 4 or
8 mg/kg DL-amphetamine sulphate. 3ach column
represents mean activity (No. of dips or
locomotor counts) of six rats.
- Standard error of the mean (G.I.M.) during
the entire period.
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IABLS 2: ■Overall behavioural reasons© in the hole-board
apparatus luring a 2-hour period following administration
of 1 aO/kg saline, or 2, 4 or 8 mg/kg Li-amphetamine
sulphate# Figures show the response of each of a
group of six animals under any one treatment. A total
of 24 animals were thus employed in the experiment.
d - " dtareotyped" clips; 2 - 1 exploratory* dips:
T - Total number of dips; 3/T ratio - ratio of





tJ ~?A M "*■ CJ T3M
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- W JLIi
S 132 107 239 24o 211 141 179 24






















LOG 287 150 211 38b 187 284 251 35




lil 534 175 340 491 326 351 369 53
2 T b83 35o bl2 9o5 503 558 bl3
*
84
3/T 0.22 0.51 0.44 0.49 0.35 0.37 0.40 + 0.04
LOO b29 209 294 - 209 300 328
+
77
2 163 242 130o 3ub 228 374 446
+
mm 175
u 862 771 518 566 862 1098 779 ♦mm 88
4 T 1025 1013 1824 932 1090 1472 122b
+
142
3/T 0.16 0.24 0.72 0.39 Q.*l 0.25 0.33 + 0.08
i
LOG 894 509 759 497 - 467 b25 .83
fN




3* 475 349 339 162 171 555 342
+
64
0 T 4141 2b45 1280 2952 4277 2764 3010
+
450
3/T 0.89 0.87 0.74 0.95 0.9b 0.60 0.87 0.04
LOG 334 - 69 81 26 344 171 69
A Kruakal-iallis one-way analysis of variance showed that the
behavioural responses produced by the four treatments were
significantly different (p < 0.01 for "stereotyped" dips
for "exploratory' dips, the 3/1 ratio and locomotor counts).
66*
ratio fell at a dosage of 4 mg/kg and then increased
markedly at 8 mg/kg. (Table 2).
A Kruskal-Wallis one-way analysis of variance shov/ea
that the differences in results between the four treat¬
ment groups for the entire 2-hour observation period were
statistically significant (p <0.01 for "exploratory" dips,
p<0.01 for "stereotyped" dips, p<0.01 for locomotor counts
and p<0.01 for the s/T ratio).
For different 10-minute intervals the results for all
three behavioural parameters were significant in the
majority of time-intervals (Table 1).
(2) Responses at repeated weekly treatments with (a)
Dl-amphetamine sulphate 4 mg/kg i.p. on six occasions
or (b) saline 1 ml/kg i.p. on three occasions
followed by PL-amphetamine sulphate 4 rag/kg.
Six animals were studied for one hour on the hole-
board following injection of 4 mg/kg DIr-amphetamine
sulphate on six occasions at exactly weekly intervals.
A further six animals were given three injections of
1 ml/kg physiological saline followed by three injections
of 4 mg/kg Dl-amphetamine, the injections all taking
place at weekly intervals.
The results are presented in Figs. 18 and 19 and
Tables 3 and 4. Repeated weekly treatment with amphetamine
led to a continuing increase in "stereotyped" dipping
response accompanied by a decrease in "exploratory"
dipping after a slight initial increase which was not
statistically significant. locomotor counts also
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TABLE 3: Changes in the behavioural response to 4 mg/kg NL-amphet-
amine sulphate during the course of repeated weekly 4..p.
administrations of the drug. Each column represents the
response of one rat during successive weekly recording for
one hour following drug administration. A total of 6
animals were thus employed in the experiment.
3 - "Stereotyped" dips; S Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of "stereo¬
typed" over total dip3; LOG - Locomotor counts.
W 81K TREAT¬ ACTIVITY RAT
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LOG 397 116 469 361 162 277 297
+
56
S 434 268 799 579 581 104 461
+
101
-r> 90b 541 343 373 92o 774 035
+
105
2 li T 1340 809 1142 952 1507 878 1105
+
113
S/T 0.32 0.33 0.70 0.61 0.39 0.12 0.41
+
0.09




o 469 412 631 970 994 729 701
+
100
E 955 601 238 61 551 871 546
+
142
3 M T 1424 1013 869 1031 154 5 1600 1247
+
128
S/T 0.33 0.41 0.73 0.94 O.04 0.46 O.58 + 0.09
LOG 42 156 814 48 154 109 220
+
120
3 816 218 876 318 *— 790 604
+
136
E 117 543 59 84 - 881 337
+
162
4 11 T 933 7ol 935 402 - 1671 940
+
207
S/T 0.87 0.29 0.94 0.79 mm 0.47 0.67 + 0.13
LOG 11 81 164 92 — 151 100
+ 28
S 356 260 1422 184 521 1319 677
+
225
E 494 387 164 47 185 505 297 4; 78
5 li T 850 647 1586 231 700 1824 974
+
243
S/T 0.42 0.40 0.90 0.80 0.74 0.72 0.66 + 0.09
LOG 32 172 132 39 29 68 79
+
24
3 1231 120 1540 1703 484 798 979 + 253
E 15 202 14 23 258 4o9 163
+
74
6 li T 124b 322 1554 1726 742 12o7 1143
+
214
S/T 0.99 0.37 0.99 0.99 0.65 0.63 0.77 + 0.11




Kruskal-Wallis one-way analysis of variance: p< 0.05 for " stereotyped'
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Week Number
FIG. 13: Behavioural response on the hole-board of six rats
following i.p. administration of 4 mg/kg DL-
amphetamine sulphate at weekly intervals. 3ach
point represents mean activity (Ho. of dips or
locomotor counts) - S. H.M. over a one-hour period
following the injection.
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TABLB 4t Behavioural responses of six rats to successive weekly
""
administration of 1 nil/kg physiological saline on three
occasions followed hy 4 mg/kg BIr-amphetamine sulphate on
three occasions. Bach column represents the behavioural
responses by one animal to the six treatments during a
period of one hour following drug administration.
S - "Stereotyped" dips; B - " Bxploratory" dips;
T - Total number of dips; s/T ratio - ratio of "stereotyped"
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LOB 197 80 249 87 131 147 143
+
26




jJS 143 168 123 55 125 88 117
+
16
2 1) T 217 253 173 74 251 186 192
+
•• 27
S/T 0.34 0* 34 0.29 0.26 0.50 0.53 0.33 0.05
LOG 130 92 185 121 108 132 128
+
13
S 37 73 134 43 90 62 83
+
13
3 193 178 71 87 104 124 126 19
3 It T 290 251 205 130 194 186 209
+
23
S/T 0.33 0.29 0.65 0.33 0.46 0.33 0.40
+
0.06
LOG 20b 80 63 149 48 96 107
+
24




































LOG 211 61 83 467 66 217 184
+
64
S 42 21 386 201 1166 419 372
+
173
E 151 183 1066 741 39 139 386 + 170
5 ti T 193 204 1452 942 1205 558 759
+
215
S/T 0.22 0.10 0.27 0.21 0.97 0.75 0.42 + 0.14
LOG 26 5 8} — 499 10 34 173
+
90




jU 89 186 077 164 44 103 244
+
128
6 l« T 182 418 1356 261 992 409 603 i 191
S/T 0.51 0.56 0.35 0.37 0.96 0.75 0.58 + 0.10
LOG 211 64 415 244 22 42 166
+
62
• • Ex ploratory'd i ps
















Week Numb e r
PIG. 19: Behavioural response of six rats in the hole-
board apparatus following weekly i.p. administration
of 1 ml/kg saline at weekly intervals for three
weeks (week nos. 1-3) and followed by weekly i.p.
administration of 4 mg/kg for three weeks (week
nos. 4-6). Bach point represents+mean activity
(No. of dips or locomotor counts) - S.3.M. over
a one-hour period following injection.
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progressively decreased after a small initial increase
which was not significant and the 3/T ratio progressively
increased. These results are consistent with an
increasing sensitivity to the effects of the amphetamine
since the changes are similar* to those produced by an
increase in amphetamine dosage in groups of naive animals
(see previous section). A Kruskal-Wallis one-way analysis
of variance showed that the behavioural changes were
statistically significant (p<0.05 for "stereotyped" dips,
< 0.05 for "exploratory" dips,< 0.01 for the ' S/T* ratio
and <0.01 for locomotor counts).
.Responses to the first dose of amphetamine were
markedly different in the six animals (Table 3). When
the results were 'normalized* by expressing the results
of each animal during the subsequent five trials as a
percentage of the initial response, the 3ame differences
in behavioural response over the six treatments was obtained.
However, the changes in "exploratory" dipping were no
longer statistically significant whereas the changes in
"stereotyped" dipping and locomotor counts were both
significant (p< 0.01).
Over three successive injections, there was no
alteration in the response to weekly saline administration
(Fig. 19,Table 4). The expected increase in hole-dipping
and locomotor counts to amphetamine given at the fourth
injection was 3esn. This response appeared less intense
thanthat seen on the fourth treatment in the group of
rats that were given amphetamine throughout (see Fig.18),
but these differences were not statistically significant.
90.
The response appeared only slightly different from that
seen on day 1 in the group treated with amphetamine
throughout and this difference was not statistically
significant. During the period of the three successive
amphetamine treatments in the saline pretreated rats
there were minor trends towards an increase in "stereotyped"
dipping response, decrease in "exploratory" dipping and
locomotor counts and increase in * S/T* ratio, these trends
however were not statistically significant in any of the
four parameters.
(3) Dffect of haloperidol pretreatment on the behavioural
response to an in.iection of saline and to the
in.iection of 8 rag/kg PL-amphetamine sulphate
Animals were pretreated with an intraperitoneal
injection of 0.05» 0,1, 0.2 or 0.4 mg/kg haloperidol
20 minutes before an injection of 1 ml/kg physiological
saline or 8 mg/kg DL-amphetamine sulphate i.p. The
results were compared with those from animals in experiment
1 above, which were treated with saline or 8 mg/kg DL-
amphetamine sulphate with no pretreatment.
On "spontaneous" behaviour (rats injected with 1 ml/kg
saline) haloperidol produced a dose-dependent reduction in
both forms of dipping as well as in locomotor counts
(Fig. 20, Table 5)* At doses of 0.2 and 0.4 mg/kg halo¬
peridol, all behaviour was almost totally eliminated.
These results were shown to be highly significant using
the Kruskal-Y/allis one-way analysis of variance (p< 0.001
for "stereotyped" dips and " exploratory" dips, <0.05 for
•S/l* ratio and < 0.01 for locomotor counts).
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TABLE 5: Effects of pretreatment with haloperidol on the
behavioural response to administration of saline.
Animals were pretreated with 0.05, 0.1, 0.2 or
0.4 mg/lcg i.p. haloperidol 20 min. before administration
of 1 ml/kg saline i.p.» following which their behaviour
was recorded in the hole-board apparatus for two hours.
The figures represent the overall activity during the
two hour period in these animals as well as the response
of non-pretreated control animals to acute saline
administration.
3 - "Stereotyped" dips; 3 - "Exploratory" dips;
T - Total number of dips; 3/T ratio - ratio of
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S 132 107 239 246 211 141 179
+
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LOG 28? 150 211 386 187 284 251
+
mm 35
S 169 111 168 162 107 165 147
+
12
E 161 219 227 268 131 253 218
+
16
0.05 T 330 330 395 430 288 418 365
+
23
3/T 0.51 0.34 0.43 0.38 0.37 0.39 0.40
+
0.02
LOG 221 156 236 206 209 293 220
+
13
S 127 137 151 172 19 121
+
26
s 154 259 261 264 59 199
+
39
0.1 T 281 396 412 436 78 321
+
65
3/T 0.45 0.35 0.37 0.39 0.24 0.36 + 0.03
LOC 271 227 310 217 291 263
+ 18
S 15 25 26 25 32 21 47 27
+
4
E 59 67 79 62 54 27 150 71
+
14
0.2 T 74 92 105 87 8b 45 197 98 + 17
3/T 0.20 0.27 0.25 0.29 0.37 0.44 0.24 0.29 + 0.03
LOG 39 68 74 — - 64 215 92
+
— 31
3 14 5 31 2 11 3 5 10
+
4
E 40 11 34 13 46 lb 22 26
+
5
0.4 T 54 16 65 15 57 19 27 36
+
9
3/T 0.26 0.31 0.48 0.13 0.19 0.16 0.19 0.25 + 0.04
LOC 79 3
^ P ,
112 — 42 — 52
+
21
"stereotyped" dips and "exploratory" dips < 0.05 for S/T ratio,















Saline Imllkg after Haloperidol (mglkg )
0 005 0-1 0-2 0-4
ex pl or.' d i ps
'stereot: dips
locom. counts
'ects of pretreatment with 0.05, 0.1, 0.2 or
• nig/kg haloperidol i.p. on the behavioural
iponse in the hole-board apparatus following
>. administration of 1 ml/kg saline. The
ju.its are compared with the response to saline
;hout any pretreatment (dose "0" ).+ "Sach
mrm represents the mean activity - S. 3.M. of
' rats during a 2—hour period immediately
Llowing the saline injection.
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Haloperidol reduced the response to 8 mg/kg DL-
amphetamine in a dose-related manner (Fig.21, Table 6
which present the results obtained following pretreatment
with different doses of haloperidol as well as those
obtained following no pretreatment with this drug.) At
the two highest doses of haloperidol (0.2 and 0.4 mg/kg)
the reoponse to amphetamine is.essentially completely
blocked. A dose of 0.1 mg/kg proved more effective in
blocking "stereotyped" dips than "exploratory1' dips and
locomotion. A striking feature of Fig. 21 is that the graph
representing the dose-rel^tad effects of haloperidol on
the amphetamine response is more or less a mirror image
of the dose-response curve to DL-amphetamine shorn beside
it. A Kruskal-Wallis one-way analysis of variance showed
that the quantitative differences in reoponse to amphetamine
with the different dose3 of haloperidol and with no pre¬
treatment were significant (p < 0.001 for
"stereotyped" and "exploratory" dips, the 3/T ratio and
locomotor counts.
(4) ,,oaif ieatlon by chronic halomeridol uretreatment of
the behavioural response following administration of
saline or 4 mg/kg PL-amphetamine sulphate
Two different experiments were performed, the first
employing a dosage of 1 mg/kg haloperidol daily, the second
employing dosages of 5 mg/kg daily.
(a) Animals were divided initially into two groups
of h- rats each. The first .^roup received an injection
of 1 ml/kg saline daily for 10 days (days 1-10) followed
by a ♦rest1 da^ when no treatment -was administered (day 11).
Amphet. 8mg/kg after Haloperi dol (mg|kg )







. 21a: Effect of pretreatment with 0.05, 0.1, 0.2 or
0.4 mg/kg haloperidol i.p. on the behavioural
response in the hole-board apparatus following
1.p. administration of 8 mg/kg DL-amphetamine
sulphate. The results are compared with the
response to amphetamine without any pretreatment
(dose Gach column represents the mean
activity - 3. S«JU of 4-7 rats during a 2-hour
period immediately following the amphetamine




















FIG. 21b: Overall behaviour during a two hour period
following i.p. administration of 1 ml/kg
saline ("0 mg/kg1') or 2, 4 or 8 mg/kg
DIr-amphetamine sulphate. Six animals were
studied at each dose. There is a striking
similarity between this figure and that of
the modification by haloperidol of the
response to 8 mg/kg amphetamine on the
opposite page (Fig. 21a).
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TA,.,LT u: Effects of pretreatment with haloperidol on the behavioural
response to administration of 8 mg/kg DL-amphetamine
sulphate. Animals were pretreated with 0.05t 0.1, 0.2 or
0.4 mg/kg i.p. haloperidol 20 rain, before administration
of 8 mg/kg JL-aniphetamine sulphate i.p. , following which
their behaviour was recorded in the hole-board apparatus
for two hours. The figures represent the overall activity
during the two hour period in these animals as well as the
response of non-pretreated control animals to acute saline
administration.
S — "Stereotyped" dips; 2 - " Exploratory" dips;
X - Total number of dips; s/T ratio - ratio of
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LOO 334 - 69 81 26 344 171
+
69
s 1023 654 2297 2556 1632
+
468
3 459 770 394 553 544
+ 82
0.05 T 1482 1424 2691 3109 2176
+
426
S/T 0.69 0.46 0.85 0.82 0.70
+
0.09
LOG 344 590 116 66 279
+
120
s 251 390 1850 90 366 590 476 573
+
221
Jj 678 1525 199 628 689 1286 1125 876
+
mm 112
0.1 T 929 1915 2049 718 1055 187 0 1601 1449
+
204
S/T 0.27 0.20 0.90 0.13 0.35 0.31 0.30 0.35
+
0.10
LOG ol5 532 259 239 293 b47 394 426
+
65
S 190 152 552 117 118 73 200
+
72
3 408 259 702 280 214 113 329
+
84
0.2 X 593 411 1254 397 332 186 530
+
154
S/T 0.32 0.37 0.44 0.29 0.36 0.39 0.3o + 0.02
LOO 261 104 208 176 95 121 161
+
27
15 16 55 73 4o 51 10 27 37
+
9
3 49 64 92 139 84 142 29 81 85
+
14
0.4 mX 64 80 147 212 130 193 39 103 122
+
1
d/T 0.23 0.20 0.37 0.34 0.35 0.2o 0.26 0.^5 0.28 + 0.02
LOG 119 152 - 85 154 156 58 196 123
+
14
Kruskal-dallis one-way analysis of variances p< 0.001 for "stereo¬
typed" dips, "exploratory" dips, S/T ratio and locomotor counts.
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The following aay (day 12) six animals were studied on
the hole-board for one hour following an injection of
1 .al/kg saline while the other six were studied following
administration of 4 mg/k& JL-amphetamine sulphate. A
second group of 1<- rats was treated with daily injections
of 1 mg/kg haloperidol for 10 days (days 1-10). There¬
after this group was treated in identical fashion to the
group treated with daily saline injections.
There was no difference between the "chronic saline"
and "chronic haloperidol" groups in the behavioural
response following saline injection (Fig.22, Table 7).
Following an injection of 4 mg/kg OL-amphetamine sulphate
the "chronic haloperidol" group showed a greater increase
in dipping activity compared with the "chronic saline"
group (Fig.22 Table 7). This increase involved "stereo¬
typed" more than "exploratory" dipping so that the d/T
ratio was increased. Locomotor counts were also greater
in the chronic haloperidol group. None of these differ¬
ences was statistically significant.
(b) In a subsequent experiment, animals were divided
into two groups of ten each. 'Each animal in the first
tproup received an i.p. injection of 1 ml/kg saline daily
for 6 days (days 1-6), while the second group received
5 mg/kg haloperidol daily for six days. There was then
a treatment-free interval of three days following which
(on day 10)equal numbers of animals from each group were
studied on the hole-board for one hour following adminis¬
tration of either 1 .al/kg saline or 4 mg/kg Jl~amphetamine
sulphate.
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TABLE 7: Effects of chronic pretreatment with 1 ml/kg saline or
1 mg/kg haloperidol for 11 days (days 1-10) on the
response to acute administration of 1 ml/kg saline or
4 mg/kg PL-amphetamine sulphate (on day 12). The
figures represent the behavioural response on the hole-
board apparatus of each rat over a one hour period
after injection.
3 - "Stereotyped" dips; 3 - " Exploratory" dips;
T - Total number of dips; s/T ratio - ratio of






























































































































































































None of the differences was statistically significant between the
two groups which received acute saline treatraent or between the groups



















FIG. 22: Effects of chronic pretreatraent with 1 ml/kg
saline or 1 mg/kg haloperidol daily on the response
to acute administration of 1 ml/kg saline or
4 rug/kg Dlr-amphetaraine sulphate. The chronic
pretreatments consisted of daily injections for
10 days (days 1-10). 48 hours later (day'12)
the animals were given either 1 ml/kg or 4 mg/kg
GL-amphetamine sulphate and behaviour recorded in
the hole-board apparatus for one hour. There were
six animals in each of the four groups. 3ach
column repi'esents mean activity - S.S.M. during
the entire one hour period.
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puring the course of haloperidol-treatment tLe
injections on Ja/s 1-2 produced marked long-lasting (up
to 24 hours) sedation. Tu.e final two or three injections
no longer produced such a sedative effect, indicating
the development of tolerance to the haloperidol. Instead
the animals were noted to be irritable.
As in the previous experiment employing a dosage of
1 mg/kg haioperidol there was no difference in the
behavioural response to saline administration between the
two groups of rats (fig.23, Table 8). There was however
a marked difference between the two groups in the response
to 4 mg/kg PL-amphetamine (Fig.23, Table 8). Compared
with the "chronic saline" group, the "chronic haloperidol"
group 3howed a marked increase in "stereotyped" dipping
(p*> 0.016) and smaller increase in "exploratory" dipping
(not statistically significant) so that the s/T ratio was
increased (p = 0.032). Locomotor counts were also
increased but this increase was not statistically
sig-nificant.
(5) Offeet of pretreatment with phenoxybenzamine
hydrochloride 20 mg/kg on the response to 4 mg/kg
■PL-amphetamine sulphate
Animals were pretreated with 20 mg/kg phenoxybenzamine
hydrochloride 40 minutes before an injection of 4 mg/kg
PL-amphetamine sulphate following which they were studied
for two hours on the hole-board. The results were
compared with those animals in experiment \ waich were

















FIG. 23* Effects of chronic pretreatment with 1 ml/kg
saline or 5 mg/kg haloperidol daily on the response
to acute administration of 1 ml/kg saline or
4 mg/kg Dl-amphetaniinb sulphate. The chronic
pretreatments consisted of daily injections for
6 days (days 1-6). 4 days later (day 10) the
animals were given either 1 ml/kg or 4 mg/kg
hlr-amphetamine sulphate and behaviour recorded in
the hole-board apparatus for one hour.. There
were five animals in each of the £our groups. Each
column represents mean -activity - S.E.M. during
the entire one hour period.
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TABLE 8: Effects of clironic pretreatment with 1 ml/kg saline or
5 mg/kg haloperidol for 6 days (days 1-6) on the response
to acute administration of 1 ml/kg saline or 4 mg/kg
DL-amphetamine sulphate (on day 10). The figures
represent the behavioural response on the hole-board
apparatus of each rat over a one hour period after
injection.
3 - "Stereotyped" dips; E - "Exploratory'' dips;
T - Total number of dips; s/T ratio - ratio of





































































































































































* p = 0.016
** p = 0.032














Phenoxybenzamine alone tended to make the animals
lethargic, sedated and ill-looking. Following amphetamine
injection the initial exploratory response during the first
10 min. was markedly reduced compared to that of control
animals receiving amphetamine only (Mann-Whitney U-test,
p = 0.002 for "exploratory" dips, p = 0.002 for locomotor
counts) and the behavioural response to the amphetamine
somewhat delayed (Fig.25»26, Tables 9»10). There was no
significant difference in the overall "stereotyped"
dipping response between phenoxybenzamine pretreated and
non-pretreated animals during the two hour period of
testing. "Exploratory" dipping and locomotor counts were
reduced (p = 0.008, N.SV respectively) whereas S/T ratio
was increased (p » 0.034).
(6) Effect of pretreatment with methysergide 2 mg/kg on
response to 4 mg/kg Mr-amphetamine sulphate
Animals were pretreated with 2 mg/kg methysergide
hydrogen maleinate 40 min. before administration of 4 mg/kg
hlr-amphetamine sulphate » following which they were studied
for 2 hours on the hole-board.
There was an overall trend towards an increase in
response to amphetamine in methysergide pretreated rats
compared to non-pretreated rats (Figs. 25t26, Tables 9»10).
Both "stereotyped" and "exploratory" dips were increased, as
was locomotor response and S/T ratio. None of these
differences achieved statistical significance.
(7) Response to Apomorohine Hydrochloride
Animals were studied on the hole-board for two hours
immediately following intraperitoneal administration of
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FIG. 25: Effects of pretreatment with 20 mg/kg phenoxy-
benzamine hydrochloride i.p. or 2 mg/kg
methysergide hydrogen maleinate i.p. 40 min.
before on the response to i.p. administration
of 4 mg/kg Di-amphetamine sulphate in the hoIn¬
board. 3ach point represents mean activity -




TABLE 9: Effects of pretreatment with 20 mg/kg phenoxy-
benzaaine hydrochloride or 2.0 mg/kg methysergide
hydrogen maleinate 40 min. before on the behavioural
response to 4 mg/kg PL-amphetamine sulphate in the
hole-board apparatus. Figures denote mean activity
- S.E.M. during successive 10 min. intervals after
the amphetamine injection. The results for the two
pretreatments are compared with the effects of
amphetamine with no pretreatment. Six or seven
animals wore studied after each treatment.
3 - "Stereotyped" dips; 2 - "Exploratory" dips;
LOO - Locomotor counts.
Fuller versions of this table, giving the responses
of individual rats, can be found in the Appendix.
















16 i 3 75 - 9 64 - 8
8 - 2 15 - 6 24 - 8
23 - 5 78 - 10 90 - 11
11 - 3 39 - 0 36 - 6
18 - 8 24 - 10 27 - 12




20 - 30 30 - 40
jsr
TREATMENT







17 - 4 57 - 11 62 - 10
26 - 12 36- 16 34 - 9
45 - 10 78 i 18 79 - 13
37 - 17 84-15 52 - 9
35 - 12 37 - 17 41 i 12




40 - 50 50 - 60
PAS-
TREATMENT







39 - 17 81 - 18 44 - 12
70 - 28 33 - 13 35 - 12
83 - 14 81 - 16 76 - 16
48 - 31 67-14 53 - 6
61 — 25 33 * 9 39 - 11







60 - 70 70 - 80
PH3-
TRSATMENT







49 1 24 76 - 12 51 ± 5
51 - 22 24 - 6 36-11
71 - 12 76 ± 12 74 - 16
51 ± 27 70-12 57 - 7
35-18 20 - 8 34 - 10




60 - 90 90 - 100
PRE-
mrE a rm t wrm
JLxi uiixiu X







53-16 74 - 9 55 ± 8
44 - 21 21 - 4 32 - 10
89 - 21 65 - 10 61 - 10
50 ±18 63 ± 12 51 ± 17
31 ± 13 23 ± 8 38 ± 9




100 - 110 100 - 120
PR3-
TR3ATMSNT







39 - 16 41 - 11 48 - 17
30-12 20 - 9 35 - 12
57 - 9 67-13 72 - 15
36 ± 11 44 ± 9 51 ± 21
26 ± 10 19 ± 9 36 ± 9
68 ±11 63 ± 13 77 ± 11
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TABLE 10: Effects of pretreatment with 20 mg/kg phenoxybenzamine
hydrochloride or 2.0 mg/kg methysergide hydrogen
maleinate 40 min. before on the overall response to
4 mg/kg DL-amphetamine sulphate in the hole-board
apparatus. Figures show the response of each animal
over a two hour period following the amphetamine
injection.
5 - "Stereotyped" dips; E - " Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of




IVITY I 2 3 4 5 6 7
S lb 3 242 1306 3b6 228 374 446
+
175
E 862 771 518 566 862 1098 779
+ 88
0 T 1025 1013 1824 932 1090 1472 1226
+
142
S/T 0.16 0.24 0.72 0.39 0.21 0.25 0.33 0.08
LOC 894 509 759 497 - 467 625
+
83





































LOC 380 717 361 362 792 54 224 413
+
98



























S/T 0.38 0.54 0.41 0.65 0.26 0.63 Q.40 0.48 +mm 0.05
LOC 952 884 1195 585 1554 597 540 901 + 141
** p = 0.008
* p = 0.034
(Mann-rfhitney 0 test)














FIG. 26: Effects of pretreatment with 20 mg/kg phenoxy-
""""
benzamine hydro chloric e i.p. or 2 mg/kg
methysergide hydrogen maleinate i.p. 40 min.
before on the overall response to i.p. administr¬
ation of 4 mg/kg PL-amphetamine sulphate during
a 2 hour period. Each column represents mean
response - S.E.M. of 6 or 7 rats during the two-
hour period immediately after the amphetamine
inj ection.
A - Amphetamine; P - Phenoxybenzamine; M - Methysergide
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The behavioural actions of aponorphine were noticeable
wituin two minutes of injection ana wore off after 40 -
50 .dinutes (Fig.27). Hole-dipping was inhibited and the
initial burst of "exploratory11 dipping was also greatly
reduced (Fi^s. 27,28, Tables l^,12). The reduction in
dipping behaviour which affected both types of dipping
appeared dose-related. Locomotor counts were less affected.
Behaviour under the influence of apoaiorphine had a
distinctive pattern. with the lowest doses, (0.75 m^, and
1.5 mg/kg) animals crawled slowly from hole to hole,
sniffing between and around the holes. At the higher
doses (1.5 and 3«0 mg/kg) the animals spent more and more
j\
time at each hole, movin^ around less. Intense sniffing
F si
ji ^fcook place around the hole, and in due course character->7 -v'
yV _ ?\
istic bitin^ movements were observed, the animal repeatedly
V
thrusting its jaws around the hole edge and snapping them
shut. This pattern of responses was identical to that
seen in a previous study ('.lakanjuola, 197u, Makanjuola
et al. 1977b).
Analysis of the results showed that for the overall
response during the entire two-hour observation period
only the decreases in stereotyped dipping with increased
dosage of apomorphine were statistically significant
(p< 0.05). During each of the first four 10 min. period,"
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60 120
T I M E ( m i n.)
FIG-. 27j Behavioural response in the hole-board apparatus
following i.p. administration of 1 ml/kg saline
or 0.75» 1*5 or 3*0 mg/kg apomorphine
hydrochloride. Bach point represents mean
response - S.E.M. of 6 or 7 rats during
successive 10 min. intervals following the
inj ection.
103
TABLE 11; Behaviour of rats in the hole-board apparatus
following administration of 1 ml/kg saline or
0.75» 1*5 or 3.0 mg/kg apomorphine+hydrochloride
1.p. Figures show mean activity - S.2.M. during
successive 10 min. intervals after injection.
Six or seven animals were studied at each dose level.
S - "Stereotyped" dips; 2 - " Exploratory" dips;
IOC - Locomotor counts.
Details of the responses of individual rats can be
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0 14 £ 4 21
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4 27 - 3
* p 0.05
** p 0.01
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TABLP lk: Overall behavioural response in the hole-board
apparatus during a two hour period following
administration of 1 ml/kg saline or 0.75* 1»5 or
3.0 mg/kg apomorphine hydrochloride i.p. Figures
show the response of each of a group of six or
seven animals under any one treatment. A total
of 26 animals were employed.
S - "Stereotyped" dips; 2 - " Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of
"stereotyped" over total dips; LOG - Locomotor counts.
LOSS ACTIVITY
EAT NO » ilEAN - 33,1
(mg/kg) 1 2 3 4 5 6 7
S 132 107 239 246 211 141 179 - 24
7JI
jU 265 191 274 350 307 173 261 - 26
0 T 397 298 513 596 518 319 44'. - 49
S/T 0.33 0.36 0.47 0.41 0.41 0.44 0.40-0.02
LOG 287 150 211 386 187 284 251 1 35
C*
O 87 344 202 167 275 107 127 187 - 36
fj*Ui 188 117 165 164 402 193 171 200 ± 35
0.75 T 275 461 367 331 677 300 298 387 - 54
S/T 0.32 0.75 0.55 0.50 0.41 0.36 0.42 0.47-0.05
LOG 271 222 - - 440 187 414 307 - 51
S 151 43 159 188 45 133 56 111 - 23
s 271 71 182 181 150 261 140 179 - 26
1.5 T 422 114 341 369 195 399 19o 290 - 45
S/T 0.36 0.38 0.47 0.51 0.23 0.35 0.29 0.37-0.04
LOG 434 210 154 234 186 - - 244- 49
S 93 122 18 92 79 95 83 - 14
E 191 273 88 167 149 80 158 ± 28
3.0 T 284 395 106 259 228 175 241 - 41
S/T 0.33 0.31 0.17 0.36 0.35 0.54 0.34-0.05
LOG 524 197 - 2t>5 225 226 287 - 66












0-75mg|kg 1 -5mglkg 3-0mglkg
EX PLOR. D I PS
STEREOT.* DIPS
LOCOM. COUNTS
>rall behavioural response in the hole-board
>aratus following i.p. administration of
il/kg saline (dose OJ or 0.75» 1*5 or 3.0 mg/kg
imorphine hydrochloride. Each column represents
in activity - S.E.M. for the entire 2 hour
^iod after injection.
(3) Effects of 5-Ife thox.y,N,H-Dimct_,~1 Tr.rotamine
Animals were studied on the hole-board for two hours
immediately following intrap ritoneal administration of
2.5> 5 or 10 mg/kg 5-methoxy - N,N-dimethyltryptamine.
This drug produced a rather bizarre behavioural
pattern which intensified with increasing dosage. Onset
of the response was within two minutes and the response
to the drug wore off within 35 - 50 minutes, the higher
doses acting for slightly longer than the lower ones.
The normal initial burst of exploratory dipping was
interrupted, and therefore reduced, by the onset of the
drug-induced behaviour (Fig.29 ,Tables 13,14). The
animal assumed a very flattened posture as it crawled
slowly round from hole to hole. Occasionally brief kyphotic
posturing was also seen. While crawling around, all four
limbs scrabbled in an incoordinated fashion on the floor
of the hole-board. This incoordination was more obvious
with the hind limbs so that the animal appeared to move
around by pulling itself forward by its fore limbs. The
animal nodded its head repeatedly both at and between
holes. In relation to a hole, characteristically the
head would remain thrust down a hole for long periods,
with the nodding continuing therein. Such changes in
motor activity ware not recordable by the apparatus and
no striking changes were recorded for hole-dipping and
locomotor activity compared with saline-treated animals,
apart from the first ten minutes, when the initial burst
of exploratory dipping normally seen in saline-treated
5-MeoDMT 25mg[kg
Sa I i ne •
O
x y
—• Explor.' d i ps




5-Meo D M T\®mg|kg
• • Explor.' dips
O— — O'Storoot' dips
X— X Locom counts
60








TIME ( m i n.)
FIG_._J!9.: Behavioural response in the hole-board apparatus
following i.p. administration of 1 ml/kg saline
or 2.5» 5 or 10 mg/kg 5-Methoxy-,N.N.-
dimethyltryptamine ( 5-ME0j^MT) . Bach point
represents mean activity - S.E.M. during
successive 10 min. intervals after injection,
locomotor counts are depicted for the first
four 10 min. intervals only in the 5~ME0DMT
treated animals.
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TABLE 13: Recorded behaviour of rats in the hole-board
apparatus following administration of 1 ml/kg
saline or 2.5» 5*0 or 10.0 mg/kg 5**methoxy-N N-
Dimathyltiyptamine i.p. Figures show mean
activity - S.B.M. during successive 10 min.
intervals after injection. Four to six animals
were studied at each dose level.
S - "Stereotyped" dips; E - "Exploratory" dips;
LOC - Locomotor counts
Details of the responses of individual rats can be




0 -- 10 10 - 20
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0 18 + 2 64
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10.0 12 5 13




5 12 - 8
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TABLE 14: Overall recorded behavioural response in the
hole-board apparatus during a 2-hour period
following administration of 1 ml/kg saline or
2.5» 5*0 or 10.0 mg/kg 5> Methoxy,-N, N-
Dimethyltryptamine i.p. Figures show the overall
response of each of a group of 4-6 rats under any
one treatment. 20 animals were employed.
S - "Stereotyped*' dips; E - "Exploratory" dips;
T - Total number of dips; /T ratio - ratio of
"stereotyped" over total dips; LOG - Locomotor counts.
DOSE A fTTirTrPV ,
HAT NO.
v- '"'AW — -navr
(mg/kg) 1 2 3 4 5 6
iuDtfUi O .J»iu
s 132 107 239 246 211 141 179 - 24
E 265 191 274 350 307 178 261 - 26
0 T 397 298 513 596 518 319 440 i 49
S/T 0.33 0.36 0.47 0.41 0.41 0.44 0.40 - 0.02
LOG 287 150 211 386 187 284 251 1 35
S 173 165 222 164 181 - 13
S 284 311 210 220 256 - 23
2.5 T 457 47o 432 384 437 - 19
S/T 0.38 0.35 0.51 0.43 0.42 - 0.03
LOG 480 339 242 443 37b - 50
S 380 139 142 182 207 210 - 44
S 262 152 270 178 359 244 - 36
5 T 642 291 412 360 566 348 - 83
S/T 0.59 0.48 0.34 0.51 0.37 0.46 - 0.04
LOG 314 150 572 191 515 348 - 83
3 221 335 306 256 194 262 - 25
E 347 311 194 112 120 217 - 47
10 T 568 646 500 368 314 479 - 60
S/T 0.39 0.52 0.61 0.70 0.62 0.57 - 0.05
LOG 672 613 462 212 227 437 - 93
None of the changes in behavioural parameters were statistically
significant (Kruskal-V/allis one-way analysis of variance).
no.
rats was reduced (Fig.29)» this being accompanied by an
increase in locomotor counts caused by the hyperactivity.
(9) Sffects of monoamine uptake inhibitors on behaviour
and their interactions with PL-amphetamine
(a) Bffects on spontaneous behaviour
Desmethylimipramine hydrochloride 25 mg/kg), chlorimi-
pramine hydrochloride (25 mg/kg) and GSA 654 (50 mg/kg)
were administered i.p. 30 minutes before saline 1 ml/kg i.p.*
immediately whereupon the animals were placed on the hole-
board. Benztropine (2.5 and 5*0 mg/kg) and LRC1 5132
(10 and 20 mg/kg) were not followed by saline injection,
the animals being placed on the hole-board immediately after
injection with the test drug. The results are compared
with those from rats given saline alone.
Structural formulae of these compounds are shown in
Figs. 5 and 30. G3A 654 and LRC1 5182 are selective
inhibitors of 5-HT and dopamine uptake respectively (see page 189)•
Desmethylimipramine (DI.1I) (Figs.31b,33, Tables 15,16)
produced a reduction in all forms of activity on the hole-
board. The initial burst of exploratory dipping and
locomotion appeared reduced compared with non-pretreated
rats but these reductions were not statistically significant.
Thereafter the subsequent level of all activity was
also reduced in comparison with animals given saline only.
(For the overall response during the 2-hour period p = 0.004
for "stereotyped" dips, p = 0.004 for "exploratory" dips,
p = 0.016 for locomotor counts.)
Chlorimioramine (CMI) produced only a slight reduction






TR3L3 15: Effects of pratreatment with desmethylimipramine
hydrochloride (Dili) 25 mg/kg chlorimipramine HGL
(CMI) 25 mg/kg or "G11A 654" 50 mg/kg 30 min.
before on the response to administration of 1 ml/kg
saline in the hole-board apparatus. Figures 3how
the mean activity - 5.3.M. during successive 10 min.
intervals following the second injection. Six
animals were studied with each treatment.
S - "Stereotyped" dips; E - "Exploratory" dips;
IjOC - Locomotor counts.
Details of the responses of individual rats can be
found in the Appendix (Tables 1; 13-15)•
INTERVAL
(min)
0 1 HO 10 - 20
PRB-
TR3ATM3NT





18-2 64 - 5 48 - 5
10 i 2 41 - 7 46 - 9
20-3 57 - 10 39 - 7
19 - 5 56 - 13 39 - 10
16-4 28-7 31-7
5-1 12 — 3 8 ± 2
19 - 4 27 - 5 16 -4




20 - 30 30 - 40
PRS-
TR3A1M TNT








18 - 3 28 - 6 19 i 3
10 i 3 15 - 4 18-7
7-1 12-5 8 i 3
16—4 15-3 7-1




40 - 50 50 - 60
PR3-
TR3ATMENT






7 - 2 9-4 6-3
12-2 13-2 6-2
19 - 4 26 - 5 51 - 19
12-4 13-4 14-5
6-1 10-1 8-1
14-3 14-3 10 i 8































































































TABLE lb: Offsets of pro treatment with. Lesmethylimipramiae HCH
(Jill) 25 ia^/kgt Chlorimipramine HCL (CHI) 2 5
or " G3A 654" 50 mg/kg on the overall response ;
1 al/kg saline during a 2 hour period. I'igur^^^MW,
the overall response of each of a group of 5
under any one treatment. 23 animals were employ#®.
S - "Stereotyped" dips; E - "Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of



















































































































































































** p as 0.004
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FIG. 31? Behavioural response in the hole-board apparatus
following i.p. administration of 1 ml/kg saline
and effect of pretreatment with desmethylimipramine
hydrochloride 25 mg/kg (DMI), chlorimipramine
hydrochloride 25 mg/kg (CMI) or G3A. 654 50 mg/kg
(a neuronal 5-HT uptake inhibitor) 30 min. before
on response to administration of 1 ml/kg saline.
Bach point represents mean activity - 5.E.M.
during successive 10 min. intervals after the
saline injection.
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©JA w'.4 (ilg.31d,Tables 15#1©) caused slight increase
in " exploratory" dipping and locomotor counta which Low-
ever were not statistically significant. Animals given
this erUi, appeared more aroused and -ore excitable than
control animals.
had! 5182 produced a marked, dose-related increase in
activity on the bole-board. At the lower dose (10 mg/kg)
dipping behaviour was greatly increased, this beina of
predominantly "exploratory" type (fig.32,Tables 17,13) with
a correspondingly low d/i ratio* At the uigher dose
(20 mg/kg) dipping behaviour further increased, but thia
time"stereotyped" dipping was mora prominent and the s/T
ratio was higher (1 ig.,32,Tableau,18)Non-dipping stereo¬
typed behaviour" defined aa repetitive _ _ head
movements, including side-to-side as well as up and down
movements and also involving gnawing and biting at the
hole—edges (see page 146) was commonly seen with the highest
dose of LHC1 5132 durin, the second hour of the recording.
locomotor activity was also markedly stimulated and
thia was more marked at a dose of 20 mg/kg. This seemed,
at first, surprising since intense stereotyped dipping
is usually associ ted wits, a reduction in locomotor activity.
However, locomotor activity stimulation was confirmed
visually; animals were observed to divide their time
between rushing around the hole-board, and dipping
repeatedly into holes. "Uvea intense "non-dipping stereo¬
typed behaviour1 in some animals was observed to persist
even during marked locomotor stimulation. There is a
large variance in activity levels recorded at the higher
\
Explor.' dips LRCL5182.
FIG. 32a: Behavioural response in the hole-board apparatus
following i.p. administration of 1 ml/kg saline
or 10 or 20 mg/kg 1RC1 5182 (a neuronal dopamine
uptake inhibitor;.. Bach point represents mean
activity - S.3.M. of 5 or 6 rats during successive
10 min. intervals following the injection.
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T I M E (m i n.)
FIG-. 32b: Behavioural response in the hole-board apparatus
following i.p. administration of 1 ml/kg saline
or 2.5 or 5*0 mg/kg benztropine (a neuronal
dopamine uptake inhibito^). Each point
represents mean activity - 3.S.M. of 6 rats
during successive 10 min. intervals following
the injection.
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TABLI 17: !Behaviour of rats in the bole-board apparatus
*
following administration of 1 ml/kg saline or
10 or 20 mg/kg "LRCL 5182" or 2.5 or 5.0 rag/kg
benztropine mesylate i.p. Figures denote mean
activity - S.E.M. during successive 10 min.
intervals after injection. Five or 6 animals
were studied at each dose level.
3 - "Stereotyped" dips; 3 - "Exploratory" dips;
LOO - Locomotor counts.
Details of the responses of individual rats, can be




0-10 10 - 20










18 - 2 64 - 5 48 - 5
14 1 4 62 - 10 53 - 14
93 -63 93 - 20 93 1 32
23 - 5 98-10 88 - 7
28 - 4 96-10 81 - 19
16 i 4 28 - 7 31 - 7
14 - 1 42 - 9 47 - 11
116 - 71 70 - 17 40 - 12
46 - 8 87-12 59 - 5




20 - 30 30 - 40










14-4 2-1- 4 30 - 7
18 - 2 49-17 32 - 9
130 i 61 88 ± 16 57 i 19
60 — 8 45-10 34 - 4
69 - 16 83-22 29 - 9
10 ~ 3 15 - 4 18 - 7
24 - 7 53 - 18 53 * 28
125 - 34 95 - 18 62 - 19
53 - 11 31 i 7 62 - 35




40 - 50 50 - 60










6-3 10 - 4 9-4
27 - 11 62 - 22 38 - 13
101 - 17 109 - 19 99 - 35
54 - 12 25 - 9 30 i 12
107 - 38 42 - 19 28 - 12
12 - 4 13 - 4 14 - 5
29 - 8 66 - 18 44 - 9
54 - 17 84 - 14 152 - 56
48-17 25 - 9 29 i 8
72-18 33 - 7 17 - 1
(Contd.)
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19 * 5 21 - 8 19 - 5
23 - 2 83-19 50 - 12
50 - 24 53 - 10 132 i 50
40-14 15 - 2 43 - 11
90 - 28 49 - 18 26 - 10
17 - 10 17 - 5 12 - 4
28 - 3 78-20 57 - 22
85-42 36 ± 8 109 - 34
43 - 11 21 - 3 25 - 4




80 - 90 90 - 100










22 - 8 20 - 7 16 - 4
43 - 8 83 - 18 34 - 7
101 i 44 33 - 5 126 - 25
36 - 8 18 - 4 51-32
77-22 32-9 27 - 5
20 - 5 18 - 5 17 - 4
37 - 7 84 - 17 23 - 5
74-34 25 - 5 154 - 51
40 - 6 19 - 4 55-27




100 - 110 110 - 120










14 - 4 21 - 5 18 - 5
39 - 7 78-15 35-11
81 i 35 17 - 5 87 - 38
26 - 9 21 i 6 27-12
49 - 25 6 - 3 2 -1
10 - 4 12 - 4 17 - 7
35 - 7 84-14 41 - 4
77 - 29 20 - 5 137 - 44
30 t 9 19 i 8 24 - 7
73 - 18 38-13 16 - 5
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jgAgjig 18: Overall behavioural response in the hole-board apparatus
during a 2 hour period following up. administration of
1 ml/kg saline or 10 or 20 mg/kg "LRCL 5182" or 2.5 or
5.0 mg/kg benztropine mesylate. Figures show the
response of each of a group of 5 or 6 rats under any one
treatment. A total of 20 animals were employed.
S - "Stereotyped"dips; 3 - "Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of
"stereotyped" over total dips; 100 - locomotor counts.
DOSE numrrw ,
RAT NO.
(rng/kg) iwlXvJ.i.1 1 2 3 4 5 6



































LOG 287 150 211 386 137 284 251
+
35























mg/kg S/T 0.36 0.23 0.33 0.41 0.24 0.31 + 0.03
LOG 298 879 648 293 417 507
+
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LOG 1670 937 1159 302 480 2448 1249
+
289


































































mg/kg S/T 0.46 0.57 0.26 0.84 0.31 0.83 0.54 + 0.10
LOG 415 J00 201 155 586 - 331
+
76
Kruskal-Wallis one-way analysis of variance. For the behavioural
responses with the two doses of LRCL 5182 and saline: p^O.Ol for
"stereotyped" dips, "exploratory" dips, s/T ratio and locomotor
counts. For the behavioural changes with the two doses of
benztropine and saline: p<0.05 for "stereotyped" dips <0.02 for
locomotor counts.
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dose, particularly in locomotor counts. This variation
in the locomotor response was confirmed visually.
A I'ruskal-.Vallis one-way analysis of variance showed
that the differences in overall response between saline-
treated controls and animals treated with 10 and 10 mg/kg
IkCI 5182 were statistically significant (p<0.01 for
"stereotyped" dips, "exploratory" dips, locomotor counts
and the S/T ratio).
Benztropine mesylate produced a dose-dependent increase
in behaviour on the hole-board. At 2.5 mg/kg both
"exploratory" and "stereotyped" dipping were stimulated as
was locomotor activity (fig.32,Tables 17,18). At 5.0 mg/kg
the further increase in dipping behaviour involved both
"stereotyped" and "exploratory" types while locomotor
activity was less affected in comparison with the lower dose.
A Kruskal-Wallis one-way analysis of variance
comparing the effects of the two doses of benztropine
with saline-treated controls showed that the differences
we re statistically significant (p<0.05 for "stereotyped"
dips and ^0.02 for locomotor counts). The differences in
"exploratory" dips and S/T ratio were not significant.
Fig.33 summarizes the results for all the monoamine
uptake inhibitors studied.
(b) Effects of pretreatment with desmethyliiaipramine
hydrochloride (Bill), chlorimipramine hydro¬
chloride (Cull), G2A 654 and ,3Ki'-525A, on the
response to 4 mg/kg BL-amphetamine sulphate
Bldl (25 mg/kg), CmI (25 mg/kg) and G1A o54 (50 mg/kg) i.p.











EX PL OR. D I PS
'stereot: DIPS
LOCOM. COUNTS
FIG.33? Overall activity in the hole-hoard apparatus
during a 2 hour period following i.p. administration
of (a) 1 ml/kg saline, (b) 25 mg/kg desmethy-
limipramine hydrochloride 30 min. before 1 ml/kg
saline, (c) 25 mg/kg chlorimipramine hydrochloride
30 min. before 1 ml/kg saline, (d) 50 mg/kg
GSA. 654 30 min. before 1 ml/kg saline, (e)
10 mg/kg IfiCL 5182, (f) 20 mg/kg IRCi 5182, (g)
2.5 mg/kg benztropine mesylate or (h) 5«0 mg/kg
benztropine mesylate. 3ach column represents mean
- S.3.M. of 5 or 6 ratsduring the entire two hour
period following the final or only injection.
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while 3KF-525A (15 or 30 mg/kg, Fig. 30) was administered
40 minutes before the amphetamine. The responses were
compared to those of rats treated with 4 mg/kg JL-
amphetamine sulphate only.
The results are presented in Fig. 34 and Tables 19 and
20 and summarized in Fig. 35*
All four drugs had similar effects on the amphetamine
response which was markedly potentiated. The initial
burst of exploratory dipping and locomotor activity was
not much affected except in the case of DMI, where this
exploratory burst was diminished (Fig.34b) (p = 0.064 i.e.
not significant for "exploratory" dips, p = 0.030 for
locomotor counts). This was probably a result of the
"sedative" effects observed when the drug was given before
saline (Fig. 31b). The level of hole-dipping thereafter
markedly increased in all four groups of animals and the
pattern became markedly "stereotyped" with an associated
decrease from the initial level in locomotor counts. The
intensity and pattern of hole-dipping seen with the uptake
inhibitors as well as at the higher dose of 3KF-525A
(30 mg/kg) approached that seen after double the dose of
amphetamine (i.e 8 mg/kg) on its own (FigJ-6).
Although DMI appeared to be the most effective of
the drugs in depressing dipping activity when the drugs
were given before saline, it also appeared to be the most
potent in potentiating the behavioural response to
amphetamine, since "non-dipping stereotyped behaviour" was
observed in the majority of animals given the DMI -
amphetamine combination but not in those given the other
1 I M r (111 i 11.)
FIG.34a: Behavioural response in the hole-board apparatus
following i.p. administration of (a) 4 iag/kg
DL-amphetamine sulphate and the effect on this
response of pretreatment with (b) 25 mg/kg
desmethylimipramine hydrochloride (DMI), (c)
25 mg/kg chlorimipramine hydrochloride (CMI) or
(d) 50 mg/kg GBA 654 30 min. before the amphetamine
injection. Each point represents mean activity -
S.E.M. of 6 rats during successive 10 min.
intervals following the amphetamine injection.
-—«✓
TIME (min.)
FIG. 34b: Behavioural response in the hole-hoard apparatus
following i.p. administration of 4 rag/kg
DL-amphetamine and effect on this response of
pretreatment with 15 or 30 mg/kg SKF-525A (a
hepatic microsomal enzyme inhibitor). Each
point represents mean activity - S.E.M. of 6
rats during successive 10 min. intervals
following the amphetamine injection.
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TAB IS 19: Effects of pretreatment with d e sme thy1imipramine KCL
(DMI) 25 mg/kg, ohlorimipramine HGL (CMI) 25 mg/kg,
"G-2A 654" 50 mg/kg 30 min. before or 15 or 30 mg/kg
SKF-5<^5A 40 min. before on the behavioural response
to 4 mg/kg JJL-amphetamine sulphate in th| hole-board
apparatus. Figures show mean response - 5.3.M.
during successive 10 inin. periods after amphetamine
injection. Six animals were studied with each
pretreatment.
S - "Stereotyped" dips; E- "Exploratory" dips;
LOG - Locomotor counts.
details of the responses of individual rats can be
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39 - 16 47 - 11 48 ± 17
117 - 51 7 - 6 0.3 - 0.:
254 * 69 46 ± 38 34 - 19
250 - 69 11 1 4 3-2
80 - 13 42 - 10 23 ± 13
278 i 73 2o - 23 25 - 21
36 i 11 44 - 9 51 ± 21
105- 58 5 - 5 0.3^0.3
259- 80 41-30 25 * 9
258- 60 17 - 8 17 - 11
74 - 12 39 - 13 22 - 9
2b6 - 70 25 - 19 23 - 15
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TA3LG 20: Effects of pre treatment with Jesme thylimipramine HGL
(UMI) 25 mg/kg, Chlorimipramine HCL (ail) 25 mg/kg,
"GrlA 654" 50 mg/kg 30 min. before or 15 or 30 mg/kg
"3KF-525A" 40 min. before on the overall behavioural
response in the hole-board apparatus to 4 mg/kg
Dlr-amphetamine sulphate during a two hour period.
Figures show the response of each of a group of six
rats under any one treatment.
S - "Stereotyped" dips; S - " 12xploratory" dips;
T - Total number of dips; S/T ratio - rati0 of
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Mann-Whitney U-test - Comparison of results with those given
amphetamine alone.
p = 0>0Q2
*** p a 0.004
** p a 0.003























EX PLOR. Dl PS
STEREOT.' DIPS
LOCOM. COUNTS
PIS* 35: Overall behavioural response during a 2 hour period
following i.p. administration of 4 mg/kg DL-
amphetamine sulphate (Amph#) and effect of pretreat—
ment with 25 mg/kg desmethylimipramine hydrochloride
(DM|), 25 mg/kg chlorimipramine hydrochloride (GMI),
50 mg/kg G2A 654 or 15 or 30 mg/kg SKF-525A on the
response to 4 mg/kg DL-amphetamine sulphate (Amph.).
Each column represents mean activity - S.E.M. of
6 rats during the entire two hour period immediately
following the amphetamine injection.
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MEAN - S 3.1













































S 3573 2799 1198 473 2039 3054 2189 - 483
SKF-525A
30 mg/kg is 288 79 520 1304 464 364 503 - 172
+ T 3861 2378 1718 1777 2503 3418 2o92 ^ 354
Amphetamine
4 mg/kg S/T 0.93 0.97 0.70 0.27 0.81 0.89 0.76 i 0.11
LOG 114 26 174 875 292 90 262 - 128
Kruskal-Wallis one-way analysis of variance: differences
between behavioural responses with the two doses of SKF-525A
and with no pre treatment (p<0.01 for "stereotyped" dips,
<0.02 S/T ratio).
125.
drug-amphetamine combinations. Presumably it was this
"non-dipping stereotyped behaviour" that was responsible
for the decrease in "stereotyped" dipping observed during
the second hour compared with the first hour in the DMI-
pretreated rats. The phenomenon has been described in
more detail on page 146 .
Consistent with the increase in'stereotyped dipping'
the locomotor stimulant effects of the amphetamine were
reduced, as again would be expected with increasing
amphetamine dosage.
The effects of SKF-52 5A on the amphetamine response
were dose-related, the higher dose producing a much more
marked potentiation of the "stereotyped" dipping response
to amphetamine.
A Mann-Whitney U-test showed that the effects of pre-
treatment with DMI, CMI and GrEA 654 on the overall response
to 4 mg/kg DIr-amphetamine sulphate, compared with the
response to the same dose of amphetamine alone, were
statistically significant at levels of 0.016, 0.008 and
0.004 respectively for "stereotyped" dips. For "exploratory"
dips only the effects of DMI and G3A 654 were significant,
(p = 0.008). For the S/T ratio the increases were signifi¬
cant for DMI and G3A 654 (p =0.002 and 0.004 respectively)
but not for CMI. For locomotor counts the differences with
GSA 654 and DMI were significant (p = 0.008 and 0.004
respectively).
A Kruska1-Wa11is one-way analysis of variance
comparing the results with 15 and 30 mg/kg SKF-525A combined
with amphetamine and with amphetamine alone showed that the
differences were significant for "stereotyped" dips (p k 0.01)
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and the S/T ratio (p<0.02) but not significant for
"exploratory" dips and locomotor counts.
(0) Plasma and Brain levels of amphetamine after
intraperitoneal administration of PL-amphetamine
sulpnate and the effects of pretreatment with
desmethylimipraminet chlorimipraminet 'G5A 654*
and »CKP-525A'
(1) Calibration curves
The calibration curve for plasma is shown in Pig. 36,
the results being compared with those from solutions of
PL-amphetamine sulphate in water. The limits of detection
of amphetamine in plasma was in the region of 25 ng/ml.
Peak heights for plasma extracts were virtually the same
as those for water extracts. A linear relationship was
demonstrated between peak height response on the gas
chromatograph and the amounts of amphetamine in the samples
between 25 and 500 ng. There was virtually no difference
in peak height response between amphetamine standards in
water and in plasma.
The standard curve for amphetamine added to whole
brain tissue extracts in 0.4 M perchloric acid is shown in
Pig. 37, again compared with those from amphetamine
solutions in water. Again a linear relationship was
demonstrated between peak height response and the
amphetamine content of each sample between 2 50 ng and 5 jig.
The results for different samples of plasma and brain were
read off directly from standard curves produced on the day
of each experiment.
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(ii) Plasma and brain levels of amphetamine after
systemic administration of PL-amphetamine sulphate
Rats in groups of five were injected intraperitoneal!/
with 1 ml/kg saline or 4, 8 or 16 mg/kg DL-amphetamine
sulphate. The animals were killed 60 minutes after the
injection.
The results are presented in Pig. 38, Table 21. Srain
levels of amphetamine were about 8 times those found in
plasma. Amphetamine concentrations in plasma and brain
increased with increasing dose of amphetamine but neither
relationship was linear. Instead, increasing amphetamine
doses appeared to cause disproportionately greater increases
in plasma and tissue levels.
(iii) affect of pretreatment with de3methylimipramine,
chlorimipramine, GGA 654 and SKF-525A on plasma
and brain levels of amphetamine after adminis¬
tration of 4 ims/kg PL-amphetamine sulphate i.p.
DMI (25 mg/kg), CM! (25 mg/kg) and GRA 654 (50 mg/kg)
were administered i.p. 30 minutes before the amphetamine.
SKF-525A (30 mg/kg) was administered 40 minutes before
amphetamine. The animals were sacrificed 70 minutes
after amphetamine injection. There were five animals
in each group.
The estimates of brain and plasma amphetamine concen¬
trations are shown in Fig. 39» Table 22. After all the
pretreatments the concentrations of amphetamine in pla.ma




FIG. 36: A calibration curve for the assay of amphetamine
in plasma by gas chromatography. The curve was
determined following analysis of plasma from
untreated rats to which the different amounts of
amphetamine (as the DL-sulphate) were added -
see page 126. Relative peak heights obtained
from assay of amphetamine in distilled deionised
water are also shown, although no curve is drawn
for these.
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At the dosages used, JDMI appeared to be the most
potent elevator of amphetamine levels (brain x 395A»
plasma x 332a) followed by G3A 654 (325^ and 256/0*
GKF-525A (320 and 225$) and chlorimipramine (224 and 216$).
This rank order relates well to that of the respective
treatments1 abilities to potentiate the behavioural
effects of amphetamine, in which respect 15 mg/kg DMI
was the most and 25 mg/kg CMI the least effective.
\
• • BRAIN EXTRACT
j?IGr» 37: A calibration curve for the assay of amphetamine
in brain tissue extracts in 0.4 M perchloric acid
by gas chromatography. The curve was determined
following analysis of brain extract from untreated
rats to which the different amounts of amphetamine
(as the DL-sulphate) were added - see page 126.
Relative peak heights obtained from assay of
amphetamine in distilled deionised water are also
shown, although no curve is drawn for these.
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TABLE 21: Plasma and brain concentrations of amphetamine
oO rnin. after i.p. injection of 1 ml/kg saline
or 4» 8 or 16 mg/kg DL-amphetamine sulphata












1 <25 < 0.25
2 < 25 < 0.25
0 3 4 25 < 0.25
4 <25 < 0.25
5 <25 4 0.25
MEAN - SSM * 25 < 0.25
1 94 0.95
2 51 0.32
4 3 85 0.85
4 85 0.65
5 77 0.35
MEAN - 3EM 78-7 0.62 i 0.13
1 46 2.35
2 215 2.00
8 3 323 3.00
4 461 2.60
5 582 2.90
MEAN - 311 325 - 93 2.69 - 0.19
1 1230 4.75
2 2815 10.75
16 3 492 -
4 1354 8.60
5 1569 8.75
1 T A »J 1 rirrr
i.i j/lll >J iitti 1492 - 377 8.21 - 1.25
AMPHET. DOSE (mg|kg ):
4 816 4 8 16
P LASMA BRA I N
FIG. 38? Plasma and brain concentrations of amphetamine
60 min. after i.p. administration of 4» 8 or
16 mg/kg Dl-amphetamine sulphate. Sach column
represents mean concentration - S.3.M. from
five animals.
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TABLE 22: Effects on plasma and brain amphetamine levels
of pretreatraent with 1 ml/kg saline, 2 5 mg/kg
i)esmethy1imipramin® IICI (DI.II), 25 mg/kg
ohlorimipramine HCL (CMI), 50 mg/kg "Oil 654"
30 min. before or 30 mg/kg "SKF-525A" 40 min.
before administration of 4 mg/kg Dlr-amphetamine
sulphate. Animals were killed 70 min. after
the amphetamine injection.
PLASMA BRAIN |
TREATMENT RAT no. CONG ITERATIONS CONCENTRATIONS
(lig/g) (ug/g)
Saline
1 100 2.10 |




4 mg/kg 4 100 2.55
5 60 1,43
MEAN - 3EM 91- - 9i— 1.39 - 0.20
1 45 6.83 j
25 mg/kg 2 340 -
Amphetamine 3 415 7.25
4 mg/kg 4 460 7.50 J
5 250 8.25 !
MEAN - OEM *302 - 73 ***7.46 - 0.30 S
CMI 1 250 3.49
25 mg/kg 2 265 4.50 1
+
Amphetamine 3 145 3.38 J
4 mg/kg 4 130 5.40 j
5 195 4.43
MEAN - OEM **197 - 27 ***4.24 -0.37 1
"GSA 654" 1 235 6.83 J




4 mg/kg 4 315 6.75
5 320 6.60 f
MEAN - SWi **233 - 39 **b.15 ± 0.95
" 3XF-525A"
1 110 5.51
30 mg/kg 2 220 5.63 j+
Amphetamine 3 230 4.84
4 mg/kg 4 265 5.93
5 200 3.40 1
MEAN - OEM **205 - 26 ***6.06 - 0.61 1
student's "t" test (comparison of saline-pretreated rats with
other pretreatments): * p<0.02: ** p<0.01: *** p< 0.001
For brain amphetamine concentrations: p< 0.001 for DMI vs C5»1I



























FIG. 39: Effect of i.p. pretreatment with (a) 1 ml/kg saline.
(b) 25 mg/kg desmethylimipramine hydrochloride (DMI),
(c) 25 mg/kg chlorimipramine hydrochloride (CMI),
(d) 50 mg/kg G3A 654 30 min. before or 30 mg/kg
SKF-525A 40 min.. before administration of 4 mg/kg
Dl-amphetamine sulphate i.p. on plasma and brain
amphetamine levels. Animals were killed 70 min.
after the amphetamine injection. 3ach column
represents mean amphetamine concentration - S.E.M.
for 5 rats.
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B. GIAiAOTAGIIC LTSIONu OP ACCULIBGNb ANJ CAUJAT3 NUCL3I
• Effects of o-hydroxydopamine-induced lesions of the
accumbens and caudate nuclei
Ten to fourteen days after operation each animal was
studied for one hour on the hole-board following adminis¬
tration of 1 ml/kg saline i.p. Seven days later the
animal was again studied following 4 mg/kg Dl-amphetamine
sulphate and after, another seven days? lo mg/kg DL-
amphetamine sulphate. The illumination of the chamber
wa3 increased durin^ the last study (i.e. after adminis¬
tration of lo mg/kg amphetamine) so that "non-dipping
stereotyped behaviour" could be more closely observed.
Preliminary analysis of the results of these experi¬
ments showed that consistent alteration in the pattern of
behavioural changes to amphetamine were associated only
with dopamine (DA) depletion of at least 05/ in the
accumbens nucleus or 75/ in the caudate nucleus. Because
of this5results are presented for those animals in which
DA depletion to 35/ or less was achieved in the accumbens
nuclei and 25/ or less in the striatum compared with sham-
lesioned animals assayed in the same batch. These results
are compared with those of the animals with sham lesions
of the two nuclei, which are grouped together since there
were no behavioural or biochemical differences between
the two sham-lesioned groups. hesuits are also presented
separately for those animals in which JA depletion did
not reach the critical level for the production of
behavioural changes (Tables 27,28).
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(a) Biochemical analyses - Estimation of catecholamines
in rat forebrain
Animals were killed and their brains removed for
analysis of catecholamine distribution 21 days after the
last behavioural testing. The delay was to minimize the
effects of drug treatments on catecholamine levels.
(i) Standard calibration curves for dopamine and
nox-adrenaline Different amounts of DA or NA
were added to tissue extract prepared by homogenizing
whole rat brain in 3Qq jj.1 0.1 N perchloric acid per
50 mg brain and carried through the procedure for
assay of catecholamines. The final d.p.m. for
samples of tissue extract containing no added cate¬
cholamine was subtracted from the d.p.m.s obtained
from these standards so that a calibration curve
could be obtained for the different amounts of DA
or NA. Two estimates were made for each point on
the curves. Results are presented in Figs. 4-0, 41
and Table 23. In both cases a linear relationship
was obtained between the final d.p.m. and the DA or
NA content of the standard put through the method.
With the highest amounts of the monoamines, 150 and
200 ng, the d.p.m. values tended to fall off
slightly. These two values were above the ranges
of d.p.m. recorded in extracts from brain tissue
samples assayed.
(ii) Control values Results obtained from sham-
lesioned rats are presented in Figs. 42, 43 and Table 24.
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TABLE 23? Calibration curve for Dopamine (DA) and Noradrenaline
(NA) assay (see page 132).
Individual amounts of monoamine were added to 300 p-1
of rat brain tissue extract and assayed. The
disintegrations per minute (D.P.M.). due to the added
monoamine v/as estimated by subtracting the D.P.M. of
the tissue extract samples from the total D.P.M.
•Tissue Blank'consisted of duplicate tubes put through
the assay procedure with the 0—methylation reaction
inhibited by adding 0.5 M borate buffer before the
incubation mixture and keeping it in an ice-bath (see
page 73). Neagent blanks consisted of duplicate
tubes of 300 ;ul 0.131 perchloric acid put through the
procedure.
The tissue extract was prepared from rat brains in
which the portion anterior to the anterior commissure
had been removed. This explains the apparent
discrepancy between the D.P.M.s of tissue extract
blanks in the NA and DA fractions.
DPM of DA fraction
(xlO-3)
DPM of NA fraction
(xl0~3)








Tissue Extract 5 23
•t 5 25
12.5 ng DA 52 47 22
It 52 * 22
25 ng DA 105 99 22
It 103 20
50 ng DA 187 182 20
»« 188 20
75 ng DA 217 214 18
tt 222 17
100 ng DA 318 319 17
It 330 15
150 ng DA 422 403 16
It 395 14
200 ng DA 513 521 15
tt 545 13
12.5 ng NA 6 37 16
tt 6 40





DPM of OA fraction
(xio-3)
DPM of NA fraction
(xio-3)








50 ng NA 10 98 73
H 10 96
75 ng NA 11 111 87
II 11 112
100 ng NA 15 162 138
t! 15 162
150 ng NA 17 198 180
It 20 211
200 ng NA 19 245 225
II 22 253
Tissue Blank 1.1 0.20
II 1.2 0.29




FIG. 40: Standard calibration curve for Dopamine (DA) assay.
Each point represents^mean disintegrations per
minute (D.P.M.) x 10 obtained following assay in
duplicate of different amounts of DA added to 300 pi
brain tissue extract in 0.1 M perchloric acid (see*
page 132 and Table 23). The final DPM was obtained
by subtracting the DPM produced by tissue extract
samples from that of the sample.
Ovars.ll behavioural responses in the hole-board—-
apparatus of animala with *shamM lesions of the
aeeuabena or caudate nuclei following administration
of 1 ml/kg physiological saline» 4 -wkj JL-
a&phetamine sulphate and lb ag/kg Jlr-aaphetamine
sulphate in. that order. The treatments were
administered at weekly intervals.
S - ♦"Stereotyped" dips; 3 - "Exploratory* dips;
T - Total number of dips; JI ratio - ratio of
"stereotyped" over total dips; LOG - Locomotor
counts.
Weight of the animals on the day of the first
teat is also shown.
At the bottom of the table are given the JA and
HA contents of different brain areas.
!iiSATM2HI 1 ACTIVITY
:■ 1 2 3 4 5 6 7 1
3 165 170 80 93 135 148
..alino
TPhi 311 159 122 213 348 222
1 ml/kg T i 476 329 202 311 483 370
S/T 0.3§ 0.52 0.40 0.32 0.28 0.40




(«) 215 220 215 230 290 205 235
'
3 75& 2b0 826 386 293 113 683
Amphetamine
3 | 410 500 530 974 645 239 334
4 mg/kg T U68j 7oQ 1408 13oQ 933 402 1017
S/T 0.65 0.34 0.59 0.23 0.31 0.28 0.67
LOG 311 *>33 224 451 763 421 65





160 57 71 190 195 19
lb mg/kg T : 1170 1429 1731 1721 2243 082 914
S/T 0.77 0.89 0.97 0.96 0.92 0.71 0.98
LOG 1 45 — 7 21 118 215 43!
•
TUB. 3146? S3o7 7906 3352 5764 9096:
DA ACC. 9226; 9423 7530 8009 10257 o464 9224
(ag/g) CAUJ. 11015: 11940 9834 7395 11054 0734 11862
GOBTEX 429 436 116 230 96 91 766
TUB. 265! 260 378 410 238 403
HA AGO. 327 47o 1112 941 292 318 629
(ng/g) CAUJ. S3; 31 214 186 44 102 105
; COAT EX 736 778 793 353 53o 398 725
» I Mi —... ■ .... —
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TUB - Olfactory Tubercles;
AGO - Accumbens Nucleus Sample;
CAUJ - Gaudate-Putamen Sample.
HAT NO.
8 9 10 11 12 13 14 15 MEAN - SM
129 134 152 102 103 137 116 154 130 - 7
187 307 243 318 135 229 225 313 238 - 19
316 441 395 420 238 366 341 467 368 - 23
0.41 0.30 0.38 0.24 0.43 0.37 0.34 0.33 0.36 - 0.02
202 254 265 394 167 251 350 415 272 - 24
205 235 235 240 260 260 245 280 238 ± 7
241 316 193 40 387 156 706 1031 426 - 78
535 887 764 885 518 305 626 186 563 - 61
776 1203 957 925 905 461 1332 1217 989 - 79
0.31 0.26 0.20 0.04 0.43 0.34 0.53 0.85 0.41 - 0.05
627 394 474 670 545 305 688 199 451 - 53
593 1483 1527 2365 1958 2273 2220 1528 ± 161
262 499 287 43 33 45 63 157 - 36
855 1982 1814 2408 1991 2318 2283 1685 - 150
0.69 0.75 0.84 0.98 0.98 0.98 0.97 0.88 - 0.03
135 263 182 87 26 168 73 106 ± 23
7438 8967 7011 6889 6107 - 4119 6657 7371 - 413
6979 10507 5958 6405 6344 5578 5600 7178 7645 - 436
9566 13630 8632 8961 8667 8177 7295 8434 9583 - 503
219 93 177 81 143 43 103 498 238 ± 54
381 348 297 230 185 - 69 336 292 - 27
1353 695 650 843 364 674 761 584 668 ± 79
266 106 103 117 76 102 103 125 121 - 15
313 513 467 410 843 707 571 721 627 i 47
NA (ng )
FIG. 4l> Standard calibration curve for Noradrenaline(NAi) assay.
3ach point repreaentcumean disintegrations per
minute (D*?.M*) x 10*"^ obtained following assay in
duplicate of different amounts of MA added to 300 ul
brain tissue extract in 0*1 M perchloric acid (see
page 132 and Table 23). The final UBS was obtained
by subtracting the DPM produced by tissue extract
samples from that of the sample*
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The dopamine concentration was about the same, in
the region of 7 - 9 ug/g wet weight in all three JJA-
rich areas assayed - the striatum, nucleus accumbens
and olfactory tubercle. There was relatively lsiw
variability in the levels found for each area. The
estimated dopamine concentrations in the cortex
samples were very much lower and these levels
showed considerable variation. This variability is
probably to be explained by the accidental inclusion,
to varying extents, of some tissue from the caudate
nucleus in the cortical samples during the dissection;
consequently the lower values are probably the more
correct estimates. The noradrenaline content of
all four areas was much lower, with maximum values
in the cortex and accumbens nuclei, followed by the
olfactory tubercles, with very low levels being found
in the striatum. Variability was quite low.
(iii) Nucleus accumbens lesions (Figs. 42, 43, Table 25)*
The greatest DA depletion was found in the nucleus
accumbens. The olfactory tubercles also showed a
marked but less severe fall in DA.
The DA reduction was less in the striatum but
even in this area the degree of reduction was
considerable (about40c/). Cortical DA content was
not affected.
There was a slight though not significant fall
(p>0.05) in NA content in the olfactory tubercles.
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FIG. 42: Dopamine (DA) concentrations in selected brain areas
of animals with bilateral 11 sham" lesions of
accumbens nuclei or caudate-putamen nuclei and
animals with bilateral 6-hydroxydopamine lesions of
the accumbens nuclei (N. Acc.) or caudate-putamen
nuclei (N. Caud.). 2ach column represents mean
concentration - S.3.M. of 13-15 rats.
0 - Olfactory Tubercles; A - Accumbens nuclei samples;
C - Caudate-putamen samples; Co - Cortical samples.
TABLE 25: Overall behavioural responses in the hole-board
apparatus of animals with 6-hydroxydopamine-induced
lesions in the accumbens nuclei following administration
of 1 ml/kg physiological saline, 4 mg/kg LL-
amphetamine sulphate and 16 mg/kg LL-amphetaniine
sulphate in that order. The treatments were
administered at weekly intervals.
S - "Stereotyped" dips; E - "Exploratory'! dips;
T - Total number of dips; s/T ratio - ratio of
"stereotyped" over total dips; LOG - Locomotor
counts.
Weight of the animals on the day of the first test
is also shown.
At the bottom of the table are given the LA and ITA
contents of different brain areas.
TREATMENT ACTIVITY
RAT NO.
1 2 3 4 5 6

















S/T 0.62 0.34 0.44 0.52 0.37 0.55
LOC 85 73 112 138 - 95
BOLY WT.
(g) 200 210 205 210 260 195

















S/T 0.72 0.70 0.93 0.62 0.39 0.53
LOC 94 162 15 245 588 170

















S/T 0.88 0.97 0.99 0.87 0.94 0.86
LOC 119 70 20 109 111 88
TUB. 5383 1820 963 4373 2917 3497
LA
ACC. 3036 1705 435 1620 1573 1397
(ng/g) CAUL. 9906 2982 4507 6605 7609 6264
CORTEX 1016 301 133 530 43 38
TUB. 270 246 171 356 166 177
NA ACC. 612 301 1089 999 644 1146
(ng/g) GAUL. 119 65 115 91 67 105
CORTEX 489 321 214 166 261 241
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*** p < 0.002
(Comparison with results from sham-lesioned animals
(Table 24) using the Mann-Whitney U-test.)
TUB - Olfactory Tubercles;
ACG - Accumbens Nucleus Sample;
CAUD - Caudate-Hutamen Sample.
HAT NO. "t OT*,T
7 8 9 10 11 12 13
114 198 180 141 128 81 86 132
+
16
167 147 159 130 124 79 129 ***134
+
9
281 345 339 271 252 160 215 266 22
0.41 0.57 0.53 0.52 0.50 0.51 0.40 ***0.48
+
0.02
217 201 262 144 253 146 154 ***157
+
18
210 225 225 230 245 240 225 222
+
5
562 703 349 582 908 565 420 511
+
50
353 135 333 86 368 59 88 ***218
+
39
915 838 682 668 1276 624 508 729
+
57
0.61 0.84 0.51 0.87 0.71 0.91 0.83 ***0.71
+
0.05
234 171 311 73 307 44 92 ***193
+
43
1063 983 1205 900 2290 705 1221 1133 + 125
93 41 229 63 36 12 67 85 + 19
1156 1024 1434 963 2326 717 1288 1218
+
128
0.92 0.96 0.84 0.93 0.98 0.98 0.95 0.93
+
0.01
73 44 211 7 48 28 62 76
+
15
3121 2818 3125 2694 1103 1991 - 2817
+
367
2285 1167 1860 1626 419 670 406 1400 + 218
5191 7454 6839 6993 4032 3808 4887 5929
+
531
43 100 60 877 225 52 49 267
+
93
195 186 163 210 237 269 - 220
+
17
442 757 402 1030 212 1128 722 730
+
91
102 75 86 63 82 87 70 87
+
5















FIG* 43? Noradrenaline (NA) concentrations in selected brain
areas of animals with bilateral "sham" lesions of
accumbens nuclei or caudate-putamen nuclei and
animals with bilateral 6-hydroxydopamine lesions
of the accumbens nuclei (N.Acc.) or caudate-
putamen nuclei (N.Gaud.). Bach column represents
mean concentration - S.3.M. of 13-15 rats.
0 - Olfactory tubercles; A - Accumbens nuclei samples;
C - Caudate-putamen samples; Co - Cortical samples.
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(iv) Au., te~E)j-^amQj3> lesion.- (Figs* 42,43, Table 26)*
The greatest DA depletion was found in the
striatum* Smaller reductions were found in the
accumbens nuclei, olfactory tubercles and cortex.
Cortical NA levels fell slightly.
(v) Animals with less severe DA depletion
hesuits are also presented for those animals in
which DA depletion did not reach the critical level.
Varying degrees of DA depletion are seen, these
depletions being greatest in the lesioned areas
(Tables, h7» d8).
behavioural Studies
(i) U-eneral behaviour Animals with lesions in the
nucleus accumbens were indistinguishable from sham-
lesioned controls in appearance, weight and general
behaviour by the time of first behavioural testing
10 - 14 days after operation. Animals with lesions
in the caudate nuclei tended to be lighter in weight
than controls; the weight difference was the
greater the more severe the DA depletion achieved
(see Table 26). They also tended to be somewhat
lethargic and were noted to move around their home
cages leas.
Significance values quoted in this section
refer to comparisons, using the m&nn-Whitney test,
of the overall responses of the animals in each
experimental Oroup during the one hour period of
recording with tme overall responses in the control
group.
TABLE 26: Overall behavioural responses in the hole-board
apparatus of animals with 6-'nydroxydopamine-induced
lesions in the caudate nuclei following administration
of 1 ml/kg physiological saline, 4 mg/kg L]>
amphetamine sulphate and lb mg/kg Llr-amphetamine
sulphate in that order. The treatments were
administered at weekly intervals.
3 - "Stereotyped" dips; 3 - " Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of
" stereotyped" over total dips; IDC — locomotor
counts.
Weight of the animals on the day of the first test
i3 also shown.
At the bottom of the table are given the LA and NA

















































































































































































* p < 0.05
(Comparison with results from sham-lesioned animals
(Table 24) using the Mann-Whitney U-test).
TUB - Olfactory Tubercles;
ACC - Aceumben3 Nucleus Sample;
CAUB - Caudate-lutamen Sample.
RAT NO. M152AN 1 swi/r
7 3 9 10 11 12 13
25 50 54 21 20 18 123 ***62 £ 13
42 35 54 34 26 38 42 ***53 1 8
67 85 108 55 46 56 165 121 £ 18
0.37 0.59 0.50 0.38 0.43 0.32 0.74 0.48 £ 0.04
150 91 196 98 90 56 165 **132 £ 17
220 220 215 245 195 150 165 200 £ 8
468 103 8 66 3 33 3 ***89 i 33
360 319 20 116 8 71 12 ***175 it 37
828 422 28 182 11 104 15 264 £ 65
0.57 0.24 0.29 0.36 0.27 0.31 0.20 0.30 £ 0.03
627 512 355 336 35 1351 39 455 - 93
490 185 73 235 29 9 16 ***135 £ 40
130 107 225 178 13 34 6 218 £ 61
620 292 298 413 42 43 22 355 - 80
0.79 0.63 0.24 0.57 0.69 0.20 0.72 0.41 £ 0.07
51 106 131 441 21 1986 24 *523 £ 169
1978 - 6533 7367 3149 2999 1241 4605 £ 651
2609 4395 3890 6515 3371 3375 1747 4571 £ 454
1578 1679 1486 1446 1086 433 135 1411 £ 190
61 63 64 43 68 84 102 75 £ 9
213 - 290 364 250 335 243 288 £ 34
350 523 1361 584 1166 1416 852 018 £ 101
52 77 62 108 166 113 128 92 £ 11
543 674 230 561 321 202 184 386 £ 44
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TABL'3 27: Overall behavioural responses in the hole-board apparatus
of animals with 6-hydroxydoparaine—induced lesions in the
aocumbons nuclei which did not produce adequate degrees
of DA depletion (see page 131) following administration
of 1 ml/kg physiological saline, 4 mg/kg JL-amphotamine
sulphate and 16 mg/kg DL-amphefamine sulphate in that
order. The treatments were administered at weekly
intervals.
S - "Stereotyped" dips; 3 - " Exploratory1' dips;
T - Total number of dips; s/T ratio - ratio of
"stereotyped" over total dips; LQC - locomotor counts.
Weight of the animals on the day of the first test is
also shown.
At the bottom of the tibia are given the DA and NA
content.- of different brain areas.
TREATMENT
ACT¬ RAT NO. MEAN
+
6 Li
IVITY 1 2 3 4 5 6 7



























S/T 0.47 0.43 0.32 0.31 0.38 0.50 0.42 0.40
■f
0.0;




WT(«) 220 245 260 245 190 230 225 231
+
9




























S/T 0.52 0.59 0.51 0.16 0.50 0.49 0.43 0,46
+
0.0!
LOC 258 113 253 869 301 047 197 377
+
104



























S/T 0.64 0.94 0.6b 0.92 0.82 0.90 0.94 0.83 + O.O;
LOC

























CAUD, 11432 lo5S3 11931 10792 5236 - 8058 10o72-I5o3
CQRTHC 533 58 184 63 90 75 71 153 uu
•TUB. 296 255 182 213 213 161 214 220 + 17
NA ACO. 1130 702 751 552 711 543 854 749
+
77
(ng/g) CAUD. 50 108 £3 79 102 - 117 92 + 10
nf\ j-nr * 489 376 394 375 401 5C7 594 448 + 32
^TUB - Olfactory Tubercles; ACG - Nucleus accumbens sample;CAUD - Caudate-putamen sample.
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TABLE 28: Overall behavioural responses in the hole-board apparatus
of animals with 6-hydroxydopamine-induced lesions in the
caudate nuclei which did not produce adequate degrees of
DA depletion (see pagel31) following administration of
1 ml/kg physiological saline, 4 mg/kg DL-amphetamine
sulphate and lb mg/kg Dlr-amphetamine sulphate in that
order. The treatments were administered at weekly
intervals.
3 - "Stereotyped" dips; 3 - " Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of
"stereotyped" over total dips; LOC - locomotor counts.
Weight of the animals on the day of the first test is
also shown.
At the bottom of the table are given the DA and NA





1 2 3 4 5 6

























S/T 0.31 0.53 0.66 0.51 0.49 0.49 0.50
+
0.05




WT.(g) 185 185 220 225 245 240 217
+
11























S/T 0.41 0.34 0.38 0.69 - 0.72 0.51 + 0.08
IOC 624 319 410 — — 203 36?
+
8?
























S/T 0.76 0.86 0.83 0.98 0.98 0.96 0.89 + 0.04
LOC 218 114 183 95 46 40 116
+
30





ACC. 5450 5451 6182 5981 5738 6280 5847
+
147
CAUD. 3026 5215 3990 4395 5034 8989 5108
+ 840
CORTEX 84 55 61 63 58 58 63
+
4





ACC. 811 1125 767 523 590 986 800
+
93
CAUD. 121 156 109 77 133 208 134
+ 18
CORTEX 386 75? 384 467 501 571 512
+
57
TUB - Olfactory Tubercles; ACC - Nucleus accumbens sample;
CAUD - Caudate-putamen sample.
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(j.i) Behaviour following an injection of 1 ml/kg
saline (Figs. 44,45, Tables 24-26, 29).
Compared with sham-lesioned controls, animals
with lesions in the aecumbens nuclei showed a
reduction in exploratory dipping (p <0.002) with
"stereotyped" dipping remaining at around control
levels. The S/T ratio was therefore increased
(p< 0.002). locomotor counts were also reduced
(p< 0.002).
Animals with lesions of the caudate-putamen
showed a general reduction in both forms of dipping
as well as locomotor counts. It was found that
this behavioural reduction was most marked in those
animals which proved to have most severe DA depletions
and which usually were the most ill-looking and
cachectic. The reductions in levels of stereotyped
and exploratory dipping as well as locomotor counts
were statistically significant (p < 0.002) in all three
cases. The increases in S/T ratio were not
significant.
(iii) Behaviour following an injection of PL-amphetamine
sulphate 4 mg/kg (Figs. 46, 47, Tables 24-26,30).
In comparison with sham-lesioned controls, animals
with lesions of the accumbens nuclei showed a marked
reduction in exploratory dipping (p< 0.002) compared
with sham—lesioned controls. "Stereotyped" dipping
levels were unchanged and the S/T ratio was increased
(p< 0.002). locomotor counts also decreased
markedly (p< 0.002).
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TABLE 29: Behaviour in the hole-board apparatus of rats with**
" sham" lesions of caudate or accumbens nuclei and of
rats with 6-hydroxydopamine lesions of the accu&bens
or caudate nuclei following administration of 1 ml/kg
saline i.p. Figures show mean activity - D. 3.M.
during successive 10 rnin. intervals after injection.
1 - 'Stereotyped" dips; 2 - '• Exploratory1 dips;




0-10 10 - 20





22 — 3 54 - 3 ©1 - 7
11-2 23-3 51-6
22 - 2 45 -5 49-7





20 - 30 30 - 40




24 - 2 39 1 5 3b — 6
22-3 16-2 lb - 4
9-3 6-1 12 — 3







40 - 50 50 - 60




21-3 30 - 4 36 - 4
23 1 3 12-1 20-4
12-3 7-2 IS - o
IS - 3 17 - 4 24 -6
22-3 1L - 2 16-3
10 -2 7-2 9 -3
Details of individual rat responses can ha found in the



































FIG. 44: Behavioural response in the hole-board apparatus by
animals with (a) Bilateral "sham" lesions of accumbens
nuclei or caudate-putamen nuclei or of animals with
(b) bilateral 6-hydroxydopamine lesions of the caudate-
putamen nuclei (N.Caud.) or (c) the accumbens nuclei
(N.Acc.) following i.p. administration of 1 ml^kg
saline. Each point represents mean activity - S.E.M.
during successive 10 min. intervals after the injection
of 13-15 animals.
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TAB LI? 30: Behaviour in the hole-board apparatus of rats with
"sham" lesions of caudate or accumbens nuclei and
of rats with 6-hydroxydopamine lesions of the
accumbens or caudate nuclei following administration
of 4 mg/kg DL-amphefamine sulphate i.p. Figures
show mean activity - S.S.M. during successive
10 min. intervals after injection, 0f 13-15 rata.
3 - "Stereotyped" dips; 3 - "Exploratory" dips;




0 1 HO 10 - 20





27 - 4 42-4 42-6
9-2 23-5 55 -9
31 - 5 88 - 9 65 -8
63-12 30-5 31-7




20 - 30 30 - 40




59 - 13 95 - 10 81 - 12
88 - 9 38 - 7 25 - 6
14 - 5 29 1 6 77-14
87 - 19 104 - 17 88 i 12
103 - 7 44-11 28 - 10




40 - 50 50 - 60




107 - 20 105 1 19 76 - 13
108 - 11 37 - 9 30 - 9
20 - 9 31 - 7 83 - 25
123 - 25 105 - 18 86 - 15
117 - 15 27 - 8 35 - 9
20 — 10 30 - 7 79 i 27
Details of individual rat responses can be found in the
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STEREOT.' DIPS
LOCOM. COUNTS
FIG. 45: Overall behavioural response in the hole-board
apparatus following i.p. administration of
1 ml/kg saline by animals with (a) 6-hydroxy-
dopamine lesions of the accumbens nuclei (N.Acc.les.)
(b) sham lesions of the eccumbens or caudate-putamen
nuclei (Sham les.) and (c) 6-hydroxydopamine lesions
of the caudate-putamen nuclei (N.Caud.les.). Each
column represents mean activity - S.E.M. of 13-15
rats during a one hour period immediately after the
inj ection.
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Animals with lesions of the caudate nuclei
showed a marked decrease in "stereotyped" dipping
(p* 0.002) as well as in "exploratory" dipping
(p< 0.002). locomotor counts were unaffected.
The S/T ratio was reduced, though this was not
statistically significant.
The marked variation in the results from
animals with lesions in the caudate nuclei is
accounted for by the fact that some of the animals
with the more severe degrees of DA depletion showed
virtually no behavioural response to amphetamine
at all (Animals 11 and 13, Table 26) whereas certain
others, again with the more severe degrees of DA
depletion, responded with a considerable locomotor
stimulation without much "exploratory dipping
(Animals 2 and 12).
(iv) Behaviour following an injection of 16 mg/kg
DIr-amphefamine sulphate (figs. 48,49,Tables 24-
26, 31). The behayioural differences between
animals with lesions in the accumbens nuclei and
sham-lesioned animals were not marked. There were
slight reductions in "exploratory" dipping and
locomotor responses which were not statistically
significant. N. accumbens-lesioned animals tended
to enter the "stereotyped" dipping phase sooner and
this was then more rapidly joined and then replaced
by "non-dipping stereotyped behaviour", which
appeared to be more intense. This accounts for
the slight reduction (not statistically significant)
Sham
Le sions
T I ME (min.)
-• Explor.' d i ps N. Caud.
° O Stereol! dips Lesions


















• • Explor." dips
O O'Stereot". dips




T I ME (min.)
60
FIG. 4b: Behavioural response in the hole-board axoparatus
by animals with (a) bilateral "sham" lesions of
accumbens nuclei or caudate-putamen nuclei or of
animals with (b) bilateral 6-hydroxydopamine
lesions of the caudate-putamen (N.Caud.) or (c)
the accumbens nuclei (N.Acc.) following i.p.
administration of 4 mg,/icg Sl^am^hetaminG sulphate. Bach
point represents mean "activity - S.E.M. during
successive 10 min. intervals after the injection
of 13-15 animals.
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TABLI 31: Behaviour in the hole-board apparatus of rats with
"sham" lesions of caudate or accumbens nuclei and
of rats with o-hydroxydopamine lesions of the
accumbens or caudate nuclei following administration
of lb rng/kg Dl-amphetamine sulphate i.p. Figures
show mean activity - S.B.Li, during successive
10 rain, intervals after injection 13-15 rats.
S - "Stereotyped" dips; 2 - "Exploratory" dips;




0H1O 10 - 20




109 ± 18 64 - 9 54 - 11
145 - 22 53 - 7 54 i 8
17 - 6 35-7 82-26
408 - 51 33 - 15 19 - 9
*285 - 39 15 - 7 10 — 5




20 - 30 0•e-1orO




*384 - 42 30 - 12 11 - 6
** - + + •+■
226-43 9-4 5-3
18 - 4 40 - 12 79 ± 28
**283 - 50 15 - 6 6 - 3
**176 ±38 3 - 2 3 ± 2




40 - 50 50 - oO




**224 -42 ,9-4 6-3
**156. ±46 4 ± a 3-2
24 - % 39 ± 14 82 - 21
113 ±34 5 - 3 11 ± 7
** •+• + +
110 ± 40 1 ± 1 1 ± 1
25 ±11 30 ± 11 86 ± 31
Details of individual rat responses can be found in the
Appendix, Tables 31 - 33•













FIG.4-71 Overall behavioural response in the hole-board
apparatus following i.p. administration of 4 mg/kg
Dl-amphetamine sulphate by animals with (a) 6-
hydroxydopamine lesions of the accumbens nuclei
(N.Acc.les.),(b) sham lesions of the accumbens or
caudate-putamen nuclei (Sham les.) and (c) 6-
hydroxydopamine lesions of the caudate-putamen nuclei
(N. Caud.Les.). Each column represents mean activity
S.E.M. of 13-15 rats during a one hour period
immediately after the injection.
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in "stereotyped" dipping also obsexved. The S/T
ratio was increased (not statistically significant).
Sniffing appeared markedly reduced.
"Non-dipping stereotyped behaviour" consisted
of intense, rapid, repetitive head movements which
on the hole-board occurred in relationship to the
holes although in certain cases with extreme stimu¬
lation this behaviour was observed also to take
place between the holes (Makanjuola et al. 1977b).
The phenomenon involved up and down as well as side
to side movements of the head which at first
accompanied "stereotyped" dipping and then gradually
replaced thi3 dipping behaviour, the up and down
movements being too shallow to be recorded as hole-
dips. Therefore, a3 the "non-dipping stereotyped
behaviour" became more intense'"stereotyped'dipping
gradually fell off (Fig. 48). Intense gnawing and
biting at the hole-edges accompany the head movements
and in intact or sham-lesioned animals intense
sniffing also occurred, although, as has been
mentioned above, sniffing did not feature in the
animals with 6-OIJDA lesions of the nucleus accumbens.
Animals with lesions in the -caudate nuclei
bahaved markedly differently from sham-lesioned
controls or animals with lesions in the accumbens
nuclei. In these animals the most prominent feature
was a marked reduction of "stereotyped" dipping
compared with sham-lesioned controls (p< 0.002).
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FIG. 48? Behavioural response in the hole-hoard apparatus by
animals with (a) bilateral "sham" lesions of accumbens nuclei
or caudate-putamen nuclei or of animals with (b) bilateral
6-hydroxydopamine lesions of the caudate-putamen nuclei (N.Caud.)
or (c) the accumbens nuclei (N.Acc.) following i.p. administra¬
tion of lb mg/kg Bl-amphetamine sulphate. "2ach point represents
mean activity - 3.3.1,1. during successive 10 min. intervals
after the injection of 13-15 animals. "Non-dipping stereotyped
behaviour" (see page 146) accounts for the apparent fall in
the level of "stereotyped" dipping in the latter half of the
experimental period in the sham lesioned and accumbens-
lesioned animals.
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observed. There was a moderate stimulation of
"exploratory" dipping (not statistically significant)
and a greater stimulation of locomotor activity
(p< 0.05 for locomotor counts). Intense sniffing
was observed. The majority of animals moved con¬
tinually around the hole-board, sniffing continuously
and dipping occasionally. Again there was a marked
variance in the results which made interpretation
somewhat difficult. As with the response to 4 mg/kg
DL-amphetamine sulphate, the same animals with
severe OA depletions showed no or relatively little
locomotor or hole-dipping response whatsoever to the
drug whereas two responded with a marked stimulation
of locomotor activity (Animals 2,11,12,13;Table 26).
Intense sniffing was observed even in these animals,
however.
2. Effects of electrolytic lesions of the nucleus
accumbens septi on oehaviour following saline and
amphetamine administration
(a) Extent of lesion lesions of various size were
achieved with current doses of 30-60 mil Generally an
oval lesion was obtained, the elongation being in the
dorso-ventral direction (Figs. 50,51). The dorsal aspect
of the lesion was continuous with the electrode needle
track, which itself was surrounded by an area of damage
too wide to be accounted for by physical passage of the
electrode per se. Needle tracks in sham-operated animals
(in which no current was passed) were much less conspicuous
















FIG. 4-9? Overall behavioural response in the hole-board
apparatus following i.p.administration of
16 mg/kg DL-amphetamine sulphate by animals with
(a) 6-hydroxydopamine lesions of the accumbens
nuclei (N.Acc.les.), (b) sham lesions of the accumbens
or caduate-putamen nuclei (Sham les.) and (c)
6-hydroxydopamine lesions of the caudate-putamen
nuclei (N^Caud.les.). Each column represents mean
activity - S.E.M. of 13-15 rats during a one hour
period immediately after the injection.
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(Pig. 50d). This damage around the needles was therefore
probably caused by passage of current around the needle,
between the two electrodes. In addition to damage to
the accumbens nucleus itself, neighbouring structures
were also damaged to some degree. The anterior commissure
which passes through the lateral aspect of the nucleus,
was invariably destroyed. The olfactory tubercle,
anterior olfactory nucleus, lateral ventricle and ventro¬
medial aspect of the anterior part of the caudate nucleus
were often damaged to some degree. Animals in which
damage to these structures (apart from the anterior
commissure) especially the caudate nucleus, was thought
to be more than minimal, were excluded from final analysis.
Aesults are presented for those animals in which greater
than 50/ of the accumbens nucleus was destroyed.
(b) General condition and behaviour Tven with the
most extreme lesions of the nucleus accumbens the animals
appeared perfectly normal at the first behavioural testing
10-14 days after operation. Weight gain continued
normally and the animals in all respects were indistin¬
guishable from sham-lesioned controls on inspection.
Ten to fourteen days after operation each animal was
studied for one hour on the hole-board following adminis¬
tration of 1 ml/kg saline i.p. Seven days later the
animal was again studied following 4 mg/kg Jl-aaphetamine
sulphate and* after another seven days, 16 mg/kg JJ>
amphetamine sulphate. The illumination of the chamber
was increased during the last study (i.e. after adminis¬
tration of 16 mg/kg amphetamine) so that "non-dipping
FIG.50: Scale drawings of sections of the rat brain adapted from
the Atlas of Konig and Klippel (1963) - see page 70. The appearance
of bilateral electrolytic lesions of the accumbens nuclei at
different antero-posterior coordinates is shown. These coordinates
are denoted below each figure in microns in accordance with the
atlas of Konig and Klippel. VO - olfactory ventricle;
TOI - intermediate olfactory track; OAP - Anterior olfactory nucleus
GAA - anterior commissure; GG - corpus callosum; A - accumbens
nucleus; GN - caudate-putamen; OC - optic chiasma.
FIG. 51: Microphotographs of rat train sections showing
appearances of bilateral electrolytic lesions of
the accumbens nuclei in 3 rat brains (a,b,c).
Fig. 3b is x section from the rat brain depicted
in Fig. 50. Fig. 3d shows the appearance of
the tracks made following a sham lesion - the
faint electrode track is seen passing through the
corpus callosum on the left side.
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stereotyped behaviour" could be more closely observed.
(o) Behaviour on the hole-board following an
injection of 1 ml/kg saline There were no
detectable differences between lesioned animals and sham-
operated controls (Fig. 52, Table. 32a).
(d) Behaviour on the hole-board following in.iection
of 4 mg/kg PL-amphetamine sulphate Here again
there was no detectable difference in any of the behavioural
parameters between lesioned and sham-lesioned animals.
This applied even to the animals with the mo3t severe
lesions (Fig. 53, Table, 32b).
(e) Behaviour on the hole-board following in.iection
of 16 mg/kg PL-amphetamine There was no
detectable difference between lesioned and sham-lesioned
rats. In both groups, the initial phase of "exploratory"
dipping and locomotor activity stimulation rapidly gave
■%
way to a high level of "stereotyped" dipping which during
the second half of the oO minute observation period was
joined and then replaced by "non-dipping stereotyped










FIG. 52: Overall "behavioural response in the hole-board
apparatus of b animals with bilateral sham lesions
of the accumbens nuclei ("Sham") or 10 animals
with bilateral electrolytic lesions of the
accumbens nuclei ("Les.") following i.p.
administration of 1 ml/kg+saline. Each column
represents mean activity - S.E.M. during a one-
hour period immediately following the injection.
150.
TABLI 32; Overall behavioural response in the hole-board
apparatus during a one-hour observation period of
animals with sham lesions of the nucleus accumbens
and electrolytic lesions of the nucleus accumbens
following administration to each animal at weekly
intervals of (a) 1 ml/kg physiological saline, then
(b) 4 mg/kg Dlr-amphetamine sulphate and finally
(c) lb mg/kg DL-aaphetamine sulphate. Figures show
mean activity during the 1 hour . Percentage
damage to the nucleus is also shown (see page 70).
S - "Stereotyped" dips; E - "Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of
"stereotyped" over total dips; LOC - Locomotor counts.
GROUP RAT WT S V T S/T LOG EXTENT OFLESIONS
1 230 95 201 296 0.32 62

















5 230 25b 192 448 0.57 219














I 230 25 139 164 0.15 92 50-55/
2 215 82 144 226 0.36 91 50-75/
3 250 113 138 351 0.32 mm 60-70/




















7 190 149 370 519 0.29 135 55-60/
8 225 253 407 660 0.38 199 70-75/
9 215 160 296 45b 0.35 310 75-80/
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FIG-. 53i Overall behavioural response in the hole-board
apparatus of 6 animals with bilateral sham
lesions of the accumbens nuclei ("Sham") or
10 animals with bilateral electrolytic lesions
of the accumbens nuclei ("les.") following i.p.
administration of 4 mg/kg llr-a,mphetamine sulphate.
Bach column represents mean activity - S.E.M.
during a one-hour period immediately following
the injection.
151.
TivBli32b - Amphetamine 4 ~a^/kg
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FIG. 54: Overall behavioural response in the hole-board
apparatus of 6 animals with bilateral sham
lesions of the accumbens nuclei ("Sham") or
10 animals with bilateral electrolytic lesions
of the accumbens nuclei ("les.") following i.p.
administration cf 16 mg/kg Dl-amphetamine
sulphate. Each column represents mean activity +
S.E.M. during a one-hour period immediately
following the injection.
152.
T*wLJ 32c - Amphetamine 16 mg/kg
GROUP RAT s E T S/T LOG
1 1082 43 1125 0.96 54
2 38b 132 518 0.75 -
Sham 3 755 43 798 0.95 86
Lesions 4 604 286 890 0.68 124
5 802 81 883 0.91 60
6 1096 30 1126 0.97 20
MEAN 787 102 890 0.87 69
- sm - 112 - 39 - 93 - 0.05 - 17
l 688 154 842 0.82 185
2 1013 167 1180 0.86 165
3 643 54 697 0.92 113
4 859 111 970 0.89 88
Nucleus 5 1852 133 1985 0.93 42
Accumbens
Lesions
6 350 39 389 0.90 67
7 459 226 685 0.67 83
8 186 99 285 0.65 159
9 1037 64 1101 0.94 64
10 201 225 426 0.47 158
M" AN 729 127 856 0.80 112
i SEU - 158 - 21 - 157 - 0.05 - 16
153.
C. STDH'30TACTIC INJECTION OF AOHQAmlH 3 TltAHOMITTSRS
INTO THT AC0UMB1N0 ANA CAUJAT2 ITUCLTI
"a. Histology
After the initial experiments during which various
modifications were made to stereotactic coordinates and
injection technique, a high degree of accuracy was
achieved in the placement of the injected material.
Txamples of needle tracks are shown in Figs. 55»56.
Varying degrees of cortical damage were often present
under the guide cannulae. This damage was presumably
incurred at the time of operation but may also represent
chronic irritation from the presence of the guide cannula
near the cortical surface. In some animals further
damage around the needle track gave the appearance of a
channel of varying width in relation to the needle track,
but in which the needle track could still be clearly
seen.
b. Behavioural "effects
The behavioural effects of DA, NA and 5-HT injected
into the two areas were studied. The monoamine solutions
were made up in chilled physiological saline just before
injection. These were dopamine hydrochloride, L-
noradrenaline hydrochloride, and 5-hydroxytryptamine
bimaleinate. 100 mg/kg nialamide was given i.p. 2 hours




FIG. 55? Scale drawings of sections of the rat brain adapted from
the Atlas of Konig and Klippel (1963) - see page 70. The appearance
of bilateral injection tracks into the caudate-putamen nuclei at
different antero-posterior coordinates is shown. These coordinates
are denoted below each figure in microns in accordance with the
atlas of Konig and Klippel. VO - olfactory ventricle; TOI - inter¬
mediate olfactory tracks; OAP - Anterior olfactory nucleus;
CAA - anterior commissure; GG - corpus callosum; A - accumbens
nucleus; GN - caudate-putamen; OG - optic chiasma.
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After injection in all cases there was usually a
period of prostration during which the animal would
lie flat on the hole-board floor, quite still. This
usually wore off within a minute, but in some animals
lasted as much as five minutes. Thereafter the rat
would attain its normal stance, crouched over a hole,
and might move around a little, dipping into a few holes.
These initial effects occurred regardless of what sub¬
stance, including control injections of 1 saline, was
injected and regardless of the injected site, This
initial behaviour was also not related to the degree of
ease of the injection procedure. (The actual injection
time was kept as constant as possible.)
(i) Response to bilateral injection of Dopamine
Hydrochloride into the nucleus accumbens in
Nialamide pretreated rats
Two hours after i.p. administration of
100 mg/kg nialamide, 5» 12.5* 2 5 or 50 jig dopamine
hydrochloride contained in 1 jal physiological
saline was injected bilaterally into the accumbens
nuclei. Control animals were injected with 1 ja.1
saline two hours after nialamide pretreatment.
This neurotransmitter produced a very character¬
istic response, with onset usually between 30 and
00 minutes and peak at 3-4 hours. The behavioural
changes lasted up to 9 hours. This behaviour
FIG. 56: Microphoto&raphs of rat brain sections showing
appearances of needle tracks produced following
bilateral injection of monoamines into the
caudate-putamen nuclei (a and b) or the accumbens
nuclei (c and d). Generally the actual injection
point on each side did not occur at exactly the
same level - see Fig. 55 which depicts serial
sections of the rat brain seen in Fig. 56b.
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consisted of a narked stimulation of locomotor
activity and "exploratory" dipping (figs.57»58,
Tables 33>34). There was only a moderate stimulation
of "stereotyped" dipping and the d/f ratio was
correspondingly low. Hearing behaviour was also
markedly stimulated and the animals sniffed continually
at holes, floor and walls of the enclosure as they
moved along. Usually the animals moved in both
directions, "out in a few cases they moved in one
direction only i.e. clockwise or anticlockwise.
This may reflect, an inequality in the injection
effects between the two sides. Tighter circling
was never observed.
Animals injected with saline (1 jxl) did not show
any such response (fig.57a). These animals spent
most of the time crouched over a hole, usually in a
corner, with occasional "stereotyped" dips inter¬
spersed with occasional forays during which they
made a few dips.
The original three doses of dopamine employed,
12.5» 25 and 50 g into each side? gave response levels
in the same range both in intensity and duration
albeit with a slight positive upward trend in
response with increasing dose. It appeared thata near
maximal response was achieved with a dose of 1^.5 jig.
An additional set of rats were therefore injected
with 5 jig OA on each side. Hesuits at this dose
were extremely variable, ranging from what appeared
to be a maximal response to a response little different
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FIG-. 57a{Behavioural response following bilateral injection
1 p.1 saline or 5 or 12.5 )ig dopamine (as the
hydrochloride salt) in 1 j&l saline into the accumbe
nuclei. The animals were pretreated with 100 mg/k
i.p. nialamide 2 hours before the intracerebral
injection. TSach point represents mean activity -
S.3.M. of 6 or 7 rats during successive 30 min.



























T I ME (m in )
FIG. 5Tb: Behavioural response following bilateral injection
of 1 yil saline or 2 5 or 50 pg dopamine (as the
hydrochloride salt) in 1 jil saline into the
accumbens nuclei. The animals were pretreated with
100 mg/kg i.p. nialamide 2 hours before the intra¬
cerebral injection. Each point represents mean
activity - S.E.M. of 6 or 7 rats during successive
30 min. intervals following the intracerebral
injection.
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H31.. 33: Behaviour in the hole-bo rd apparatus following
application of 1 h1 physiological saline or 5» 12. 5»
25 or 50 lig dopamine hydrochloride in saline to
the accumbens nucleus on each side. Bach animal was
pretreated with Nialamide 100 mg/kg i.p. two hours
before the intracerebral injection. Figures show
mean activity - S.S.M. during each successive 30 min.
period following intracerebral injection of 6-7 rata.
S - "Stereotyped" dips; E - "Exploratory" dips;




0-30 30 - 60
JOSE
(fig)
S E LOG S S LOG
0 12
+
5 17 * 5 42 - 23 11
+
7 9 ± 3 6 £ 4
5 18
■+*
5 29 ± 8 37 - 10 22
+
8 45 1 13 56 - 16
lk. 5 14
+
3 52 1 15 71 - 26 29
+
11 66 - 17 99 - 40
25 11
+
5 27 1 13 29 - 13 20
+
9 61 - 11 65 - 34
50 20
+




60 - 90 90 - 120
JOSE
(fig)
s E LOO s S LOG
0 14
+
10 11 ± 7 16 - 9 12
+
7 12 - 7 16 - 8
5 31
+
9 108 - 29 95 £ 29 60 + 26 233 - 54 188 - 51
12.5 51
+
21 194 £ 48 208 - 67 54
+
12 375 - 84 372 - 97
25 41
+
8 175 ± 33 64 - 32 52
+
11 301 - 68 139 - 48
50 24
+
3 237 - 94 320 - 89 33
+









s E LOG s E LOG
0 13
+
mm 5 9 * 5 25 - 11 12
+
7 7 - 5 17-9
5 55
+
lb 337 - 84 301 - 91 67
+
36 285 -123 248 -117
12.5 75 15 445 - 79 596 -103 6b
4*
13 508 - 7b 697 -135
25 45
+
9 495 - 73 279 1 62 40 + 10 537 ± 57 342 - 65
50 35
+
10 49b -118 533 -149 43
4-







180 - 210 210 - 240
DOSE
(jlft)
S E LOO S E LOG
0 14 5 8 ± 4 7 1 5 16 + 7 11 i 5 20-9
5 51
+
23 266 -140 282 -103 46 £ 15 234 -141 151 - 66
12. 5 66
+
11 514 1 75 730 -132 67
+
15 495 t 78 818 -129
25 33
+ 8 546 - 81 339 - 48 36 9 551 - 81 377 -114
50 45
+
12 588 -108 535 -124 84
+




240 - 270 270 - 300
LOSE
(jL?)
s E LOG 3 s LOG
0 20
+
12 11 ± 5 7-4 25
+
14 10 ± 5 26 - 15
5 49 £ 25 228 -150 141 - 78 49
+
16 228 -132 165 - 64
12.5 52 10 495 - 97 694 -117 45
+
11 387 -112 634 -126
25 37
+
11 526 - 60 382 -118 35
+
9 455 - 93 405 -138
50 139 67 521 -112 561 -164 162
+




300 - 330 330 - 360
LOSE
s Li LOG 3 E LOG
0 24 9 10 i 4 19 - 11 23
+
7 12 ± 4 16-9
5 54
+
18 161 - 82 104 - 33 56
+
17 96 - 39 91 - 30
12.5 48 12 333 -118 400 *114 40 + 14 168 - 60 264 -105
25 39
+
9 324 -104 341 -131 44
+
12 295 -123 312 -131




360 - 390 390 - 420
L0v>
(}lg)
s E LOG S ■qiXJ LOG
0 22
+
7 11 * 5 24 - 14 4o
+
13 18 - 4 31 - 14
5 37
+
9 56 - 8 o5 - 26 33
+
13 34 1 15 72 - 28
12.5 41
+
13 99 1 43 173 - 87 27
+ 8 60 1 37 168 - 74
25 71 14 2ob -110 244 - 87 o2 + 19 225 -102 194 1 69
50 221 -117
'







420 - 450 450 - 480
DOSS
(p:)
S S IOC S S LOC
0 36
+
11 19 - 4 21-9 38
+
12 19 - 7 21 - 11
5 38
+
13 27 - 10 41 1 24 33 mm 16 16 ± 8 36 - 21
12.5 22
+
8 45 - 28 171 - 71 32
+
11 61 ± 33 142 - 71
25 93
+
37 151 - 74 96 - 47 6b
+
27 81 - 37 55 1 28
50 205
+
73 279 - 76 227 - 69 : .18
+




480 - 510 510 - 540
DOSS
(p?)
3 3 LOC S S LOC
0 54
+
16 19 ± 8 22-9 30
■f
5 16 - 8 31 - 12
5 43
+
21 27 - 14 32 ± 14 33 + 17 22 ± 6 2b - 9
12.5 31
+ 8 55 i 35 110 * 50 44 + 11 57 1 24 156 ± 79
25 47
+
15 42 - 20 69 - 48 42 17 18 ± 7 38 i 15
50 75
+
16 88 - 21 149 - 61 84




540 - 570 570 - 600
DOSS
(p?)
3 "Qlit IOC s •nMi LOC
r
0 22
+ 8 10 - 4 10-2 35
+





- 0 20-6 27
■f
11 12 i 3 28 - 5
12.5 24
+
10 36 t 27 87 - 58 27
+
14 26 - 17 38 - 28
25 34 20 8 1 3 16 - 13 29
+
21 5 * 3 20-9
50 57
+
22 24 - 10 83 - 19 35
+
15 23 1 9 48 - 22
Details of the responses of individual rats can be found in the
Appendix (fables 34 - 38)•
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TABLE 34: Overall behaviour in the hole-board apparatus during
a 10-hour observation period following application
of 1 |il physiological saline or 5» 12.5» 25 or
50 jig dopamine hydrochloride in 1 jil saline into the
nucleus accuabens on each side. Rats were pretreated
with nialamide 100 mg/kg i.p. 2 hours before the
intracerebral injection. Figures 3how overall
response of each rat during the entire 10 hour period.
S - "Stereotyped" dips; 3 - "Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of
"stereotyped" over total dips; LOO - Locomotor counts.
DOSS ACT¬ RAT NO. TJfVAN 1 cs-I**
()lg) IVITY 1 2 3 4 5 6 7
la 0 J3B&
S 384 331 792 220 394 757 480 - 96
S 154 234 447 204 99 416 259 - 53
0 T 538 565 1239 424 493 1173 739 - 150
S/T 0.71 0.59 0.64 0.52 0.80 0.65 0.65 - 0.04
LOC 117 411 595 334 124 — 316 ± 91
S 2279 404 628 1220 798 305 225 837 - 272
3 2729 7183 2753 2558 551 685 711 2453 - 877
5 T 5003 7587 3381 3778 1349 990 936 3290 - 929
S/T 0.48 0.05 0.18 0.32 0.59 0.31 0.24 0.31 - 0.07
LOC 3256 3818 3599 1359 923 756 1069 2111 - 520
S 1195 1022 707 266 999 840 949 854 * 114
3 6114 6620 3769 3383 6110 1327 3900 4460 - 722
12.5 T 7309 7642 4476 3649 7109 2167 4349 5314 - 790
S/T 0.16 0.13 0.16 0.07 0.14 0.39 0.20 0.18 - 0.04
LOC 13524 9225 5412 5947 5632 2633 6545 - 1404
S 814 320 693 1031 732 1673 878 ± 185
3 3344 2999 3745 6581 6002 7862 5089 - 816
25 T 4158 3319 4438 7612 6734 9540 5967 - 978
S/T 0.20 0.10 0.1b 0.14 0.11 0.18 0.15 - 0.02
LOC 4239 1043 965 8407 — 3587 3648 ± 1360
S 1421 2597 989 400 14o7 5422 2049 - 736
3 7882 7435 6369 5968 6990 4212 c476 ± 535
50 T 9303 10032 7358 6366 6457 9635 8526 - 561
S/T 0.15 0.26 0.13 O.Oo 0.17 0.56 0.22 ± 0.07
LOC - 6083 - 5757 1959 4929 4682 - 910
Kruska1—7»a11is one-way analysis of variance: p< 0.001 for
"exploratory" dips,<0.01 for 3/T ratio and locomotor counts.
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FIG. 58: Overall behavioural response in the hole-board
apparatus following bilateral injection of 1 pi
saline or 5» 12.5» 25 or 50 pg dopamine (as the
hydrochloride salt) into the accumbens nuclei^
Each column represents overall mean activity -
S.E.M. of 6 or 7 rats during the 10 hour period
immediately following the intracerebral injection.
Each animal was pretreated with 100 mg/kg nialamide
i.p. 2 hours before the intracerebral injection.
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A Kruskal-Wallis one-way analysis of variance
comparing the overall response during the 10 hour
observation period in all five groups of rats showed
that the behavioural differences between the different
doses of DA and of saline were statistically
significant(p< 0.001 for "exploratory" dips, <0.01
for locomotor counts and <0.01 for S/T ratio, not
significant for stereotyped dips.) It should be
noted that locomotor counts were subject to great
variation.The maximal locomotor response appears to have
occurred with a dose of 11.5 p-S -OA.
(ii) response to bilateral injection of dopamine
hydrochloride into the caudate nucleus in
hialatai^e pre treated rats
Two hours after administration of 100 mg/kg
nialamide, 12. 5» 25» 50 jig dopamine hydrochloride
contained in 1 jil physiological saline was injected
bilaterally into the caudate nucleus. Control
animals were injected with 1 saline two hours
after nialamide pretreatiaent.
A very different pattern of response was obtained
in comparison with that following the n.accumbens
injections. The behavioural response had its onset
at 30 - 60 min. and peak at 5 hours. The response
thereafter lasted up to 10 hours. In contrast to
the response to OA injection into the aocuabens
nuclei, the injection into the caudate nuclei
resulted in a marked dose-related stimulation of
"stereotyped" dipping. "Exploratory" dipping and
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locomotor activity were also stimulated moderately,
but "stereotyped" dipping was predominant (Figs.59*
60,Tables 35,36). The o/T ratio therefore remained
very high. Not much sniffing behaviour was noted.
At the highest dose of DA employed, "non-dipping
stereotyped" behaviour (see page 146) was also evident
usually between 4 and 6 hours after injection. A
Kruska1-Dallis one-way analysis of variance showed
that the differences between the responses over the
entire 10 hour period of the record to saline and the
three doses of DA employed (11.5> 15 and 50 jig) were
statistically significant (p<0.00l)for "stereotyped"
dips but not for the S/T ratio. The differences
in "exploratory" dipping were also significant
(p< 0.001) but changes in locomotor counts were not.
Because the d/T ratios for saline-treated controls
were rel tively high and the DA administration
increased this only slightly, the changes in S/T
ratio were also not significant.
(iii) Dffect of pretreatment with haloperidol on the
response to bilateral injection of kb px>< dopamine
hydrochloride into the accumbans and caudate
nuclei in nialamide pretreated rats
Animals were pretreated with nialamide 100 mg/kg
i.p.Ninety min. Later they were further treated with
0.4 mg/kg haioperidol or O.S mg/kg haloporidol i.p. A
further 30 minutes later /i_ DA was injected
bilaterally into the accuubens or caudate nuclei and
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FIG. 59a: Behavioural response in the hole-hoard apparatus
following bilateral injection of 1 /il saline or
12.5 or 25 jig dopamine (as the hydrochloride sal"
in 1 jil saline into the caudate-putamen ijiucleus.
Bach point represents the mean activity - S.E.M.
of 6 or 7 rats during successive 30 min. interval
following the intracerebral injection. Animals
were pretreated with 100 mg/kg nialamide i.p.
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FIG. 59b: Behavioural response in the hole-hoard apparatus
following bilateral injection of 1 |il saline or
50 jiq dopamine (as the hydrochloride salt) inl/l saline into the caudate-putamen nucleus.
Bach point represents the mean activity - S.3.M.
of 6 or 7 rats during successive 30 min. intervals
following the intracerebral injection. Animals
were pretreated with 100 mg/kg nialamide i.p.
2 hours before the intracerebral injection.
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TABLE 35? Behaviour in the hole-board apparatus following
application of 1 /il physiological saline or 12. 5»
25 or 50 jig dopamine hydrochloride in 1 ul saline
to the caudate nucleus on each side. Bach animal
wa3 pretreated with Nialamide 100 mg/kg i.p. two
hours before the intracerebral injection. Figures
show mean activity - S.3.M. during each successive
30 min. period following intracerebral injection of 6 rats.
S - "Stereotyped" dips; 3 - "Exploratory*! dips;




0-30 30 - 60
BOSS
(ps)
s 3 LOG S E LOC
0 11
+
4 34 - 10 46-9 27
+
10 18 ± 7 5-4
12.5 12 4 30 -134 42 - 11 64
+
22 31 ± 11 18 - 6
25 34
+
8 58 - 20 51 - 12 121
+
34 62 - 15 43 - 14
50 17
+




60 - 90 90 - 120
BOSS
(p«)
s 3 LOG s T"l& LOC
0 29
+
7 15 * 5 21 - 16 21
+
4 13 -+ 4 12-5
12.5 101
+
32 74 ± 33 49 1 19 206 + 68 82 -+33 79 - 37
25 207
+
60 100 - 11 51 - 14 304 65 168 - 37 65 - 15
50 202
+
58 71 - 16 38 - 9 439
+




120 - 150 150 - 180
BOSS
(jig)
s E LOC S E LOC
0 50
+
17 10 ± 3 13 i 6 31 + 10 7 - 4 13-5
12.5 314 -131 47 - 19 52 - 18 237
+
61 41 1 15 66 i 23
25 352 -111 210 - 58 129 1 39 562 -214 167 - 58 130 - 34
50 565
+







180 - 210 210 - 240
e03s
(fix)
s s loc s e loc
0 14 ± 3 5 - 2 9 1 7 41 - 14 18 ± 9 21 ± 17
12.5 346 - 89 49 - 17 48 - 24 346 -108 43 ± 14 55 - 18
25 562 -215 167 - 58 130 - 34 657 -201 159 ± 59 91 ± 29




240 - 270 270 - 300
lose
s "PJIxJ log s e loc
0 24 ± 5 8 ± 3 8-4 47 ± 12 13 ± 5 13 - 7
12.5 254 -103 48 ± 18 45 - 12 208 -107 26 - 15 27 1 12
25 726 -225 135
+
55 101 ± 34 728 -220 154 ± 36 96 ± 24




300 - 330 330 - 360
loss
(jig)
s e loc s s loc
0 58 ± 26 12 ± 4 13 - 9 36 * 13 16 ± 5 12 ± 5
12.5 110 ± 36 22 ± 6 61 ± 19 77 ± 27 18 ± 5 41 ± 15
25 62 5 -139 124 - 49 99 - 25 703 - 99 127 ± 48 82 ± 28




360 - 390 390 - 420
lose
(fw)
s e loc s e loc
0 51 ± 13 16 ± 6 12-7 50 ± 10 20 ± 5 18 ± 10
12.5 71 ± 14 12 ± 4 18-6 51 ± 14 20 ± 6 31 ± 13
25 617 -106 80 - 30 51 1 14 429 ± 22 79 ± 24 61 ± 16







420 - 450 450 - 480
DOSS
(p)
3 E LOC S S LOC
0 32
+
13 14 £ 4 16 - 6 48
+
15 31 i 9 28 £ 13
12.5 42
+
6 25 £ 5 44 - 10 39
+
8 24 ± 6 34 £ 11
25 295
+
50 52 - 16 53 - 15 188
+
62 46 - 28 34 £ 13




480 - 510 510 - 540
DOSS
(p)
s E LOC S S LOC
0 41
+
16 22 - 7 35 - 14 47
+
11 20 i 7 37 £ 17
12.5 41
+
6 25 £ 4 34 - 7 26
+
5 15 - 5 20 £ 8
25 164 70 30 - 9 30-6 130
+
47 24 - 10 35 £ 10
50 306
+
84 79 - 19 134 - 25 195
+




540 - 570 570 - 600
DOSS
(iu?) s S LOC s E LOC
0 27
+
12 16 * 5 17 £ 6 19 + 9 9 i 5 10 £ 7
12.5 25
+
5 14 - 4 33 1 10 20 + 6 15 i 4 37 £ 11
25 152
+
49 37 £ 6 40 - 13 86
+
35 17 - 8 34 £ 15
50 205
+
91 101 ± 59 82 - 23 148
+
96 38 1 19 53 £ 24
Details of the responses of individual rats can be found in the
Appendix (Tables 39 - 43).
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TABLE 36: Overall behavioural response in the hole-board
apparatus during a 10 hour observation period
following injection of 1 pi physiological saline or
12.5» 25 or 50 ug dopamine hydrochloride in 1 p.1
saline into the caudate nucleus on each side. Animals
were pretreated with nialamide 100 mg/kg two hours
before the intracerebral injection. figures show
overall response of each rat during the 10 hour period.
S - "Stereotyped" dips; E Bxploratory" dips;
T - Total number of dips; S/T ratio - ratio of





(>lg) IVITY 1 2 3 4 5 6 7
-Calu |
0 S 543 832 394 1249 494 732 707
+
126
3 369 66 133 327 440 561 316
+
77
T 912 898 527 1576 934 1293 1023
+
148
S/T 0.60 0.93 0.75 0.79 0.53 0.57 0.69
+
0.06
IOC 352 22 99 - 424 752 330
+
130
s 4093 4706 1401 3874 1793 961 1317 2592
+
603
3 633 1424 478 443 432 542 337 649
+
145
12.5 T 4981 6130 1879 4317 2225 1503 1654 3241
+
705
S/T 0.82 0.77 0.75 0.90 0.81 0.64 0.80 0.78 + 0.03
LOC - 808 757 717 934 665 132 677
+
105
S 5229 4930 11696 5832 6054 10415 7359
+
1192
3 4489 2025 1597 1250 1713 1413 2081
+
494
25 T 9718 6955 13293 7032 77o7 11828 9440
+
1082
S/T 0.54 0.71 0.88 0.82 0.78 0.88 0.77 + 0.05
LOC 1462 2668 454 1622 1294 1297 1466
+
291
S 6932 9262 16294 10711 8073 13965 10873 + 1471
3 1686 3391 1473 2345 4443 972 2385
+
536
50 T 8618 12653 17767 13056 12516 14937 13258
+
1233
S/T 0.80 0.73 0.92 0.82 0.65 0.93 0.81 + 0.04
IOC 2379 - 1498 llo4 6567 1485 2619
+
1002
Kruskal-iallis one-way analysis of variance: p<0.001 for








FIG. 60: Overall behavioural response in the hole-board
apparatus following bilateral injection of l/il
saline or 12.5» 25 or 50 jig dopamine (as the
hydrochloride salt) into the caudate-putamen
nuclei.
+Sach column represents overall mean
activity - S.E.M. of 6 or 7 rats during the
10 hour period immediately following the intra¬
cerebral injection. Each animal was pretreated
with 100 mg/kg nialamide i.p. 2 hours before
the intracerebral injection.
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The results were compared with those from injection
of DA into rate pretreated with nialamide only (see
previous two sections).
Pre treatment with 0.4 mg/kg haloperidol i'.p.
completely blocked the response to a5 jag DA injected
bilaterally into the accumbens nuclei over a three
hour observation period (i:ig.bl, Table 37) (Mann-
iVhitney U-test, p = 0.002 for exploratory dips
p = 0.002 for stereotyped dips, p = 0.008 for
locomotor counts.)
0.4 mg/kg haloperidol did not invariably block
the stereotyped dipping response to DA injection into
the caudate nuclei but appeared to block the response
in some animals and not in others in all-or-none
fashion (i'ig. o2,Table 38). However, a dose of
0.8 mg/kg haloperidol virtually abolished the response
(Kruskal-dallis one-way analysis of variance of
results for controls, 0.4 and 0.8 mg/kg haloperidol
p<0.01 for •'stereotyped" alps <0.01 for expioi'atory
dips, < 0.02 for locomotor counts.)
(iv) Response to 50 jig L-noraarenaline hydrochloride
injected bilaterally into the nucleus acoumbans
in nialamide pre tree, tea rats
50 jig L-norad renal in e hydrochloride was injected
into the nucleus accumbens on each side two hours
after pratreatment with 100 ag/kg nialamide i,.p. and the
behaviour studied on the hole-board for 10 hours.
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TABLI 37: Effect of pretreatment with 0.4 mg/kg haloperidol*
i.p. 30 min. before the DA application on the
response to 25/ig dopamine hydrochloride injected
into the accumbens nucleus on each side in nialamide
pretreated rats. Figures show the overall response
of each rat during a 3 hour period after
intracerebral injection.
S - "Stereotyped" dips; 3 - "Exploratory" dips;
T - Total number of dips; 3/T ratio - ratio of







IVITY 1 2 3 4 5 6 7
S 178 114 159 327 192 288 210 ± 33
s 890 1122 1644 1729 2311 1881 1596 - 211
0 T 1068 1236 1803 2056 2503 2169 1805 - 228
S/T 0.17 0.09 0.09 0.16 0.08 0.13 0.12 ± 0.01
LOG 1062 333 478 1661 - 694 846 ± 238




100- 623 463 5 7 50 7 25 140
0.4 T 539 12 9 67 14 34 245 131 - 75
S/T 0.14 0.58 0.22 0.25 0.50 0.26 0.39 0.33 - 0.06
LOG 894 120 14 59 66 34 244 *238 - 125
** p = 0.002
* p = 0.008
(Mann-Whitney U test)















FIG, 61: Effect of i.p. pretreatment with. 0.4 mg/kg
haloperidol (30 min. before) on the response to
bilateral injection of 2 5 dopamine (as the
hydrochloride salt) in 1 y.l saline. Animals
were also pretreated with 100 mg/kg nialamide i.p.
2 hours before the intracerebral injection. The
results after pretreatment with haloperidol are
compared with those from control animals which
did not receive any haloperidol (dose 0)^ Each
column represents mean overall activity - S.E.M.
of 6 or 7 rats during the 3 hour period immediately
after the intracerebral injection.
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TABLI 38: Sffeot of pretreatment with 0.4 or 0.8 mg/kg
haloperidol i.p. 30 lain. before the JA application
on the response to 2 5 ug dopamine hydrochloride
injected into the caudate nucleus on each side in
nialamide pretreated rats. Figures show the overall
response of each rat during a 3 hour period following
the intracerebral injection.
S - "Stereotyped" dips; 2 - "exploratory" .dips;
T - Total number of dips; S/T ratio - ratio of







1 2 3 4 5 6
3 386 1035 1356 1172 1165 2661 1296
+
305
S 1382 622 1064 571 646 560 841
+
134
0 T 176£ 1857 2420 1743 1811 3221 2137 240
S/T 0.22 0.56 0.56 0.67 0.64 0.83 0.58 + 0.08
LOG 157 1787 574 541 144 510 619
+
246
3 lQoS 346 28 64 1146 530
+
241
S 518 654 48 63 201 297
+
123
0.4 T 1563 1000 76 127 1347 827
+
311
S/T 0.67 0.35 0.37 0.50 0.85 0.55 +mm 0.09
LOG 243 830 193 68 237 314 1 133
3 4 13 16 39 14 17
+
6
S 11 ac 30 6 8 12
+
5
0.8 T 15 19 46 45 22 29
+
7
S/T 0.26 0.68 0.34 0.8b 0.64 0. 56 +mm 0.11
LOG 5 37 - 11 14 17
+
7
Kruskal-Wallis one-way analysis of variances p<"0.01 for
















FIG, 62; Effect of i.p. pretreatment with 0.4 or 0.8 mg/kg
haloperidol on the response to bilateral injection
of 2 5 jxg dopamine (as the hydrochloride salt)
into the caudate-putamen nuclei. The results
are compared with those from animals which did
not receive haloperidol pretreatment (dose 0).
All animals were pretreated with nialamide
100 mg/kg i.p. JJach column represents mean
overall response - S.3.M. of 5 or b animals
during the 3 hour period immediately following
the intracerebral injection.
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Noradrenaline caused a slight increase in
exploratory dipping and locomotor counts when
injected into the accumbens nuclei (Fig.63b,64»
Tables 39»40). These changes were not statistically
significant. The animals appeared no different
from those that had been given saline on visual
observation.
(v) Response to 90 jig L-noradrenaline hydro¬
chloride injected bilaterally into the
caudate nuclei in nialamide pretreated rats
50 jig L-noradrenaline hydro chloride was injected
into the caudate nucleus on each side two hours after
pretreatment with 100 mg/kg nialamide i.p. and the
behaviour studied on the hole-board for 10 hours.
Noradrenaline injected into the caudate nuclei
produced a moderate stimulation of "stereotyped"
dipping with no effect on "exploratory" dipping or
locomotor counts when compared with the responses of
saline-injected controls (Figs. 65b,6b, Tables 41,42).
In comparison with the response of DA-injected rats,
the onset of the "stereotyped" dipping response to NA
was much delayed since it occurred only after 2-3
hours; the peak response was also much delayed. The
intensity of the "stereotyped" dipping showed much
variation between animals. The increase in the "stereo¬
typed" dipping response was significant when compared
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FIG. 63: Behavioural response in the hole-board apparatus
following bilateral injection of 1 .ml saline or
50 jig L-noradrenaline (as the hydrochloride salt)
or 50 jig 5-hydroxytiyptamine (as the bimaleinate
salt) into the acoumbens-nuclei of nialamide-
pretreatetji rats. Bach point represents mean
response - S.B.M. of 6 or 7 rats during each
successive 30 min. interval following the
intracerebral injection. Animals were pre-
treated with nialamide 100 mg/kg i.p. 2 hours
before the intracerebral injection.
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TABLE "39: Behaviour in the hole-board apparatus following
application of 1 jil physiological saline or 50 jig
L-noradrenaline hydrochloride or 50 jig 5-HT bimaleinate
into the accumbens nucleus on each side. Each animal
was pretreated with 100 mg/kg nialamide i.p. two hours
before the intracerebral injection. figures show mean
response - 3.3.M. during successive 30 min. intervals
after the intracerebral injection of 5-6 rats.
S - "Stereotyped" dips; E - "Exploratory" dips;










12-5 49 - 13 70 - 25
14 * 2 21 - 3 73 - 14
11 - 7 9 - 3 6 - 4
12-4 33-13 42 - 12




60 - 90 90 - 120




14-10 11-7 16 - 9
30 i 14 33 - 13 68 * 27
36 i 13 22 - 7 182 - 58
12 - 7 12-8 16 - 8
19-8 39 - 18 47 - 21




120 - 150 150 - 180




13-5 9-5 25 - 11
15 - 7 36 - 17 82 i 33
29 -12 39 - 13 168 * 48
12 — 7 7*5 17 *9
15 * 5 43 * 21 71 * 35




180 - 210 210 - 240




14 - 5 8 - 4 7-5
8-3 31 - 14 67-35
21-7 72 - 39 182 - 62
16 * 7 11 * 5 20 * 9
12 * 3 28 * 13 53 * 28







240 - 270 270 - 300




20 i 12 11-5 7 - 4
7 i 3 15 1 9 40 - 16
16 - 4 15-4 81 - 34
25-14 10-5 26 - 15
12 - 3 18 - 4 29 i 8




300 - 330 330 - 360





8 - 3 14 - 8 9i4
54 - 28 25 ± 14 33 - 21
23-7 12-4 16-9
4 - 1 10 i 3 10-4




360 - 390 390 - 420




22 - 7 11 - 5 24 - 15
8 - 4 6 - 2 8 - 3
28-6 27-8 46 - 15
46-13 18-4 31 - 14
11-5 16-5 15-4




420 - 450 450 - 480




36 - 11 19 * 4 21 - 9
13-7 10-3 21 - 8
27-10 18-5 18-2
38 ± 12 19 i 7 21 — 11
7 * 4 17 - 7 25 4 5




480 - 510 510 - 540




54-16 19 i 8 22 -9
7-3 11-3 14-5
23 - 10 24 i 10 29 - 10
30-5 16-8 31 - 12
7-3 10-3 14-4







540 - 570 570 - 600




22-3 10-4 10 -+ 2
3-1 9-3 11-4
24-7 19-4 35 -+10
35 - 12 18 - 11 32 - 16
5 - 1 5 - 2 3 - 3
12 - 3 15 - 5 29 -8
Details of the responses of individual rats can be found in the
Appendix (Tables 34* 44» 45).
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TABU 40: Overall behavioural response in the hole-board
apparatus during a 10 hour period following
application of 1 jil physiological saline or
50 jig L-noradrenaline hydrochloride or 50 jig
5-IIT bimaleinate into the accumbens nucleus on
each side. Each animal was pretreated with
nialamide 100 mg/kg 2 hours before the intracerebral
inj action. Figures show overall response of each
animal during the 10 hours.
3 - "Stereotyped" dips; B - "Exploratory" .dips;
T - Total number of dips; 3/T ratio - rat^0 of






1 2 3 4 5 6
S 384 331 792 220 394 757 480
+
96
3 154 234 447 204 99 416 259
+
58
0 T 538 565 1239 424 493 1173 739
+
150
3/T 0.71 0.59 0.64 0.52 0.80 0.65 0.65
+
0.04
LOG 117 411 595 334 124 - 316
+
91
S 332 237 192 122 237 224
+
35
3 705 342 725 183 208 433
+
119
NA T 1037 579 917 305 445 657
+
139
50jig S/T 0.32 0.41 0.21 0.40 0.53 0.37 + 0.05
LOG 1100 - 1404 243 270 754 294









5-HT T 1510 1293 865 1507 873 989 1173
+
124
50jig S/T 0.43 0.46 0.65 0.47 0.41 0.63 0.51 + 0.04
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FIG. 64? Overall response in the hole-board apparatus
following bilateral injection of 1 jil saline or
50 fxs L-noradrenaline (as the hydrochloride
salt; or 50 Jig 5-hydroxytryptamine (as the
bimaleinate salt) into the accumbens nuclei.
+
Bach column represents overall mean activity -
S.B.M. of 6 or 7 rats during the 10 hour period
immediately following the intracerebral injection.
Bach animal was pretreated with nialamide
100 mg/kg i.p. 2 hours before the intracerebral
injaction.
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(vi) Iffeet of bilateral injection of 50 ftm 3-mv~drox./-
tr.ro tamine bimaleinate into the aceumbens nuclei
in nialamide pretreated rats
50 ug 5-HT bimaleinate was injected into the
nucleus accumbens on each side two hours after pre-
treatmsnt with 100 mg/kg nialamide i.p. and the behaviour
studied on the hole board for 10 hours.
When injected into the accumbens nuclei, 5-HT
produced somewhat variable behavioural responses
(rigs.o3cfU4, Tables 33»40). The most prominent
response was a locomotor activity stimulation which
began within 30 min. and was usually over within
5 hours. The locomotor activity was in most cases
sporadic. A less marked stimulation of dipping
behaviour of both types also occurred. On visual
observation, the behavioural response showed marked
differences from that seen with DA injection into the
nucleus. The animal's movements appeared less co¬
ordinated and less purposeful. The body was
flattened on the floor of the hole-board as it moved
around. Rearing never took place. Intense sniffing
was observed.
The increase in locomotor counts compared with
saline-injected controls was highly significant
(p = 0.008) and the increase in " exploratory'1 dipping
was also significant (p = 0.026)..
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(vii) Sffect of injection of 50 jig 5-hydroxy-
tryptophan bimaleinate into the caudate nuclei
in nialamide pretreated rats
50 jig 5-HT bimaleinate was injected into the
caudate nuclei on each side two hours after pre-
treatment with 100 mg/kg nialamide i.p. and behaviour
studied on the hole board for 10 hours.
Here again the 5-HT injections produced variable
results. In some animals no striking response
occurred whereas in others a moderate stimulation of
both forms of dipping behaviour and locomotor activity-
occurred (Figs. 65c,66, Tables 41,42). The time-
course of the response was similar to that of 5-HT
injected into the accumbens nuclei. The animals*
postures were not abnormal and some rearing behaviour
was observed.
When compared with control animals which had
saline injected into the caudate nuclei» the
increase in " stereotyped" dipping and exploratory-
dipping were not statistically significant, while
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FIG« 65« Behavioural response in the hole-board apparatus
following bilateral injection of 1 jil saline or
50 jig Jj-noradrenaline (as the hydrochloride salt)
or 50 jig 5-hydroxytryptamine (as the bimaleinate
salt) into the caudate-putamen nuclei of
nialamide-pretreated rats. Each point represents
mean response - S.E.M. of 6 or 7 rats during
each successive 30 min. interval following the
intracerebral injection. Animals were pretreated
with nialamide 100 mg/kg i.p. 2 hours before the
intracerebral injection.
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TABLE 41: Behaviour in the hole-hoard apparatus following
application of 1 jil physiological saline or 50 jig
L-noradrenaline hydrochloride or 50 jig 5-HT bimaleinate
into the caudate nucleus on each side. Each animal
was pretreated with 100 mg/kg nialamide i.p. two hours
before the intracerebral injection. Figures show mean
response - S.E.M. during successive 30 min. intervals
after the intracerebral injection of rats.
S - "Stereotyped" dips; E - "Exploratory" dips;




0-30 30 - 60




11 ± 4 34 - 10 46 -9
15-5 14-5 26 i 9
28-8 57 - 10 66 - 23
27 - 10 18 - 7 5 -4
25 - 10 13 - 5 24 - 12




60 - 90 90 - 120




29 - 6 15 - 5 21-16
18 - 8 17 - 5 24 - 8
62 i 26 69 - 25 136 - 83
21 i 4 13-4 12 - 5
25 - 13 14-3 54 - 15




120 - 150 150 - 180




50-17 10-3 13 - 6
48 - 18 29 - 10 54 - 17
107 - 52 58 - 15 139 - 89
31-10 7 - 4 13 - 5
42 -11 39 - 17 69 - 13




180 - 210 210 - 240




14 -3 5 - 2 9 - 6
62 - 10 51 - 16 45 1 12
106 i 38 72 - 25 120 ± 67
41-14 18 i 9 21 ± 17
72 - 30 34 - 11 29 1 12







240 - 270 270 - 300
TREATMENT s S LOG S E LOC
Saline 24
+
mm 5 8 ± 3 8-4 47
+
12 13 - 5 13-7
NA 50 jig 121
+
mm 53 25 ± 10 46 - 15 148
+
73 27 ± 8 24-9
5-HT 50 fig 67
+
14 28 - 9 92 - 35 43
+




300 - 330 330 - 360
TREATMENT S E LOG s E LOC
Saline 58
+
26 12 ± 4 13 - 9 36
+






























360 - 390 390 - 420
TREATMENT s T?ill LOG s E LOC
Saline 51 13 16 * 7 12-7 50
+
10 20 ± 5 18 i 10
NA 50 jig 182
+
92 24 ± 10 46 - 13 195
+
85 37 - 14 54 - 13
5-HT 50 jig 39
+
13 29 - 12 35-9 34
+
9 30 - 18 28 - 15
TIME
420 - 450 450 - 480
TBBAMENT s E LOC s 1?J2» LOG
Saline 32
+
13 14 ± 4 16-7 48
+
15 31 - 9 28 - 13
NA 50 jig 211
+ 86 27 - 12 60 i 17 175 + 69 34 - 9 41 - 12
5-HT 50 jig 50
+
15 23 ± 8 36 - 9 42
+




480 - 510 510 - 540
TREATMENT 3 1?Hi LOG 3 E LOC
Saline 41
+
16 22 - 7 35 1 14 47 +mm 11 20 - 7 37 ± 17
NA 50 jig 191
+
63 36 - 9 79 ± 13 121 + 62 27 - 10 67 - 21
5-HT 50 jig 41
+







540 - 570 570 - 600




27 - 12 16-5 17-7
82 - 44 35 * 13 62 - 14
28 i 9 12 - 3 35 - 9
19 - 9 9-5 10 — 6
110 ± 46 26 - 8 51 - 13
25 - 12 10 i 3 11-5
Details of the responses of individual rats can be found in the
Appendix (Tables 39» 46, 47).
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TABLE 42i Ovarall behavioural response in the hole-board
apparatus during a 10 hour period following application
of" 1 p.1 physiological saline or 50 jig L-noradrenaline
hydrochloride or 50 }ig 5-KT bimalemate into the
caudate nucleus on each 3ide. Bach animal was pre-
treated with nialamide 100 mg/kg 2 hours before the
intracerebral injection. Figures show ovarall
response of each animal aurin0 the 10 hours.
3 - "Stereotyped" dips; 3 - "Exploratory" dips;
T - Total number of dips; S/T ratio - ratio of
"stereotyped" over total dips; IOC - Locomotor counts.
KAT NO. -L.
rr\T) T? A rrr8T??J Hf* A rwnTVTTV ifftJAW Z. QtmAUii / in iu - kJ
1 2 3 4 5 6 7
3 543 832 394 1249 494 732 707
+
126
3 369 66 133 327 440 561 316
+
77
saline T 912 898 527 1576 934 1293 1023
+
148
l/il S/T 0.60 0.93 0.75 0.79 0.53 0.57 0.69 + 0.06
LOG 352 22 99 - 424 752 330
+
130





3 599 918 398 334 500 390 723 552
+
80
NA T 1879 7842 107 o 2503 1559 1342 2292 2713
+
873









S 1214 445 294 840 1583 729 2876 1140
+
334
T? 1676 1418 244 329 1114 848 395 775
+
173
5-KT T 2290 1863 538 1169 2697 1577 3271 1915
+
351
50 jig S/T 0.53 0.24 0.55 0.72 0.58 0.4o 0.88 0.57 + 0.03
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TIG. 66: Overall response in the hole-board apparatus
following bilateral injection of 1 p.1 saline or
50 jug L-noradrenaline (as the hydrochloride salt)
or 50 jug 5-hydroxytryptamine (as the bimaleinate
salt) into the caudate-putamen nuclei. 3ach
column represents overall mean activity — S.S.M.
of 6 or 7 rats during the 10 hour period immediately
following the intracerebral injection. Each
animal was pretreated with nialamide 100 mg/kg i.p.
2 hours before the intracerebral injection.
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DISCUSSION
In this study the behavioural responses of rats to
drugs and to other manipulations have been studied
using an automated hole-board technique for the
simultaneous monitoring of exploratory, stereotyped and
locomotor activity. The interest in the role of mono¬
amine systems in the regulation of the three forms of
behaviour stems from an attempt to relate changes in
these behaviours in animals to the behavioural changes
in patients with psychotic illness. A better under¬
standing of the way in which monoamine systems regulate
the behaviours should increase our understanding of the
behavioural changes in psychotic illness and of how
these changes can be modified in the clinical situation.
Both in animals and in man these behaviours occur and
change in association with each other; in spite of this
most previous work with anima3_s has concentrated on
only one or occasionally two of the behaviours in question.
With respect to stereotactic manipulations of central
monoamine systems exploratory behaviour has been largely
ignored.
An attempt has been made to rectify these problems
by studying all three behaviours simultaneously, and
this lias allowed a closer examination of the relation¬
ships between the three behaviours as well as examination
of the roles of monoamine systems in their mediation.
Techniques which monitor a variety of behaviours
simultaneously are probably more likely to provide animal
models of psychotic illness than those which depend on
observation of just one aspect of behaviour.
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Monitoring of behavioural responses The hole-hoard
method was originally introduced as a technique for the
study of exploratory behaviour of small animals (Boissier
and Simon, 1962). Several workers subsequently have
used it for thi3 purpose with both rats and mice (e.g.
Boissier and Simon, 1964; U'Prichard and Steinberg, 1972;
Ljungberg and Ungerstedt, 1976). The frequency of head-
dipping into holes has been shown to be a valid and
reliable method for measuring exploratory activity
(File and Ward ill, 197 5a,b; Makanjuola, 1976; Liakanjuola
et al. 1977a). Automated recording of hole-dipping has
been achieved using infra-red detection techniques
(Boissier and Simon, 1967; Ijungberg and Ungerstedt, 1976;
Makanjuola, 1976; Makanjuola et al. 1977a), and simul¬
taneous automated recording of locomotor activity, using
a technique similar to that in the present study,
introduced by ljungberg and Ungerstedt (1976). The
major advance in the application of this methodology
for behavioural measurements in the study with which the
author has been involved has been the differentiation of
stereotyped from exploratory patterns of behaviour on
the hole-board. The method relies on recognition of
a form of stereotyped behaviour by the repetitive
(stereotyped) patterns of hole-dipping in contrast to
the random patterns which have been found to be associated
with exploration. The quantitative differentiation of
"exploratory" from "stereotyped" hole-dipping activity
has been described on page 61 •
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" Exploratory" and "stereotyped" hole-dipping do
not encompass the complete expression of exploration
and stereotypy hut are facets of these activities which
may he exhibited by forms of behaviour other than hole-
dipping e.g. behaviour under the influence of apomorphine.
However, it has been shown that changes in the overall
intensities of these two types of hole-dipping, accompanied
by changes in their relative proportions (as represented
by the S/T ratio.; the ratio of stereotyped over total
dips) do reflect changes in the two forms of behaviour
(Makanjuola, 1976; Makanjuola et al. 1977a), A fuller
discussion of other methodological considerations
concerning the hole-board apparatus appears later (page 235 ).
Behavioural responses to aaphetamine
Amphetamine administered to adult male rats led to
the expected behavioural responses (page 82 ), The
lower doses (2 and 4 mg/kg DIfamphetamine sulphate)
caused a moderate stimulation predominantly of "exploratory"
dipping and locomotor activity as well as of sniffing and
rearing movements. At the highest dose used (8 mg/kg),
after an initial stimulation of exploratory dipping and
locomotor activity, the levels of these two activities
actually fell to below control levels (Fig. 16 ) whereas
"stereotyped" dipping increased markedly. In previous
experiments (Makanjuola, 1976; Makanjuola et al. 1977b)
it had been found that a still higher dose of amphetamine
(16 mg/kg) induced an intense form of stereotyped
behaviour ("non-dipping stereotyped behaviour") which
was not registered by the hole-board technique (page 146).
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Amphetamine is thought to accentuate the activities
of both dopaminergic and noradrenergic systems, and to
a lesser extent of serotonergic systems, mainly by
causing transmitter release from neuronal terminals
(page 23). Information regarding the relative roles of
different monoamine systems in the amphetamine-induced
response may be derived from observation of the effects
on the response of drugs with selective actions on
different systems.
Modification of response to amphetamine by haloperidol.
Kaloperidol is a potent antagonist of DA receptors (AndIn
et al. 1970a; Seernan et al. 1976) but also has relatively
weaker -adrenoceptor blocking properties (Anden et al,
1970a), This drug at low doses markedly inhibited
spontaneous exploratory and locomotor activity (page 90 )
and also when given previously, reduced the amphetamine-
induced stimulation of exploratory, locomotor and
stereotyped behaviours. The degree of inhibition by
haloperidol of both spontaneous and amphetamine-induced
activities was dose-related. In this respect, amphetamine-
induced stereotypy was more susceptible to the inhibitory
actions of haloperidol than the other two behaviours.
Furthermore it was shown (Fig. 21 ) that the effects of
increasing dosages of haloperidbl on the amphetamine
response mirrored the effects of reduction in doseage of
amphetamine without neuroleptic pretreatment. These
findings provide good evidence that DA systems play a
major role in the mediation of "spontaneous" exploratory
and locomotor activity as well as amphetsmine-induced
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stimulation of exploratory, locomotor and stereotyped
"behaviours.
The other two monoamine receptor blockers, phenoxy¬
benzamine and methysergide, did not produce such marked
effects on the amphetamine response in spite of the
relatively high doses of the antagonists employed.
Modification of behavioural response to amphetamine by
phenoxybenzamine. Phenoxybenzamine is a potent
^adrenoceptor antagonist (And^n et al. 1967b; Doxey
A
et al. 1972) with predominantly post-synaptic actions
(Doxey et al. 1972; Starke et al. 1975) but it also has
antagonist actions at 5-HT, histamine and acetylcholinergic
receptors (Nickerson and Collier, 1975). It is accordingly
difficult to draw conclusions from the effects of this
drug on the amphetamine-induced response particularly in
view of the fact that the animals pretreated with this
drug were invariably ill-looking and lethargic.
Relatively severe peripheral autonomic effects must be
taken into consideration. In confirmation of other
reports (luxe and Ungerstedt,1970;Hplinski and Scheel-Kruger,
1973; Ijungberg and Ungerstedt, 1976) it was found that
pretreatment with phenoxybenzamine reduced the locomotor
and exploratory stimulation induced by amphetamine,
leaving "stereotyped" dipping relatively unaffected.
These results seem to indicate that noradrenergic systems
exert facilitatory influences on exploratory and loco¬
motor behaviour. This evidence is, however, suspect in
view of the lack of selectivity of action of phenoxy¬
benzamine. However, the conclusion is supported by the
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similar reduction of amphetamine- and Ir-ROPA-induced
locomotor and exploratory stimulation produced by prior
dopamine-^)-hydroxylase inhibition (page 35). It would
have been of interest to study the effects of phenoxy-
benzamine on the response to a higher dose of amphetamine
which on its own would have led to a more clear-cut
stereotyped response. However, in view of the obvious
undesirable side-effects of the ^-adrenoceptor antagonist
further studies were not undertaken. Other workers have
observed that oL -adrenoceptor blockade with a variety of
agents including phenoxybenzamine, phentolamine and aceperone
has little or no effect on drug-induced stereotypy (page 35).
Modification of behavioural response to amphetamine by
methysergide Methysergide is a potent antagonist at 5-HT
receptors (Garattini and Valzelli, 19c5; Aghajanian et
al. 1975). This agent produced a moderate potentiation
of the response to 4 mg/kg DL-amphetamine sulphate
affecting all three behavioural parameters under study
(page 98 ). This observation contradicted one other
report that 5-HT receptor blockade reduces the
locomotor response to amphetamine (van Riezen, 1972),
although most studies have failed to demonstrate any
effect of such blockade on apomorphine- or amphetamine-
induced stereotyped behaviour (page 35). This failure
by other workers to observe any effects by 5-HT receptor
antagonists on stereotyped behaviour may be because
the potentiation observed in this study is not marked
and thus may remain undetected in experiments relying on
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visual observation only. Bven in the present study
the potentiation of stereotyped dipping was not partic¬
ularly intense and did not achieve statistical significance.
Behavioural responses to apomorphine
Apomorphine}a potent agonist at DA receptor sites;
(page 26) induced responses identical to those found in
a previous study (ivlakanjuola, 1976; Llakanjuola et al.
1977b).While the exploratoiy and stereotyped actions
monitored by hole-dipping were actually inhibited, the
behavioural effects observed visually were consistent
with a stimulation of exploratory beh viour at low doses
and of stereotyped behaviour at high doses, both forms
cf behaviour involving principally motor activities
involved in gustation and olfaction. Although other
workers have claimed that apomorphine stimulates loco¬
motor behaviour at lower doses (Fuxe and Ungerstedt,
1970; Igungberg and Ungerstedt, 1976), in the present
study the stimulant effects on locomotor activity were
not marked. In fact most animals under the influence
of apomorphine tended to crawl slowly around the hole-
board, much more of its activity being directed towards
sensory stimulation which mainly involved the olfactory
ana gustatory senses.
Behavioural responses to 5-Methoxy,-II,H,-Mmeth.vltryptamine
5-Methoxy,-NfNy-dimethyltryptamine (5-M3QDLT),a
putative agonist at 5-HT receptors (Grahame-Smith, 1971b;
Green and Grahame-Smith, 1976),produced behavioural
responses very different to those induced by apomorphine
187.
and amphetamine. In accord with the findings of other
workers, the drug induced a bizarre hyperactivity
syndrome involving an unco-ordinated hyperactivity,
hyperextension of the body, sniffing and repetitive head
movements. Inco-ordination was the most prominent
feature of the syndrome unlike those induced by apomor-
phine and amphetamine at least with lower doses, in
which activity was co-ordinated and explicable in terms
of motivation towards specific ends e.g. locomotion or
exploration. whichever dose of 5-M30DL1T was employed
within the tested range of 2.5 - 10 mg/kg the behavioural
response was qualitatively the same. The drug is known
to be a potent hallucinogen (Grahame-Smith, 1971b).
It would have been useful to study the response to
noradrenergic receptor stimulants. However there are
no readilyavailable/'-adrenoceptor agonists which can
penetrate the CUTS on systemic administration. Clonidine,
an (/-adrenoceptor agonist (Anden et al. 1970b) also has
effects (probably indirect) on OA and 5-HT systems (page
28) and more importantly exerts actions on presynaptic
^-adrenoceptors as well as postsynaptic receptors.
This presynaptic activity has been proposed as an
explanation of the drug's sedative effects (page 28). In
preliminary studies using the drug it was found that
clonidine caused locomotor depression and ataxia.
Apparently in an attempt to overcome these presynaptically-
induced sedative actions some workers have pretreated
animals with reserpine which would have the effect of
eliminating presynaptic mechanisms by depleting monoamine
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neurones of their transmitters. Under these circum¬
stances clonidine has been found to potentiate the
locomotor stimulant effects of apomorphine in mice
(Anden and Strombom ,1974; Pycock et al. 1977) or to
stimulate exploration of an open field in rats that were
also given a small dose of apomorphine (Fuxe and
Ungerstedt, 1970) but to have no effect on apomorphine-
induced stereotypy (Pycock et al. 1977). On the face
of it these results would seem to indicate that activation
of postsynaptic o( -adrenoceptors leads to a stimulation
of locomotor and probably exploratory behaviour in the
presence of some dopaminergic receptor activation.
Perhaps a more definitive study v/ould be to investigate
the behavioural effects of clonidine in animals that had
been pretreated with a dopamine- P - hydroxylase inhibitor
which would preferentially decrease presynaptic nora¬
drenergic neuronal activity. In these circumstances
clonidine should stimulate locomotor activity.
Behavioural responses to inhibitors of neuronal
transmitter reuptake mechanisms
Attempts were made to study the effects of facili¬
tation of activity in individual monoamine systems by
employing a variety of inhibitors of neuronal transmitter
re-uptake of varying degrees of selectivity on individual
monoamines.
In support of widely-reported observations (page 38),
the tricyclic antidepressant drugs studied, desmethylimi-
pramine (DMI) and chlorimipramine (GMI) were found to
give rise to behavioural depression in rats. It i3
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interesting that the drug GrEA 654 tended to stimulate
locomotor and exploratory behaviour, although not to a
statistically significant degree. The effect of this
drug was examined because it has been reported to be a
very selective inhibitor of 5-HT uptake with virtually
no effects on DA or NA uptake (Astra, 1976) and also
because it is structurally different from the conventional
tricyclic drugs (Fig. 30). It also appears to be devoid
of other types of action (Astra, 1976). Chlorimipramine
is somewhat more effective in inhibiting neuronal uptake
of 5-HT than of NA (page 38) and in the experiments on
rats caused less behavioural sedation than desmethylimi-
pramine which is more selective against NA uptake
(page 38). It will be recalled that the ^-adrenoceptor
agonist clonidine also causes behavioural sedation,
although this action of clonidine may be presynaptically-
induced (page 187). These observations could therefore
be interpreted as indicative of a primary inhibitory
effect on behaviour by noradrenergic systems.
The effects of postsynaptic^ -adrenoceptor blockade
on spontaneous as well as amphetamine-induced behaviour
(page 184) are inconsistent with such an interpretation.
However, the effects of such drugs on spontaneous activity
are not particularly marked (l.iungberg and Ungerstedt,
1976) and the possible influence of peripheral side-
effects as well as actions on other neurones have been
discussed above (page 184 ). The widely-observed
reduction of amphetamine-induced exploratory and
locomotor stimulation by these drugs is not so easily
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dismissed, but interactions of NA systems on a primarily
BA-mediated response could well result in different
effects from those of primary stimulation of NA-
mediated systems on that behaviour through other mechanisms.
Behavioural responses to selective inhibitors of neuronal
.DA uptake "1RCL 5182" is a potent inhibitor of DA uptake
with no activity against NA or 5-HT uptake, no effects
on monoamine release and no anticholinergic activity
(Pullar, personal communication). This drug, like
amphetamine, induced a marked stimulation of "exploratory"
dipping and locomotor activity at a low dose (10 mg/kg)
and a marked stimulation of "stereotyped" dipping and
"non-dipping" stereotyped behaviour at higher doses. In
contrast to amphetamine, however, the higher dose of
LAC1 5182 also caused a further marked stimulation of
locomotor activity. Indeed thi3 is the only drug 30
far tested in the hole-board apparatus which produced
both intense stereotypy and locomotor stimulation
simultaneously.
Benztropine, originally thought to exert its clinical
effects in the treatment of Parkinsonism through its
anticholinergic properties (See 3arbeau, 1962; Cal»e,
1970), also has potent inhibitory actions against neuronal
JA uptake (Coyle and Snyder, 1969; Horn et al. 1974)•
This drug caused a marked stimulation of hole-dipping of
both types and, particularly at a lower dose (2.5 mg/kg
of the mesylate salt),of locomotor activity. It is
difficult to be certain whether it is the anticholinergic
or the dopamine uptake-inhibiting properties of the drug
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that is the more important for the behavioural response
to benztropine. A variety of anti-Parkinsonian agents
which have both anticholinergic and dopamine-uptake
inhibiting properties (including benztropine) have been
shown to cause locomotor and exploratory stimulation in
rats and mice (e.g. Arnfred and Randrup, 1968; Scheel—
Kruger, 1970; Kulka?®Aand Pandiya, 1974). Anticholinergic
drugs which lack significant PA uptake inhibiting
properties such as atropine and scopolamine (Horn et al.
1971) on their own do cause exploratory and locomotor
stimulation at relatively high doses, but are not so
effective in inducing stereotyped behaviour (Arnfred and
Randrup, 1968; Scheel-Aruger, 1970; Blozovski and
Blozovski, 1973). It is presumed that these effects
are mediated through a functional interaction between
acetylcholinergic and dopaminergic systems (see Bartholini
et al. 1973). On the other hand LRCL 5182, a dopamine
uptake inhibitor without anticholinergic properties w-s
found in this study to produce intense stimulation of
exploratory, locomotor and stereotyped behaviours.
Nomifensine} a potent . inhibitor of PA as well as NA
uptake, also stimulates all three behaviours whereas
substances such as desmethylimipramine, which inhibit NA
uptake but not PA uptake (page 38), do not. It is there¬
fore very likely that both the dopamine uptake-inhibiting
properties and the anticholinergic properties of
benztropine pl^y a part in mediating the response.
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Conclusions drawn from behavioural effects of
ays temically-adminis tered drugs
The one major conclusion that can be drawn from
the studies with systemic drug administration so far
discussed is that dopaminergic systems play a major role
in the mediation of all three behaviours under consider¬
ation! namely exploration! stereotypy and locomotion. Drugs,
with stimulant actions, either direct (apomorphine) or
indirect (amphetamine or DA uptake inhibitors), on DA
receptors markedly stimulate all three behaviours whereas
drugs (e.g. haloperidol) which inhibit DA systems can
in sufficient dose completely block spontaneous and drug-
induced exploratory, stereotyped and locomotor behaviours.
Manipulations of the noradrenergic and serotonergic
systems produce much less marked effects. oL^ -noradrenergic
receptor blockade may reduce spontaneous locomotor and
exploratory behaviour and does significantly reduce but
not abolish amphetamine-induced stimulation of exploratory
and locomotor behaviour. On the other hand stimulation
of noradrenergic systems by selective noradrenaline uptake
inhibitors or by clonidine also seems to reduce activity.
Manipulation of 5-HT systems produced opposite
results to those of the NA systems. Inhibition of 5-HT
re-uptake with GdlA 654 caused a slight (not statistically
significant) stimulation of exploratory and locomotor
behaviour whilst direct activation of serotonergic
receptors by 5-methoxy-N.N.-dimethyltryptamine produced
a bizarre hyperactivity syndrome which however is
probably mediated at the level of the brain stem or
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spinal cord (page 51)• The 5-HT receptor antagonist
methysergide potentiated amphetamine-induced locomotor,
exploratory and probably also stereotyped behaviour.
It may be that HA and 5-HT systems directly exert
minor effects on exploratory and locomotor behaviour as
well as possibly stereotyped behaviour, perhaps inter¬
acting with DA inputs at postsynaptic receptors in
terminal areas. The NA and 5—HT systems may also exert
their effects through modification of activity in DA
systems at a presynaptic level (and probably also vice
versa). Interactions between the monoamine systems
have been discussed in detail on page 19.
She induction of1 supersensitivity'in dopaminergic systems
An apparent supersensitivity to the behavioural
effects of amphetamine was demonstrated in two separate
experiments, one by chronic pretreatment with amphetamine
itself and the other by chronic pretreatment with a
dopamine receptor antagonist.
liesults from a study of the response to amphetamine
by animals with unilateral 6-hydroxydopamine lesions of
the nigro-striatal pathway had indicated that repeated
weekly treatment with amphetamine tended to lead to an
increasing behavioural response to the drug (Llakanjuola,
1976). If this was so then the interpretation of
results from behavioural studies involving repeated
treatment with amphetamine (and possibly other drugs)-
would be made difficult, even if statistically valid
experimental procedures such as a "latin-Square" design
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were used. In a further investigation reported here
it has been shown that repeated weekly administration
of amphetamine does indeed lead to an increase in the
behavioural responses to the drug, the overall effect
being similar to that of the administration of higher
doses of amphetamine in naive animals. Similar observa¬
tions have been described in another study (Segal and
Mandell, 1974). An earlier report (iewander, 1968b)
of the development of tolerance to the stereotypy-
inducing response to amphetamine may be explained by the
more frequent ("'"wice daily) and larger doses of amphetamine
used (16 mg/kg DL-amphetamine sulphate). This potenti¬
ation of the motor effects of amphetamine is in contrast
to the widely-reported observations of tolerance to
certain other actions of amphetamine with chronic treat¬
ment, in particular the anorexogenic, hyperthemic and
cardiovascular effects (Harrison et al. 1952; Brodie et
al. 1970; Lewander, 1974).
The reasons for this potentiation of the motor effects
of amphetamine are not clear. In the first place the
augmentation may not be related to amphetamine adminis¬
tration at all, but to independent changes within the
animal's central nervous system, for example as the animal
grows older. It has been demonstrated that brain levels
of all three monoamines increase with age even in the
adult rat (Karki et al. 1962; Gunne, 1963). Whether
this increase in transmitter levels is reflected in
functional changes is uncertain, however. The augment¬
ation of the effects of amphetamine may occur within
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only six days of the first dose of the drug (Bebec and
Groves, 1976) and definite changes were observed in some
animals at the second treatment in the present study.
Also in the present study when rats were given saline
injections on three successive occasions at weekly inter¬
vals the behavioural responses to amphetamine administered
a week after the last saline injection was smaller than
that of animals that had been given amphetamine on the
three occasions before that (Figs. 18, 19). If ageing
of the animal during the period of chronic treatment was
an important factor in the phenoaemon then it would have
been expected that the behavioural responses toaaphetamine
in the two groups of rats would have been the same. The
same argument applies regarding the effects of previous
exposure to the apparatus.
In the study reported in this thesis, the animals were
isolated during the period of behavioural study and on each
experimental day animals that had been studied earlier were
kept out of contact with those that had not yet been studied.
However, the animals were put back together at the end of
each experimental day, at a time when some of the animals
were still under the influence of the amphetamine. It is
known that the stimulant and the lethal actions of amphetamine
are potentiated when the drug is given to mice in a crowd
as opposed to isolated mice (Chance, 1946; Greenblatt and
Osterberg, 1961). It seems unlikely that such an effect
would carry over to the extent that this potentiation could
still occur when an animal was studied in isolation a week
later. Segal and Mandell (1974) performed their studies on
rats that remained isolated throughout.
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There is some evidence to suggest that increased
sensitivity of dopaminergic receptors may be responsible
for the potentiation of amphetamine effects following
repeated treatments. Rebec and Groves (1376) have
demonstrated that long-term amphetamine administration
to rats resulted in a potentiation of the depression of
activity of neurones in the caudate-putamen induced by
acute administration of amphetamine or apomorphine.
Since the site of action of apomorphine is held to be
post-synaptic (page 26) these results would suggest that
the augmentation of the motor response to apomorphine and
amphetamine is due to an increase in sensitivity of
dopaminergic receptors. tenner et al. (1977) observed
an attenuation of apomorphine-induced rotation in animals
with unilateral 6-hydroxydopamine-induced lesions of the
nigro-striatal pathway following long-term amphetamine
administration. They suggested that the attenuation
might be due to increased sensitivity of DA receptors in
the contralateral neostriatum. Increased binding of
tritiated haloperidol and apomorphine to DA receptors
from the caudate-putamen has been demonstrated following
exposure of a preparation of such receptors to DA at
high concentrations in vitro (Seeman et al. 1978).
These workers suggest that this increase in receptor binding
following expsoure to DA may reflect increased sensitiv%
of the receptors and that a similar mechanism might lead
to the potentiation of the behavioural effects of agonist
drugs; both amphetamine and apomorphine would cause
increased occupation of the post-synaptic receptor sites
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by agonist substances (DA in the case of amphetamine or
the drug itself in the case of apomorphine ) and thus
lead to increased receptor sensitivity.
Behavioural supersensitivity to the effects of
amphetamine and apomorphine has been previously observed
following long-term neuroleptic pretreatment (Ungerstedt
et al. 1975; Christensen et al. 1976; Smith and Davis,
1976; Nielsen et al, 1977; Ungerstedt and Ljungberg, 1977)«
or even after a single dose of a neuroleptic agent after
the acute effects of the neuroleptic have worn off
(Christensen et al. 1976; Ungerstedt et al. 1975).
In the present study, contrary to the report of
Smith and Davis (1976) and in agreement with that of
Ungerstedt and Ijungberg (1977), it was found that chronic
haloperidol administration produced no effects on
spontaneous activity. However, chronic haloperidol
administration (daily injection of 1 or 5 mg/kg i.p.) did
appear to lead to a potentiation of the behavioural
response to amphetamine. This potentiation was statisti¬
cally significant only in the second experiment in which
a higher dose of haloperidol (5 mg/kg) was employed
(instead of 1 mg/kg) and a longer interval of 3 days
(instead of 1 day) allowed between cessation of haloperidol
administration and behavioural testing. Which of the two
factors was the more important is uncertain. It has
been proposed that the behavioural supersensitivity,
after neuroleptic treatment, to drugs which stimulate DA
systems is due to increased dopaminergic receptor
sensitivity and an analogy has been made between this
> 198,
situation and the apparent increase in sensitivity of
DA receptors in the caudate-putamen following denervation
hy 6-hydroxydopamine-induced lesions of the nigro-
striatal pathways (Arbuthnott, 1976).
Long-term administration of the neuroleptic agent
penfluridol has been observed to lead to increased
sensitivity to the locomotor effects of bilateral appli¬
cation of DA to the nucleus accumbens and to the
stereotypy-inducing effect of application of DA to the
neostriatum (Jackson et al. 1975b). Chronic haloperidol
pretreatment of rats has been observed to be followed by
an increase in the amount of binding of neuroleptics and
s,pomorphine to dopaminergic receptors in the striatum;
this findin^ was considered to provide direct evid ence for
the development of an increase in the sensitivity of DA
receptors following chronic neuroleptic pretreatment
(Seeman st al. 1978).
The development of tolerance to the tranquillizing
actions of haloperidol was also noted durin0 the course of
haloperidol pretreatment; the effects of acute haloperidol
administration in inducing behavioural sedation lasting
for progressively shorter intervals and decreasing in
intensity. These findings confirm those of other
observers , (Christensen et al. 1976; vQn Stralendorff
et al. 1976; Zzrin-waters and Seemans 1977). Tolerance
to the effects of neuroleptic drugs on the increase of
DA turnover in the nigro-striatal and mesolirabic systems
has also been observed (Burki et al. 1976; Gcatton,1978).
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It would appear from these experimental results that
we have an apparently paradoxical situation whereby
chronic treatment either with dopaminergic receptor
antagonists or with dopaminergic receptor agonists both
appear to cause sensitization of the dopaminergically-
innervated systems, this most likely being a result of
the development of receptor supersensitivity. It is
possible to explain the development of supersensitivity
following neuroleptic treatment in terms of a homeostatic
response to underactivity of those receptors in a way
analogous to the compensatory supersensitivity which can
develop following reduction in transmitter release from
the presynaptic neurones, e.g. following denervation.
Whatever the postsynaptic mechanism involved, the develop¬
ment of this homeostatic phenomenon would lead to tolerance
to the effects of further neuroleptic administration and
potentiation of the response to a dopaminergic receptor
agonist. A longer time course of the reversion of the
homeostatic mechanism to its normal levels than the time
course of clearance of the neuroleptic after cessation of
administration would account for the apparently greater
potentiation of the actions of a potential dopaminergic
receptor activation when these were measured at a longer
interval after stopping the neuroleptic administration
than when determined shortly afterwards. This would
explain the greater potentiation of the amphetamine
actions when the drug was tested 3 days after the chronic
haloperidol pretreatment than when it was tested only
one day after. It would be expected that the opposite
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phenomenon would ensue following administration of an
agonist drug - such treatment should lead to a sub-
sensitivity and the development of tolerance to the agonist
drug, instead of the sensitization that has been
observed. One explanation for this discrepancy could
be that binding to the OA receptor by any drug, whether
agonist or antagonist, will lead to the development of
supersensitivity i.e. that it is occupation of the
receptor per se that produces the effect. This would
fit with the findings of Seeman et al. (1978) that pre¬
exposure of a OA receptor preparation to high concentra¬
tions of OA in vitro loads to increased binding of both
haloperidol and apomorphine to the receptors. However,
other hypotheses would have to be invoked to explain the
behavioural supersensitivity to dopaminergic agonists
following denervation or following reserpine or tyrosine
hydroxylase inhibition (Dominic and Moore, 1969;
Friedman et al. 1975; Ungerstedt et al. 1975). All
three procedures should result in a reduction in
occupation of post-synaptic receptor sites.
Recently some interesting evidence has been advanced
concerning the properties of presynaptic and postsynaptic
DA receptors in the caudate-putamen (Nagy et al. 1978).
According to these workers, neuroleptic agents, apomorphine
(and presumably DA) bind to the postsynaptic receptor
whereas the presynaptic receptors bind only apomorphine
and DA but not the neuroleptics. It is presumed that
the presynaptic receptors would act as autoreceptors for
the homeostatic regulation of activity in the dopaminergic
nerve ending.
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These findings may provide an alternative explana¬
tion for the apparent paradox that pretreatment with
either antagonist or agonist drags can produce super¬
sensitivity of HA innervated postsynaptic systems. The
supersensitivity following neuroleptic pretreatment
could he explained purely on the basis of the post¬
synaptic changes, since antagonists do not directly affect
the presynaptic receptor. However, dopaminergic agonists
would produce effects on the presynaptic receptors as
well as the postsynaptic ones. Tolerance to the pre¬
synaptic effects would facilitate dopaminergic neuronal
output and thus potentiate agonist effects synergistically.
Such a theory would require that the presynaptic receptor
changes would outweigh the postsynaptic changes.
The recent report of Nagy et al. (1978) showing a
higher affinity of apomorphine for the presynaptic than
for the postsynaptic dopamine receptors indicated that
the receptors at the two sites are not identical. In
consequence one might expect a difference in susceptibility
of receptors at the two sites to modification by an
agonist. Friedman et al (1975) have observed that the
increase in the potentiation of the stereotypy-inducing
actions of apomorphine by chronic reserpine pretreatment
were further enhanced if either apomorphine or^-methyl-/3-
tyrosine were given along with the reserpine during the
pretreatment. These results support the hypothesis
that the potentiation of the effects of apomorphine and
other HA receptor agonists might be induced through
presynaptic actions.
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These theories do not exhaust the possibilities
regarding the aetiology 0f tolerance and supersensitivity
in dopamine mediated systems. Various other theories
exist concerning these pheonomena (Goldstein et al.1968)
and in view of the relative lack of information available
one cannot easily discount some of these possibilities.
Extensions of investigations such as those of Seeman and
his colleagues on receptor binding may provide useful
information in the future. Studies of changes in
adenylate cyclase in DA-innervated areas following chronic
neuroleptic pratreatment may possibly provide useful
information. DA-stimulated adenylate cyclase is thought
to be involved in the activation of post-synaptic
receptors and antagonism of the activity of this enzyme
by neuroleptic drugs has been observed (Iversen and
Miller, 1976). It might be expected therefore that
striatal HA-stimulated adenylate cyclase activity would
be increased in a situation of receptor supersensitivity.
However, studies of changes in HA-stimulated striatal
adenylate .cyclase following 6-hydroxydopamine lesions
of the nigro-striatal pathways have yielded inconsistent
results (see Seeman et al. 1978).
Effects of inhibitors of monoamine uptake on the behavioural
response to amphetamine and on the concentrations of
amphetamine in plasma and brain
The two tricyclic antidepressant drugs employed,
chlorimipramine (GMI) and desmethylimipramine (Hill) as
well as GHA 654; a potent inhibitor of neuronal 5-KT
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uptake( all caused a .narked potentiation of the
behavioural response to a small dose of amphetamine#
This confirms the findings of various other workers
(page 39)* It had been found that tricyclic anti-
depressants inhibit the metabolism of amphetamine (Sulser
et al. 1966? iewander, 1968; Valzelli et al. 1968;
Garattini et al. 1976) and this inhibition was proposed
by these workers to be the cause of the potentiation of
the behavioural effects of amphetamine although the
facilitation of the actions of amphetamine through
inhibition by the tricyclic drugs of the uptake of amines
released from neuronal terninals by the amphetamine
could not be excluded. If inhibition of the metabolism
by the tricyclic agents was the important element in the
potentiation! then inhibition of microsomal enzyme
systems by other drugs should potentiate the behavioural
response to amphetamine. It was found in this study
that 3KF-525Af a well-known inhibitor of microsomal
enzyme (Brodie,19'5S ) systems did potentiate the behavioural
response to amphetamine to a degree comparable with that
induced by the three uptake inhibitors studied.
Furthermore all four drugs(the three uptake inhibitors
as well as the inhibitor of hepatic metabolism) produced
a marked elevation of plasma and brain levels of amphet¬
amine. The abilities of the various drug treatments to
potentiate the behavioural response to amphetamine was
proportional in the same rank order as their abilities
to potentiate the behavioural response to the amphetamine!
25 mg/kg DMI being the most effective and 25 mg/kg CS.il
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the least affective. Unfortunately this relationship
could not be proved statistically because at the dose
used DMI actually potentiated the amphetamine response
to such a degree that "non-dipping stereotyped behaviour";
which was not registered on the hole-board apparatus
record, was a major effect. This is a response which
is normally observed with very high doses of amphetamine
(page 146). There was also too much variation in
individual amphetamine levels, particularly in plasma.
The results of these experiments strongly support
the view that the potentiation of the amphetamine response
by antidepressant monoamine uptake inhibitors are related
in major degree, to the abilities of these drugs to
inhibit the metabolism of amphetamine. It still cannot
be excluded that a role may also be played by prevention
of the neuronal re-uptake of released monoamines, however.
It seems probable that the higher concentrations in
brain and plasma of amphetamine detected following pre-
treatment with the hepatic microsomal enzyme inhibitor
SKF-525A as well as the tricyclic antidepressants or
G1A 654 result from a decrease in the rate of metabolism
because of an inhibitory action of the drugs on the
hepatic microsomal system.
The effects of lesions of the caudate-putamen and aocumbens
nuclei and the resultant modification of the response to
amphetamine
The distribution of DA in the four areas examined
(the olfactory tubercles, accumbens nuclei, caudate-putamen
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nuclei and cortex) in shain-lesioned animals corresponded
to the findings of other workers(page 238 ). The
6-hydroxydopamine injections induced severe degrees of DA
depletion which was maximal in the target areas. There
was also considerable DA depletion in adjoining areas,
this being most marked in the olfactory tubercles following
injection of the neuroleptic into the accumbens nuclei.
NA depletion in these areas was not marked. A detailed
discussion of the distribution of the catecholamines in
the selected brain areas as -well as of the effects of
the 6-OHDA injection appears later (page 238 ).
Striking effects were obtained following stereotactic
manipulation of DA terminals within the nucleus accumbens
and caudate-putamen. Bilateral 6-hydroxydopamine (6-OHDA)
lesions of the accumbens nuclei produced a decrease of
spontaneous, as well as of amphetamine-induced, locomotor
and exploratory activity. Amphetamine-induced stereotyped
bead movements, gnawing and biting were potentiated but
amphetamine-induced sniffing was eliminated. This
potentiation of the more extreme aspects of stereotyped
behaviour may be due to an elimination of competing
influences towards locomotion and exploration.
6-OHDA lesions of the caudate-putamen also produced
striking behavioural changes. These animals showed a
marked reduction in spontaneous locomotor and exploratory
behaviour as well as relatively slow weight gain associ¬
ated with reduced food intake which was more marked the
greater the degree of neostriatal DA depletion. The
most prominent behavioural effect, however, was a
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complete elimination of amphetamine-induced stereotypy -
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such as stereotyped hole-dipping, stereotyped head movements
and gnawing and biting. Amphetamine-induced sniffing was
not so affected and was if anything potentiated. Under
the influence of amphetamine the majority of animals
engaged in a high level of locomotor activity, even at
the high dose of 16 mg/kg, which in control animals as
well as animals with nucleus accumbens lesions produced
intense stereotyped behaviour with an inhibition of loco¬
motion and exploration. However, certain animals with
severe striatal DA depletions were virtually immobile
(except for intense sniffing) under the influence of
amphetamine shile others with equally severe degrees of
DA depletion and equally low body weight engaged in a
high level of locomotor activity without any hole-dipping.
This immobility following amphetamine administration in
certain animals with lesions in the caudate-putamen did
not appear to be related to the degree of incidental DA
depletion in the nucleus acoumbens, since this depletion
was not greater than in those which responded with marked
locomotor stimulation.
Animals with less severe degrees of striatal DA
depletion engaged in a high degree of both locomotor
activity and "exploratory" dipping under the influences
of both doses of amphetamine used (4 and 16 mg/kg).
It is tempting to speculate that a minimal level of
dopaminergic input into the neostriatum is essential for
all forms of motor activity including those which are
mediated primarily from other areas. Below a certain
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level the more complex activities such as hole-dipping
and other exploratory activities may be unable to occur
while simpler activities such as locomotor activity can
still take place. With more extensive depletion all
actions ma;, cease, and the basic actions of feeding and
drinking, which have been gradually becoming increasingly
impaired as DA depletion increased, are finally halted
and death eventually occurs. However, the striatal DA
concentrations in the groups of animals which showed no
motor stimulation under the influence of amphetamine were
no different from the concentrations in those animals in
which marked locomotor activity (without exploratory
dipping) was observed (Table 26). Different degrees of
DA depletion in other areas, which inevitably occur
after 6-OHDA lesions of the caudate-putamen particularly
in the nucleus accumbens which appears to be involved in
locomotor activity and exploration,also do not provide
an explanation for the presence or lack of a motor
response, since there were no apparent differences in
the degree of such depletion between the two groups.
Certain animals with bilateral 6-OHDA lesions of the
caudate-putamen engaged in tight circling activity
under the influence of amphetamine, presumably because
of an imbalance in the degree of DA depletion achieved
on each side. (The responses of such animals were
excluded from analysis of the results of bilateral
lesioning.) Animals with lesions in the nucleus
accumbens never displayed such tight turning behaviour
with amphetamine administration. Similarly, when DA
was injected unilaterally into the striatum (on occasions
when bilateral injection could net be performed) tight
turning in a direction contraversive to the injection
site occurred. Unilateral injection into the nucleus
accumbens did not produce turning and indeed did not
produce any abnormality in locomotor activity. These
observations support the findings of Kelly and Moore
(197b) which showed that inbalance in neostriatal
dopaminergic activity was necessary for circling behaviour
to occur.
Electrolytic lesions of the accumbens nuclei Even severe
electrolytic lesions of the accumbens nuclei were
ineffective in altering the behavioural responses
following saline or amphetamine administration.
(Behavioural tests were started 10-14 days after
induction of the lesions.) Naylor and his colleagues
(page 44) have claimed that "stereotyped sniffing"
induced by amphetamine and apomorphine is eliminated by
such lesions. (They did not report any effects of
these lesions on locomotion and exploration.) No such
changes were observed in this study.
It would have been expected that spontaneous and
amphetamine-induced locomotor ana exploratory behaviour
would be reduced by such lesions in view of the observed
effects of o-hydroxydopamine-induced lesions of the
nucleus. It has been demonstrated in this study with
6-OHDA lesions that quite severe depletions of JA in
the nucleus, presumably indicative of marked reductions
in the number of functional dopaminergic neurones, are
required before consistent behavioural changes would
occur. Such a relation between DA concentration and
behavioural changes was also ftoted by Ungerstedt and
Marshall (1975)* It may be that the degree of damage
to the nuclei by the electrolytic lesions in the present
study was inadequate. However, even lesions involving
up to 80/o of both nuclei were ineffective in altering
behaviour. Perhaps more important i3 the fact that
electrolytic lesions damage all types of neurones associ¬
ated 'with the nucleus, in contrast to the 6-OHDA injection
which induced selective damage to DA terminals. Damage
to other neuronal inputs may compensate for the damage
to DA inputs, particularly if all three monoamine
systems as well as other systems interact in the nucleus
(see page 19)* Oell bodies, efferent neuronal terminals
and afferent fibres and fibres of passage are all damaged
by the electrolytic lesion.
At this sta^e it would be useful to examine in
detail a recent paper by Naylor and his colleagues
(Gostall et al. 1977) in which were reported the results
of studies related to those which had been already
performed in the project reported in this thesis.
Bilateral 6-hydroxydopamine lesions were induced in
various areas of the nigro-striatal and mesolimbic
dopaminergic systems.
In the study by Naylor and his colleagues it was
found that the effects of lesions varied according to
the time after operation. It is difficult to decide
which effects to accept as representing the primary
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result of the lesioning. Initial effects seen in the
first few days after operation and which thereafter
disappear may tend to be regarded as non-specific effects
even though they may not be present in control animals
but could equally well be a true lesion effect which
becomes reversed by compensatory processes in that
system or others which interact with it. Similarly a
more persistent effect which arose only after a delay
of several days could reflect compensatory changes to
the original functional change induced by the lesion.
In their study Costall et al. found that anteriorly
placed bilateral 6-0HLA- induced caudate-putamen lesions
reduced amphetamine- and apomorphine-inauced biting but
centrally placed lesions reduced amphetamine-induced
bitin0 only. Globus pallidus lesions (which also caused
a marked fall in caudate-putamen JA levels) initially
potentiated apomorphine- and amphetamine-induced biting
but after a week led to a reduction in this response.
Amphetamine-induced hyperactivity was potentiated.
Lesions of the substantia nigra or ascending LA pathways;
both of which caused substantial reductions in mesolimbic
as well a3 neostriatal LA content, caused a permanent
potentiation of apomorphine-induced biting. Lesions of
the ascending LA pathways caused a slight hut permanent
reduction of amphetamine-induced biting, while substantia
nigra lesions caused an initial potentiation of amphet¬
amine-induced biting and hyperactivity.
Lesions in the nucleus accumbens reduced the duration
of amphetamine-induced hyperactivity and potentiated
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apomcrphine-induced biting. Amphetamine-induced stereo¬
typed sniffing was markedly and permanently reduced,
lesions of the olfactory tubercles enhanced the hyper¬
activity response to both drugs and potentiated apomorphine
but not amphetamine-induced biting. Lesions of the
central nucleus of the amygdala reduced both amphetamine-
induced sniffing and biting as well as apomorphine-
induced biting.
This study by Naylor and Lis colleagues lends strong
support to their contention that different DA innervated
regions in both neostriatal and me30 limbic areas mediate
different forms of drug-induced stereotyped behaviour
(page 45) as well as hyperactivity. There was also a
suggestion that different areas may mediate the same
stereotyped response to different drugs. The important
element which may at least partly explain the widely
discrepant claims of different groups of workers concerning
the mediation of stereotyped behaviour is that of
"stereotyped sniffing". Costall and his colleagues have
claimed (page 45) that this component of stereotyped
behaviour is mediated from the accumbens nucleus and
olfactory tubercle. In this study they showed that
6-OILDA lesions of the accumbens nucleus led to a reduction
in amphetamine-induced sniffing and a "potentiation of
apomorphine-induced sniffing to biting". Other workers
have also demonstrated reduction of amphetamine-induced
sniffing and potentiation of apomorphine-induced sniffing
following 6-OHJA lesions of the nucleus accumbens.
(Kelly and Ivarsen, 1976). The so-called high intensity
component of stereotypy - licking, biting and gnawing -
seems to be associated more with the nigro-striatal
pathway. The significance of the abolition of the high
intensity component of stereotypy following lesions of
the central nucleus of the amygdala is uncertain since
application of agonist drugs to this area is ineffective
(page 47).
Unfortunately Navlor and his colleagues by their
very method of assessing stereotyped behaviour exclude
the two components of stereotypy (the sniffing activity
component and the biting-licking-gnawing component) as
distinct entities. According to their system of assess¬
ment any marked increase in sniffing would not warrant a
particularly high stereotypy rating. Decreases in
sniffing without changes in the high intensity component
of gnawing, biting and licking would not warrant any
change in stereotypy rating. It would be useful if
these two forms of stereotypy (sniffing, and gnawing,
biting and licking) were scored separately, as these
workers did in some of their earlier studies. One other
problem with the concept of "stereotypyed sniffing" as
a distinct entity is the fact that with some lesions
apomorphine-induced "sniffing" could be "potentiated into
biting". This suggests rather that the two components
exist as a continuum as was originally suggested
(Schiorring, 1971). Naylor and his colleagues have
demonstrated that certain drugs can selectively induce
or inhibit one of the two components of stereotypy
(Costall et al. 1975a, 1975b). There is some reason to
consider sniffing behaviour as exploratory in nature,
since it involves intense sensory stimulation and is
invariably accompanied by locomotor stimulation. It is
only when the "lickin0-biting-gnawing" stereotypy is
occurring that locomotion stops.
It is rather worrying that in the study of Naylor
and his colleagues some lesions produced changes in
amphetamine response which were not mirrored by opposite
changes with apomorphine as should be expected folio-wing
a 6-OEJA lesion (page 42); for example the effects of
anterior caudate-putamen and globus pallidus lesions on
stereotyped biting and the potentiation of the hyper¬
activity response following olfactory tubercle lesions.
This discrepancy would be explained if the claims of Naylor
et al. that different areas mediate the effects of
the two drugs is true. That claim requires further
substantiation.
These findings of Costall et al. (1977) are in broad
agreement with most of the observations made in the study
reported in this thesis concerning the effects of 6-OHDA
lesions of tne accumbens nuclei and caudate putamen.
In conclusion the results observed following 6-OEDA
lesions of the accumbens nuclei and caudate-putamen areas
in the present study, though not supported by those from
electrolytic lesions of the accunbens nuclei (possibly
for the reasons already discussed - page 208), indicate
that different behavioural responses are mediated from
the two OA-rich terminal areas. The nucleus accumbens
i3 concerned with the mediation of exploratory and loco-
motor behaviour as well as sniffing, which I consider to
be a feature of exploratory behaviour. Stereotyped
behaviours, on the other hand, are mediated from the
caudate-putamen. It also seems likely that a minimum
level of hA input into the caudate-putamen is necessary
for any form of behaviour to occur.
It would be interesting to study the behavioural
affects following selective lesions of noradrenergic and
serotonergic terminals in these areas. Such studies
should provide information regarding the functional inter¬
actions of the three monoamine systems in those areas.
It might be possible to induce selective destruction of
noradrenergic neurones in discrete areas of the brain
using 6-hydroxydopamine injections following inhibition
of uptake of the 6-OEDA into dopaminergic neurones with
benztropine or some other drug -with potent inhibitory
properties against DA but not NA uptake. 5-HT depletion
could be achieved using the neurotoxic diliydroxytryptamines
(Breese et al. 1975).
Having obtained significant information from the
effects of discrete lesioning of different DA-innervated
areas, it follows that studies of the responses to
selective stimulations of these areas should provide
further evidence in support of those findings.
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Aespon.es foil0,7in/; stereotacticclly-controlled injections
of monoamine transmitters into the accumbens nuclei and
caudate-putamen areas
The results obtained following direct application of
monoamine transmitters into the accumbens nuclei and
caudate-putamen areas strongly support the findings
following stereotactic 6-hydroxydopamine-induced lesions
of these areas.
Methodological points relrted to this study are
discussed on page 241.
Dopamine injected into the caudate-putamen in nialamide-
pretreated rats produced a marieed dose-related stimulation
"stereotyped" dipping, and at the highest dose (50 jig)
"non-dipping stereotyped behaviour" consisting of side-
to-side as well as up and down movements of the head as
well as gnawing and biting around the holes. Sniffing
activity was noticeably absent. There was also a
moderate stimulation of "exploratory" dipping and loco¬
motor activity, more marked at the highest dose of DA
(50 y.g). This stimulation of exploration and locomotion
may have been caused by diffusion of the injected material
into the neighbouring accumbens nuclei. Widespread
diffusion of injected DA along a concentration gradient
has been demonstrated by autoradiography .Fog & Pakkenburg(l97l)•
Very different results followed bilateral application
of DA into the accumbens nuclei of nialamide-pr3treated
rats. A marked stimulation of locomotor activity and
"exploratory" dipping was recorded. Intense continuous
sniffing and frequent rearing were also noted. The
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response to JA applied to the accumbens nuclei was not
convincingly demonstrated to be dose-related, however.
There was no great difference in the intensity or
character of the behavioural response induced by the
three highest doses of i)A employed (12.5, 25 and 50 iig
of dopamine hydrochloride) although there was a slight
trend towards an increase in dipping activity with
increasing dosage. locomotor counts were maximal with
12.5 )ig* A dose of 5 JM5 produced a variable response,
ranging from none (compared to saline-treated animals)
to a near maximal response. This situation is consistent
with an all-or-none response, with recruitment occurring
at the dose of 5 Mg and thereafter no great increase.
It may be that because the accumbens nucleus is relatively
small all neurones within it would tend to be affected
by a dose of the transmitter slightly above the threshold,
any further increase in dosage would not produce any
further increase in response. If this were so it would
still be expected that increasing the JA dose would prolong
the behavioural response, since concentrations of DA
•would be maintained at or above threshold for a longer
period of time. This, however, was not the case.
Other workers have claimed that the response is dose-
related (Pijnenburg and van Aossum, 1973; Jackson et al.
1975, Gostall et al, 1975b). These workers employed the
same dose range as in the present study. The discrepancies
are therefore inexplicable. The moderate stimulation of
"stereotyped" dipping which was observed particularly
with the highest dose may be due to diffusion of DA
into the neighbouring caudate-putamen area3.
The response to DA applied to either area was
completely blocked by systemic administration of halo¬
peridol, a potent antagonist at DA receptors (AndIn et al.
1970a; Seeman et al. 1976). The response from the
accumbens nucleus was much more susceptible to the action
of haloperidol than that from the caudate-putamen* We
have observed in the Ll.h. G. Brain Metabolism Unit that
the dose of haloperidol required to control the symptoms
of mania is generally lower than that which causes extra¬
pyramidal symptoms. This observation supports the
hypothesis that dopaminer0ic neurones projecting' to the
nucleus accumbens mediate the antipsychotic effects of
neuroleptics whereas nigro-striatal neurones mediate
their extrapyramidal effects (page 6). However, these
differences in susceptibility to the effects of haloperidol
by the two nuclei are somewhat at odds with the effects
on the response to systemically administered amphetamine
(page 92 ). In that case haloperidol was more effective
in blocking amphetamine-induced stereotyped behaviour
than locomotor and exploratory behaviour. It would
have been of interest to study the actions of noradrenergic
and serotonergic receptor antagonists on the DA response.
Other workers have found that - or f$ - adrenoceptor
antagonists are relatively ineffective in inhibiting
these responses (Pijnenburg and van Possum, 1973;
Jackson et al. 1975)* The 5-HT receptor antagonist
cyproheptadine was also ineffective (Costall et al.1976).
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Noradrenaline allied to the nucleus aooumbens in
nialamide pretreated rata caused only a alight stimulation
of locomotor and exploratory behaviour in the hole-board
apparatus wuieh was not statistically significant; other
workers have reported a moderate locomotor stimulation
(rijnenburg and van kossum, 1973? Jackson at al. 1975)#
which did not occur in the absence of pre treatment with
a monoamine oxidase inhibitor (rijnenburg et &1.137b).
Noradrenaline applied to the eauuate-putamen induced
a moderate stimulation of "stereotyped" dipping, although
other workers have failed to observe any response
following application of NA (CoataHat al. 19741 Jackson
at al. 1975)* 2he stimulation of stereotyped dipping
observed was not particularly intense, and it is possible
that aueh relatively mild stereotypy would not be picked
up by the visual monitoring techniques employed in the
other studies. It is likely that the stimulation of
"stereotyped" dipping by HA is mediated through stimulation
of i)A receptors. direct evidence for this might be
provided by observation of the effects of dopaminergic
or noradrenergic receptor blockers on the response.
Another possibility is that the response is mediated
indirectly through actions of IJA on the vascular supply
to the neostriatum. SJhis seems unXixaly since if thin
were the case it would he expected that a behavioural
response woulc also h ve beon induced following application
of the drug to the accunbens nuclei.
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Effects on behaviour were also observed following
application of 5-HT to both areas. The responses were
rather variable, but certain features were prominent.
When applied to the nucleus accumbens 5-HT induced a
moderate locomotor stimulation, but this locomotion has
characteristics different from that seen in control rats
or animals stimulated with systemically applied amphetamine
or DA applied into the nucleus. The locomotor stimulation
was usually sporadic and the animal's body was hyper-
extended with the abdomen close to the floor. Hearing
did not take place. Continuous sniffing was observed.
This phenomenon has some resemblance to the behaviour
induced by the 5-HT receptor agonist 5-methoxy,-N,N,-
dimethyltryptamine. There was also a small increase in
dipping behaviour of both types but this increase was
not statistically significant. These observations are
at variance with other studies in which either no response
to 5-HT was observed (Jackson et al. 1975) or a decrease
in spontaneous locomotor activity was reported (Costall et
al. 1976} Pijnenburg et al. 1976).
5-HT applicationinto the caudate-putamen elicited
a stimulation of dipping behaviour of both types, pre¬
dominantly "stereotyped"} locomotor stimulation was less
intense and sniffing unaffected. Occasional rearing was
observed. Body posture appeared normal. Jackson et
al. (1975) did not observe any behavioural effects
following 5-HT administration into the neostriatum.
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It is surprising that these responses to 5-HT
application into the two areas were not observed by other
workers. Methodological differences may explain the
discrepancies. Firstly, the use of closed-circuit
television allowed close observation of the animals
without disturbance to them. Also the hole-board apparatu
used provided a somewhat different environment from those <
of other studies. Finally the behavioural parameters
of hole-dipping may not have any parallel in these other
studies which were concerned with the recording of
" locomotor" activity and simple visual observation of
stereotyped movements.
It must be stressed that the behavioural responses
to administration of 5-HT to the two areas was quantitat¬
ively variable and in no instance as marked as with DA
application. In the otherstudies referred to (Jackson
at al. 1975; Costall et al. 1976; Pijnenburg et al.1976),
various doses of 5-HT, including the dose employed in
this study (50 jig of the bimaleinate salt), was employed
without inducing behavioural stimulation.
The latent period consistently observed before the
response following the intracerebral administration of
the neurotransmitters requires some explanation. This
delay was of the order of 30-90 min. following DA
injection into either area (the delay being of relatively
longer duration with lower doses of DA) and even longer
following NA injection into the caudate-putamen, but was
much less in the case of 5-HT administration to either
area. Pijnenburg and van Acssum (1973) also noted this
r "j
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delay, which however apparently did not occur when
animals were not pretreated with nialamide (Pijnenburg
et al. 1976). These workers suggested that the latency
following intracerebral monoamine administration in
nialamide pretre; ted animals might be a result of inter¬
action of other monoamine systems* in which activity would
have been facilitated by monoamine oxidase inhibition,
but they offered no direct evidence in support of this
suggestion.
It is possible that high concentrations of DA
(maintained high by monoamine oxidase inhibition) at
receptors in the immediate area of the injection might
cause an initial desensitisation. The appearance of
the behavioural effects of the DA after some delay could
then be due either to recovery of sensitivity of these
receptors as the concentration of the amine gradually
fell or to activation of receptors at a distance from the
site of injection by lower ccncentrations of the amine
reaching these more distant sites by diffusion.
A general point must be made concerning the possibility
that other properties of the intr cerebrally administered
material might have been responsible for the responses
induced. In particular, the question arises as to
whether local changes in pH or osmolarity induced by the
injected material might play a part. However, Pijnenburg
et al. (197b) could not demonstrate behavioural effects
following injection of solutions of different pH and
osmolarity into the accumbens nuclei. Solutions of all
three substances used in the present study, dopamine
hydrochloride, L-noradrenaline hydrochloride and 5-
hydroxytryptamine bimaleinate had pH values of 4»5 * 0.1
and at least the NA and DA solutions injected would have
been of near equal acidity and molarity. However, very
different behevioural responses were obtained following
administration of the three substances. Therefore, it
seems unlikely that molarity or pH of the injected
material played any role in the behavioural responses
induced, particularly in view of the relatively long
delay in the appearance of the response.
The implications of these studies of the effects of
monoamine transmitters applied to the two areas would
appenr to be quite clear. DA receptors in the nucleus
accumbens are involved in the mediation of exploratory
and locomotor behaviour as well as of sniffing and rearing
activities. Both the latter activities may be regarded
as part of the exploratory response. It seems very
likely that the DA injections into the accumbens nuclei
must have affected the olfactory tubercles and it might
be that these behaviours were mediated from the latter
site. However, injection into the more dorsal aspects
of the nucleus accumbens (which would be expected to have
less effect on the olfactory tubercle) did not result
in a quantitatively different response from injections
into the ventral aspect. Because of the relative
thinness (in the dorso-ventral plane) of the olfactory
tubercle it would be expected that accurate placement of
injected material into that structure would be difficult.
However, Pijnenburg et al. (197b) claim to have succeeded
in this; they found that DA injections intc the olfactory
tubercles does produce as marked a locomotor response as
with injections into the nucleus accumbens.
DA receptors in the caudate-putamen, on the other
hand, appear to mediate stereotyped behaviour but not
sniffing, locomotion or other forms of exploratory
activity. No evidence was obtained of a role for adreno¬
ceptors in the accumbens nucleus and the mild stimulation
of "stereotyped" dipping by NA applied to the caudate-
putamen is probably mediated by stimulation of DA
receptors but .nay reflect a facilitatory input into the
nucleus which would play a secondary role to DA inputs.
5-HT applied to both areas produced variable stimulant
effects on all three behaviours in different individual
animals. These effects of 5-HT may also be mediated
through direct activation of DA receptors by the 5-HT.
However, the behavioural response, particularly from the
accumbens nuclei, was quantitatively different (page 174)
from that of DA and it therefore seem3 more likely that
the response was mediated directly by 5-HT receptor
activation.
Further evidence concerning the interactions of the
three monoamine inputs in these areas might be provided by
studying the effects of two (or even three) monoamines
applied simultaneously. One study did show that 5-HT
applied to the accumbens nuclei reversed the locomotor
stimulation induced by previous application of DA therein
(Gostall and Naylor, 1978).
TABLE 43:
The following table gives a brief summary of the behavioural
effects of the different procedures.
5-ME0DMT - 5-Methoxy,-N.N.-dimethyltryptamine;
DMI - Desmethylimipramine; CMI - Chlorimipramine5
GSA 654 - A neuronal 5-HT uptake inhibitor;
1RCL 5182 - A neuronal DA uptake inhibitor;
SO-525A - A hepatic microsomal enzyme inhibitor;






























GEA 654 + Saline
LRCL 5182 10 mg/kg


























































0 - denotes normal activity level
+ - denotes stimulation of activity
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The relationships between exploratory« stereotyped and
locomotor behaviours
What, then, of the relationship between the three f a
behaviours under consideration? In only one situation,
that with systemic administration of the DA-uptake
inhibitor LHCL 5182, did intense locomotor stimulation
coexist with a high level of stereotyped behaviour. In
all other situations when stereotyped behaviour of high
intensity was taking place exploratory and locomotor
behaviour did not occur. I had previously suggested
(Makanjuola, 1976; Llakanjuola et al. 1977b) that
exploratory and stereotyped behaviour were closely related
phenomena, stereotypy representing extreme stimulation of
exploratory activity to the extent that the component
activities involved in exploration became fragmented and
repetitive (i.e. stereotyped). Drugs which induced loco¬
motor and exploratory behaviour at low doses would induce
stereotypy at high doses. Furthermore both exploratory
and stereotyped behaviours involved stimulation of sensory
receptors which in the case of stereotypy was extremely
intense and this sensory stimulation was felt to be the
central aim of both forms of behaviour.
It appears from the experiments reported in this
thesis as well as the reviewed work of other workers that
locomotor and exploratory behaviours are mediated through
the accumbens nuclei and probably also the olfactory
tubercles while stereotyped behaviour is mediated through
the caudate-putamen. This would suggest that stereotyped
behaviour is not in fact directly related to exploration.
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But it is still necessary to explain the fact that
aystemically administered dopaminergic stimulants induce
a pattern of behaviour in which as the dose of the drug
is increased (or as tissue levels increase) locomotor
and exploratory behaviours are gradually replaced by
stereotyped behaviour in a manner which would suggest
that it is the component activities involved in exploration
that are becoming involved in the stereotypy. It was
shown in this study that maximal stimulation of exploratory
and locomotor behaviour were achieved with a relatively
low dose of DA (12.5 jig) applied to the nucleus accumbens
(in comparison to the caudate-putamen) while further
increases in dose of DA applied to the caudate-putamen
continued to produce increases in stereotyped response.
It is probable that relatively low levels of activation
of dopaminergic systems would produce a stimulation pre¬
dominantly of exploration and locomotion from the
mesolimbic system while increased levels of dopaminergic
activation would involve the caudate-putamen more and more,
this involvement being expressed in the form of stereotyped
behaviour. This still does not explain the apparent
inhibition of exploratory and locomotor behaviour generally
observed when intense stereotyped behaviour is taking
place following systemic drug administration. The
inhibition may result from simple competition between the
behaviours (i.e. that the behaviours are incompatible).
It is also tempting to postulate an inhibitory input from
the nigro-striatal system to mesolimbic DA neurones.
However, there is no evidence for such an interaction,
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although some projections do pass from the nucleus
accumbens to the substantia nigra (Conrad and Pfaff, 1976,
Nauta et al. 1978).
The behavioural response to the DA uptake inhibitor
1RC1 5182 is somewhat against the hypothesis that
9
exploratory and locomotor behaviour on the onehand and
stereotyped behaviour on the other, are mutually
incompatible, since this drug was able to induce intense
locomotor and stereotyped behaviours simultaneously.
It is possible that this drug is more selective in its
effects on dopamine neurones in the mesolimbic system
than the nigro-striatal system, in which case a relatively
more intense stimulation of stereotypy (compared with the
response to amphetamine, for instance) would be required
to overcome the exploratory and locomotor stimulation
induced from the nucleus accumbens. There is some
evidence that some different dopaminergic agonists have
selective actions on different forms of activity (Costall
et al. 1975a, b. ). The same could equally well apply
to other agents.
Animal models of psychotic illness. Clinical relevance
of studies of the roles of monoamine systems in controlling
behaviour in animals.
These various observations of alterations in rat
behaviour by the varied ways of manipulating raonoaminergic
systems in the brain raise the question of the extent to
which such experiments serve to elucidate the problem of
the aetiology of psychotic illness.
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It was observed earlier (page 12) that in the affective
disorders there were usually gross changes in exploratory
and locomotor behaviours as well as the appearance of a
variety of stereotyped behaviours. Animal experiments
indicate that the dopaminergic .systems play a major role
in the mediation of these behaviours and it therefore
seems very likely that disturbances of dopaminergic
function are involved in the affective disorders. Whether
the primary disorder lies within these dopaminergic
systems or the changes in dopaminergic function are merely
an expression of disturbance in some other area or areas
of the brain is open to question. Various other symptoms
observed in the affective disorders may also be under
dopaminergic control, including food intake and sexual
and reproductive function? the latter two functions may be
influenced by the tubero-inpendibular dopaminergic
systems (see Fuxe et al. 1970 and 1978). Indeed thi"*e
are few changes in the affective disorders that cannot be
interpreted in terms of changes in exploratory, stereotyped
and locomotor behaviour of some other area of behaviour
under dopaminergic control. Manic illness is very
amenable to therapy with neuroleptic drugs which are
potent dopaminergic receptor antagonists (see page 8 ).
The neuronal NA and 5-IIT reuptake blockers employed in
the treatment of depressive illness may be influencing
the courseof the disease through interactions with
dopaminergic systems (see page 20) or through their
relatively less potent effects on OA-mediated behaviour.
It should be noted that these antidepressant drugs often
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may be only partially effective or even ineffective (Davis and
Janowsky, 1974). It would be of interest to study the
effects of drugs with more selective actions on dopaminergic
systems in depressive illness. The newly-introduced drug
nomifensine inhibits DA as well as NA uptake (page 39).
Its antidepressant actions are still being assessed
clinically, but preliminary trials, though promising, have
not as yet demonstrated any dramatic advantage over other
antidepressants (e.g van Scheyen et al. 1977; Grof et al.1977).
Previously, amphetamine-induced stereotyped behaviour
in animals has been proposed as a model for acute psychosis
(Angrist and Gershon, 1974; Wallach, 1974). It is
presumed that by "acute psychosis" these workers mean
schizophrenia-like illness. However, amphetamine (and
other drugs which stimulate DA systems) produce in animals
behavioural changes which appear more in line with manic
illness, since they induce an increase in coordinated
exploratory and locomotor activity, with stereotyped
behaviour replacing the former two activities as the
amphetamine dosage is increased (page 82). Thi3 pattern
of behaviour in animals is very similar to that seen in
mania (page 12).
On the other hand schizophrenia involves qualitative
changes in the form of behaviour (both in activity and
thought) which are less easily interpreted as simple
increases or decreases of normal behavioural patterns.
The behavioural changes induced by 5-MEODMT (page 106)
are more reminiscent of the changes in schizophrenia, in
so far as the drug produces a syndrome of bizarre,
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uncoordinated hyperactivity w. ich i- not readily
interprstable in terras of quantitative behavioural
change3. It is therefore tempting to postulate the
behavioural changes induced by this drug (and perhaps
other hallucinogens such as Lib) as models of
schizophrenic illnesses# It must however be stressed that
the aberrations induced by hallucinogens are claimed to
be different from the symptoms experienced in schizophrenia
(see Snyder et al. 1974)# nevertheless, the symptoms of
schizophrenia in the acute stage do bear a much greater
resemblance to the psychological changes induced by these
drugs (Bowers and Freedman, 196b). Many hallucinogens,
including 5-1- 30i)MT (see above), LbJ (see page 27) and possibly
mescaline have potent agonist actions at 5-HT receptors
(Aghajanian et al. 1970; Fuxe et al. 1972).
Thus it may be that disturbances of 5-HT systems
feature more prominently in schizophrenic illne33es than
is currently acknowledged and that the behaviour of
animals following stimulation of 5-HT systems with these
drugs may be useful animal models of these illnesses.
The clinical usefulness of the neuroleptic drugs in
schizophrenia may be used as an argument against this
proposition, because of their prominent inhibitory action
on transmission at dopaminergic synapses (page 8).
However, these drugs can also exert antagonistic actions
at 5-1.T receptors (leysen et al. 1978). It should be
remembered th t the behavioural response to 5- X.JMT or
to stimulation of 5-HT synthesis appear to be mediated
from areas of the central nervous system caudal to the
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mesencephalon (Jacobs, 1976). Mediation even at the level
of the spinal cord cannot be excluded. However, the
question regarding involvement of 5-HT systems in
schizophrenia is at least worthy of further study, in
spite of the fact that the evidence for the involvement
of dopaminergic systems in schizphrenia is currently much
more impressive (page 8).
Turning to the observations concerning the behavioural
response to direct application of monoamines to intra¬
cerebral nuclei, there are certain features which stand
out and which may bear comparison with behaviour in
psychotic patients. The effects of application of HA
into the nucleus accumbens (page 154) bears a striking
resemblance to the symptoms of mania in man. In both
situations the subject makes rapid progress from one
situation to the next, never stopping long enough to
give each item more than a cursory examination. An
analogy can be made between the behaviour of the rat
darting about from hole to hole and the flight of ideas
expressed by manic patients (page 12). The high level
of motor activity and exploration seen in the milder
forms of mania may thus be due to increased dopaminergic
activity in the accumbens nuclei or other areas of the
mesolimbic system. The stereotyped activity observed
in the more severe forms of mania may be caused by involve¬
ment of the nigro-striatal system by increasing levels of
dopaminergic activity. Evidence was presented earlier
(page227) that relatively lower levels of dopaminergic
stimulation were required to achieve a maximal behavioural
233.
response fron the accumbens in comparison with the oaudate-
putaaien since a relatively small dose of JA (1^.5 p&)
would produce a near maximal response when administered
to the nucleus aocumbens, whereas further increases in
dosage of JA applied to the caudate-putamen produced
increasing stimulation of stereotyped behaviour. It may
well be that the milder cases of mania are associated
with a level of stimulation of JA systems which would
induce greater behavioural effects from the mesolimbic
system so that behavioural stimulation would predominantly
affect locomotion and exploration. In more severe cases
of mania this stimulation of JA systems would be great
enough also to involve the nigro-striatal system so that
stereotyped behaviour also occurs and gradually replaces
the other two behaviours.
5-HT injections into the nucleus accumbens in rats
led to behaviours (page 154) which were qualitatively
dissimilar from those of JA injections. The behavioural
responses were qualitatively as well as quantitatively
abnormal. Posture was abnormal amid hole-dipping on
visual observation seemed to occur in uncontrolled,
indecisive fashion. Sniffing behaviour was stimulated
but this was not obviously directed at any particular
source of sensory stimulation in the environment. It is
tempting- to compare this situation with schizophrenia in
so far as the behaviour induced in animals by the 5-HT
injection and the behaviour observed in schizophrenia are
not easily rationalised in terms of motivation and appear
incoordinated and haphazard. The stereotypies seen in
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schizophrenia (page 13), and which also appear to be
les3 related to sources of sensory stimulation, may in
that case be caused by increased serotonergic activity in
the neostriatum. 5-KT produced some stimulation of
"stereotyped dipping" when injected into the caudate-
putamen (page 175). These suggestions are of course,
extremely speculative. More direct evidence would be
needed to allow such a suggestion regarding serotonergic
involvement in schizophrenia to be taken seriously. If
it were so it is possible that the addition of a seroton¬
ergic receptor antagonist to medication in schizophrenics
might lead to beneficial effects. It would also be of
interest to study the effects of these antagonists in
acute psychoses induced by hallucinogenic drugs. Perhaps
also the comparison of the effects of neuroleptic drugs
with differing degrees of activity against 5-HT receptors
(Leysen et al. 1978) in controlling the symptoms of
schizophrenia might be worthwhile.
Comments on various points of the methodologies employed
in the experimental work
There are various points concerning the methodologies
employed in the experimental work which are worthy of
comment and discussion.
The hole-board apparatus. With the continuing experience
of the different possible forms of drug-induced behaviour
which were observed in the course of the experiments
reported in this thesis it has become evident that the
hole-board apparatus used for quantitative monitoring of
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behavioural patterns had several important limitations.
Perhaps the greatest limitation lies in the fact that as
presently arranged not all forms of exploratory and
stereotyped behaviour are autom; tically detectable. For
example exploratory and stereotyped activity with sniffing
or gnawing and biting components as seen with apomorphine
and in the "non-dipping stereotyped behaviour" (page 146)
seen with large doses of amphetamine and other dopaminergic
agonists was not readily detected by the apparatus.
Provision of pressure Jetectors around the edges of the
holes to signal biting and gnawing activities would allow
automated recognition both of this "non-dipping stereotyped
behaviour" and the stereotyped behaviour of the type
induced by apomorphine.
Some of the problems with the method of measuring
locomotor activity have already been discussed on page 59 •
It should be possible to overcome the problem of mains
supply electrical interference with the locomotor activity
count by technical improvements. From experience it
seems important that future models of the automated hole-
board apparatus should differentiate between repeated
interruptions of the same overhead infra-red beams (e.g.
from repetitive up and down movements of the head) from
successive interruptions of different beams which would
represent true locomotion. Repeated interruptions of
the same beam may even provide a measure of stereotyped
head movements in certain circumstances provided they
occurred within the orbit of a beam.
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A new automated hole-board apparatus is at present
being developed which should solve some of these diffi¬
culties as well as providing other improvements on the
old model. Instead of a teletype, a digital cartridge
magnetic tape recorder controlled by a microprocessor i3
being used to record behaviour detected by the apparatus.
This tape recorder can note a monitored signal within
0.5 m.sec. instead of the 400 m.sec. or more which the
teletype takes to record an event. This means that
signals from hole-dipping, locomotor and any other
behavioural parameters can be recorded in rapid succession
as they occur, with little chance of their interfering
with each other in the recording process. A further set
of infra-red beams set higher above the hole-board will
be used to detect rearing behaviour, which has been
observed in this study to accompany certain procedures.
At present the two sets of infra-red beams subserving
hole-dipping (page 56 ) are positioned at the same level
beneath the hole-board floor. Because of this, if after
inserting its snout into a hole an animal moves it around
therein such movements could be recorded as "stereotyped"
dips. It is proposed that in the new hole-board this
problem will be eliminated by positioning the two sets of
infra-red beams at different levels beneath the floor,
one set passing close beneath the floor and the other set
deeper. The detection apparatus will be set to record
hole-dips only after both beams passing underneath any
one hole have been interrupted and disinterrupted, so
that the animal will hove to insert its head deep into
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the hole and withdraw it completely for a hole-dip to be
recorded. Such a signal would comply more closely with
the commonly held definition of a "hole-dip", which is
considered to occur when the animal's snout i3 first
inserted to a depth that the eyes reach the level of the
edge of the hole and ends when it is withdrawn completely
(File and Day, 1973).
A further refinement of the behavioural monitoring,
already suggested, by the addition of pressure detectors
around the hole ed^es is planned for future incorporation
into the holo-board structure. I cannot envisage any
practical method of automatically monitoring sniffing
activity.
In the writer's opinion this envisaged version of
the hole-board apparatus and its recording system probably
represents the best that can be achieved without great
expenditure. Beyond this point one can only picture a
costly set-up involving three-dimensional scanning above
and below the '!hole-board" with computer analysis of the
recorded signals.
The Assay of DA and HA in selected brain areas. The radio-
enzymatic assay employed for analysis of dopamine and
noradrenaline in brain tissue proved very sensitive (less
than 50 ng/g of NA or DA could be detected). Both the
DA and NA assay procedures exhibited linearity for
different amounts of catecholamines within the range of
D.P.M.s obtained from brain tissue samples estimated (Figs.40,
Table 23). It was observed that noradrenaline interfered
with the dopamine assay producing an increase in D.P.Ms
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from the DA fraction in proportion to the amount of
noradrenaline added. On the other hand increasing
amounts of dopamine led to a proportionate (but smaller
in comparison with the contamination of the DA fraction
by NA) decrease in D.P.M.s obtained in the noradrenaline
fraction. Coyle and Henry (1973) had observed the
contamination by NA in the DA assay but not the reverse.
No attempt was made to correct for these interferences
since the assays were being used primarily to compare
relatively gross changes in the same brain areas between
different groups of animals. The estimates of i)A in the
cortex may, however, as a result of this interference be
slightly overestimated whereas the NA content of the three
DA-rich areas are probably underestimated.
The distribution of dopamine and noradrenaline found
in the four areas examined (the olfactory tubercles,
accumbens nuclei, caudate-putamen are and cortex) in
animals with sham lesions of the accumbens nuclei or
caudate-pubamen (page 135) are in agreement with those
found in other studies ( Kelly et al. 1975; Kelly and
Iversen, 1976; Gostall et al. 1977; Verssteeg et al. 1976).
The accumbens nuclei, caudate-putamen and olfactory
tubercles have, relative to other brain areas, extremely
high concentrations of DA, this being highest in the
caudate-putamen sample. (Fig.42Table 24). Cortical DA
levels v/ere very low. Noradrenaline levels were much
lower in the three DA-rich areas. The nucleus accumbens
and cortex contained the highest amounts of NA. Much
lower values were found in the olfactory tubercles and the
caudate-putamen contained very little.
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Effect of 6-OHJA lesions on JA and 1TA content* The
6-OHJA injections produced maximal JA depletion in the
target areas, the caudate-putamen areas or accumbens nuclei.
However, there was also substantial depletion in other
contiguous areas, this depletion being particularly
noticeable in the olfactory tubercles following injections
into the accumbens nuclei. This is not surprising in
view of the close proximity of the two structures. Other
workers have made similar observations (Kelly et al. 1975?
Costall et al. 1977 )• The greater the JA depletion in
the target area the greater it was in the other areas also.
An apparent depletion of cortical JA accompanied 6-OHJA
lesions of the caudate nuclei. While this reduction of
the JA concentration of the cortical samples may truly
indicate JA depletion in the cortex since the cortical
sample was taken from an area adjacent to the caudate-
putameny it is also possible that the jSepletion
reflected the fall in JA content of caudate tissue which
may have been accidentally included in the cortical sample
(page 135). The desmethylimipramine pretreatment
appeared to afford a great deal of protection to nora¬
drenergic neurones since JA depletion was slight or even
did not occur even in the target areas. N A depletion
would of course be somewhat masked by the effect of
reduction in the JA content of the samples, this would
tend to cause an overestimation of HA content since it
was shown that high concentrations of JA tended to inter¬
fere with the HA assay in such a way as to cause a lower
d.p.m. value in the NA fraction (page237).
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It might be possible tc minimize the bA depletion
in areas other than the target organ by increasing the
concentration of o-hydroxydopamine, thus reducing the
injection volume. Whether this would reduce the extent
of diffusion of the neurotoxin away from the target
areas is uncertain, particularly when the animal is pren¬
treated with a monoamine oxidase inhibitor.
The assay of Amphetamine in plasma and brain. Although
the method for the assay of amphetamine (page 77 ) in
plasma and brain was not extensively investigated it
appeared adequate for the purpose to which it was put.
Although amphetamine was still detectable below the
"limits of sensitivity" set for accurate measurement,
25 ng/ml for plasma and 250 ng/g for brain, below those
limits the calibration curve no longer showed linearity.
This was presumed to be caused by background interference.
All sample concentrations exceeded these limits.
The two major metabolites of amphetamine, p-hydrcxy-
amphetamine and p-hydroxynorephedrine, being phenolic in
character, would not be expected to be extracted into the
toluene from a highly alkaline solution (pH 12+), and
these metabolites should not therefore interfere with the
assay. Furthermore the trichloroacetyl derivatives of
these metabolites would be expected to occupy different
locations in the chromatogram from that of amphetamine
itself. These aspects of the specificity of the assay
procedure were not, however, investigated experimentally.
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Technique fox- injection of monoamines into discrete
brain areas* While a high degree of accuracy was achieved
in the placement of the injected material, as confirmed
by histological examination (page 153) certain improve¬
ments could be made to the technique.
Firstly, the injection procedure (page 67) would
have been made easier if suitable stylets had been
available to keep the cannulae patent in the interval
between the operation to implant the cannulae and the
actual injection. Stylets were in fact constructed at
one stage but the animals kept pulling them out. It
should be possible to design stylets which would be
resistant to such interference.
The injection procedure itself involves acute
penetration of overlying brain tissue by the needle, and
in addition to this trauma, there was also the possibility
that some of the injected material might leak into the
brain tissue from the needle tip during penetration. It
might be better to use cannulae which protrude into the
brain and terminate within or just dorsal to the target
area and which are kept patent with a stylet. Such
modifications of the injection techniques have been
employed by some other workers (e.g. lijnenburg et al.
1976; Gostall et al. 1975a). The foreign object inside
the brain tissue might however produce a reaction from
the brain tissue which would interfere with the response
to an injection but this conceivably could be minimized
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APP3u)II
The following tables give details of the responses
of individual rats in the hole-board apparatus during
successive 10 or 30 min. intervals with different
treatments. The results given in the tables are
summarized in various tables in the main text which give
|.
mean responses - standard errors of the means (S.E.K.s)
during the different time intervals. These tables in
the main text are referred to in brackets at the top of
each table in the Appendix.
S - " Stereotyped1' dips;
'3 - "Exploratory" dips;
IOC - locomotor counts.
TABLE 1; Behavioural response to 1 ml/kg physiological
saline i»p» (lor mean response - S£2a during




0-10 10 - 20 20 - 30
RAT NO. s S LOG S
-p*
Zi LOG s E LOG
1 14 66 60 12 47 45 3 16 42
2 23 77 53 26 25 21 11 21 7
3 11 63 44 11 17 17 lo 20 18
4 26 77 62 35 45 37 30 40 48
5 13 57 30 8 24 10 18 22 22






30 -40 40 - 50 50 - 60
RAT NO. a 3 LOG 3 Hi LOG 3 E LOG
1 17 16 26 5 7 8 0 0 0
2 1 6 19 0 0 0 1 0 0
3 1 0 0 2 3 0 12 23 24
4 11 22 45 12 24 25 13 19 20
5 12 18 9 18 23 18 25 14 Ps




60 - 70 70 - 80 30 - 90
RAT NO. QJ E LOG C*o E LOG S LOC
1 19 32 21 5 11 13 7 11 11
2 0 0 0 2 10 1 33 44 29
3 20 26 23 63 40 31 52 23 11
4 14 10 11 8 6 3 31 33 32
5 40 50 18 20 27 11 1 5 4




90 - 100 100 - 110 110 - 120
RAT NO. 3 -J LOG r-lo E LOC s E LOG
1 10 3 20 29 29 17 11 27 24
2 6 6 20 4 2 0 0 0 0
3 8 14 7 9 30 27 28 10 9
4 33 31 27 20 21 38 8 22 38
5 26 18 4 lo 36 22 14 13 34
6 31 39 26 5 9 3 1 1 0
TABLE 2i Behavioural response to 2 mg/kgBL-amphetamine
sulphate. (For mean response - S.E.M. during




0 *- 10 10 f roo 20 - 30
RAT NO. 3 3 LOG S 2 LOG S VIII LOC
1 10 95 55 12 55 77 9 73 129
2 5 46 71 6 13 13 6 19 14
3 15 60 64 32 28 28 24 23 45
4 8 93 53 26 64 55 14 56 77
5 21 74 53 20 37 14 8 13 11




30 - 40 40 - 50 50 - 60
RAT NO. Q S LOG 3 V LOG S JS LOG
1 10 35 108 10 78 66 9 22 36
2 3 10 11 5 20 10 18 23 33
3 28 45 59 24 38 15 23 16 13
4 39 39 16 45 11 4 89 8 43
5 20 18 22 16 26 24 1 1 0




60 - 70 70 - 80 80 - 90
RAT NO. 3 u LOG nO E LOC 3 3 LOC
1 12 43 45 5 29 13 28 34 39
2 17 13 12 27 14 7 21 4 10
3 51 60 30 45 48 26 25 17 14
4 51 35 13 24 45 - 83 6 8
9 9 2 14 43 29 21 31 14




90 - 100 100 - 110 110 - 120
RAT NO. 3 Ja LOG S 2 LOC S 3 LOC
1 18 28 48 20 34 12 6 8 1
2 18 3 9 24 1 7 31 9 12
3 5 4 0 0 1 0 0 0 0
4 52 37 14 26 42 47 37 55 20
5 0 0 0 14 35 20 33 39 20
6 0 0 0 31 5° 28 25 44 49
TABLE 3: Behavioural response to 4 mg/kg^bl-amphetamine
sulphate. (For mean response - 3.3.M. during




0-10 10 - 20 20 - 30
rat no. 3 s log s a log s i2i loc
1 10 74 76 4 38 54 6 47 100
2 5 41 53 1 8 50 14 32 48
3 19 79 55 12 40 25 35 63 56
4 25 64 46 10 30 24 7 27 41
5 21 109 - 19 71 - 26 99 -




0-=*•1o 40 - 50 50 - 60
rat no. s T?M4 l0c 3 s loc S 3 log
1 4 58 85 11 87 65 4 52 71
2 23 105 51 23 130 79 36 97 55
3 122 48 33 119 28 27 201 29 55
4 24 44 43 45 36 32 14 49 53
5 31 127 - 19 77 - 12 54 -




60 - 70 70 - 80 80 - 90
RAT no. 3 s log 3 e log S 3 log
1 15 7o
4
67 28 64 59 34 98 53
2 26 98 4o 19 86 42 17 55 41
3 168 29 55 186 30 72 140 47 87
4 41 50 50 27 47 73 48 69 48
& 23 100 - 19 84 - 34 80 -




90 - 100 100 - 110 110 - 120
RAT no. 3 s log 3 s loc 3 3 loc
1 22 114 50 14 88 96 11 66 118
2 27 53 27 13 23 8 38 43 9
3 135 41 120 101 44 85 68 40 89
4 62 51 34 33 oO 34 30 39 19
5 20 37 - 3 17 - 1 7 -
6 37 85 25 73 51 19 68 72 22
TABL3 41 Behavioural response to 8 mg/kg+DL-am.phQtamine
sulphate. (For mean response - S.E.M. During




v - 10 10 - 20 20 - 30
RAT 110. S E LOO S E LOG 3 S LOC
1 18 119 72 60 in 45 163 103 41
2 40 95 30 35 23 - 137 52 -
3 26 95 29 44 67 6 1 6 0
4 23 57 45 121 88 27 113 6 0
5 50 69 24 214 96 2 440 2 0




30 - 40 40 - 50 50 - 60
RAT NO. S 3 LOO S 3 LOC S E LOC
1 335 13 25 462 1 4 482 0 0
2 115 64 28 241 35 12 309 17 6
3 23 7 0 0 1 0 0 2 0
4 209 0 0 113 0 6 281 0 0
5 526 0 0 419 0 0 300 0 0




60 - 70 70 - 80 50 - 90
RAT NO. 3 LOG S E LOC 3 3 LOG
1 4o9 0 0 428 5 20 356 6 4
2 289 4 0 270 10 0 277 4 0
3 97 15 0 75 5 0 158 39 4
4 314 0 0 340 0 1 343 0 0
5 201 0 0 62 3 0 248 1 0




90 - 100 100 - 110 110 - 120
RAT HO. CIU E LOO 3 3 LOC S 3 LOG
1 340 14 21 295 37 5 258 66 97
2 236 10 5 202 8 21 145 27 18
3 168 23 17 189 36 8 160 43 5
4 336 0 0 275 4 0 312 7 2
5 bib 0 0 557 0 0 473 0 0
6 242 0 0 153 41 29 146 38 9
TABLE 5i Effect of pretreatment with 20 mg/kg phenoxy-
benzaaine hydrochloride i.p. on the response to
4 mg/kg Olr-amphetamine sulphate i.p. (lor mean
response - S.E.M. during each time interval see




0 - 10 10 - 20 20 - 30
RAT NO. $ pLi LOC s TjlJul LOC S S LOC
1 10 7 6 62 47 37 74 61 31
2 17 50 59 25 68 83 65 123 70
3 9 4 7 8 9 0 6 20 36
4 3 21 31 2 1 5 12 16 21
5 3 15 35 19 39 47 13 34 61
6 9 6 14 8 4 5 3 6 8




30 - 40 40 - 50 50 - 60
RAT NO. S E LOC s E LOC S S LOC
1 65 32 36 34 33 59 19 27 62
2 67 134 70 140 109 59 162 81 47
3 4 21 44 3 11 26 19 22 36
4 53 41 25 164 18 19 132 43 41
5 3 19 90 10 30 7o 5 19 81
6 1 4 2 1 8 0 4 8 8




60 - 70 70 - 80 80 - 90
RAT NO. s E IOC 3 E LOC r~*O E LOC
1 24 18 49 13 13 18 14 15 21
2 133 52 17 79 60 75 89 29 39
3 10 21 37 12 10 27 21 16 22
4 113 40 66 130 25 21 148 27 25
5 4 22 74 4 24 70 9 33 85
6 1 1 0 4 5 6 11 5 4





90 - 100 100 - 110 110 - 120
RAT NO. s 3 LOG 0 T?XI LOG S S LOG
1 21 18 51 28 4 3 14 5 7
2 74 62 42 46 65 88 31 7 68
3 25 13 55 9 7 17 5 8 49
4 86 32 32 95 21 34 77 42 42
5 6 32 63 20 38 69 38 59 41
6 0 0 0 5 2 5 1 4 2
7 2 E-jL 21 7 3 28 18 8 41
TABLE 6; Effect of pretreatment with 2.0 mg/kg methysergide
hydrogen oaleinate i.p. on the response to 4 mg/k^
LL-amphetamine sulphate i.p. (For mean response -





0-10 10 - 20 20 - 30
HAT NO. s T-1■dt LOG S E LOG s 1?J2i LOG
1 13 122 111 36 136 55 22 160 67
2 18 90 88 26 94 110 43 95 83
3 25 68 98 30 59 94 73 109 90
4 43 62 40 44 51 54 80 62 75
5 10 100 127 17 76 119 11 60 138
6 40 50 90 67 42 56 56 58 77




30 - 40 40 - 50 50 - 60
RAT NO. S n LOG S E LOG S :*U LOG
1 35 164 58 53 158 67 86 122 87
2 82 53 94 84 76 55 60 77 48
3 103 145 102 120 98 81 90 105 118
4 119 47 38 141 64 40 99 57 33
5 14 63 174 44 97 170 42 112 185
6 28 23 30 88 27 53 85 6 33




60 - 70 0CO1o 80 - 90
RAT NO. S E LOG S E LOG s E LOG
1 123 115 84 133 121 72 202 102 64
2 56 81 66 79 91 113 116 64 89
3 52 112 98 40 99 122 78 78 96
4 88 47 25 126 42 28 67 27 27
5 30 71 149 26 48 125 50 80 71
6 85 26 38 67 44 65 48 41 33





90 - 100 100 - 110 110 - 120
RAT NO. s S LOG s 3 LOC 3 TT»i-i LOG
1 87 117 90 52 120 91 90 96 106
2 142 26 57 96 26 14 114 14 67
3 56 87 87 46 98 120 69 78 89
4 82 28 51 71 34 55 71 34 119
5 17 58 112 21 69 114 40 89 70
6 56 28 47 46 40 41 38 33 34
7 64 61 33 65 85 08 56 96 52
TABLI 7: Behavioural response to 0.75 mg/kg apomorphino
hydrochloride i.p. (lor mean responses - S.B.Li,




0 •- 10 10 - 20 20 - 30
RAT NO. 3 2 LOG S 7"1J# LOG s la LOG
1 3 18 22 2 2 61 4 8 40
2 41 18 20 118 0 59 123 6 2
3 13 9 14 6 6 2 10 17 0
4 1 17 26 2 2 1 0 0 0
5 21 58 75 10 30 35 2 1 0
6 8 15 23 9 14 11 10 17 0




30 - 40 40 - 50 50 - 60
lik't NO. O ala LOG s ■—■IJI LOG Q '? LOG
1 6 21 10 8 14 8 0 0 0
2 11 24 23 0 1 0 2 2 0
3 6 11 11 11 12 8 1 0 0
4 22 19 13 13 10 40 27 18 -
5 6 9 1 21 32 28 21 56 54
6 0 0 0 7 31 10 6 27 88




60 - 70 70 - 80 80 - 90
RAT NO. o LOG s rt" 1 "JJji LOG s vnat LOG
1 0 0 0 9 11 2 23 59 71
2 4 12 0 15 27 12 17 13 13
3 25 31 23 20 16 - 27 13 19
4 1 8 3 17 21 95 11 12 7
5 33 35 9 13 31 27 26 21 40
6 3 9 4 12 21 12 23 17 25




90 - 100 100 - 110 110 - 120
RAT NO. 5 "TPJa LOG
•
O 7?la LOG 3 la LOG
1 1 4 1 3 10 10 23 41 40
2 9 9 93 2 0 0 2 0 0
3 22 9 11 23 20 8 28 lb 5
4 43 24 9 28 30 14 2 3 0
5 05 37 23 33 44 103 24 43 40
6 18 27 7 10 15 5 1 1 2
7 12 21 82 11 23 15 17 13 14
TABLE 3: Behavioural response to 1.5 mg/kg apomor^hine
hydrochloride i.p. (For mean responses - S.S.M.




0 1 HO 10 - 20 20 - 30
RAT NO. S 3 LOG 3 —\JUI LOG s S LOG
1 5 7 28 0 5 54 0 8 65
2 4 10 14 1 1 11 3 3 19
3 1 9 30 0 0 0 0 0 0
4 35 9 26 0 1 24 17 13 42
5 1 20 35 2 19 32 C,J 7 38
6 16 25 - 0 10 23 6 9 34




30 - 40 40 - 50 50 - 60
RAT NO. S T?Hi LOG oo 7?JCI LOG 3 7J1J LOG
1 2 13 55 1 10 37 11 37 53
2 2 7 10 6 11 32 3 7 41
3 4 8 7 7 8 24 5 7 2
4 23 32 22 4 3 5 18 21 12
5 3 18 32 0 0 0 0 0 0
b 8 22 11 1 4 5 5 6 7




60 - 70 70 - 80 80 - 90
RAT NO. 3 S LOG 3 S LOG <2b -riJUt LOG
1 16 30 27 4 20 18 45 36 35
2 5 7 29 0 0 0 11 8 1
3 14 25 9 36 30 22 14 37 23
4 20 22 35 3 1 0 0 0 0
5 5 29 22 0 0 0 3 25 10
6 0 0 0 14 28 72 11 30 28




90 - 100 100 - no 110 - 120
RAT NO. o -r»J2§ LOG 3 3 LOG S rr»u LOG
1 12 22 13 19 49 27 3b 34 22
2 6 15 13 1 0 10 1 2 30
3 14 11 2 12 20 24 50 27 11
4 22 21 7 22 23 2b 24 35 35
5 21 31 14 0 1 3 0 0 0
o 17 36 10 25 48 29 35 43 57
7 14 24 8 8 32 - 4 5 47
TABLE 9: Behavioural response to 3*0 mg/kg apomor^hine
hydrochloride i.p. (lor mean responses -




c l HO 10 - 20 20 - 30
HAT NO. 5 T?J* LOG 3 3 LOC 3 2 LOC
1 0 10 50 0 9 69 0 3 81
2 11 52 31 28 37 19 9 33 13
3 2 15 23 0 2 33 2 1 2
4 1 21 14 0 14 16 1 1 36
5 0 10 14 0 0 3 1 1 0




30 - 40 40 - 50 50 - 60
RAT NO. S 3 LOG s 3 LOG 3 E LOC
1 4 20 69 10 19 13 0 1 38
2 2 3 0 12 27 19 12 27 21
3 0 4 39 1 19 27 3 4 -
4 0 1 76 1 10 21 7 10 31
5 0 1 82 16 14 28 12 27 25




60 - 70 70 - 80 80 - 90
HAT NO. s T71JQl LOG 3 3 LOG S 3 LOC
1 14 21 25 10 17 43 26 29 49
2 4 6 4 0 1 1 0 1 0
3 0 0 0 3 13 16 1 9 13
4 8 7 2 9 4 0 13 34 32
5 2 2 0 0 0 0 0 0 0




90 - 100 100 - 110 110 - 120
HAT NO. 3 TP-U LOG 3 1?.A LOG 3 3 LOG
1 15 28 32 2 3 2 12 31 53
2 9 23 13 25 40 49 10 23 27
3 3 6 18 1 3 10 2 12 14
4 19 24 18 20 25 7 13 16 12
5 14 22 35 26 47 20 8 22 18
6 0 0 6 11 1 3 29 11 8
TmBLO 13: Behavioural response to 2.5 mg/kg 5-Methoxy-N 3jT-
dimethyltryptamine i.p. (For mean responses -





0-10 10 0CM1 20 - 30
RAT NO. s 3 IOC S •d# LOC s .3 IOC
1 33 59 83 43 36 14 12 16 15
2 19 40 61 26 19 6 17 42 24
3 46 38 31 36 69 103 15 38 35




30 - 40 40 - 50 50 - 60
HAT NO. S 3 LOO S S LOC S 3 LOC
1 8 12 17 12 36 4o 5 13 45
2 28 38 36 10 31 31 5 29 37
3 9 11 10 10 10 8 21 13 29




60 - 70 70 - 80 80 - 90
RAT NO. s 3 LOC s 3 LOC 5 "C?Lj LOC
1 14 9 66 5 21 27 9 12 9
2 8 3 3 11 8 7 12 58 80
3 37 8 4 26 16 6 18 0 8




90 - 100 100 - 110 110 - 120
NAT NO. S T7»lit LOC S r* LOC s LOC
1 11 37 33 14 20 105 7 23 45
2 4 18 19 8 6 10 17 19 25
3 0 0 0 0 1 1 4 5 nt
4 31 20 77 15 13 39 4 6 6
TABLP 11; Behavioural response to 5 mg/kg 5-Methoxy,-I7 N-
dimettayltryptaraine i.p. (For mean responses «•





0 - 10 10 - 20 20 - 30
AAT NO. S 3 LOO 3 E LOO 3 3 LOG
1 23 31 50 39 37 2b 25 49 28
2 27 44 73 35 34 25 7 27 15
3 13 25 92 26 49 75 12 47 62
4 65 59 50 16 26 5 6 21 18




30 - 40 40 - 50 50 — 60
HAT NO. S 3 LOO s 3 LOG S -r*».Of LOO
1 3b 30 6 21 14 24 27 12 10
2 6 9 13 1 8 10 25 5 2
3 6 16 30 3 21 24 11 12 46
4 9 5 34 1 5 17 2 3 1




60 - 70 70 i Coo 80 - 90
RAT NO. 3 7?hi LOC 3 3 LOG 3 3 LOO
1 33 14 89 65 26 13 65 26 18
2 6 2 1 12 5 2 9 9 9
3 17 24 68 26 35 41 6 2 17
4 1 2 1 12 14 JL 35 19 30




90 - 100 100 - 110 110 - 120
RAT NO. o r\ LOO 3 3 10 G 3 3 LOG
1 40 24 32 25 12 6 2 1 7
2 7 4 0 3 4 0 1 1 0
3 11 17 b3 10 22 54 1 0 0
4 11 19 27 8 0 0 16 5 7
5 39 34 28 6 11 16 2 0 0
TABLI 1.21 Behavioural response to 10 mg/kg 5~Hethoxy,-N+N—
d sine thy!tryptamine i.p. (For mean response -





0 1 HO 10 - 20 20 - 30
RAT NO. 3 ■nli1 LOG 3 "I? LOG 3 3 L0C
1 39 43 155 54 80 126 31 3b 35
2 5b 35 115 64 35 128 54 59 27
3 27 29 101 3 9 89 25 22 157
4 49 7 99 5b 20 25 45 19 15




30 - 40 40 - 50 50 - 60
RAT NO. 3 E LOG oO J2i LOG 3 3 LOG
1 24 38 29 17 50 103 5 9 39
2 28 60 91 26 32 67 27 29 46
3 67 20 44 79 34 17 56 46 36
4 39 32 31 24 9 19 25 18 16




60 - 70 70 - 80 80 - 90
RAT NO. 3 B LOG s 3 LOG S 3 LOG
1 0 0 21 11 20 35 0 0 5
2 7 5 9 28 31 73 5 0 0
3 7 16 18 8 6 0 3 1 0
4 2 3 4 0 0 0 7 1 0




90 - 100 100 - 110 110 - 120
RAT NO. c*o 3 LOG 3 •£»Li L0C 3 3 LOG
1 1 2 23 24 41 59 15 23 42
2 11 4 1 24 20 50 5 1 6
3 6 0 0 1 1 0 24 10 0
4 0 0 0 9 3 3 0 0 0
5 9 4 2 2 0 0 14 6 9
TABLI 13: Effects of pretreatment with 2 5 mg/kg
desmethylimipramine hydrochloride i.p. on the
behavioural response to 1 ml ^kg physiological
saline. (Por mean responses - 3.3.M. Luring
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IA3LS 14: Effects of pretreatment with 25 mg/kg
chlorimipramine hydrochloride on the behavioural
response to 1 xii^ /kg physiological saline. (For
mean responses - 3.3.M. during the different time




0 - 10 10 - 20 20 - 30
EAT NO. 3 3 LOG s ■jn LOG s 3 LOG
1 20 70 37 23 35 20 26 25 19
2 26 70 54 10 19 9 11 9 5
3 29 86 53 34 53 33 15 26 14
4 11 21 16 16 13 11 19 0 15
5 13 46 39 7 15 4 14 9 p.




30 - 40 40 - 50 50 - 60
RAT NO. S -ri.j LOG c?kj T*1 LOG s -U LOG
1 20 30 11 10 21 15 12 11 13
2 9 18 10 13 6 7 12 15 1
3 5 8 1 3 12 4 4 5 0
4 9 7 4 8 15 5 14 16 0
5 21 14 9 14 18 5 9 9 3




60 - 70 70 - 80 80 - 90
EAT NO. 3 E LOG S 3 LOG S 2 LOG
1 4 6 24 0 0 0 7 3 7
2 9 16 5 6 9 2 lo 14 0
3 1 1 0 0 0 0 16 3d 23
4 10 10 5 22 28 12 29 28 o
5 12 18 5 7 11 10 18 47 64




90 - 100 100 - 110 110 - 120
RAT NO. s i-iJul LOG 3 -rj%mi LOG 3 E LOG
1 1 0 0 1 1 3 0 0 0
2 9 14 11 11 32 21 7 0 0
3 6 7 5 6 0 0 1 1 0
4 15 12 11 11 7 2 13 17 14
5 10 2 0 4 3 0 4 0 0
6 25 37 33 24 17 7 4 17 40
TABLE 151 Effects of pretreetraent with 50 mg/kg "GEA 654"
on the behavioural response to 1 ml/kg physio¬
logical saline. (lor mean responses - S.E.M.





0 •- 10 10 - 20 20 - 30
RAT NO. S La LOC C!KJ E LOG 3 E LOG
1 13 65 72 17 51 35 19 50 29
2 3 5 11 3 12 15 8 16 20
3 38 34 41 42 65 29 30 22 14
4 17 70 49 15 44 31 13 21 10




30 - 40 40 - 50 50 - 60
RAT NO. S LOG s T2*Ja LOG s Li LOG
1 36 43 »! 21 37 75 22 51 47
2 0 6 0 1 4 22 8 15 24
3 j 17 25 lo 26 38 116 22 22 15
4 1 27 29 6 19 25 10 24 58 32




60 - 70 70 - 80 80 - 90
RAT NO. 3 E LOC ! 3 E LOG S iSi LOG
1 10 4 20 14 35 15 23 42 21
2 2 9 20 9 8 21 10 16 33
3 23 25 20 13 14 5 3 0 0
4 IS 41 36 24 53 35 13 37 19




90 - 100 100 - 110 110 - 120
RAT NO. 3 E LOG 3 3 LOG 3 E LOG
1 9 3 0 4 1 0 4 0 0
2 0 4 0 17 30 26 7 12 11
3 11 23 27 37 52 50 29 15 6
4 21 43 22 27 33 24 19 31 10
5 24 19 3 24 23 3 33 9 0
TABLI 16i Behavioural re3ponse+to 10 mg/kg "LRG1 5132" i.p.
(ior mean responses - S«E.M. during each time




0-10 10 - 20 20 - 30
HAT NO. S ■n LOG S 73 LOG S 3 LOG
1 5 48 65 11 20 26 11 4 22
2 16 69 43 13 70 56 12 71 46
3 11 91 102 10 42 85 23 47 57
4 10 35 23 18 24 43 20 24 10




0-e-1o 40 - 50 50 - 60
MAT NO. s E LOG S E LOG S -rpIII LOG
1 0 1 0 0 0 5 6 17 38
2 18 78 lbl 11 94 71 16 85 65
3 26 48 43 56 53 52 34 68 47
4 3b 36 18 48 31 9 49 39 12




0t>1ovO 0001oc- 80 - 90
BAT NO. S VIxJ LOG 3 3 LOG 3 3 LOG
1 25 40 33 15 37 28 22 38 37
2 35 130 75 31 108 134 57 133 55
3 21 83 80 30 77 80 53 79 21
4 26 39 15 29 31 12 28 50 39




90 - 100 100 - 110 110 - 120
BAT NO. S E LOG s E iiO G 3 3 LOG
1 22 40 11 46 36 10 22 48 23
2 55 117 49 44 122 76 43 103 48
3 49 89 25 56 84 26 51 94 49
4 23 50 26 20 51 42 17 54 44
5 37 124 29 31 99 20 40 120 41
TABLI 17: Behavioural response^to 20 mg/kg "LRCL 5182" i.p.
(lor mean responses - S.E.M. during each time




0r—11o 10 - 20 20 - 30
RAT NO. S 2 LOG 3 S LOG S 2 LOG
1 18 69 65 41 74 51 33 113 136
2 83 61 67 21 58 85 86 99 50
1
J 404 178 62 465 20 6 424 22 8
4 23 105 248 54 116 35 43 136 75
5 11 36 27 21 35 10 47 51 14




30 - 40 40 - 50 50 - 60
RAT NO. S S LOG S 2 LOG S T"1xJ LOG
1 73 104 118 47 91 259 27 72 357
2 86 40 31 107 97 46 23 69 48
3 258 42 15 170 47 41 39 61 83
4 46 162 99 117 159 104 133 138 CMo!—i
5 88 110 17 79 90 26 4o 53 32




0t—1oCO 70 - 80 CO0 1 o
1 .
RAT NO. S T*-Rl LOG 3 E LOG S T?El LOG
1 25 54 128 60 52 119 31 35 130
2 66 62 32 59 53, 60 75 36 156
3 4 18 177 0
s
5 118 2 14 144
4 164 94 36 292 36 5 278 29 5
5 25 56 18 39 52 91 33 52 141




90 - 100 1Q0 - 110 110 - 120
RAT NO. 3 JuJ LOG 3 .2i LOG S S L0C
1 35 27 110 19 15 36 22 37 161
2 64 19 89 115 21 44 129 33 179
3 1 6 212 0 2 158 19 17 135
4 233 32 86 232 2 0 213 8 7
5 35 4o 46 24 42 24 27 24 34
6 75 21 COCO 96 19 261 53 3 306
TABLI 18: Behavioural response+to 2.5 Benztropine mesylate i.p.
(For mean responses - S.2.M. during each tame




0H1O 10 i roo 20 - 30
BAT NO. S E L0C S mJA' L0C S
rn LOC
1 37 118 114 28 136 44 79 89 35
2 19 90 93 25 60 73 23 23 49
3 49 87 78 61 102 62 67 40 30
4 29 118 63 66 78 43 60 32 17
5 9 57 88 35 56 59 55 32 30




30 - 40 40 - 50 50 - 60
BAT NO. S E LOG S 3 LOG s 3 LOC
1 43 58 19 57 67 23 57 60 55
2 10 12 168 19 15 88 13 11 51
3 52 33 - 29 21 11 15 25 10
4 68 14 9 61 12 14 73 40 28
5 58 27 - 50 10 25 14 oC. 7




60 - 70 70 - 80 80 - 90
HAT NO. S iJi LOG S LI L0C S E LOG
1 17 10 48 34 26 43 49 23 213
2 21 14 38 12 16 29 23 8 11
3 43 12 11 41 21 12 36 31 24
4 30 25 79 64 31 25 25 16 19
5 22 12 - 21 12 21 16 5 25




90 - 100 100 - no 110 - 120
BAT NO. 3 E LOG s E LOC S 3 LOC
1 46 18 13 28 19 15 42 29 14
2 26 13 22 3 1 0 1 0 8
3 26 37 - 20 46 37 13 16 16
4 47 29 19 35 15 9 48 53 34
5 28 9 59 11 8 17 23 3 -
6 10 162 62 40 82 56 12 46
TABLE 19t Behavioural response to 5*0 mg/kg b|nztropine
mesylate i.p. (For mean responses - S. AM.




o a MO 10 - 20 20 - 30
RAT NO. S S L0C 3 S L0C s E LOG
1 35 108 58 67 141 36 63 139 33
2 32 83 68 74 81 52 62 47 15
3 10 85 30 7 33 12 14 24 7
4 36 122 61 106 71 29 129 80 25
5 21 119 117 64 lb9 63 48 156 68




30 - 40 40 - 50 50 — OQ
RAT NO. s T*.Si LOG 3 S LOG 3 ri LOG
1 b2. 117 64 98 92 54 73 51 14
2 75 81 25 79 32 11 87 41 19
3 6 6 4 3 19 7 9 16 17
4 158 30 8 261 2 0 112 12 20
5 43 140 60 36 108 7b 32 49 14




60 - 70 0CO1otr- 80 - 90
RAT NO. S T1-'I# 10 C C*Kj E LOG oo T? LOG
1 78 82 36 74 43 16 88 55 43
2 70 44 17 92 33 13 55 47 31
3 13 42 13 8 2 0 13 46 33
4 196 0 0 186 0 0 14b 18 7
5 3b llo 73 44 72 33 28 29 18




90 - 100 100 - 110 110 - 120
RAT NO. 3 ra L0C 3 m LOG 3 S L0C
1 7b 53 39 20 7 1 75 74 21
2 87 32 23 10 0 0 71 71 26
3 11 19 76 5 4 2 4 0 0
4 142 5 5 163 2 0 143 2 0
5 62 48 29 17 0 8 43 48 27
6 8b 2 23 77 22 - 100 3b 22
TABIE 20t Effects of pretraatment with 2 5 mg/kg
desmethylimipramine hydrochloride i.p. on the
behavioural response to 4 mg/kg ^L-amphetamine
sulphate. (For mean responses - 5.E.M. for




0 - 10 10 - 20 20 - 30
RAT NO. s T>& LOG QO 3 LOG s E LOG
1 43 85 56 121 74 48 281 39 42
2 16 21 51 14 12 27 37 20 Jo
3 9 3 8 29 1 0 135 9 0
4 8 43 15 28 41 5 175 20 0
5 30 40 27 19 36 18 35 7 74




30 - 40 40 - 50 50 - 60
RAT NO. 3 triJj LOG S 3 LOG 3 E LOG
1 154 29 28 239 9 4 284 0 0
2 34 19 32 45 7 0 101 2 23
3 Id6 2 0 157 2 3 151 0 0
4 136 6 86 243 10 0 147 12 0
5 168 1 31 153 0 0 207 0 0




60 - 70 70 - 80 80 - 90
RAT NO. 3 •nUl LOG s 3?Li LOG S —J LOG
1 213 0 0 211 0 0 86 0 0
2 136 0 48 143 0 72 88 0 0
3 196 0 0 109 2 7 180 2 0
4 105 0 0 61 6 0 66 0 0
5 63 0 0 27 2 0 3 0 0




90 - 100 100 ~ 110 110 - 120
RAT NO. S Li LOC 3 T~1.Li JJO G 3 7? LOG
1 143 0 0 86 37 0 87 31 2
2 70 0 9 13 0 0 21 0 0
3 274 0 0 201 2 2 107 0 0
4 29 0 0 63 1 0 17 0 0
5 10 0 0 3 0 0 1 0 0
0 332 21 0 322 4 0 377 0 0
TABLE 21: Effects of pretreatment with 25 mg/kg
chlorimipraraine hydrochloride i.p. on the behavioural
response to 4 mg/kg JL-amphetamine sulphate. (For
mean responses - S. S.M. for each time interval see




0-10 10 - 20 20 - 30
RAT NO. S 3 LOG S 7?HI LOG S 3 LOG
1 20 91 45 11 60 37 18 57 37
2 9 74 173 11 86 39 13 109 46
3 4 27 29 14 78 59 35 51 22
4 15 57 25 46 32 23 108 87 46
5 11 o3 95 40 52 20 118 77 221




30 - 40 4=. 0 1 VJ10 vxi0 1 crO
•' RAT NO. S ill LOG S 3 LOG S 3 LOG
1 1 33 GO 55 80 105 19 175 104 12
2 20 152 137 22 150 183 16 195 33
3 53 80 19 103 93 lo 120 51 73
4 205 81 58 275 42 30 251 26 14
5 132 89 80 132 97 0 109 84 0




0r~10Vf> 70 - 80 80 - 90
RAT NO. S T?hi LOG s S LOG S E LOG
1 327 35 8 440 0 0 488 2 0
2 2o 189 28 41 219 125 51 221 45
3 198 20 27 163 12 30 228 20 40
4 205 25 31 248 6 0 119 7 19
5 135 49 0 118 67 41 96 58 1




90 - 100 100 - 110 110 - 120
RAT NO. S 3 LOG S -7*—1 LOG S 3 LOG
1 454 5 0 559 3 0 615 1 0
2 70 241 50 73 234 48 04 193 55
3 238 0 0 27u 5 11 240 11 42
4 145 17 5 224 0 0 194 13 11
5 95 45 32 123 25 31 121 20 25
5 2 50 5 0 209 10 2 317 10 15
•TABIT? 7.2s Bffects of pretreatment with 50 mg/kg "G3A 654" i.p.
on the behavioural response to £ mg/kg BL-amphetamine
sulphate. (For mean responses A 3. S.M. for each




0 - 10 10 - 20 20 - 30
BAT NO. S s LOG S 3 LOG 3 "I?ill LOG
1 159 19 34 15o 24 25 200 42 12
2 12 41 15 34 49 15 20 36 9
3 40 o7 70 81 85 50 103 192 91
4 1 13 22 21 26 16 20 25 20
5 21 23 104 38 49 32 49 72 3o




30 - 40 40 - 50 50 - 60
RAT NO. S -r*A LOG s ■J LOG S
- »
xA LOG
1 236 33 322 4 0 304 0 0
2 36 29 3 , 186 52 5 157 64 10
3 271 154 65 443 3o 1 463 4 129
4 127 68 31 225 38 22 260 33 30
5 69 70 21 87 54 26 123 33 22




60 - 70 70 - 30 80 - 90
RAT NO. S S LOG S 3 LOG r*»o S LOG
1 339 0 0 335 0 0 323 0 0
2 140 39 0 144 53 2 177 42 3
3 527 24 20 499 28 13 52o 11 74
4 280 26 28 281 19 13 236 46 22
5 124 21 9 137 27 43 134 29 23




90 - 100 100 - 110 110 - 120
RAT NO. S S LOG C1 3 LOG S ill LOG
1 187 20 5 219 2 2 253 2 0
2 179 25 3 125 27 3 183 16 1
3 527 6 4 578 4 1 543 5 70
4 245 51 17 259 13 4 227 54 21
5 121 64 21 140 23 11 137 24 11
6 165 0 0 180 0 0 196 0 0
TAB1? 23: Effects of pretreatment with 15 mg/kg "3KF-525A"
i.p. on the behavioural response to 4 mg/kg .
LL-amphetamine sulphate. (For mean responses -





0;—11o 10 - 20
1
20 - 30
RAT NO. S 3 LOG E LOG Q E LOG
1 4 30 43 25 40 28 77 42 3
2 43 86 40 29 102 45 22 86 27
3 9 45 11 8 20 6 0 0 0
4 7 79 23 19 73 IS 52 98 44
5 39 65 49 14 9 0 61 0 -




30 - 40 40 - 50 50 - 60
RAT NO. s ?r»j LOG j 3 7?mi LOG s "CIj2i LOG
1 124 26 19 103 22 12 125 18 11
2 19 111 14 31 60 18 48 44 11
3 7 0 0 6 13 23 9 44 14
4 118 69 23 115 53 35 145 53 2b
5 172 0 - 242 15 58 329 2 0




60 - 70 70 - 80 80 - 90
RAT NO. s S LOG 3 3 LOG s "T»ml LOG
1 107 20 lb 70 21 17 bO 23 28
2 45 41 9 69 30 11 30 64 15
3 11 30 22 12 29 33 27 47 20
4 138 35 17 140 39 10 125 55 20
5 386 0 41 203 26 44 197 56 50




90 - 100 100 - 110 110 - 120
RAT NO. 3 S LOG S 3 LOG S E LOG
1 52 2o 19 101 30 21 105 14 6
2 23 43 17 18 45 18 22 17 12
3 40 53 3b 71 61 30 84 b7 22
4 105 47 10 108 54 10 62 75 38
5 179 80 42 96 62 91 102 64 56
6 202 0 0 85 0 0 68 0 _o\
T -31".? e.'i-t Effects of pretreataient with 30 ag/kg " 3KF-525A"
i.p. on the behavioural response to 4 mg/kg
Llr-amphetamine sulphate. (For mean responses -





0-10 10 - 20 20 - 30
RAT NO- S 33 LOG S E LOG 3 E LOC
1 28 36 28 34 73 2b 70 120 26
2 24 11 6 9 13 7 7 31 9
3 4 32 34 16 33 29 52 36 22
4 14 75 75 6 71 58 16 82 62
5 19 71 59 28 91 72 05 108 68




01o 0 1 U10 50 - 60
RAT NO. s S mo S •riJi LOG 3 E LOG
1 218 31 6 291 6 24 309 13 A*
2 55 2 1 107 5 3 227 0 0
3 65 112 24 99 125 21 171 55 11
4 32 135 89 50 121 84 41 126 87
5 129 67 18 225 24 0 196 33 0




60 - 70 70 - 80 80 - 90
RAT NO. S T*-Cs LOG 3 3 LOG 010 T?•-J LOG
T
J. 423 6 0 453 0 0 459 0 0
2 271 2 0 348 2 0 421 2 0
3 187 31 0 130 42 6 44 21 14
4 56 35 47 46 115 40 51 118 39
5 281 36 0 342 2 0 251 4 0




90 - 100 100 - 110 110 - 120
RAT NO. 3 •nj LOG 3 -T-J LOG S 7? LOG
1 461 1 0 439 2 0 388 0 0
2 441 0 0 452 0 0 437 0 0
3 152 4 4 122 9 3 150 20 6
4 42 113 88 o5 141 112 54 117 94
5 210 13 29 lo4 3 8 129 12 38
0 422 0 0 425 0 0 432 0 0
TABLE 25: Behavioural responses of animals with sham lesions
of the caudate nuclei and accumbens nuclei
following administration of 1 ml/^g physiological
saline i.p. (for main responses - S.2.M. see




0 - 10 10 - 20 20 - 30
RAT NO. S TpjU LOO 2 3 LOG s 3 LOC
1 34 69 44 27 63 82 22 38 8
2 37 58 120 18 19 20 39 19 4
3 26 57 50 15 15 9 15 20 36
4 22 54 48 26 29 18 18 44 33
5 22 82 88 43 70 54 24 53 47
6 13 65 70 26 38 66 16 30 66
7 35 91 116 21 48 74 22 25 42
8 28 84 100 22 63 85 26 82 86
9 • UTT^^TMri.
10 22 67 73 25 37 32 23 27 32
11 20 83 91 9 53 49 34 57 30
12 22 72 114 27 45 16 28 37 22
13 17 79 75 27 75 81 25 64 62
14 9 59 72 12 26 35 15 10 12




30 - 40 40 - 50 50 - 60
RAT NO. S E LOG os TJIHi LOG S E LOC
1 27 51 46 23 4b 22 32 50 22
2 35 24 16 25 23 14 lb 16 6
3 7 18 52 16 11 28 1 1 0
4 13 31 57 19 51 72 0 4 53
5 23 55 49 15 44 54 8 44 85
6 21 37 50 44 30 - 28 22 36
7 14 45 8b 10 12 24 14 4 8
8 12 bl 93 32 18 35 34 5 16
9 REC0RJ I T ^T?\Tn. ——JLlN Or
10 20 22 7 2 9 27 32 25 31
11 33 49 35 20 46 40 18 19 9
12 33 37 47 2b 33 49 16 19 17
13 15 50 112 16 46 53 2 4 11
14 10 16 26 14 20 19 43 4 3
15 21 27 24 29 26 28 23 26 30
TABLE 26; Behavioural responses of animals with 6-hydroxy-
dopamine (bOHLA)-induced lesions of the accumbens
nuclei following administration of 1 ml/kg +
physiological saline i.p. (lor mean responses -




0 - 10 10 - 20 20 - 30
RAT NO. 3 Li LOC S E LOG S E LOC
1 52 54 24 35 25 10 41 23 9
2 15 4b 23 8 13 13 5 6 3
3 20 61 61 21 27 20 21 11 7
4 17 58 85 8 5 8 34 24 23
5 24 77 57 22 48 42 15 21 7
6 17 43 44 22 14 19 36 14 3
7 14 54 76 25 36 24 12 25 45
8 28 4c 35 37 42 53 23 23 37
9 24 71 117 23 52 65 28 3 5
10 19 52 58 29 23 22 19 18 19
11 18 41 72 22 22 15 20 16 37
12 17 41 42 16 15 29 12 5 6




30 - 40 40 - 50 50 - 60
RAT NO. S TTIEi LOG S T7Ei LOG 3 E LOG
1 47 20 14 45 20 13 48 25 15
2 9 11 21 6 11 6 3 3 7
3 8 12 9 10 7 6 13 8 9
4 20 11 4 31 16 12 22 10 6
5 15 21 - 18 14 12 24 20 10
6 22 13 8 15 12 5 17 11 16
7 25 13 26 21 16 28 17 23 13
8 34 16 22 42 11 18 34 9 36
9 34 11 22 29 13 25 42 9 28
10 21 12 8 24 12 18 29 13 19
11 21 13 43 34 11 69 13 21 17
12 11 12 24 8 2 21 17 4 24
13 10 11 3 12 17 27 11 6 0
TABLE 271 Behavioural responses of animals with 6-0HBA-
induced lesions of the caudate putamen nuclei
following administration of 1 ml/kg physiological
saline i.p. (For mean responses - S.E.M. see




0 - 10 10 - 20 20 - 30
RAT NO. s E LOO s T*Hi LOG S E LOG
1 7 44 45 5 6 6 16 14 8
2 4 29 36 1 6 23 2 10 11
3 20 22 57 12 5 10 22 5 3
4 5 36 98 4 10 52 12 0 8
5 8 15 33 IS 23 39 1 3 19
6 28 44 27 26 18 119 22 14 34
7 11 19 69 4 8 21 0 5 10
8 14 14 29 11 6 11 5 9 20
9 16 19 86 13 12 35 2 7 24
10 7 21 65 0 2 29 1 2 0
11 0 7 29 9 4 16 0 3 10
12 3 6 25 0 5 11 2 1 3




30 - 40 40 - 50 50 - 60
RAT NO. C!O E LOO cnO •51Hi LOO 3 E LOO
1 23 11 1 12 14 3 6 26 43
2 8 4 4 2 2 5 4 5 6
3 32 1 2 24 6 12 17 10 0
4 8 7 25 6 6 29 14 3 4
5 16 10 28 23 31 11 19 8 4
6 15 16 20 28 9 75 28 16 13
7 0 3 12 6 4 19 4 3 19
8 6 2 15 14 4 16 0 0 0
9 7 4 16 8 9 31 8 3 4
10 0 5 2 1 3 2 12 1 0
11 5 o 18 3 1 0 3 5 17
12 4 13 6 3 4 4 6 9 7
13 37 6 14 26 0 37 13 7 4
TABLE 2S: Behavioural responses of animals with sham lesions
of the aceumben3 and caudate putamen nuclei
following administration of 4 mg/kg+BI>amphetamine
sulphate i.p. (For mean responses - S. J.LI, see




0 1 s 0CM1or~1 20 - 30
RAT NO. s •nill IOC s E LOC S E LOC
1 15 79 80 28 112 50 83 145 124
2 60 50 23 48 132 60 43 100 83
3 35 48 28 80 69 35 131 112 29
4 13 85 53 40 111 51 32 134 46
5 13 77 86 21 86 100 28 72 131
6 7 44 70 17 62 91 8 26 40
7 10 97 121 11 167 136 56 122 171
8 55 20 102 58 43 53 207 39 21
9 30 89 26 36 102 18 73 75 5
10 14 44 47 24 86 56 44 103 79
11 10 25 13 30 58 41 57 152 114
12 14 109 63 27 100 44 21 97 85
13 3 97 67 12 105 85 6 136 151
14 11 68 99 7 40 91 65 68 90




30 - 40 40 - 50 50 - 60
RAT NO. S E LOC S S LOC 3 7?Jul LOC
1 128 74 57 195 0 0 309 0 0
2 19 84 157 54 75 158 36 59 152
3 186 111 61 186 112 32 210 128 39
4 42 246 98 107 202 115 152 196 88
5 46 122 157 75 150 144 108 138 145
6 18 28 85 35 58 39 28 71 96
7 159 93 120 210 82 53 2o0 65 87
8 247 23 5 224 31 8 240 30 10
9 154 23 16 223 10 0 167 35 0
10 27 115 152 78 38 127 54 99 166
11 36 193 59 53 258 71 80 201 96
12 46 142 88 37 149 91 48 167 101
13 6 lb 2 112 7 I85 126 6 200 129
14 109 93 115 83 112 123 112 137 127
15 26 46 41 35 55 57 30 45 47
IABL3__22: Behavioural responses of animals with 6-0HBA-
induced lesions of the accumbens nuclei following
administration of 4 mg/kg ^L-amphetamine sulphate





0H1o 10 - 20 20 - 30
RAT NO. s J2t LOG S V±J L0C s E LOC
1 28 45 28 53 38 11 84 22 9
2 19 53 42 71 42 21 71 42 21
3 24 27 15 73 18 0 96 3 0
4 5 12 38 7 17 64 76 62 40
5 14 53 84 20 45 91 24 86 75
6 19 56 41 21 29 24 89 34 20
7 28 43 48 43 65 44 104 68 36
8 41 37 38 111 18 18 141 23 23
9 19 58 74 28 61 70 50 59 49
10 55 48 26 81 12 1 98 13 38
11 35 62 61 185 20 21 151 62 2
12 24 35 28 72 5 15 90 4 4




01o 40 - 50 50 - 60
RAT NO. oo E LOG aO E LOG 5 E LOG
1 80 15 9 67 15 25 77 15 12
2 119 26 7 96 34 16 115 21 55
3 164 2 0 158 2 0 152 0 0
4 93 45 41 73 34 34 53 18 28
5 73 100 120 43 115 126 141 90 92
6 90 58 14 76 57 41 53 76 30
7 114 50 21 118 76 32 155 51 43
3 129 23 45 150 20 31 131 14 16
9 83 73 24 37 46 7 82 36 87
10 lib 4 0 126 0 0 106 9 8
11 110 145 84 184 63 54 243 16 85
12 57 20 13 80 15 28 77 9 4
13 113 5 2 150 0 0 131 1 0
TA3L.3 30i Behavioural responses of animals with 6-0I1DA-
induced lesions of the caudate-putamen nuclei
following administration of 4 mg/kg JL-amphetamine
sulphate i.p. (For mean responses - S.J.M. see




0 - 10 10 - 20 20 - 30
RAT NO. 5 77Ml LOG 0 77JU LOG S E LOG
1 3 33 30 12 33 30 5 50 35
2 1 5 100 5 9 135 6 8 134
3 16 45 73 29 36 78 22 35 91
4 9 24 112 7 42 125 9 35 105
5 13 28 63 9 66 94 19 52 61
6 9 36 56 12 5o 74 17 58 69
7 7 16 40 13 37 70 70 64 98
8 20 65 102 17 64 83 19 42 103
9 7 13 54 0 4 81 1 3 67
10 3 11 27 4 11 55 12 23 58
11 1 1 8 0 0 0 0 1 5
12 13 11 20 8 13 101 0 10 173




30 - 40 40 - 50 50 - 60
RAT NO. S 17 LOG 3 77XJk LOG 3 3 LOG
1 8 59 32 10 57 37 19 38 16
2 4 4 99 4 3 68 8 5 52
3 15 34 55 15 39 55 17 25 33
4 9 42 116 12 35 122 9 23 82
5 23 45 56 27 54 57 15 44 103
6 25 70 71 20 62 79 21 70 50
7 102 77 193 130 80 106 141 86 115
8 15 54 121 19 42 39 13 52 64
9 <£- 0 0 45 0 0 64 0 0 44
10 14 24 o6 13 28 70 15 19 60
11 0 0 0 2 1 10 0 5 12
12 2 10 300 1 7 3o3 4 14 339
13 0 0 0 0 1 5 0 1 4
TABLIS 31t Behavioural responses of animals with sham lesions
of the caudate-putamen nuclei or aceumbens nuclei
following administration of 16 mg/kg DL-amphetamine
sulphate i.p. (For mean responses - S.E.M. see




0-10 10 - 20 20 - 30
RAT NO. s ■qi LOC s E LOG s E LOC
1 166 64 45 211 85 0 266 91 0
2 158 41 - 312 40 - 330 34 mm
3 147 57 7 531 0 0 584 0 0
4 109 71 21 529 0 0 400 0 0
5 215 47 26 400 2 2 470 30 1
6 4o 83 68 182 101 97 242 6 37
7 137 45 168 567 0 0 514 0 0




40 14 14 173 0 20 210 2 9
110 147 52 210 0 0 145 65 0
12 25 77 49 198 183 86 289 163 75
13 15 122 90 460 48 16 327 32 21
14 103 41 65 624 0 22 663 0 0




30 - 40 40 - 50 50 - 60
RAT NO. 00 7?U LOO S E LOC s E LOG
1 202 33 0 52 0 0 0 0 0
2 301 17 - 150 22 - 18 6 mm
3 324 0 0 123 0 0 15 0 0
4 111 0 0 183 0 0 318 0 0
5 282 16 10 352 49 33 339 46 46
b 4 1 0 11 2 8 2 2 5
7 308 0 0 578 0 0 169 0 0




169 0 0 115 0 0 188 3 0
52 32 0 72 16 0 4 2 83
12 490 72 32 261 4 21 220 0 0
13 157 44 35 229 35 17 239 6 3
14 587 0 0 354 0 0 34 2 0
15 378 0 0 304 0 0 38 0 0
TABLE 32: Behavioural responses of animals with b-OKDA-
induced lesions of the aceumbens nuclei following
administration of 16 mg/kg j^L-amphetamine sulphate





0 - 10 10 - 20 20 - 30
RAT NO. s 2 LOO Qo -7101 LOO s 3 LOC
1 76 83 54 479 15 14 102 9 11
2 132 42 67 275 6 3 361 1 0
3 150 12 20 368 0 0 183 0 0
4 60 57 103 51 3 3 0 0 3
5 273 89 111 492 0 0 531 0 0
6 50 93 58 78 51 21 162 19 0
7 176 60 73 229 2 0 78 29 0
8 108 40 34 3o5 0 0 229 1 10
9 73 66 o5 121 95 72 236 50 34
10 130 59 7 348 4 0 303 0 0
11 154 36 48 286 0 0 385 0 0
12 320 12 28 345 0 0 40 0 0




30 o-s-t 40 - 50 50 0vo1
RAT NO. S 3 LOO S 3 LOO 3 7^xU LOO
1 178 41 16 321 35 18 20 4 6
2 304 0 0 291 0 0 156 0 0
3 81 0 0 33 0 0 2 0 0
4 20 1 0 168 1 0 109 0 0
5 55 0 0 5 0 0 4 0 0
0 293 0 0 271 4 0 226 14 9
7 197 2 0 331 0 0 52 0 0
3 80 0 0 144 0 0 57 0 0
9 317 9 19 228 8 21 230 1 0
10 115 0 0 4 0 0 0 0 0
11 478 0 0 493 0 0 494 0 0
12 0 0 0 0 0 0 0 0 0
13 174 1 0 183 0 0 84 0 0
TABLE 33i Behavioural responses of animals with 6-OEDA -
induced lesions of the caudate-putaaen nuclei following
administration of 16 mg/kg PL-amphetamine sulphate





0-10 H0 1 roo 20 - 30
RAT NO. s 3 LOG 3 3 LOG S -n\i LQC
1 24 61 83 22 102 182 31 113 183
2 0 9 84 0 5 202 6 2 205
3 9 40 - 13 59 106 7 81 39
4 7 59 120 3 52 149 3 44 151
5 85 80 79 75 63 48 26 136 38
6 26 64 122 39 62 81 19 31 4
7 7 27 34 91 27 17 56 23 0
8 12 29 32 36 9 17 22 31 17
9 19 58 50 18 90 50 9 16 10
10 25 27 31 30 33 39 37 37 58
11 0 0 0 1 2 1 6 2 8
12 0 4 339 0 0 267 1 6 308




01o 40 - 50 01otn
RAT NO. S 1?u LOG 3 Jl LOG S T»A LOG
1 21 121 19o 18 156 206 11 113 190
2 4 10 143 2 8 87 0 3 79
3 5 68 38 11 77 33 7 55 4
4 6 36 171 4 49 177 8 43 184
5 41 136 70 31 109 82 33 110 114
b 35 7 22 56 0 4 30 0 58
7 99 20 0 92 27 0 145 6 0
8 73 14 26 34 18 6 8 O 3
9 3 12 0 7 17 9 17 32 12
10 37 32 42 41 36 19 65 13 80
11 11 5 12 8 4 0 3 0 0
12 3 11 336 1 5 352 4 8 384
13 2 2 1 4 0 8 0 0 2
TA3Lj 34: Behavioural responses of nialamid e-pretreated rats
"
following bilateral injection of 1 ul physiological
saline into the accumbens nuclei. (For mean




0 - 30 30 - 60 60 - 90 90 - 120
RAT NO. s 7?Jj LOG 3 ud LOG 3 7?U LOG 3 E LOC
1 2 13 2 0 0 0 5 6 9 0 0 0
2 2 9 16 13 4 0 2 3 0 0 0 5
3 39 37 51 42 27 25 62 41 33 39 45 43
4 14 7 128 10 6 4 9 3 0 4 9 12
5 4 3 11 2 6 3 2 1 1 4 0 0




120 - 150 150 180 180 - 210 210 - 240
HAT NO. 3 T*ill LOG Qkj E LOG 3 E LOG 3 E LOC
1 0 0 0 0 1 0 0 1 2 4 2 0
2 1 1 40 1 3 19 10 1 0 29 26 36
3 27 15 29 8 3 28 20 10 28 24 7 33
4 18 4 0 5 2 0 17 5 0 0 0 0
5 5 2 16 15 1 5 3 5 4 4 0 0




240 - 270 270 300 300 - 330 330 - 360
RAT NO. 3 3 LOG 3 E LOG 3 E LOC 21 E LOC
1 12 7 4 6 9 2 8 10 3 16 15 5
2 0 1 1 0 1 1 28 26 68 3 7 11
3 17 15 12 64 6 10 21 10 3 39 30 6
4 6 7 0 3 5 0 0 0 0 10 11 13
5 6 1 0 5 2 50 25 0 0 24 0 0




360 - 390 390 - 420 420 - 450 450 - 480
RAT NO. S E LOG s E LOG 3 E LOG 3 E IOC
1 40 2 2 63 26 9 27 3 0 2 3 12
2 5 1 0 46 31 49 17 21 32 23 14 9
3 19 7 23 38 b 0 83 25 22 75 48 67
4 2 3 5 12 10 40 24 34 15 16 23 12
5 27 17 13 lb 6 0 11 18 3 52 9 5





480 510 510 - 540 540 570 570 - 600
RAT NO. 3 E LOG 3 3 LOG 3 S LOC S 3 LOC
1 110 24 51 38 5 0 51 27 15 14 0 1
2 56 25 27 3 0 77 10 9 5 82 51 15
3 78 54 45 36 6 36 16 3 11 47 52 80
4 0 1 0 37 55 23 11 17 14 22 2 63
5 65 8 4 42 13 3 41 6 6 41 1 0
6 18 5 5 27 17 44 6 1 8 0 0
TABLS_3£: Behavioural responses of nialamide-pretreated rats
following bilateral injections of 5 Jig dopamine
hydrochloride into the accumbens nuclei. (For




0 - 30 0 1 O'.o 60 - 90 90 - 120
BAT NO. s E LOO S X1 LOG S 7?Jml LOC S E LOC
1 30 50 77 31 21 37 80 122 101 211 329 144
2 22 17 33 7 30 38 26 71 75 17 351 290
3 40 29 23 9 20 26 33 227 255 48 421 432
4 11 26 19 24 93 51 29 187 106 39 237 206
5 19 59 60 63 90 135 16 22 22 15 32 31
6 2 12 43 19 52 49 26 106 61 71 165 124




120 - 150 150 - ISO 180 - 210 210 - 240
RAT NO. S *T?Hi LOG S E LOG S E LOC S T?I2i LOC
1 139 374 244 262 147 229 126 123 279 79 96 237
2 23 663 416 15 896 387 16 1021 405 12 1051 471
3 21 545 6b2 16 559 384 23 453 717 51 247 234
4 90 271 159 124 235 89 150 233 52 109 214 71
5 34 30 10 17 12 22 38 13 28 55 15 27
6 45 120 99 27 66 51 3 13 5 3 10 12




240 - 270 270 - 300 300 - 330 0v.orO1Orn
RAT NO. S E LOG u T?Jj LOG S E LOC s E LOC
1 99 187 178 97 261 263 124 265 229 79 186 248
2 lb 1106 591 24 978 490 63 598 204 36 149 114
3 24 67 48 37 60 84 9 3 1 31 35 29
4 178 203 87 114 254 191 111 195 12 b 130 261 113
5 17 12 71 53 32 80 28 29 104 89 25 87
b 0 0 0 1 3 1 11 21 17 1 0 17





360 390 390 • 420 420 - 450 450 - 430
RAT NO. s E LOC s T?£* LOG s I LOC S E LOC
1 39 103 200 109 127 220 91 71 181 125 56 156
2 39 131 102 15 23 111 15 22 4 8 3 11
3 67 23 31 17 6 40 65 1 14 22 3 16
4 59 34 14 19 36 33 3 1 3 1 0 0
5 44 36 77 31 26 13 69 29 19 45 19 21
6 10 9 22 22 10 73 19 24 21 14 27 33




480 510 510 - 540 540 570 570 - 600
RAT NO. ob E LOG S T?Li LOC oo E LOC s E LOC
1 139 96 84 132 44 57 202 52 29 85 12 13
2 19 12 4 12 46 47 13 4 12 6 11 13
3 40 25 54 44 16 10 1 1 3 30 18 46
4 2 0 0 17 15 10 6 12 9 4 1 20
5 102 53 74 12 7 7 7 1 9 44 4 26
6 0 0 7 9 19 49 1 1 21 21 27 51
7 1 1 0 3 6 5 9 14 55 2 10 28
TABLID 36: Behavioural responses of nialamid e-pre treated rats
following bilateral injection of 12.5 MS dopamine
hydrochloride iigto the accumbens nuclei. (For




0 - 30 30 - 60 60 - 90 90 - 120
RAT NO. 3 JmJ LOC 3 7?all LOG 5 E LOG S E LOG
1 23 101 136 80 114 325 153 312 558 101 541 714
2 6 24 14 30 90 110 43 296 263 59 623 654
3 2 8 13 4 22 20 9 61 91 13 43 97
4 15 103 191 13 49 111 22 136 211 43 444 507
5 21 71 72 47 121 70 40 282 176 39 415 283
6 24 35 48 4 2 11 0 0 1 36 85 67




120 - 150 150 - 180 180 - 210 210 - 240
RAT NO. s 3 LOG S S LOG S E LOG 3 E LOG
1 56 453 882 36 482 1101 38 439 1116 31 354 1205
2 31 643 929 74 755 1195 78 704 1155 116 736 1210
3 28 121 628 27 2 53 329 82 461 524 123 545 727
4 52 635 742 27 613 890 19 574 986 20 394 1001
5 60 524 387 89 713 514 57 778 573 56 731 776
6 105 192 223 109 269 436 95 172 277 71 174 343




240 - 270 270 - 300 300 - 330 330 - 360
RAT NO. S 3 LOG S E LOG S E LOC s E LOC
1 40 411 971 40 357 882 56 369 799 74 335 82 5
2 80 816 1054 43 742 1006 50 782 732 25 187 168
3 70 607 740 94 635 737 104 531 517 83 364 349
4 16 350 758 10 56 262 0 0 42 7 10 133
5 80 768 741 71 659 767 5o 509 435 82 266 307
6 40 80 162 32 25 112 27 29 113 5 9 51





3bO 0cn1 390 - 420 420 - 450 450 - 480
HAT NO. S s LOG s IS LOG TPmU 10C S S L0C
1 58 322 676 48 296 561 39 215 572 30 247 562
2 109 167 122 51 13 254 19 8 181 46 58 80
3 18 21 87 8 9 96 10 11 150 11 17 117
4 0 1 21 0 0 3 1 3 8 5 1 3
5 37 87 145 42 67 127 16 24 97 24 23 70
6 33 28 86 28 28 111 56 25 146 91 55 113




430 510 510 _ 540 540 - 570 570 - 600
RAT NO. oO 3 LOG S B L0C S £ 10C S 3 LOC
1 55 258 392 68 200 617 72 191 425 97 117 205
2 32 17 41 52 31 25 28 8 32 0 0 0
3 4 11 72 14 48 112 3 1 6 0 0 0
4 5 2 0 9 10 70 2 2 29 0 0 0
5 35 31 47 84 37 89 42 4 lb 21 0 0
6 38 29 93 29 33 124 13 46 103 4 11 13
7 4b 38 126 49 41 54 9 1 1 60 57 45
J
TABL3_37i Behavioural responses of nialamide-pretreated rats
following bilateral injection of 25 jug dopamine
hydrochloride into the accumbens nuclei. (For




0 - 30 o » oo 60 - 90 90 - 120
EAT NO. 3 S LOC 3 S LOC 3
T-1
Li LOC 2 S LOC
1 6 42 19 5 39 20 14 59 25 28 128 152
2 0 0 10 9 27 9 30 97 34 26 107 18
3 37 71 21 8 55 9 39 232 7 33 331 95
4 14 47 82 22 103 92 51 244 189 84 360 288
5 0 0 - 20 67 43 42 242 130 58 549 264




120 - 150 150 - 180 180 - 210 210 - 240
EAT NO. 3 -r»Li LOC s 2 LOC S E LOC S S LOC
1 53 261 400 72 361 446 52 296 298 44 246 556
2 34 427 100 15 4o4 162 10 373 108 14 437 175
3 21 398 15b 21 507 190 39 540 167 29 561 124
4 85 494 453 71 481 557 55 524 716 77 530 734
5 38 779 392 34 674 427 20 809 489 29 704 -




240 - 270 270 - 300 300 - 330 330 - 360
RAT NO. 3 T?L LOC S E LOC 3 3 LOC S 7?-Ul LOC
1 70 330 281 69 269 323 73 285 312 80 260 391
2 15 511 180 16 295 120 19 84 20 7 16 40
3 25 450 61 23 244 25 33 61 14 30 66 2
4 67 46 9 859 40 462 888 34 492 885 4b 511 873
5 18 663 577 18 742 722 IS 291 381 24 126 179





360 — 390 390 420 420 450 450 - 480
RAT NO. S MJ IOC s T*& IOC S Jul LOC 3 3 IOC
1 74 272 401 59 217 342 47 161 125 27 56 30
2 92 121 21 0 0 0 2 3 16 7 4 0
3 80 38 5 72 47 4 20 8 0 60 40 14
4 74 440 514 91 507 340 99 490 311 69 243 179
5 1 18 169 16 22 82 142 86 73 53 86 94




430 510 510 - 540 540 570 570 - 600
RAT NO. s 3 IOC s -rj» LOC s 3 IOC s E LOC
1 14 21 46 22 31 50 1 0 0 4 10 22
2 15 18 10 2 10 16 2 2 0 5 3 4
3 45 26 14 26 16 2 32 4 1 20 0 54
4 27 133 266 8 3 61 7 24 81 10 19 39
5 77 38 - 85 44 93 36 12 14 3 0 1
6 106 13 10 108 6 5 126 6 0 L35 0 0
SABLI 38: Behavioural responses of nialamide-pretreated rats
following bilateral injection of 50 )xg dopamine
hydrochloride into the accumbens nuclei. (for




0 - 30 o01or*~> c0 1 VDo 90 - 120
RAT NO. 3 E LOG S Tp LOG 3 S LOG s E LOC
1 37 50 55 61 412 159 29 670 684 29 711 459
2 5 6 11 46 153 99 38 217 148 60 416 245
3 lb 26 29 12 94 289 22 230 464 35 408 725
4 25 105 96 47 181 120 16 220 300 16 373 CDCDCM
5 30 112 57 20 40 104 29 42 159 35 76 40




120 - 150 150 - 180 180 - 210 210 - 240
RAT NO. 5 Tpu LOG S Hi LOC 3 E LOC S S LOC
1 13 788 - 36 78b 691 42 492 60b 52 392 mm
2 7b 455 340 118 bl7 510 87 773 589 156 766 539
3 3b 718 786 13 756 - 15 CD ro CD 1012 19 627 1120
4 11 674 974 7 768 434 9 857 53b 10 734 565
5 37 115 133 36 269 127 69 313 90 67 480 81




240 - 270 270 - 300 300 - 330 330 - 360
RAT NO. s 3 LOG 3 3 LOG C3o E LOC s E LOC
1 24 204 1002 40 287 755 60 407 6.08 113 568 619
2 213 881 538 204 795 661 i\? VJl CO 700 710 236 669 615
3 28 253 1078 32 237 973 72 344 - 66 374 873
4 50 747 423 40 420 977 37 430 486 49 307 230
5 79 633 73 52 849 97 49 818 136 64 950 153





3oO - 390 39C - 420 42C - 450 450 000-=J-1
RAT NO. s E LOG s T*-1 LOG S ryJul LOG 3 E LOG
1 138 411 5b7 171 488 - 178 511 548 81 343 484
2 239 404 404 255 272 227 287 196 217 80 51 120
3 TO 52 5 6b4 99 469 501 121 200 180 99 150
4 7 17 101 28 51 49 8 45 64 1 2 38
5 38 66b 133 94 676 121 113 500 126 57 232 134




430 - 510 51C - 540 54C - 570 570 - 600
RAT NO. S ■n LOG S E LOG S S LOG s S LOG
1 48 146 330 68 93 193 116 70 133 85 53 114
2 87 58 41 104 3 20 58 2 49 0 1 0
3 94 48 - 76 25 137 20 15 - 44 41 722
4 6 24 33 19 3 48 6 4 27 8 6 15
5 109 117 65 209 35 9 129 32 107 71 35 9
6 108 137 270 27 44 168 12 19 97 1 1 31
TABLE 39? Behavioural responses of nialamide-pretreated rats
following bilateral injection of physiological
saline into the caudate-putamen. (For mean responses




0-30 30 — 50 60 90 so - 120
PH3 S2|o * 3 ■*? LOC s Jj LOC 3 3 LOC S E LOC
1 5 26 39 10 9 0 17 20 5 4 14 3
2 9 18 21 32 16 0 29 0 0 28 10 0
3 3 18 69 0 0 0 10 0 0 14 3 23
4 9 23 mm 42 12 2 32 13 15 31 3 2
5 8 33 37 9 25 2 32 33 104 17 29 11




120 - 150 150 180 180 .» 210 210 - 240
RAT NO. 3 3 LOC S *njj LOC s 3 LOC S E LOC
1 10 9 4 10 4 6 18 17 41 40 33 15
2 82 0 0 26 0 0 17 0 0 19 0 0
3 7 0 0 5b 0 0 7 2 0 10 4 0
4 107 22 15 41 26 31 30 0 1 66 2 2
5 19 15 3o 0 1 10 8 8 11 14 11 2




240 - 270 270 300 300 mm 330 330 - 360
RAT NO. 3- 3 LOC 3 7ii LOC S 7 LOC s 3 LOC
1 21 12 8 36 18 3 27 16 2 1 0 0
2 18 0 0 79 2 0 185 0 0 90 5 0
3 5 3 1 21 0 2 44 19 0 45 24 1
4 32 0 0 88 2 3 64 19 41 40 10 32
5 31 15 10 41 37 33 30 20 38 32 39 26





360 390 390 • 4-20 420 4-50 450 - 480
RAT NO. 3 3 LOG S u IOC S "T7JU LOG S S LOC
1 61 46 15 56 27 23 33 19 30 52 4=- OJ CO
2 103 4 1 70 5 0 19 0 0 17 4 0
3 17 10 0 7 3 0 5 11 2 17 5 0
4 69 8 11 73 14 11 96 15 12 118 31 45
5 39 2 1 48 31 10 33 35 43 37 45 6




430 - 510 510 mm 540 540 mm 570 570 - 600
RAT NO. 3 T?■j LOG S 77u LOC S 3 LOG s 3 LOC
1 47 27 59 58 18 32 15 13 27 22 7 2
2 1 0 0 2 0 0 0 2 0 6 0 0
3 11 5 0 28 10 0 60 12 1 27 4 0
4 111 27 65 76 26 87 66 33 29 56 36 39
5 28 41 15 60 16 8 5 4 12 3 0 9
6 49 34 72 60 50 97 18 28 34 2 6 8
TABL3 40' Behavioural responses of nialamide-pretreated rats
following Bilateral injection of 11.5 PS dopamine
hydrochloride into the caudate-putamen. (For mean




0 - 30 30 - 50 60 90 90 - 120
RAT NO. r*O *n IDC S -n LOC S -r*Smi LOC 3 3 LOC
1 13 18 56 18 14 mm 42 14 96 187 147 158
2 21 75 83 113 82 38 214 229 145 474 246 262
3 32 95 30 145 56 30 175 81 28 187 27 56
4 9 2 63 114 44 173 69 29 423 91 48
5 3 6 19 15 11 5 65 26 15 59 7 2
6 4 9 38 16 11 9 29 27 28 68 27 9
7 12 V 2 23 r. c- e
*•%




120 - 150 150 130 130 mm 210 210 - 240
RAT NO. S tt».1/ 10c S 3 LOC s s LOC 3 3 LOC
1 146 46 - 317 71 193 595 124 185 692 98
2 586 153 81 543 114 38 592 102 14 574 85 21
3 64 5 19 115 19 34 64 27 35 49 24 127
4 915 57 132 281 11 60 552 12 13 647 7 26
5 230 12 46 204 2 63 309 8 19 244 56 95
6 96 38 23 85 54 64 88 28 48 12 10 44




240 - 270 270 300 300 330 330 - 360
RAT NO. S 3 LOC S 3 LOC c*O 3 LOC s 3 LOC
1 552 42 89 497 13 89 303 43 100 201 37 119
2 728 150 55 549 113 27 13 0 0 3 4 5
3 62 16 21 71 29 24 65 15 65 40 8 45
4 63 2 13 206 11 37 142 10 85 141 18 17
5 134 20 51 36 8 10 105 42 141 57 29 50
6 65 35 74 15 14 1 96 39 39 79 32 53





360 «** 390 390 - 420 420 - 450 450 - 480
RAT NO. s E LOG S S LOG 3 JSi LOG S T»Jj LOC
1 133 0 7 120 33 37 64 53 90 58 51 47
2 108 13 8 10 0 0 50 10 47 27 3 8
3 40 6 28 62 11 23 33 19 56 61 19 40
4 82 0 0 59 17 15 22 16 25 21 14 15
5 6'5 36 52 47 41 103 54 27 41 54 36 87
6 25 12 12 4c 35 33 21 18 42 37 28 29




480 510 510 — 540 540 mm 570 570 - 600
RAT NO. S S LOG S Hi LOG S TJI-HI LQC s xa LOC
1 60 23 41 44 24 45 25 34 25 26 34 63
2 25 5 17 30 25 24 25 5 3 21 10 12
3 56 17 24 21 0 0 41 10 43 18 4 29
4 24 2o 29 9 11 12 4 4 9 12 21 62
5 65 34 68 20 6 17 24 22 61 3 3 9
6 33 34 47 47 34 44 43 31 74 56 26 75
7 27 33 10 11 2 0 18 21 15 6 4 11
TABLE 411 Behavioural responses of nialanide-pretreated rats
following bilateral injection of 25 Jig dopamine
hydrochloride into the caudate-putamen. (for mean




0 - 30 30 - JO 60 90 9C 120
RAT NO. s '*?J LOG s E LOG 3 E LOG s "7JJ LOC
1 9 13 50 19 29 9 74 104 15 117 34o 22
2 45 119 31 132 80 83 168 108 109 320 153 146
3 14 23 10 32 43 19 122 106 32 400 120 75
4 3b 37 29 113 56 54 171 83 65 225 114 108
5 33 31 45 233 34 9 215 139 20 206 162 30




120 - 150 15C - 180 180 - 210 21C - 240
RA.T NO. S E LOG 3 3 LOO S Li LOG S S LOC
1 76 463 11 91 427 50 186 432 142 213 428 163
2 202 200 lbO 118 162 208 115 19b 245 353 223 192
3 298 434 175 490 338 2o3 1268 52 26 1433 15 8
4 316 155 129 311 126 156 340 96 190 321 107 31
5 202 133 19 271 147 21 264 167 123 530 97 88




24C - 270 270 — 300 300 330 33C - 360
RAT NO. oO -Jj LOG S r» LOC r»O T?aJ LOG S -ri LOC
1 219 371 160 259 322 101 337 369 156 581 348 144
2 399 194 207 461 153 130 220 116 177 652 38 100
3 1476 0 0 1756 88 11 1159 76 19 1156 76 5
4 3b4 122 144 337 153 144 450 70 124 467 29 61
5 525 102 75 684 92 59 62 54 752 111 67





360 390 390 mm 4-20 420 «» 450 450 0CO*41
HAT NO. s E LOG 3 3 IOC 3 E LOG 3 3 LOC
1 313 201 74 484 123 31 508 119 55 432 185 71
2 790 23 61 421 94 98 173 62 118 116 22 23
3 1027 42 14 394 29 12 217 14 6 166 17 3
4 462 2 4 362 8 31 365 12 54 298 6 22
5 461 108 62 415 163 102 234 47 53 111 42 76




480 510 510 540 540 570 570 - 600
NAT NO. 3 .12* LOC S 3 LOG S 3 LOG s 3 LOC
1 496 08 29 296 49 61 358 40 18 111 52 100
2 54 20 15 24 5 6 110 41 53 3 6 6
3 105 13 3 82 24 43 53 14 2 43 13 12
4 204 33 35 212 8 46 243 21 15 235 2 0
5 47 10 53 0 0 1 72 60 84 23 6 53
6 78 24 41 168 60 50 79 47 70 101 21 33
TABLG 42 ■ Behavioural responses of nialamide-pretreated rats
following bilateral injection of 50 MS dopamine
hydrochloride into the caudate-putamen. (For mean




0 - 30 30 •— oO 60 90 9C - 120





1 14 18 71 4b 27 31 140 40 13 126 150 100
2 20 19 9 40 76 46 80 54 10 517 49 36
3 24 55 73 60 30 40 398 71 40 b37 55 11
4 20 43 49 86 22 12 94 4b 36 17 9 50 46
5 17 30 28 34 22 54 3ob 143 69 555 355 459




12C - 150 150 180 130 210 21C - 240
RAT NO. S 7?XJ LOG S 7?jJi LOG S -ir*-Uf LOG S 1?-i LOC
1 177 244 297 385 151 158 450 86 69 593 35 40
2 513 20 85 637 97 64 b82 208 128 786 175 70
3 534 157 199 511 258 256 820 19b 47 1174 99 86
4 786 8 0 638 74 22 695 39 77 820 5 1
5 532 423 547 656 426 344 521 598 581 807 570 527




240 - 270 270 mm 300 300 330 330 360
iiAT NO. S J LOG S B LOG r«o +J LOC O 3 LOC
1 611 59 81 b37 35 45 574 93 173 732 130 128
2 7o4 131 - 1113 204 57 913 284 183 759 370 165
3 1422 18 19 1445 0 14 1043 0 0 924 2 15
4 b45 20 23 7bb 42 23 973 33 7 705 82 67
5 786 611 453 72 5 357 721 596 313 280 944 192 63





360 390 390 - 420 420 — 4-50 450 - 480
RAT NO. S B LOG s 3 LOG S ■J LOG S 3 LOC
1 637 133 144 454 137 231 459 73 175 349 119 256
2 5d6 375 130 604 333 121 386 405 145 309 186 89
3 1592 18 92 1571 27 94 1651 0 0 858 46 93
4 590 81 66 564 176 106 562 117 57 547 227 79
5 824 108 68 67 6 135 155 504 105 171 126 55 131




480 — 510 510 - 540 540 570 570 - 600
RAT NO. 3 E LOG 3 13 LOG 3 S LOG 3 E LOC
1 420 121 160 64 9 25 64 26 151 0 0 0
2 207 130 76 164 115 124 110 53 66 87 61 79
3 589 87 121 475 140 104 400 94 35 166 120 156
4 439 245 96 425 597 218 565 393 155 612 45 24
5 76 83 112 14 1 18 26 23 49 1 1 0
6 105 28 248 30 5 4 63 Id 36 23 2 58
TABLE 43? Behavioural responses of nialamide-pretreated rats
following bilateral injection of 5°)fd L-noradrenaline
hydrochloride into the accurabens nuclei. (for mean




0 - 30 30 — oO 60 90 90 - 120
RAT NO. s S LOG s 3 LOC S T>Hi LOG s E LOG
1 38 93 112 36 65 61 85 57 94 45 60 84
2 17 32 mm 9 16 42 29 21 51 26 27 37
3 20 67 121 17 67 76 25 73 158 20 98 107
4 8 23 20 4 12 11 4 8 17 3 6 0




120 - 150 150 180 180 210 210 - 240
RAT NO. S 3 LOG S 7?U LOG s S LOG s 3 LOG
1 34 40 119 31 87 129 17 71 127 9 76 134
2 11 32 92 26 27 46 8 25 - 26 25 21
3 26 103 185 11 98 180 14 59 137 14 35 107
4 4 1 13 1 0 0 1 0 3 3 4 5




240 - 270 270 300 300 330 330 - 360
RAT NO. S 3 LOG 3 li LOG 0O S LOG S 3 LOC
1 6 36 12 5 35 24 3 42 22 5 16 12
2 16 2 48 10 9 17 12 9 3 4 7 10
'
3 10 35 103 9 12 52 0 11 13 6 18 27
4 2 0 22 14 17 11 8 4 0 2 10 2




360 - 390 390 mm *20 420 - 450 450 - 480
RAT NO. S Hi LOG S •Q-J LOG s *r»Xj LOG S 3 LOG
1 6 12 16 1 4 22 1 0 2 2 3 7
2 6 6 10 5 24 8 5 16 12 1 21 22
3 1 2 12 7 9 25 3 6 37 2 7 43
4 1 1 0 10 8 4 11 13 14 7 11 22





480 510 510 540 540 570 570 - 600
RAT NO. s "PU LOG 3 E HOC 3 E LOG 3 S IOC
1 1 1 9 0 3 4 1 1 0 6 3 0
2 4 16 1 5 7 8 6 7 7 11 13 21
3 1 6 10 0 5 6 1 10 11 5 4 4
4 16 20 34 15 18 28 6 23 30 2 4 7
5 11 12 6 14 15 23 2 3 9 2 3 3
TABLE 44-: Behavioural responses of nialamide-pretreated rats
following bilateral injection of 50 Jig 1-norad¬
renaline hydrochloride into the cauoate-putamen.




0-30 30 - 60 60 30 90 120
RAT NO. S T*JLA LOC s E LOC 3 E LOC S E LOC
1 35 10 27 35 19 70 26 19 25 25 29 65
2 4 2 14 0 0 0 1 0 0 7 8 60
3 5 14 69 19 23 61 13 38 49 15 19 86
4 5 16 - 39 5 4 59 36 54 100 22 -
5 15 13 8 7 2 4 2 10 34 3 3 93
6 35 41 26 68 40 27 23 9 4 19 10 1




120 - 150 150 - 180 130 210 210 240
RAT NO. s T-1.U LOC s TSui LOC s E LOC s E LOC
1 36 49 101 36 57 90 55 67 74 40 64 88
2 21 73 101 31 135 109 117 136 94 224 40 14
3 11 22 47 39 27 44 43 43 54 15 14 39
4 113 11 7 107 9 - 53 1 29 23 4 0
5 7 4 0 27 5 67 53 19 11 17 11 2
6 123 34 20 28 17 21 60 39 17 46 23 10




240 - 270 270 - 300 300 330 330 360
RAT NO. 3 1?JU LOC 3 e LOC 3 e LOC S 3 LOC
1 88 66 76 119 40 52 146 26 14 51 13 20
2 417 59 8 569 34 11 656 32 3 555 58 41
3 10 2 46 25 11 12 16 3 11 28 5 19
4 156 12 - 161 62 - 72 6 31 122 2 89
5 8 10 55 3 4 0 19 33 128 56 23 37
6 59 7 1 87 16 19 80 37 14 161 11 48
7 109 20 91 71 20 51 126 36 59 90 26 49




360 390 390 - 420 420 - 450 450 - 430
HAT NO. 3 S LOG r«O 3 LOG S T?Mi LOC S 3 LOC
1 11 4 3 30 0 30 63 11 132 101 33 14
2 714 57 21 646 29 18 702 0 23 539 62 66
3 14 4 19 37 17 66 49 3 20 74 54 52
4 170 2 77 136 58 53 254 10 73 292 32 50
5 110 34 104 342 107 92 138 64 31 23 0 0
6 175 13 35 48 3 16 98 19 30 64 13 17




480 510 510 540 540 570 570 - 600
HAT NO. 3 S LOG ri3 Mi LOG 3 S LOG 3 3 LOC
1 214 29 28 32 13 26 54 36 35 33 20 14
2 544 55 49 436 44 27 330 45 52 361 49 30
3 130 21 132 38 17 21 50 37 49 47 19 21
4 135 27 107 75 17 67 5 1 11 42 19 71
5 67 79 91 39 20 131 17 6 76 56 53 55
6 52 13 77 15 3 43 23 19 84 188 23 51
7 148 26 68 110 77 157 95 100 124 44 14 118
T/.BL" 45i Behaviour-'1 responses of nialaiaida-pi'atreated rata
following bilateral injection of 50 yx 5-hydroxytryp.tamine
bimaleinate into the accumbens nuclei. (For mean responses




0 -- 30 30 - 60 60 90 90 - 120
HAT NO. 3 j IOC ij % IDC S T*4# r r\ isJV 0/ | o 3 LOC
1 10 28 lOo 18 5o 232 31 26 223 ©4 14 235
c 21 20 2b 131 4o 56 24 40 178 57 8o 257
3 19 13 73 62 29 315 100 3 434 17 4 132
4 9 14 69 20 80 43 42 39 29 77 191 129
3 12 21 41 31 56 102 12 25 152 21 21 165




120 - 150 150 180 180 210 210 - 240
HAT NO. a *3** LOG 3 mt jjG C Q 3 LOG 3 LOC
1 50 43 329 54 193 524 48 258 387 33 83 139
C
c 72 o7 244 49 84 274 27 69 237 20 •>oo104t>CO
3 0 0 12 7 2 12 0 2 9 0 0 0
4 13 75 70 24 45 68 19 20 35 10 3 75
C
✓ 35 51 2 lb 4o 121 202 15 81 123 12 24 91




240 - 270 270 300 300 330 380 - 360
HAT NO. 3 >j» LQC 3 "PU LOC cO 3 LOC 3 3 LOC
1 31 12 25 27 0 0 7o 20 35 84 22 35
2 5 4 112 3 3 31 11 3 13 8 7 19
3 6 0 0 23 10 0 50 40 18 67 31 31
4 18 34 84 29 6 2o 7 0 0 7 26 57
5 12 12 3o 14 3 24 0 0 0 8 8 12





360 390 390 4-20 420 •» £50 450 - 480
RAT NO. s S LOO s S LOO 0 2 LGC 3 S LOG
1 10 1 18 50 18 95 24 26 15 13 1 16
2 39 25 63 13 14 38 29 2b 19 23 19 36
3 46 57 103 10 5 16 16 28 28 18 8 23
4 27 33 14 48 6 18 72 25 18 71 14 15
5 21 16 32 14 15 28 9 3 18 24 2 4




480 a. 510 510 540 540 570 570 - 600
RAT NO. S T-tZi LOO co T"1.j LOG 3 S LOG 3 S LOG
1 7 1 9 18 19 45 8 23 34 7 17 33
2 9 39 45 15 14 38 26 27 60 11 34 55
3 37 28 18 21 8 22 33 21 23 26 12 32
4 63 63 69 104 67 110 47 24 61 16 21 29
5 18 12 32 14 10 32 28 20 30 14 12 24
6 2 1 0 8 0 4 1 0 0 0 0 0
IABL3_4o: Behavioural responses of nialaiaide-pre treated rats
following bilateral injection of 50 jig 5-hydroxy-
tryptamine biinaleinate into the caudate-putamen.




0 - 30 30 - oO 00 - 90 90 - 120
RAT NO. 3 -r*Li LOG s E LOG oo S LOC s E LOC
1 48 131 22 30 72 40 69 150 94 160 86 46
2 54 118 183 49 186 542 21 123 631 30 134 555
3 7 9 14 13 11 51 10 13 9 20 33 24
4 8 2 77 15 46 47 83 31 46 73 16 121
5 38 21 22 7 6 14 12 1 39 60 46 13
6 23 82 93 46 118 52 33 136 87 52 132 45




120 - 150 150 180 130 210 210 - 240
RAT NO. S E LOG S E LOC <—<b E LOG S E LOC
1 97 65 60 118 76 67 198 155 125 164 85 70
2 27 140 662 18 148 578 33 180 515 38 143 401
3 16 46 38 12 31 27 51 41 43 10 18 32
4 57 18 122 72 13 74 27 9 44 61 3 146
5 83 41 1 131 74 9 120 51 18 122 68 56
6 54 53 23 56 83 128 32 42 74 33 9 17




240 - 270 270 300 300 - 330 330 - 360
RAT NO. S 3 LOC s "HIui xD 0 S -rj*Ji LOC S E LOC
1 101 52 75 17 22 22 22 9 14 10 7 7
2 32 56 231 23 35 23 24 31 62 11 15 3
3 74 7 34 38 17 24 10 3 11 1 0 0
4 53 8 116 41 25 88 58 11 105 32 27 69
5 131 47 87 86 87 35 70 101 62 87 99 60
6 23 6 24 16 7 100 29 2 24 17 9 31





360 390 390 «■» 4-20 420 «■» 450 450 - 480
RAT NO. 3 *pj~J LOG s 3 LOG Q mJ LOG E LOO
1 21 34 40 15 16 14 37 43 44 23 26 69
2 15 44 38 28 19 26 13 13 39 13 9 12
3 1 0 11 2 0 0 0 1 70 3 3 2
4 32 17 58 34 0 8 56 30 31 29 10 65
5 101 92 70 61 138 115 120 57 77 113 72 44
6 28 15 25 43 17 21 38 15 25 43 31 54





480 510 510 - 540 540 570 570 - 600
RAT NO. S E LOO 3 E LOG S E LOG 3 S LOO
1 46 23 26 28 15 56 10 7 48 0 2 0
2 5 7 9 3 12 15 2 2 10 1 3 2
3 10 4 4 3 1 2 12 5 17 1 1 0
4 21 10 31 0 1 14 20 15 54 13 18 11
5 94 45 38 57 35 22 51 20 68 39 13 36
6 27 19 15 4o 20 44 51 24 28 39 28 19
7 85 0 10 106 4 41 51 11 20 83 7 9
